<SEC-DOCUMENT>0001628280-22-024751.txt : 20220912
<SEC-HEADER>0001628280-22-024751.hdr.sgml : 20220912
<ACCEPTANCE-DATETIME>20220912165205
ACCESSION NUMBER:		0001628280-22-024751
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		56
CONFORMED PERIOD OF REPORT:	20220731
FILED AS OF DATE:		20220912
DATE AS OF CHANGE:		20220912

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		221239066

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>csbr-20220731.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ec52204b-131e-4198-92e8-02fb9363ce20,g:7d91c0c2-82c1-4c83-ab39-3140ef69ee6c,d:29549160a5144e4580af449aef8108b5--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:csbr="http://championsoncology.com/20220731" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>csbr-20220731</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF8zLTEtMS0xLTE4ODEz_df90eceb-59ca-4101-a626-453dde1f6219">false</ix:nonNumeric><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF82LTEtMS0xLTE4ODEz_85c72ed4-f5a5-40a4-8d05-5a20064eb03d">2023</ix:nonNumeric><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF83LTEtMS0xLTE4ODEz_2287ddf1-ef09-4013-9285-cf79ee05969d">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF84LTEtMS0xLTE4ODEz_406e4708-5291-4976-8de4-6913e019d3fa">0000771856</ix:nonNumeric><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF85LTEtMS0xLTE4ODEz_28e4fa94-ba4f-4185-ba19-656e2b8ae19f">4/30</ix:nonNumeric><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:TypeOfRevenueExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0wLTEtMS0xODgxMw_1a314bab-bc49-462d-9774-0a2a9e532563">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" name="us-gaap:TypeOfRevenueExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0wLTEtMS0xODgxMw_b5d3071c-49b2-43e4-8afd-750cbba73f89">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0wLTEtMS0xODgxMw_24738fed-0e57-44c5-8ac4-6f88cd052e09">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0wLTEtMS0xODgxMw_4e771243-6a18-4c99-aa0e-f31efb2e55ca">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzI3_71ed8872-0f98-4a2c-950c-1fa4fcc01343">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="csbr-20220731.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7162da0ccfc34694a9c545f0084622ec_I20220909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i577c8b3d14454bb0b350f284ca6c1329_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic065ecda714549d8b9539d3a70cf972f_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17924741f22b459ca3fec613390b6179_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa96ae2b58864431a19fca9982f05809_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b4dfd18191429c9ceb14b3f8c13d1f_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf29f85b5bd541b7a5f20864ebcdbfe0_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9898920fb7064f9fb12fba471bc4597c_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d47b40f944a4de88ffdac21c78c982d_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i288a79b1b3d641ffa7490e0d5672f7f7_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c77242238dc46cfa4a8582a2c07efca_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73be74dc4a704955a13d4a6e605014c1_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if98b46a595474311b3a3c697506f8d81_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a87370111849e4b06dd3c5817bbbb1_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa6bb1922094929b2d547692aefd75c_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2585e39e17d7472a892cc1d2e2e61c94_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb484428e98e40b38348d54e643addb7_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia61c6e91da644288a202775dd72f34f0_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085ec6b98bf6466f8ea58b578ad7c55d_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7278dee4bfc4f0db784f5737bf65204_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a3076d34d446dfa338a23dc5b09cac_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12ebeded0a02450a9d446437bbbc576c_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>csbr:subsidiary</xbrli:measure></xbrli:unit><xbrli:context id="i6eca0785cd844297b787bca9c17b7117_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-08-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:FewContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie70d8f70a5944b69be752032e3c823a4_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-08-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:FewContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91fabe7ea07840b0ad07eea382c68f2c_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PharmacologyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia438aed8edee4499a8c76234ae8091b1_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PharmacologyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98127e2a2ada454e83135bf30e7094f4_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f5707fdf6d74465854a45083439a864_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0cd432221fb46c5b2ff6c3f14dae6c0_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PersonalizedOncologyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7484f64f1cd4b20ba501dd09db89691_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PersonalizedOncologyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia612a5a694ed4a2aab99e2c1b7c1e7b9_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b2bd8d2bae64d3a8a1229b5763b483f_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99022b6aeb5849f68381125e8cdb97ea_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11effbe8666d492bb6247738f880f0a4_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5212cdfd144c8188adcfed3bf2b746_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ee763a8872248559a69477fb7ba51ef_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7470cfb3a4e24c169da0a95c73f21990_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba47105892b84c23a2e865ef51894ed5_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib57b0077fa424cfa9994c70df2820ec2_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:AssetInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7446b75d7234b01989cb3824d3109aa_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:AssetInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7b897b038814dab831bf20fd743486c_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id123ab3740ed4938a93cc09d1793ca01_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dfc15decd0849a7ba09ebc4e674af89_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1695cc594a4e7cad70f212f82cb391_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2022FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9b610a04f8314e00a08a6a9b91c33292_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2022FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7396db6674049dd925725f824b27e50_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2022FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2023FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42bfc0d6ba246b783fdd25ce27859cb_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2023FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca13514049f49afa46dab0656a44d2a_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bab8e5b86cc43df8e6b97165cdc5f3c_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3752fc3c3d8408694ab9b64622ad170_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5753fa1a19a74139a0f74c566b7aa853_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8e1fd8a290f4d44b5e8552f71eede35_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51dcfb3a899c4a8e813069354ef8efcd_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb0d823f162b4a5193235bd46686af4b_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3f6897bc8834b8f904bba44f16469a8_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac79db879ea4f6eb1f558ff7ea89f1d_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d9fcd2385f4e39a7cbdd2d532819d7_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce03b4537c94cf7b7799c4e749ac6bc_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i080c253670fa426ea429272a7273cf12_D20110218-20110218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2010Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-02-18</xbrli:startDate><xbrli:endDate>2011-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86bc626a809147259f5f564000ed6a2d_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b9d5525af9d4411bcbf399d302cd535_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd81da0b91f449c284d6c5416e74f934_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96b45f148ed94f2b987822093a127b64_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b2c162c0b10404093ec52141324084c_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6e0ef2a12e441258eba05a1fce64ef5_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafaf30d9b4bb4f1a9ecbae72caf1fb8f_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:CorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ac3aca3d2e4e09a8d672880d693ede_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:CorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b7f92a0f504fe8a62ea065fb7de171_I20200330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0a29219b6d948bfb1a15242e7e2ee28_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1318dfe0a0ec49f5acc43f0ba736b4ba_D20200501-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708a863763c143c7b34dd9a365f1231f_I20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf77001db0284d6e948b1a45819dd957_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:AdditionalExpansionPremisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900f808a09d14b639e4c9009b851f365_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bf7db3dbce34511bf24eb8231dc9fb6_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b3db1ffdd35458cb1b2797cc1c3e7a7_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:MilanItalyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib656d8c6403f4dc78fd543334a957220_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:MilanItalyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa35d5bbbd94ab5a12de9c850a4deef_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:MilanItalyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fed9c77e8f43daad4d3e42d103bedc_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851e5a2ac2a74afc89c6b93db67bab8b_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7dd96fbc4b344fc8421b1c148328401_D20220501-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b1cc212cb794f45b5fa375773a069c2_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i29549160a5144e4580af449aef8108b5_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc2_66272536-2705-4a24-8891-46d5bb52d75a">10-Q</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MjUzNTA3MTRjMDIyNDZjMGFjZjAwZTgzNjk3ZWM0MWEvdGFibGVyYW5nZToyNTM1MDcxNGMwMjI0NmMwYWNmMDBlODM2OTdlYzQxYV8wLTAtMS0xLTE4ODEz_3ea80d7c-7671-468a-b55f-d0a50fe585f0">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OR 15(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the quarterly period ended <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MjUzNTA3MTRjMDIyNDZjMGFjZjAwZTgzNjk3ZWM0MWEvdGFibGVyYW5nZToyNTM1MDcxNGMwMjI0NmMwYWNmMDBlODM2OTdlYzQxYV8xLTEtMS0xLTE4ODEzL3RleHRyZWdpb246YzA2MWM1NzgwZTEzNGRlYWE1NjMyM2M2NzE1ZmQxY2ZfMzU_e114e1aa-b881-49d8-988e-424940428b89">July&#160;31, 2022</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZGI1Y2E3YWY5N2U2NDA2OWI0NTA1MjI3NzM2ZWU1YWIvdGFibGVyYW5nZTpkYjVjYTdhZjk3ZTY0MDY5YjQ1MDUyMjc3MzZlZTVhYl8wLTAtMS0xLTE4ODEz_91c08457-0042-49c4-b025-144808c8d2a7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 13 OR 15(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">to</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc3_346554ba-2293-40f8-b696-c32dcf365c2c">001-11504</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc4_e15618b5-d906-4ac5-9eeb-3836bf2c19f3">CHAMPIONS ONCOLOGY, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as defined in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8wLTAtMS0xLTE4ODEz_f79ca3a6-213f-47ae-ba59-0e723a8f0f81">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8wLTEtMS0xLTE4ODEz_100ff35c-0590-40d8-9934-e4774f8ef970">52-1401755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8zLTAtMS0xLTE4ODEz_ac4e357c-e319-456b-9c07-e727aea28571">One University Plaza, Suite 307</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8zLTEtMS0xLTE4ODEz_71bc240d-5727-495e-bb38-e5323548357d">07601</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV80LTAtMS0xLTE4ODEzL3RleHRyZWdpb246MDA2ZTRjNDJmZjg1NDcwY2FlMjYwYTY3YmU0YmJmMWZfNA_8037ed1c-95f1-4dfd-8737-1866b098262f">Hackensack</ix:nonNumeric>, <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV80LTAtMS0xLTE4ODEzL3RleHRyZWdpb246MDA2ZTRjNDJmZjg1NDcwY2FlMjYwYTY3YmU0YmJmMWZfOA_a24fb280-739c-4491-9709-bd5c9710fd7b">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDcx_e610ad8a-d5b6-4da0-aa33-b05385f2dbbf">201</ix:nonNumeric>) <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDcy_27a45650-6791-4fb5-a92e-68d566bedd59">808-8400</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:34.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MTllMGExMGI1YWFjNGZjNTk1MWFjNTkxNGUzZmU4ODcvdGFibGVyYW5nZToxOWUwYTEwYjVhYWM0ZmM1OTUxYWM1OTE0ZTNmZTg4N18xLTAtMS0xLTE4ODEz_e47dc286-ec0d-41e0-ba80-f436be75a028">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MTllMGExMGI1YWFjNGZjNTk1MWFjNTkxNGUzZmU4ODcvdGFibGVyYW5nZToxOWUwYTEwYjVhYWM0ZmM1OTUxYWM1OTE0ZTNmZTg4N18xLTItMS0xLTE4ODEz_22be72fa-a4a1-4176-820b-c405d50f5fda">CSBR</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MTllMGExMGI1YWFjNGZjNTk1MWFjNTkxNGUzZmU4ODcvdGFibGVyYW5nZToxOWUwYTEwYjVhYWM0ZmM1OTUxYWM1OTE0ZTNmZTg4N18xLTQtMS0xLTE4ODEzL3RleHRyZWdpb246N2YzZDc0YTFiZGJjNDUwN2E4OTFlZTYzMzkzNzk2ODNfOA_c0c69e28-6ba8-4524-8ae5-e9a9e58128e3">Nasdaq</ix:nonNumeric> Stock  Market LLC</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDcz_30ea8013-b262-4d01-8203-b337e143d477">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc0_21305b40-1ed6-4fd3-88b3-74b6fbed7ef3">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221;, and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZTAzZGQxNGNlYmY0NDRlNTkyZjJjMmJmNGNkYzBhZTYvdGFibGVyYW5nZTplMDNkZDE0Y2ViZjQ0NGU1OTJmMmMyYmY0Y2RjMGFlNl8wLTItMS0xLTE4ODEzL3RleHRyZWdpb246YWE1NTg3MDI4OGFlNDIxNzllNDkzZTlmZDhjMWYwODFfNA_d2b19260-e5c8-477b-a8f7-057cd0eabe54">Non-accelerated filer</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZTAzZGQxNGNlYmY0NDRlNTkyZjJjMmJmNGNkYzBhZTYvdGFibGVyYW5nZTplMDNkZDE0Y2ViZjQ0NGU1OTJmMmMyYmY0Y2RjMGFlNl8wLTMtMS0xLTE4ODEzL3RleHRyZWdpb246ZTgxMDdhNzY2MmQ1NGQxN2JlYzEyNGYwYjNjZjUyODRfMzA_84854e34-9cd4-4043-bc03-e497f83c10d1">&#9745;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZTAzZGQxNGNlYmY0NDRlNTkyZjJjMmJmNGNkYzBhZTYvdGFibGVyYW5nZTplMDNkZDE0Y2ViZjQ0NGU1OTJmMmMyYmY0Y2RjMGFlNl8xLTMtMS0xLTE4ODEzL3RleHRyZWdpb246MmE1NzlkNTRmYTE2NDRiMGFhZDYxZDEzZWFlNmQ5ZjVfMjg_b228c16e-3ae9-4abd-ad83-1e91de8a31cf">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc1_9d026bdc-50af-432b-b1b4-417ea4426d55">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The number of Common Shares of the Registrant outstanding as of September 9, 2022 was <ix:nonFraction unitRef="shares" contextRef="i7162da0ccfc34694a9c545f0084622ec_I20220909" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF81NDk3NTU4MTU5OTM_9beea35c-bf42-471f-ae75-552b28858dd4">13,522,441</ix:nonFraction>.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE - None</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTERLY PERIOD ENDED JULY&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_10">PART I - FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_13">Financial Statements.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_16">Condensed Consolidated Balance Sheets as of July 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_16">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_16"> (unaudited) and April 30, 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i29549160a5144e4580af449aef8108b5_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_22">Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended July  31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_22">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_22"> and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_22">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_22">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i29549160a5144e4580af449aef8108b5_22">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_25">Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity for the Three  Months Ended July 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_25">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_25"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_25">21</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_28">Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended July 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_28">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_28"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_28">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_28">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_31">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_61">17</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_64">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_64">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_67">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_67">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_70">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_73">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_73">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_76">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_76">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_79">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_79">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_82">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_82">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_85">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_85">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_88">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_88">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_94">Exhibits</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i29549160a5144e4580af449aef8108b5_91">23</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHAMPIONS ONCOLOGY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in Thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNC0xLTEtMS0xODgxMw_92f6a24a-5bd2-4993-a911-73ab0d1ce4d9">8,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNC0zLTEtMS0xODgxMw_751b8fed-1d18-488a-bfcf-61596a58f458">9,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNS0xLTEtMS0xODgxMw_de6e222c-bf78-4f67-a821-705888a5a9a3">9,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNS0zLTEtMS0xODgxMw_177f998e-98b3-46f5-9f3d-30ca460e7287">9,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNi0xLTEtMS0xODgxMw_09160e28-bba6-41ea-a028-e357f956b9de">958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNi0zLTEtMS0xODgxMw_4fdf2d90-6d07-4d2d-8303-331a74e735db">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfOC0xLTEtMS0xODgxMw_a790da13-dd3d-42ae-a695-98adb0cee25f">18,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfOC0zLTEtMS0xODgxMw_12c1111a-41d4-485c-8cea-b9b0b4f42908">19,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTEtMS0xLTEtMTg4MTM_b7716579-abb6-483e-82ab-e8de7440020a">7,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTEtMy0xLTEtMTg4MTM_f479680b-e76d-4b43-be4e-7b322ab311ac">8,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTItMS0xLTEtMTg4MTM_2245aa85-b00c-4c6a-8904-7be766e45c5a">7,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTItMy0xLTEtMTg4MTM_bc2dcf7c-f84e-4886-b5e9-59d89a8c208d">7,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTMtMS0xLTEtMTg4MTM_1fca41b1-714b-4ad7-81dc-bdfe820b8e4c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTMtMy0xLTEtMTg4MTM_07aa8dcd-dff9-4f5e-9694-319ab4811840">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTQtMS0xLTEtMTg4MTM_76b0d4f8-4fc3-45d7-9a63-5744a5a81623">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTQtMy0xLTEtMTg4MTM_988a264a-3aa4-46af-ac1b-a65f3af9f77f">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTYtMS0xLTEtMTg4MTM_551acbbf-324d-433e-b885-723e397eca73">34,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTYtMy0xLTEtMTg4MTM_b36eee9d-76f2-46ab-864d-52e358705495">35,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjEtMS0xLTEtMTg4MTM_88e73bf2-ed42-44d5-8322-65cadde1b820">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjEtMy0xLTEtMTg4MTM_6b518760-bed5-4c50-be6e-a71ac80988f7">2,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjItMS0xLTEtMTg4MTM_63409165-5959-476b-bbea-b3cc87825112">1,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjItMy0xLTEtMTg4MTM_d67be8e4-4c04-4288-bf3f-edc19434980a">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjQtMS0xLTEtMTg4MTM_3b8250a0-3a15-4c5c-bc3b-b2c4db0c8a37">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjQtMy0xLTEtMTg4MTM_7768062d-b059-4900-8987-d40c918ff454">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjUtMS0xLTEtMTg4MTM_01177a0b-0a4c-4b33-a291-f828fecf7857">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjUtMy0xLTEtMTg4MTM_a07979cf-b016-4378-b0db-9981b7bf8e29">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjYtMS0xLTEtMTg4MTM_c7b123b2-2530-4582-8d98-bc534b3501e5">10,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjYtMy0xLTEtMTg4MTM_c963a410-ed58-49a4-ba46-94fd34a43741">11,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjgtMS0xLTEtMTg4MTM_86faf195-c19c-421d-a3cf-12bef25893da">16,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjgtMy0xLTEtMTg4MTM_72eb6194-c500-4952-8256-b8b02b887165">17,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzAtMS0xLTEtMTg4MTM_e8e05f41-20e8-48c1-9adf-86d939df5aa6">8,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzAtMy0xLTEtMTg4MTM_b2bd8c6f-0bef-40c5-9fa4-3e61f3a03243">8,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzItMS0xLTEtMTg4MTM_ecb82038-e477-4099-a5cb-63153d6f5f4c">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzItMy0xLTEtMTg4MTM_c9b1eaff-21ee-4af0-a465-d021c7382a99">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzQtMS0xLTEtMTg4MTM_5ff07f03-5c6f-4435-8a25-0aef27fd7700">25,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzQtMy0xLTEtMTg4MTM_fed93668-6fe4-41fa-be93-98e91e4267dc">26,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8xOA_79f11c41-bf79-413a-9bcd-2fc8e1d4b37f"><ix:nonFraction unitRef="usdPerShare" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8xOA_a10fc626-949b-40b7-ad85-70b111eb15da">.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8zMg_1ed0637d-6bc2-48e0-9a23-8d8b9a08cd23"><ix:nonFraction unitRef="shares" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8zMg_3587a112-714f-48f1-b596-9dcea28a0ab5">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_02f5d3a3-9e46-4964-b709-88a39c89879b"><ix:nonFraction unitRef="shares" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_403fb7de-48dd-4e0e-825f-fb326b5dcd47"><ix:nonFraction unitRef="shares" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_415b40ac-ff8a-4060-a182-9c4d76330304"><ix:nonFraction unitRef="shares" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_c5bd30c5-8388-4b61-8e17-4370927e02de">13,522,441</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of July 31, 2022 and April 30, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMS0xLTEtMTg4MTM_da066e6e-916c-4ec0-986a-4af12934e516">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMy0xLTEtMTg4MTM_69740329-c1ca-461a-b093-bef63e529375">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzktMS0xLTEtMTg4MTM_1b6a3c34-99fd-46a8-9866-86707cf941bf">81,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzktMy0xLTEtMTg4MTM_9d37cc61-b865-40b0-95b3-09ed346931f0">81,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDAtMS0xLTEtMTg4MTM_d957e3cb-0c38-4175-b63b-f6618cd4b3d5">72,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDAtMy0xLTEtMTg4MTM_d24ffd21-c0ee-4d30-8971-b27737c474ed">71,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDItMS0xLTEtMTg4MTM_fe7faa3b-218b-471b-a45f-4325c88c06d6">8,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDItMy0xLTEtMTg4MTM_bc1bf99d-4cae-4d97-85d6-f5cc9d137ba5">9,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDQtMS0xLTEtMTg4MTM_a496b477-c414-4bc0-a0a2-2f3304f0c063">34,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDQtMy0xLTEtMTg4MTM_82c9c687-0bda-473e-a6e2-6acbf86eb3b1">35,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHAMPIONS ONCOLOGY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in Thousands, Except Per Share Amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.690%"><tr><td style="width:1.0%"></td><td style="width:65.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.883%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0wLTEtMS0xODgxMw_1a314bab-bc49-462d-9774-0a2a9e532563"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0wLTEtMS0xODgxMw_b5d3071c-49b2-43e4-8afd-750cbba73f89">Oncology services revenue</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0xLTEtMS0xODgxMw_f7118e87-87c4-4033-ba2f-ef4785ea3df8">13,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0zLTEtMS0xODgxMw_11ab57b6-7371-4897-90a9-a8d2bda927f3">11,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs and operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0wLTEtMS0xODgxMw_24738fed-0e57-44c5-8ac4-6f88cd052e09"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0wLTEtMS0xODgxMw_4e771243-6a18-4c99-aa0e-f31efb2e55ca">Cost of oncology services</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0xLTEtMS0xODgxMw_1f10d309-5af5-413a-abcd-68d1a4ee5e81">7,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0zLTEtMS0xODgxMw_088a5caa-249b-4430-90e0-2a840e23ba08">5,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNy0xLTEtMS0xODgxMw_3d6bec5e-5943-45ab-a24a-f2cc67c41d6b">2,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNy0zLTEtMS0xODgxMw_41277ca6-5624-44d2-94f4-cfd02de0b84d">2,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOC0xLTEtMS0xODgxMw_639efffb-0093-413e-b396-36c59f76df7b">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOC0zLTEtMS0xODgxMw_03748802-acd2-4aea-918e-dcac18114d64">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOS0xLTEtMS0xODgxMw_1865ad4e-81c3-4e10-9e22-ce2008ee6f35">2,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOS0zLTEtMS0xODgxMw_b481eab0-1e77-4faa-a6e6-3a7ccd806a13">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTEtMS0xLTEtMTg4MTM_5cb0f818-655b-40d4-80af-a88535c78468">14,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTEtMy0xLTEtMTg4MTM_3fe51a63-7e64-4ae9-8e00-4b26e8a7ae5a">11,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTMtMS0xLTEtMTg4MTM_2ab39b52-be31-44d4-9a2c-b5bb56efb2a9">284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTMtMy0xLTEtMTg4MTM_a8cac567-390c-4a0e-95f2-98005fa55b83">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTYtMS0xLTEtMTg4MTM_573d71b2-cf63-46ff-a2b0-5e7aa4332dbe">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTYtMy0xLTEtMTg4MTM_5590cc7a-2c69-44b4-aa7a-aa029503fdf0">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTgtMS0xLTEtMTg4MTM_29610426-286a-4f1e-9c32-a9b913023080">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTgtMy0xLTEtMTg4MTM_a94aea05-3b20-4fd8-9e21-d8c2882f81b8">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTktMS0xLTEtMTg4MTM_9d58388b-cc7d-4584-92f8-d978c2ce7aed">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTktMy0xLTEtMTg4MTM_e64394ee-6095-4ab1-936f-6d0ff32c8fea">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjEtMS0xLTEtMTg4MTM_a6206146-1a50-41af-bc23-9b9ca8d92fc6">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjEtMy0xLTEtMTg4MTM_9684cb09-d4c8-4c2a-b528-e973ae70a726">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjQtMS0xLTEtMTg4MTM_43bdab28-e65e-4308-82ec-05e071e4eb5e">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjQtMy0xLTEtMTg4MTM_95c6965f-51bb-4e31-a52a-14a76c5bef77">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjUtMS0xLTEtMTg4MTM_663311ce-bee4-4116-87db-9839dacb09ca">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjUtMy0xLTEtMTg4MTM_5b0ba707-4f8b-43b6-81f1-63f0d369a3a8">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjgtMS0xLTEtMTg4MTM_febe507d-d009-4fec-a1dc-88d610aa00fe">13,522,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjgtMy0xLTEtMTg4MTM_7755bc3b-4be9-4dba-ab01-b08b3820e1de">13,401,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjktMS0xLTEtMTg4MTM_59f78b56-28b5-461e-a2ba-f035813bf358">13,522,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjktMy0xLTEtMTg4MTM_d195bd01-53a6-45b2-945b-d24b0ed1a26c">13,401,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHAMPIONS ONCOLOGY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in Thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.854%"><tr><td style="width:1.0%"></td><td style="width:42.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.230%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.560%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance April 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17924741f22b459ca3fec613390b6179_I20220430" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0xLTEtMS0xODgxMw_68cbabcb-9d8c-4651-8c15-3bd585a54196">13,522,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17924741f22b459ca3fec613390b6179_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0zLTEtMS0xODgxMw_a2e779a5-5132-488f-a831-e52db1000ab1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96ae2b58864431a19fca9982f05809_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi05LTEtMS0xODgxMw_bac38e31-3d19-4d1f-a8c2-276dd4e78ea9">81,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74b4dfd18191429c9ceb14b3f8c13d1f_I20220430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0xMS0xLTEtMTg4MTM_558fbdc4-b461-47f5-99b1-cda66ba09f93">71,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0xNS0xLTEtMTg4MTM_65746780-5aae-4a29-a572-4c4ca87896dd">9,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf29f85b5bd541b7a5f20864ebcdbfe0_D20220501-20220731" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMy05LTEtMS0xODgxMw_f977ba4e-a089-4a48-a44f-841768bea348">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMy0xNS0xLTEtMTg4MTM_4a4be7e8-6ca6-44df-876e-d2e2050527e7">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9898920fb7064f9fb12fba471bc4597c_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTAtMTEtMS0xLTE4ODEz_29d85fdf-5602-404b-9c44-1c8d8ec5c21b">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTAtMTUtMS0xLTE4ODEz_552053d5-22f3-4eb4-870b-6768648c127f">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance July 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d47b40f944a4de88ffdac21c78c982d_I20220731" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMS0xLTEtMTg4MTM_a9cf53b9-6da2-4648-ad2e-f8f2f2990785">13,522,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d47b40f944a4de88ffdac21c78c982d_I20220731" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMy0xLTEtMTg4MTM_8b07b0b6-3767-40fe-8752-2d2616889229">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i288a79b1b3d641ffa7490e0d5672f7f7_I20220731" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtOS0xLTEtMTg4MTM_47c13cda-ed8d-4f30-9a10-d68a8bbec35c">81,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c77242238dc46cfa4a8582a2c07efca_I20220731" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMTEtMS0xLTE4ODEz_f552847f-822a-4e1c-95c2-525f64971eca">72,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMTUtMS0xLTE4ODEz_188b059b-db98-4e22-b362-f9e323947564">8,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance April 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73be74dc4a704955a13d4a6e605014c1_I20210430" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMS0xLTEtMTg4MTM_1e50bd65-99fe-4516-999e-1af69c8b6f26">13,414,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73be74dc4a704955a13d4a6e605014c1_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMy0xLTEtMTg4MTM_54515e6e-9294-4154-919f-a01c3f266d38">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if98b46a595474311b3a3c697506f8d81_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtOS0xLTEtMTg4MTM_89db9241-cda7-4549-ac66-276cf9eaceea">79,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40a87370111849e4b06dd3c5817bbbb1_I20210430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMTEtMS0xLTE4ODEz_a449d7dd-3f30-4267-ba4b-0aafea0a9d2a">72,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa6bb1922094929b2d547692aefd75c_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMTUtMS0xLTE4ODEz_1dcc2983-8c62-4222-b438-e0f61a73a4d8">7,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2585e39e17d7472a892cc1d2e2e61c94_D20210501-20210731" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjktOS0xLTEtMTg4MTM_3d785673-78d9-4cbc-9b11-a34309aa92d1">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjktMTUtMS0xLTE4ODEz_ace51c78-2235-406c-8182-aa8ea26a9637">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock on exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb484428e98e40b38348d54e643addb7_D20210501-20210731" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesOther" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzEtMS0xLTEtMTg4MTM_19b49e48-c5a0-4190-9273-bab6f95175a0">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2585e39e17d7472a892cc1d2e2e61c94_D20210501-20210731" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzEtOS0xLTEtMTg4MTM_9973722e-449d-467f-a013-e147f14cd971">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzEtMTUtMS0xLTE4ODEz_99be71bd-c3b0-4fd6-b3ab-64bdc8d5a8fa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia61c6e91da644288a202775dd72f34f0_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzItMTEtMS0xLTE4ODEz_bbf5cf67-230d-482f-8e51-da79d5dd07de">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzItMTUtMS0xLTE4ODEz_251f1a25-50d6-4e5a-8d86-44a4d6f68887">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance July 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i085ec6b98bf6466f8ea58b578ad7c55d_I20210731" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMS0xLTEtMTg4MTM_e72f7923-2083-4eef-8f52-1dcd551e9c1e">13,415,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i085ec6b98bf6466f8ea58b578ad7c55d_I20210731" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMy0xLTEtMTg4MTM_919367ae-0054-434a-af5f-15643b6ff735">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7278dee4bfc4f0db784f5737bf65204_I20210731" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtOS0xLTEtMTg4MTM_c7ae09ed-cecd-4822-9eef-f9e382623816">80,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06a3076d34d446dfa338a23dc5b09cac_I20210731" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMTEtMS0xLTE4ODEz_7cdaf7a3-73b2-4160-9d36-a7aec971d227">72,702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ebeded0a02450a9d446437bbbc576c_I20210731" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMTUtMS0xLTE4ODEz_39873705-3952-4342-9d3e-fbb957e795a4">7,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHAMPIONS ONCOLOGY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in Thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:72.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMy0xLTEtMS0xODgxMw_aac5de13-fd66-47f6-93bd-188297be0fd0">319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMy0zLTEtMS0xODgxMw_b266182e-f780-4dcd-b6dc-6f63f7cb262d">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNi0xLTEtMS0xODgxMw_054a9208-73c7-4c9b-9657-42f081a3c136">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNi0zLTEtMS0xODgxMw_11fa73fd-ba13-4a1d-a74a-7b7a4bb41c65">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfOC0xLTEtMS0xODgxMw_8c93aead-060b-4747-86a0-d03fb69f11f6">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfOC0zLTEtMS0xODgxMw_1a53aa3e-d2e4-41e8-9a90-b2c6c1a76c72">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on disposal of equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTAtMS0xLTEtMTg4MTM_9702388d-96d8-4f9e-bf4d-f917b69d818e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTAtMy0xLTEtMTg4MTM_0003d266-1438-49b8-ae5b-3a91b7a5b709">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="csbr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTItMS0xLTEtMTg4MTM_589f68b5-1157-4906-a560-0ad4c326c2b4">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="csbr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTItMy0xLTEtMTg4MTM_12ca6637-f30b-45d9-9f15-a96eb2474ecf">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="csbr:ReversalOfProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTMtMS0xLTEtMTg4MTM_cc117a6c-e801-4e75-b4b9-5d8a98735ba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="csbr:ReversalOfProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTMtMy0xLTEtMTg4MTM_12c0b7d2-0999-449e-aa88-a082db2ad73b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTYtMS0xLTEtMTg4MTM_79f1e75e-b772-4813-86f8-b5dabb89b431">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTYtMy0xLTEtMTg4MTM_edfa6abc-6835-4e4d-8a15-43a656f997d0">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTctMS0xLTEtMTg4MTM_c69b3400-22c4-45ac-8a0f-41853c60b9ac">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTctMy0xLTEtMTg4MTM_e08211a0-b7d5-42e6-88dc-6a5d1bb0bff6">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTgtMS0xLTEtMTg4MTM_cd44c358-692b-44c2-859b-61e16ed8b6d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTgtMy0xLTEtMTg4MTM_0f84eaaf-3bfd-4aba-98a5-6d08f240e358">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTktMS0xLTEtMTg4MTM_a36fcb50-bd32-4947-9b33-7fc8a4fc1211">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTktMy0xLTEtMTg4MTM_86369483-dde1-4feb-ae70-041e86abfe82">1,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjAtMS0xLTEtMTg4MTM_eae1dd5c-3ead-442f-96be-93381aa48599">456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjAtMy0xLTEtMTg4MTM_87123160-f864-47b7-9cdb-209381b8bf2e">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjItMS0xLTEtMTg4MTM_5fd92f28-00b2-4cff-bc00-53874eaaf12f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjItMy0xLTEtMTg4MTM_b5c83b9b-e8a4-4324-a709-651ab8f51d6c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjMtMS0xLTEtMTg4MTM_8e5f68bb-6684-4feb-beea-54da27fbaea5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjMtMy0xLTEtMTg4MTM_41866dad-acb8-40bd-9385-b2debaaa8c54">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="csbr:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjQtMS0xLTEtMTg4MTM_2cb3404c-0c17-47e3-94f6-5ad065b795b0">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="csbr:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjQtMy0xLTEtMTg4MTM_c2fcefb4-f78e-475a-a4aa-f65bb8d00b40">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjUtMS0xLTEtMTg4MTM_def365f1-2b6e-4cc9-b3a4-1d4d57344fa6">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjUtMy0xLTEtMTg4MTM_869efaf9-2446-455b-afbb-ab26d2ea27a3">775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjctMS0xLTEtMTg4MTM_6d3b617c-6e7c-415b-b296-76eda8b608cf">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjctMy0xLTEtMTg4MTM_e5525745-3987-4a89-96b3-f343eae90d49">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzAtMS0xLTEtMTg4MTM_4aeccccc-9920-47c6-91cb-dc3360be389e">754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzAtMy0xLTEtMTg4MTM_9ff24112-3dd3-4075-af16-7f151fbabdb9">907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzUtMS0xLTEtMTg4MTM_5e9f81bf-9777-4539-83bb-3cd5954ce880">754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzUtMy0xLTEtMTg4MTM_7c9adad5-cbf7-412a-928e-fdccd3308a4a">907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="csbr:ProceedsFromExerciseOfOptionsAndWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzktMS0xLTEtMTg4MTM_717c6a01-ec8b-4cbe-8661-4b231da28938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="csbr:ProceedsFromExerciseOfOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzktMy0xLTEtMTg4MTM_35d50d61-51b4-44a3-abe1-10273cea64c5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDUtMS0xLTEtMTg4MTM_48cb7cde-51b5-42d0-a120-2c9eb31a141c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDUtMy0xLTEtMTg4MTM_9164a351-abf8-4a80-9768-2bc9e7a99c47">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDctMS0xLTEtMTg4MTM_229356dc-a442-4a30-b35e-161c81b6db46">949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDctMy0xLTEtMTg4MTM_59be240c-2305-46ff-b189-8cae48b7d003">689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDgtMS0xLTEtMTg4MTM_07969cfa-1a1e-4b15-873b-3cfcb5dee347">9,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa6bb1922094929b2d547692aefd75c_I20210430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDgtMy0xLTEtMTg4MTM_a9a02016-1709-4048-962a-e657060459f7">4,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNTAtMS0xLTEtMTg4MTM_d0393124-a390-42e0-98da-5920064db3c1">8,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ebeded0a02450a9d446437bbbc576c_I20210731" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNTAtMy0xLTEtMTg4MTM_05ba20b1-da0b-434b-98c7-f4144d2aba34">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHAMPIONS ONCOLOGY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNC9mcmFnOjIxMzU0ZDNmNDUxNjRkNTI5OTA3YmZjYWE0YWZkMWZjL3RleHRyZWdpb246MjEzNTRkM2Y0NTE2NGQ1Mjk5MDdiZmNhYTRhZmQxZmNfNDE1MA_c149cb49-987b-44cb-a918-f28e288c7e19" continuedAt="iffe37263b3a24f1d8d998c5055ba000b" escape="true">Organization, Use of Estimates and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="iffe37263b3a24f1d8d998c5055ba000b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Champions Oncology, Inc is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The Company has <ix:nonFraction unitRef="subsidiary" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="INF" name="csbr:NumberOfOperatingSubsidiaries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNC9mcmFnOjIxMzU0ZDNmNDUxNjRkNTI5OTA3YmZjYWE0YWZkMWZjL3RleHRyZWdpb246MjEzNTRkM2Y0NTE2NGQ1Mjk5MDdiZmNhYTRhZmQxZmNfMTk2MA_a6fb67dd-aa64-4789-8e13-b9d7de81ab14">three</ix:nonFraction> operating subsidiaries: Champions Oncology (Israel), Limited, Champions Biotechnology U.K., Limited, and Champions Oncology, S.R.L. (Italy). For the three months ended July 31, 2022 and 2021, there were no revenues earned by these subsidiaries.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s foreign subsidiaries functional currency is the U.S. dollar. Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company&#8217;s international operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC. All significant intercompany transactions and accounts have been eliminated. Certain information related to the Company&#8217;s organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, or GAAP, has been condensed or omitted. The accounting policies followed in the preparation of these unaudited condensed consolidated financial statements are consistent with those followed in the Company&#8217;s annual consolidated financial statements for the year ended April&#160;30, 2022, as filed on Form 10-K. In the opinion of management, these unaudited condensed consolidated financial statements contain all material adjustments necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended April&#160;30, 2022. The results of operations for the interim periods are not necessarily indicative of the results of operations for a full fiscal year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDI_4bbfbcdc-4c9e-46d7-ae9e-5c5494933080" continuedAt="i706f9c10da634cf3a827bad72bd1210c" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i706f9c10da634cf3a827bad72bd1210c" continuedAt="i0389b498f73b46f1aff48ebd590a1948"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MTU_ba154dbd-8d1d-49c4-a0c6-9767d5f4002f" continuedAt="i44e0d855d88c4154b0d65ac098b0e481" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i44e0d855d88c4154b0d65ac098b0e481">The Company considers only those investments which are highly liquid, readily convertible to cash, and with original maturities of three months or less to be cash equivalents.</ix:continuation> As of July&#160;31, 2022 and April 30, 2022 the Company had <ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjk0_30ebaa08-4c4c-4923-99a3-97a1a4678237"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjk0_5d176159-ac47-4730-b981-be3d97ca7edf">no</ix:nonFraction></ix:nonFraction> cash equivalents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity needs have typically arisen from the funding of our research and development programs and the launch of new products, working capital requirements, and other strategic initiatives. Recently, we have met these cash requirements through our cash on hand, working capital management, and sales of products and services. In the past, we have also received proceeds from certain private placements and public offerings of our securities. For the three months ended July&#160;31, 2022, the Company had a net loss of approximately $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfODE1_dfbf829a-6ecb-4910-9e51-78f8dc5a8366">319,000</ix:nonFraction> and cash used in operations of $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfODUz_df847133-9251-4681-baae-40b0cfc45db8">195,000</ix:nonFraction>. As of July&#160;31, 2022, the Company had an accumulated deficit of approximately $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfOTIz_6ed93604-b766-46f1-92de-4c66f537b341">72.3</ix:nonFraction> million, working capital of $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-5" name="csbr:WorkingCapitalDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfOTQ2_a73fe660-d9e8-449b-8049-261850178b39">1.8</ix:nonFraction> million and cash of $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfOTYx_acbcecba-2225-4d97-8a19-408a0307f620">8.1</ix:nonFraction> million. We believe that our cash on hand, together with expected net positive cash provided by operations for fiscal year 2023, are adequate to fund operations through at least 12 months from the filing of this 10-Q.  However, should our revenue expectations not materialize, we believe we have cost reduction strategies that could be implemented without disrupting the business or restructuring the Company. Should the Company be required to raise additional capital, there can be no assurance that management would be successful in raising such capital on terms acceptable to us, if at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTMzOTg_8e970e6e-f548-44d0-bd37-958ed12c6069" continuedAt="i1513496947b044818a886363bd5e3afe" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1513496947b044818a886363bd5e3afe">The Company accounts for its leases under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease, if applicable, or the Company&#8217;s incremental borrowing rate. As the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line rent expense over the lease term.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDk_49d30e93-08bf-4f96-aa3c-6b663a0a6d22" continuedAt="i091a614bd49f4fa4967098b1f4b22ca2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i091a614bd49f4fa4967098b1f4b22ca2">Basic net income or loss per share is computed by dividing the net income or loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. Such dilutive shares consist of incremental shares that would be issued upon exercise of the Company&#8217;s common stock options.</ix:continuation> </span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 31, 2022 and 2021, all of the Company's potential common stock is considered anti-dilutive. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.666%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.896%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.896%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.899%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDQ_04d64c5b-3a26-419d-9442-0eb0a01c54ce" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the total potential share-based instruments outstanding at July&#160;31, 2022 and 2021 that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"><tr><td style="width:1.0%"></td><td style="width:71.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total common stock equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RhYmxlOjM0ZTU0YjQzOWZhMzRiZDI5YTVmZDNjY2IyNDJiMWM3L3RhYmxlcmFuZ2U6MzRlNTRiNDM5ZmEzNGJkMjlhNWZkM2NjYjI0MmIxYzdfNS0xLTEtMS0xODgxMw_49b530fc-459f-47ad-952b-9b4d6dfe71ee">1,722,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RhYmxlOjM0ZTU0YjQzOWZhMzRiZDI5YTVmZDNjY2IyNDJiMWM3L3RhYmxlcmFuZ2U6MzRlNTRiNDM5ZmEzNGJkMjlhNWZkM2NjYjI0MmIxYzdfNS0zLTEtMS0xODgxMw_b41ba699-c390-4c9f-a28e-5fef47f10b83">1,734,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MTM_20fad32b-20cc-4fed-b998-5d07ab5a355c" continuedAt="idf51cc4b3a5745d7a791ac485022e466" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#160;&#160;&#160;&#160;Deferred income taxes have been provided to show the effect of temporary differences between the recognition of expenses for financial and income tax reporting purposes and between the tax basis of assets and liabilities, and their reported amounts in the consolidated financial statements.  In assessing the realizability of deferred tax assets, the Company assesses the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0389b498f73b46f1aff48ebd590a1948" continuedAt="i9af7b365b2cd4ed795ce8abd10bb7039"><ix:continuation id="idf51cc4b3a5745d7a791ac485022e466"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">likelihood that deferred tax assets will be recovered through tax planning strategies or from future taxable income, and to the extent that recovery is not likely or there is insufficient earnings history, a valuation allowance is established. The Company's ability to utilize net operating losses (&#8220;NOL&#8221;) carryforwards to offset future taxable income would be limited if the Company had undergone or were to undergo an &#8220;ownership change&#8221; within the meaning of Section 382 of the Internal Revenue Code (the &#8220;IRC&#8221;). The Company adjusts the valuation allowance in the period management determines it is more likely than not that deferred tax assets will or will not be realized.  Changes in valuation allowances from period to period are included in the tax provision in the period of change.  As of&#160;July&#160;31, 2022 and April&#160;30, 2022, the Company provided a valuation allowance for all net deferred tax assets, as recovery is not more likely than not based on an insufficient history of earnings.</span></div><div style="padding-left:11.25pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reflects tax benefits only if it is more likely than not that the Company will be able to sustain the tax position, based on its technical merits.&#160;&#160;If a tax benefit meets this criterion, it is measured and recognized based on the largest amount of benefit that is cumulatively greater than 50% likely to be realized.&#160;&#160;The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNTY4Mw_9e835435-a74c-434c-a050-ef9c22a9401e"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNTY4Mw_c024fcae-ff57-4a04-9db7-4a96314cf006">181,000</ix:nonFraction></ix:nonFraction> of liabilities related to uncertain tax positions relative to one of its foreign operations as of July&#160;31, 2022 and April&#160;30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company did <ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjA1Ng_5c871b9d-30af-49cd-a971-b77c308ff598"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjA1Ng_79a28594-0040-4121-ad35-24a2638ee78e">no</ix:nonFraction></ix:nonFraction>t recognize interest or penalties on its consolidated statements of operations during the three-month periods ended July 31, 2022 and 2021. The Company does <ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjIxNQ_b4a6d6f2-73cb-43a2-9057-8cd29268cf61">no</ix:nonFraction>t anticipate unrecognized tax benefits will be recorded during the next 12 months.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the three months ended July 31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjM1NQ_f94be35d-a380-4f98-9e75-2c95bcdf53da">17,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjM2Mg_0c54d1b0-2c60-499d-8774-315cdcfa14d0">14,000</ix:nonFraction>, respectively, mainly attributable to taxable income earned in Israel and/or Italy relating to transfer pricing. &#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MTQ_0a85f1ec-7d70-486e-98f1-59747cc15310" continuedAt="i1c6d59319f594676b6e6ce3bf7d213e1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The objective of the standard is to establish a single comprehensive revenue recognition model that is designed to create greater comparability of financial statements across industries and jurisdictions.  Under this standard, companies recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      All revenue is generated from contracts with customers. The Company's arrangements are service type contracts that mainly have a duration of less than a year. The Company recognizes revenue when control of these services is transferred to the customer in an amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange for those services.  The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when, or as, the Company transfers control of the product or service for each performance obligation. The Company records revenues net of any tax assessments by governmental authorities, such as value added taxes, that are imposed on and concurrent with specific revenue generating transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The majority of the Company's revenue arrangements are service contracts that are completed within a year or less. There are a few contracts that range in duration between <ix:nonNumeric contextRef="i6eca0785cd844297b787bca9c17b7117_I20220731" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjE5OTAyMzI3MjM3MQ_a0d1618b-4439-4a44-a352-a01fdca49248">1</ix:nonNumeric> and <ix:nonNumeric contextRef="ie70d8f70a5944b69be752032e3c823a4_I20220731" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjE5OTAyMzI3MjM3NQ_34549f65-16df-420c-8ec8-b0f924f7eb1c">3</ix:nonNumeric> years. Substantially all of the Company's performance obligations, and associated revenue, are transferred to the customer over time. Most of the Company's contracts can be terminated by the customer without cause. In the event of termination, the Company's contracts provide that the customer pay the Company for services rendered through the termination date. The Company generally receives compensation based on a predetermined invoicing schedule relating to specific milestones for that contract.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Amendments to contracts are common. The Company evaluates each amendment which meets the criteria of a contract modification under ASC 606. Each modification is further evaluated to determine whether the contract modification should be accounted for as a separate contract or as a continuation of the original agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The Company accounts for amendments as a separate contract as they meet the criteria under ASC 606-10-25-12.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pharmacology Study and Other Services</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally enters into contracts with customers to provide oncology services with payments based on fixed-fee arrangements. At contract inception, the Company assesses the services promised in the contracts with customers to identify the performance obligations in the arrangement. The Company's fixed-fee arrangements for oncology services are considered a single performance obligation because the Company provides a highly-integrated service.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9af7b365b2cd4ed795ce8abd10bb7039"><ix:continuation id="i1c6d59319f594676b6e6ce3bf7d213e1"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time using a progress-based input method since there is no single output measure that would fairly depict the transfer of control over the life of the performance obligation. Revenue is recognized for the single performance obligation over time due to the Company's right to payment for work performed to date and the performance does not create an asset with an alternative use. The Company recognizes revenue as portions of the overall performance obligation are completed as this best depicts the progress of the performance obligation.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incremental Costs of Obtaining a Contract (Sales Commissions)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">       Under ASC 606, the costs of obtaining a contract can be expensed immediately, rather than capitalized and amortized, if the amortization period is one year or shorter. Sales commissions for the Company represent contract costs with a term of one year or less. Therefore, under ASC 606, the Company elected the practical expedient to expense these costs as incurred.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Consideration</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, contracts provide for variable consideration that is contingent upon the occurrence of uncertain future events, such as the success of the initial performance obligation. Variable consideration is estimated at the expected value or at the most likely amount depending on the type of consideration. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimate of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of its anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables, Unbilled Services and Deferred Revenue</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, billings and payments are established by contractual provisions including predetermined payment schedules, which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. In general, the Company's intention in its invoicing (payment terms) is to maintain cash neutrality over the life of the contract. Upfront payments, when they occur, are intended to cover certain expenses the Company incurs at the beginning of the contract. Neither the Company nor its customers view such upfront payments and contracted payment schedules as a means of financing. Unbilled services primarily arise when the revenue recognized exceeds the amount billed to the customer. Such situations occur due to divergences between revenue recognition and the invoicing milestones which are based on predetermined payment terms.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of unearned payments received in excess of revenue recognized. As the contracted services are subsequently performed and the associated revenue is recognized, the deferred revenue balance is reduced by the amount of the revenue recognized during the period. Deferred revenue is classified as a current liability on the condensed consolidated balance sheet as the Company expects to recognize the associated revenue in less than one year.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDc_d6ebf3f8-b24b-427b-924b-6e38540b6c20" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Being Evaluated</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, "Financial Instruments - Credit Losses".  This update requires immediate recognition of management&#8217;s estimates of current expected credit losses ("CECL").  Under the prior model, losses were recognized only as they were incurred.  The new model is applicable to all financial instruments that are not accounted for at fair value through net income.  The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies.  Early adoption is permitted.   The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i29549160a5144e4580af449aef8108b5_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RleHRyZWdpb246ZDA2N2JjMWFlYTcxNDhkZjk1OTEzZWNiODA2OTE2YzNfMzE2_20087b8f-5653-4fbe-863e-5768f628bdf5" continuedAt="ibfcc83fb51b74370b872d8772f228b77" escape="true">Accounts Receivable, Unbilled Services and Deferred Revenue</ix:nonNumeric></span></div><ix:continuation id="ibfcc83fb51b74370b872d8772f228b77" continuedAt="ic867dcba7e73462b98cacb95dc357009"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RleHRyZWdpb246ZDA2N2JjMWFlYTcxNDhkZjk1OTEzZWNiODA2OTE2YzNfMzE4_a0d0bed4-cad2-4ad8-bccc-79ebda4fd9a6" continuedAt="ia5f98d9e11a8453e8ff55706c071a552" escape="true">Accounts receivable and unbilled services were as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic867dcba7e73462b98cacb95dc357009"><div style="margin-top:5pt;text-align:center"><ix:continuation id="ia5f98d9e11a8453e8ff55706c071a552"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:71.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMS0xLTEtMS0xODgxMw_310aa7ea-318a-4a01-9c9a-67558b8ef9b8">5,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMS0zLTEtMS0xODgxMw_d274830c-5cbb-4922-8a9d-8845047c5307">6,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMi0xLTEtMS0xODgxMw_44d5a84d-d340-4f05-bfd3-791820f6ca27">4,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMi0zLTEtMS0xODgxMw_15362270-3b4f-461b-8fe9-13209e35b0e5">4,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable and unbilled services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMy0xLTEtMS0xODgxMw_15e74baf-54bc-46e9-9d21-ef5707e070eb">9,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMy0zLTEtMS0xODgxMw_a5c946c7-3b7b-4068-b5e1-683bc412be1d">10,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNC0xLTEtMS0xODgxMw_81a0248d-1216-4aac-816e-52c86204eb02">630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNC0zLTEtMS0xODgxMw_202473de-68b7-48e7-8ada-b11a1376598b">630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNS0xLTEtMS0xODgxMw_b10c2e46-5e75-486f-aab5-fa9ad0e9a451">9,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNS0zLTEtMS0xODgxMw_da2a21f3-1f9b-4320-b1f6-a82caefdeffe">9,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RleHRyZWdpb246ZDA2N2JjMWFlYTcxNDhkZjk1OTEzZWNiODA2OTE2YzNfMzE1_25fff69c-499d-46ee-aa9e-d42bf9360db6" continuedAt="i3711233fbfdc4afe8ae20d1dfe8b40b0" escape="true">Deferred revenue was as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i3711233fbfdc4afe8ae20d1dfe8b40b0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:71.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjQ2ZjNhMjNmYzU3ZDQ0NTNiZDYzMGNiMmZlMmMzMTJmL3RhYmxlcmFuZ2U6NDZmM2EyM2ZjNTdkNDQ1M2JkNjMwY2IyZmUyYzMxMmZfMS0xLTEtMS0xODgxMw_240261d4-0538-4246-b7f2-e84ef9fdbb15">10,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjQ2ZjNhMjNmYzU3ZDQ0NTNiZDYzMGNiMmZlMmMzMTJmL3RhYmxlcmFuZ2U6NDZmM2EyM2ZjNTdkNDQ1M2JkNjMwY2IyZmUyYzMxMmZfMS0zLTEtMS0xODgxMw_920202f7-dbee-467c-9333-4bc853dc4788">11,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue is shown as a current liability on the Company's condensed consolidated balance sheets.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div id="i29549160a5144e4580af449aef8108b5_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RleHRyZWdpb246Njg1NzBjZjJkMmI2NDY3NGI2ZjNhMDdiYTNiZjJkNTVfMzEzMg_592b6863-ac3c-49d9-828c-569e02efb6b3" continuedAt="ic145293f7cf840978967e9566d4dc5a5" escape="true">Revenue from Contracts with Customers</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic145293f7cf840978967e9566d4dc5a5" continuedAt="i495cae2d22784cc9ae5b3a234b19957d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oncology Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RleHRyZWdpb246Njg1NzBjZjJkMmI2NDY3NGI2ZjNhMDdiYTNiZjJkNTVfMzEzNg_03e234a9-0619-4dac-9ebe-11885ee3aec1" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents disaggregated revenue for the three months ended July 31, 2022 and 2021:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacology services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91fabe7ea07840b0ad07eea382c68f2c_D20220501-20220731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMi0xLTEtMS0xODgxMw_14a6075f-db56-4c45-8113-545768246603">12,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia438aed8edee4499a8c76234ae8091b1_D20210501-20210731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMi0zLTEtMS0xODgxMw_bbf042b6-7019-4a39-93ed-6c809a9a0d21">10,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other TOS revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98127e2a2ada454e83135bf30e7094f4_D20220501-20220731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMy0xLTEtMS0xODgxMw_14f54c4c-b8a5-47eb-8014-5b86961c4ebe">948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5707fdf6d74465854a45083439a864_D20210501-20210731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMy0zLTEtMS0xODgxMw_9279008b-410b-4b00-922d-1271b37ae498">526</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personalized oncology services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cd432221fb46c5b2ff6c3f14dae6c0_D20220501-20220731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNC0xLTEtMS0xODgxMw_bfb5a387-0f5d-47af-aaa1-8967a80c513a">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7484f64f1cd4b20ba501dd09db89691_D20210501-20210731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNC0zLTEtMS0xODgxMw_c1d31b4d-e0bf-4788-8d68-f88b726f87fa">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oncology services revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNS0xLTEtMS0xODgxMw_0ea7f1b0-feff-4e6a-9b31-9985a2e0d78d">13,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNS0zLTEtMS0xODgxMw_3fd14d05-2bf4-4b88-8476-fc6332b815f4">11,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other TOS revenue represents additional services provided to the Company's pharmaceutical and biotechnology customers, specifically flow cytometry services and SaaS provided via our Lumin Bioinformatics software ("Lumin").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i495cae2d22784cc9ae5b3a234b19957d">Contract assets include unbilled amounts typically resulting from revenue recognized in excess of the amounts billed to the customer for which the right to payment is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are classified as current. Contract liabilities consist of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period. Contract assets and liabilities are presented on the balance sheet on a net contract-by-contract basis at the end of each reporting period.</ix:continuation> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div id="i29549160a5144e4580af449aef8108b5_46"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTMyMg_e25e043f-8eb3-4667-b4e0-70b080b28e2a" continuedAt="i8c6db013c38144f0bf5752bd407c529b" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="i8c6db013c38144f0bf5752bd407c529b" continuedAt="id5ad5feb73d447979dc980e453516fba"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is recorded at cost and primarily consists of laboratory equipment, computer equipment and software, capitalized software development costs, and furniture and fixtures. Depreciation and amortization is calculated on a straight-line basis over the estimated useful lives of the various assets ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzI3_71ed8872-0f98-4a2c-950c-1fa4fcc01343">three</span> to <ix:nonNumeric contextRef="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzMz_f9d6074e-5c21-4823-88c2-8668a40dcb2a">nine years</ix:nonNumeric>. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTMxOQ_a28cb09a-c31d-4cd6-a372-4517f5c0d77f" continuedAt="i1d3a88732236465ea1ae0a88cce15c3f" escape="true">Property and equipment consisted of the following (table in thousands):</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i1d3a88732236465ea1ae0a88cce15c3f" continuedAt="i6d6737f975ec4cbeafadfd7b6d95ed9a"> </ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id5ad5feb73d447979dc980e453516fba" continuedAt="ifd47524d62034dab8e3042ea25561e5d"><div style="margin-top:5pt"><ix:continuation id="i6d6737f975ec4cbeafadfd7b6d95ed9a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia612a5a694ed4a2aab99e2c1b7c1e7b9_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMS0xLTEtMS0xODgxMw_26c9f620-cf46-48bf-b1f3-8fba852a5860">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2bd8d2bae64d3a8a1229b5763b483f_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMS0zLTEtMS0xODgxMw_93b7742c-dce6-4c7b-a1be-a1cd191a0aeb">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99022b6aeb5849f68381125e8cdb97ea_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMi0xLTEtMS0xODgxMw_8bf7024e-1942-422e-af87-b91a792ee61a">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11effbe8666d492bb6247738f880f0a4_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMi0zLTEtMS0xODgxMw_c3578cc2-0379-445b-8ea0-95fae876bfbf">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5212cdfd144c8188adcfed3bf2b746_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMy0xLTEtMS0xODgxMw_3af0cbca-a22b-466f-8f98-a2b6bac26dae">1,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee763a8872248559a69477fb7ba51ef_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMy0zLTEtMS0xODgxMw_65943223-9579-4435-9053-017aebd891af">1,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7470cfb3a4e24c169da0a95c73f21990_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNC0xLTEtMS0xODgxMw_b6f8cc72-c258-4dbe-82dc-e675382f42b3">9,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba47105892b84c23a2e865ef51894ed5_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNC0zLTEtMS0xODgxMw_86215522-32bc-4e3d-8ac7-cd99c8886f8a">8,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57b0077fa424cfa9994c70df2820ec2_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNS0xLTEtMS0xODgxMw_88eda126-2c21-4bf9-b755-1961ec65107b">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7446b75d7234b01989cb3824d3109aa_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNS0zLTEtMS0xODgxMw_ce2d4206-93e5-4ade-8b2c-893b5513331b">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7b897b038814dab831bf20fd743486c_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNi0xLTEtMS0xODgxMw_f0a45050-2cc5-467e-bbe3-c454e7e73b28">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id123ab3740ed4938a93cc09d1793ca01_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNi0zLTEtMS0xODgxMw_beeb9d93-7645-4dd0-81ca-a909ea0819e0">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOC0xLTEtMS0xODgxMw_96991f6d-1039-4588-9a2d-1ca35b2e897a">13,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOC0zLTEtMS0xODgxMw_39ecd58a-191d-415d-a411-e4da1a3aeb05">12,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOS0xLTEtMS0xODgxMw_06138550-3fc3-4c2f-8a7a-38339f876c22">6,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOS0zLTEtMS0xODgxMw_cc4c7596-7a7f-4e45-b290-c0e661c2b467">5,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233">Property and equipment, net</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMS0xLTEtMTg4MTM_5afda43b-f8f8-4ffa-8f3e-ff6b507b8365">7,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMy0xLTEtMTg4MTM_b8fbabf9-95f1-4e70-9e85-eab2fa526b6d">7,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTEw_9c22f49b-3d49-4dc8-8f13-f7c19be6818d">528,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i12ebeded0a02450a9d446437bbbc576c_I20210731" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTE3_81bac4f4-c851-4b4a-a2f7-1b668cdc6810">317,000</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively. Depreciation and amortization expense, excluding expense recorded under finances leases, was $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMDY1OQ_eeabdbfa-d439-4f17-84b7-c6128189537e">499,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMDY2OA_4f408684-262b-4249-b882-621f09556c25">317,000</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;31, 2022 and April&#160;30, 2022, property, plant and equipment included gross assets held under finance leases of $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNjU4_00cfbdef-b56d-43c9-aa11-c44400d526ae">1,081,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTg2MQ_ef2f9962-68d9-4897-baae-a6f97471a693">713,000</ix:nonFraction>, respectively. Related depreciation expense was approximately $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="csbr:FinanceLeaseDepreciationAndAmortizationExpenses" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNzA5_4cb4bab1-1534-4c1c-ab97-9ee44967cfed">29,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="csbr:FinanceLeaseDepreciationAndAmortizationExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNzE2_669641d1-01fe-4ae9-9bbb-d3cea5ecb33d">0</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized software development costs under a hosting arrangement</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the cost of computer software obtained or developed for internal use as well as the software development and implementation costs associated with a hosting arrangement ("internal-use software") that is a service contract in accordance and with ASC 350, Intangibles - Goodwill and Other ("ASC-350"). We capitalize certain costs in the development of our internal-use software when the preliminary project stage is completed and it is probable that the project itself will be completed and the software will perform as intended. These capitalized costs include personnel and related expenses for employees and costs of third-party consultants who are directly associated with and who devote time to these internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended purpose. Costs incurred for significant upgrades, increased functionality, and enhancements to the Company's internal-use software solutions are also capitalized. Costs incurred for training, maintenance, and minor modifications are expensed as incurred. Capitalized software development costs are amortized using the straight-line method over an estimated useful economic life of <ix:nonNumeric contextRef="i6dfc15decd0849a7ba09ebc4e674af89_D20220501-20220731" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMjA5MA_50ad1c6c-2e63-4662-af02-177d0fd5865b">three years</ix:nonNumeric>.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has capitalized development and implementation costs in accordance with accounting guidance for its Lumin platform. Lumin is the Company's oncology data-driven software program and data tool which operates as Software as a Service. These capitalized costs represent salaries, including direct payroll-related costs, certain software development consultant expenses and molecular sequencing programming costs incurred in the engineering and coding of the software development. Capitalized costs are classified as assets in progress during the development process until development is complete and the asset is available for sale. The initial version of the Lumin platform was launched during fiscal year 2021, at which time initial capitalization ceased and amortization commenced. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continued to develop increased functionality, expand product design and usability, and add enhancements to the Lumin platform. In accordance with accounting guidance, these costs were capitalized. This developmental work did not render the initial released version to be obsolete or diminished in value but, rather, added to the base functionality of the existing platform. During the third quarter of fiscal year 2022, these capitalized costs were placed into service as the enhanced version was launched and made available for sale. The total cost of the Lumin asset placed into service and available for sale was $<ix:nonFraction unitRef="usd" contextRef="ibc1695cc594a4e7cad70f212f82cb391_I20220131" decimals="-5" name="us-gaap:ServicingAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTgyMg_e9120e9d-5a3e-4bff-b394-79bebd9c5e86">1.9</ix:nonFraction>&#160;million. As of July&#160;31, 2022, the carrying value of the asset net of accumulated amortization was $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-5" name="us-gaap:ServicingAssetAtAmortizedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTQ5NzU1ODI2NzQy_90daa031-b6b2-4d65-b17e-a38ba1e3e262">1.3</ix:nonFraction>&#160;million. Amortization expense related to this asset was $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMzczMA_b19f0d40-256a-4185-8042-60eff0c88a36">157,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMzc0MQ_9fd090d2-c61c-4dbc-8b80-5621f88b0806">40,000</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Lease</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifd47524d62034dab8e3042ea25561e5d"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2022, the Company recognized a finance lease for laboratory equipment. This equipment was obtained as the result of a laboratory supplies purchase commitment with costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430" decimals="-3" name="csbr:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc3Mg_ee0e6733-3558-43fd-b45f-0e98da1f4f65">370,000</ix:nonFraction> at inception through December 2025. Cash payments for this lease are in the form of consideration for purchasing lab supplies under a purchase commitment agreement. At the commencement of the commitment, the present value of the minimum future obligations of $<ix:nonFraction unitRef="usd" contextRef="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430" decimals="-3" name="csbr:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc2Mg_903ddc57-f888-4310-9156-a594c7a1beb4">370,000</ix:nonFraction> was calculated based on an interest rate of <ix:nonFraction unitRef="number" contextRef="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430" decimals="INF" name="csbr:PresentValueMinimumFutureObligationsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc1NQ_59fc5895-bf6d-4e84-b524-d6f5b2a5875c">3.25</ix:nonFraction>%. Depreciation and amortization expense related to this finance lease was $<ix:nonFraction unitRef="usd" contextRef="i9b610a04f8314e00a08a6a9b91c33292_D20220501-20220731" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzNjU2Nw_a90c29b9-d580-4531-b5b0-da9f1dd244c8">18,000</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="id7396db6674049dd925725f824b27e50_D20210501-20210731" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc1Mw_0f7e180a-f5a2-4810-ad6d-2e30473129d7">zero</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2023, the Company recognized a finance lease for laboratory equipment. This equipment was obtained as the result of a laboratory supplies purchase commitment with costs of approximately $<ix:nonFraction unitRef="usd" contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731" decimals="-3" name="csbr:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc0NA_92c6ebf5-5caa-4212-832d-d72273ef9544">368,000</ix:nonFraction> at inception through June 2027. Cash payments for this lease are in the form of consideration for purchasing lab supplies under a purchase commitment agreement. The present value of the minimum future obligations of $<ix:nonFraction unitRef="usd" contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731" decimals="-3" name="csbr:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTczNA_25f69b4d-2226-424c-9e05-ce24617fa7f7">368,000</ix:nonFraction> was calculated based on an interest rate of <ix:nonFraction unitRef="number" contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731" decimals="3" name="csbr:PresentValueMinimumFutureObligationsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTcyOA_5d8753a8-b006-4e32-b304-cf5357678c2b">3.5</ix:nonFraction>%. Depreciation and amortization expense related to this finance lease was $<ix:nonFraction unitRef="usd" contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731" decimals="0" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTgxMQ_2e6c8699-b44a-4d1a-9d8a-9a4895f70f7f">11,250</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="id42bfc0d6ba246b783fdd25ce27859cb_D20210501-20210731" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTcyNg_dfd72023-bc83-439a-8a58-014471c13862">zero</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1OQ_ecaf7f2e-613b-4c22-8cbe-639eee9f61da" continuedAt="i095bdb65e04e4047a5f2032647f149aa" escape="true">Share-Based Payments</ix:nonNumeric></span></div><ix:continuation id="i095bdb65e04e4047a5f2032647f149aa" continuedAt="i0922e288342a46fabc98caada11c36fc"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1MQ_6464855f-7bdb-4cc8-a24d-8e134f227864" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was recognized as follows (table in thousands):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.011%"><tr><td style="width:1.0%"></td><td style="width:65.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.749%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.960%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.961%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca13514049f49afa46dab0656a44d2a_D20220501-20220731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMi0xLTEtMS0xODgxMw_1e14b17d-b344-488f-9383-5b77fb3addfd">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bab8e5b86cc43df8e6b97165cdc5f3c_D20210501-20210731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMi0zLTEtMS0xODgxMw_6b20d405-0413-41fc-bf2c-3a2d21b50067">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3752fc3c3d8408694ab9b64622ad170_D20220501-20220731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMy0xLTEtMS0xODgxMw_fb785f99-9bd3-42d4-81cf-0a6947e8c619">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5753fa1a19a74139a0f74c566b7aa853_D20210501-20210731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMy0zLTEtMS0xODgxMw_ad8d690a-445e-418c-93fe-b86c7058cc1b">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e1fd8a290f4d44b5e8552f71eede35_D20220501-20220731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNC0xLTEtMS0xODgxMw_ca7ab1ff-f7d8-4f68-8201-79dfe14af3aa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51dcfb3a899c4a8e813069354ef8efcd_D20210501-20210731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNC0zLTEtMS0xODgxMw_d4239d2e-939e-4262-a53e-538a0abe9a8d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb0d823f162b4a5193235bd46686af4b_D20220501-20220731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNS0xLTEtMS0xODgxMw_c13768a8-f2d4-492e-a222-a734fd66e2fe">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3f6897bc8834b8f904bba44f16469a8_D20210501-20210731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNS0zLTEtMS0xODgxMw_65bcc66b-cfe1-4051-a938-8958d8a65345">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNi0xLTEtMS0xODgxMw_5c26faca-a967-4224-bb95-5b5c05583700">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNi0zLTEtMS0xODgxMw_77893e46-2156-4e98-a7f9-af3b1fe692db">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has in place a 2021 Equity Incentive Plan and 2010 Equity Incentive Plan ("the Plans"). In general, these plans provide for stock-based compensation to the Company&#8217;s employees, directors and non-employees. The plans also provide for limits on the aggregate number of shares that may be granted, the term of grants and the strike price of option awards. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Equity Incentive Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the 2021 Annual Shareholders Meeting, shareholders approved the adoption of the 2021 Equity Incentive Plan (&#8220;2021 Equity Plan&#8221;). The purpose of the 2021 Equity Plan is to grant (i) Non-statutory Stock Options; (ii) Incentive Stock Options; (iii) Restricted Stock Awards; and/or (iv) Stock Appreciation Rights (collectively, stock-based compensation) to its employees, directors and non-employees. Total stock awards under the 2021 Equity Plan shall not exceed <ix:nonFraction unitRef="shares" contextRef="i4ac79db879ea4f6eb1f558ff7ea89f1d_I20210430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0Mjg5OA_0571aa4f-5273-467a-847a-5fdac699ddae">2</ix:nonFraction>&#160;million shares of common stock. Options and Stock Appreciation Rights expire no later than <ix:nonNumeric contextRef="i45d9fcd2385f4e39a7cbdd2d532819d7_D20220501-20220731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkwOA_a2b79001-cf6f-47ff-b263-dbe3010df7ab">ten years</ix:nonNumeric> from the date of grant and the awards vest as determined by the Board of Directors. Options and Stock Appreciation Rights have a strike price not less than <ix:nonFraction unitRef="number" contextRef="i45d9fcd2385f4e39a7cbdd2d532819d7_D20220501-20220731" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkxMA_2b0ea322-1238-41e5-b28f-14355d68cae3">100</ix:nonFraction>% of the fair market value of the common stock subject to the option or right at the date of grant. As of July&#160;31, 2022, approximately <ix:nonFraction unitRef="shares" contextRef="i0ce03b4537c94cf7b7799c4e749ac6bc_I20220731" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkxNg_1c31a694-ac08-467f-8023-100c2c812422">1.7</ix:nonFraction>&#160;million shares were left to issue under this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2010 Equity Incentive Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2011, shareholders owning a majority of the issued and outstanding shares of the Company executed a written consent approving the 2010 Equity Incentive Plan (&#8220;2010 Equity Plan&#8221;). The purpose of the 2010 Equity Plan is to grant (i) Non-statutory Stock Options; (ii) Restricted Stock Awards; and (iii) Stock Appreciation Rights (collectively, stock-based compensation) to its employees, directors and non-employees. Total stock awards under the 2010 Equity Plan shall not exceed <ix:nonFraction unitRef="shares" contextRef="i080c253670fa426ea429272a7273cf12_D20110218-20110218" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkyOQ_b3a3e423-19b1-4801-8e31-9163c3e762be">30</ix:nonFraction> million shares of common stock. Options and Stock Appreciation Rights expire no later than <ix:nonNumeric contextRef="i86bc626a809147259f5f564000ed6a2d_D20220501-20220731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0Mjk0MA_24ff7cf1-fcdc-4b7e-ac2f-e019ef71ef98">ten years</ix:nonNumeric> from the date of grant and the awards vest as determined by the Board of Directors. Options and Stock Appreciation Rights have a strike price not less than <ix:nonFraction unitRef="number" contextRef="i86bc626a809147259f5f564000ed6a2d_D20220501-20220731" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0Mjk0Mg_e826adb7-fa27-41a8-a6c8-c71ddef8c0cf">100</ix:nonFraction>% of the fair market value of the common stock subject to the option or right at the date of grant. After February 2021, no more shares were available to be issued from this plan.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Grants</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0922e288342a46fabc98caada11c36fc"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1Mg_995d0a05-a874-4f0c-84e5-0da391777b1b" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.192%"><tr><td style="width:1.0%"></td><td style="width:35.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.200%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.200%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.204%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMi0xLTEtMS0xODgxMy90ZXh0cmVnaW9uOmMxYjM4NDQzOGVhNDQzN2NhYmM0MjZkMzI0ZmI4Y2ZiXzQ_f302694d-7bd6-42ff-a3b1-c43dae2a5d45">6</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMi0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOmIwNzc5NGE4NTMyNjQ0ZDJiMzA3ZGQ3NzNiZGExOTYzXzU0OTc1NTgxMzg4ODY_f775e16d-8a93-43f4-9fad-7313dd8d8159">6</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMy0xLTEtMS0xODgxMy90ZXh0cmVnaW9uOjFjYjUxYjhhMTZmNTQ2ZmZiZDgwZjM5ZWQ0Yjk5ZWQ2XzQ_d3a4a2a7-2e3a-4598-95b5-017ce92eca02">2.87</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMy0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOjczOWYxN2VkYmU5YTRmZGZiY2Q3ZjFkMjhlNmQzODdkXzQ_8179ea08-d121-459a-8c4d-4a75643211a0">0.82</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNC0xLTEtMS0xODgxMy90ZXh0cmVnaW9uOmUxZjU5ZTQ2MGFiNTQwZDM4NWRlZjc2YmI1MTg0MzYxXzQ_52ccfc61-08a0-43ab-b6d7-2a90f869c201">62.58</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNC0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOmFjZDZlNTM5ODhmZTRiZWM5YjhlMzBiNDhiOTk4YjBmXzQ_6085c2e2-4403-491f-9179-7d8b449661a7">65.94</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNC0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOmFjZDZlNTM5ODhmZTRiZWM5YjhlMzBiNDhiOTk4YjBmXzU0OTc1NTgxMzg4ODk_6d585173-7840-46b0-9e9f-0619759f7d75">66.21</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNS0xLTEtMS0xODgxMw_70588a4e-00fb-4828-8e61-0d5a318e6ef9">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNS0zLTEtMS0xODgxMw_c23f5c6e-f4f2-476a-984d-b428e1af598f">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the three months ended July 31, 2022 and 2021 was $<ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfOTQ2_578a39c0-c781-4246-a487-39f642d7e1f9">4.50</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfOTUz_a9516a49-018d-40d2-8e1a-a86f27eafd25">5.33</ix:nonFraction>, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1Mw_ab08cb70-1967-48ae-80e4-8789e01fa7be" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock options activity for the three months ended July 31, 2022 was a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s follows:</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:28.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors<br/>and<br/>Employees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-<br/>Employees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, April 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b9d5525af9d4411bcbf399d302cd535_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS0xLTEtMS0xODgxMw_85db92a8-7cd3-4638-b480-3930a35118e9">1,617,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifd81da0b91f449c284d6c5416e74f934_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS0yLTEtMS0xODgxMw_22eec4e4-32e6-4457-a270-12f0be99e9cd">40,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS01LTEtMS0xODgxMw_97a2c8eb-a026-4c55-91b1-83d267cfd45c">1,658,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS03LTEtMS0xODgxMw_2b68c66a-ce46-4a5f-a5a1-9f78ea169a13">4.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i96b45f148ed94f2b987822093a127b64_D20210501-20220430" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS05LTEtMS0xODgxMw_69aeb27f-646f-4376-a2c8-2cab6a269016">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS0xMS0xLTEtMTg4MTM_dbab6dd0-204a-48ee-8198-74b38f0c6b14">6,131,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi0xLTEtMS0xODgxMw_a2aaa03c-91b7-4439-925a-a8d3c77e200c">78,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi0yLTEtMS0xODgxMw_9b2731fa-5803-4b54-8ece-e29ecf0cba78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi01LTEtMS0xODgxMw_d73dc64a-5ae5-4b30-9a70-bf93ff7fd59a">78,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi03LTEtMS0xODgxMw_7785f9be-8799-420a-8f55-d41fc94eacbe">7.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi05LTEtMS0xODgxMw_01884120-2a83-45a7-981d-68aed0ac28c5">9.90</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC0xLTEtMS0xODgxMw_839a9472-1a77-4f6e-ac6b-21c76b9c7918">7,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC0yLTEtMS0xODgxMw_937f9650-79da-4488-ac5f-bbbae654cdb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC01LTEtMS0xODgxMw_cb558559-19c2-4212-95bd-8aa8c29d4f49">7,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC03LTEtMS0xODgxMw_127110c6-07dc-4261-90aa-f5e1c35fb9bc">7.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731" decimals="INF" name="csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS0xLTEtMS0xODgxMw_64479959-0d01-4b83-a798-82a9317a5f5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731" decimals="INF" name="csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS0yLTEtMS0xODgxMw_cb0c816d-2c76-4ebd-8df6-1e655efa136e">1,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="INF" name="csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS01LTEtMS0xODgxMw_e368351d-e36f-4c8e-9847-285a24bcdbce">1,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" name="csbr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS03LTEtMS0xODgxMw_00e2dc4d-8b63-4242-8f62-dd39b6d40cd6">4.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi0xLTEtMS0xODgxMw_90d076a6-9e25-4ad1-a003-65585c5b8d94">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi0yLTEtMS0xODgxMw_eee16b58-f110-4a99-824d-be140be4f555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi01LTEtMS0xODgxMw_655bd1e2-f0c8-407f-b653-8798e4be9f98">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi03LTEtMS0xODgxMw_41d08153-3792-49c4-8e52-0f69ca63c82b">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6e0ef2a12e441258eba05a1fce64ef5_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC0xLTEtMS0xODgxMw_2f5b1301-dc29-4077-be0a-a6039897abc3">1,683,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC0yLTEtMS0xODgxMw_733daa80-9f6e-497c-a757-2c9aefbfeaf2">39,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC01LTEtMS0xODgxMw_eeef82a9-b8a1-4521-86ce-d21c698a8d7b">1,722,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC03LTEtMS0xODgxMw_b8a6aca1-3e38-48d7-bd08-deec9e4919b6">4.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC05LTEtMS0xODgxMw_faa81b3c-7d3c-490d-a050-f925cb7e8697">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC0xMS0xLTEtMTg4MTM_62f84bd2-d015-437d-82a2-488969749907">7,462,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6e0ef2a12e441258eba05a1fce64ef5_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtMS0xLTEtMTg4MTM_4de18112-a3d9-4d24-afde-a2dc117a7a02">1,683,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtMi0xLTEtMTg4MTM_8ef141dd-4c0a-4bfd-99f6-28264bedbe22">39,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtNS0xLTEtMTg4MTM_2b42f1dd-b4b5-4650-b079-c25c5b91e8ad">1,722,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtNy0xLTEtMTg4MTM_908abc1f-c498-4862-b04e-3deae7be0ce9">4.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtOS0xLTEtMTg4MTM_80a57f51-6b1f-41d8-a48c-4d2b5525916d">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtMTEtMS0xLTE4ODEz_0c2c76a4-7af8-4cc6-90f5-909a33fbdac8">7,462,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6e0ef2a12e441258eba05a1fce64ef5_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItMS0xLTEtMTg4MTM_ff8690f1-d8dc-4c17-9b64-46fa843e5b0d">1,380,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItMi0xLTEtMTg4MTM_b223cf40-313c-4f4e-8e2a-8ccc488c1d68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItNS0xLTEtMTg4MTM_2cb4eccf-a9ed-4c36-8ff9-7bdd07d2a1e4">1,380,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItNy0xLTEtMTg4MTM_096706d6-2ac0-4c3d-ae06-7b3d6fe537f0">4.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItOS0xLTEtMTg4MTM_54b7babb-9b1b-497b-bfbe-e52721b49ad5">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItMTEtMS0xLTE4ODEz_b4e76031-c3bd-4b77-af34-3a646fe2580e">6,846,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i29549160a5144e4580af449aef8108b5_52"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDU5Ng_2ad9a436-b868-406d-bf0a-18081a97eff0" continuedAt="i733f312670584c009d4c187e0b0d50bc" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i733f312670584c009d4c187e0b0d50bc" continuedAt="if194b91c660a4e75b75a3d4d9fffdab0"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently leases certain office equipment and its office and laboratory facilities under non-cancelable operating leases. Rent expense for operating leases is recognized on a straight-line basis over the lease term from the lease commencement date through the scheduled expiration date. Rent expense totaled $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDg3NA_1868e1e5-c425-4c63-988e-e02123ada6d8">467,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDg4NA_0a9d7abc-9a2f-4a56-a6dd-254c8d74c7d9">452,000</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively. The Company considers its facilities adequate for its current operational needs.</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the following facilities:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">One University Plaza, Suite 307, Hackensack, New Jersey 07601, which, since November 2011, serves as the Company&#8217;s corporate headquarters. The lease was renewed during fiscal year 2022 and expires in November 2026. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="iafaf30d9b4bb4f1a9ecbae72caf1fb8f_D20220501-20220731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDg5NA_071a5e84-f8ca-45d4-8890-563f94cd4e6d">21,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib1ac3aca3d2e4e09a8d672880d693ede_D20210501-20210731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkwMw_8717ad0c-0415-407c-a962-f25b3dcd59b8">24,000</ix:nonFraction> of rent expense relative to this lease for the three months ended July 31, 2022 and 2021, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if194b91c660a4e75b75a3d4d9fffdab0"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1330 Piccard Drive Suite 025, Rockville, MD 20850, which consists of laboratory and office space where the Company conducts operations related to its primary service offerings. The Company executed this lease (the "Original Premises") on January 11, 2017. The operating commencement date was August&#160;11, 2017. This lease was originally set to expire in August 2028. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">On March 30, 2020, the Company executed the first amendment to this lease to expand the existing premises at 1330 Piccard Drive, Suite 025 ("Expansion Premises") to add on Suites 050 and 104.  This amendment also extended the current lease term by <ix:nonNumeric contextRef="i53b7f92a0f504fe8a62ea065fb7de171_I20200330" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTUxMQ_345d3397-4963-483d-bd0f-184f11b7e262">six months</ix:nonNumeric>.  The Expansion Premises operating lease commencement date was June 1, 2020 and, under the amendment, both leases expire February 28, 2029.  </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In accordance with ASC 842, "Leases", the Company evaluated the first amendment and also performed a reassessment of the existing lease for Suite 025 to determine the impact of the <ix:nonNumeric contextRef="i53b7f92a0f504fe8a62ea065fb7de171_I20200330" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDU5Nw_4805de50-e780-4131-9418-66d50c9f9243">six-month</ix:nonNumeric> term extension.  As a result of this assessment, the Company recognized an additional operating ROU asset and related operating lease liability for Suite 025 of $<ix:nonFraction unitRef="usd" contextRef="if0a29219b6d948bfb1a15242e7e2ee28_I20200731" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjAwNw_df4dda9c-b69f-49ca-9e77-7b95758c2c5b">118,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if0a29219b6d948bfb1a15242e7e2ee28_I20200731" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjAxNA_c4fada49-b6af-4c25-bc4f-c7c3ab547838">125,000</ix:nonFraction>, respectively, as well as an incremental net rent expense of $<ix:nonFraction unitRef="usd" contextRef="i1318dfe0a0ec49f5acc43f0ba736b4ba_D20200501-20200731" decimals="-3" name="csbr:OperatingLeaseIncrementalRentExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjA3OA_8bf1de5f-5426-4421-a8b0-184b1f4b7072">8,000</ix:nonFraction> during the three months ended July 31, 2020 related to fiscal year 2021.  </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Upon the Expansion Premises operating lease commencement date (June 1, 2020), the Company recognized an operating ROU asset and related operating lease liability for Suites 050 and 104 of $<ix:nonFraction unitRef="usd" contextRef="i708a863763c143c7b34dd9a365f1231f_I20200601" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjMxNg_242bfdb8-31c0-457e-8de6-e3a7f48e4b15"><ix:nonFraction unitRef="usd" contextRef="i708a863763c143c7b34dd9a365f1231f_I20200601" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjMxNg_3d349e46-a743-4b54-9c14-8d09dc3d329e">3.8</ix:nonFraction></ix:nonFraction> million, each, respectively.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">On December 22, 2020, the Company executed the second amendment to this lease to expand the existing premises at 1330 Piccard Drive, Suites 025, 050, and 104 ("Additional Expansion Premises") to add on Suite 201.  The Additional Expansion Premises operating lease commencement date is April 1, 2021 and, under the second amendment, reaffirms that all three leases expire February 28, 2029.  Upon the Additional Expansion Premises operating lease commencement date (April 1, 2021), the Company also recognized an operating ROU asset and related operating lease liability for Suite 201 of $<ix:nonFraction unitRef="usd" contextRef="idf77001db0284d6e948b1a45819dd957_I20210401" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMzEyMA_8c738813-01af-412c-9b05-66cd7e691011"><ix:nonFraction unitRef="usd" contextRef="idf77001db0284d6e948b1a45819dd957_I20210401" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMzEyMA_fa13b3b6-3607-4108-a76e-04c44e338791">3.3</ix:nonFraction></ix:nonFraction>&#160;million, each, respectively.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">For the leases related to the premises at Piccard Drive, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i900f808a09d14b639e4c9009b851f365_D20210501-20210731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDk0MA_3a170ef1-5d1f-42ea-ad7f-c71e5a8aee09"><ix:nonFraction unitRef="usd" contextRef="i1bf7db3dbce34511bf24eb8231dc9fb6_D20220501-20220731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDk0MA_c2e3c17e-6834-4aee-b604-b582ae702732">422,000</ix:nonFraction></ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">VIA LEONE XIII, 14, Milan, Italy, which consists of laboratory and office space where the Company conducts operations related to its flow cytometry service offerings. The Company executed the lease for its laboratory space in June 2021, and commenced occupancy during the three months ended October 31, 2021. This lease expires May 2023. The Company executed the lease for its office space on October 1, 2021. This lease expires September 2027.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company recognized an operating ROU asset and related operating lease liability for the lab and office space of $<ix:nonFraction unitRef="usd" contextRef="i3b3db1ffdd35458cb1b2797cc1c3e7a7_I20220731" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkzMA_2aa51f56-7e07-4767-addc-d18b244c22f9"><ix:nonFraction unitRef="usd" contextRef="i3b3db1ffdd35458cb1b2797cc1c3e7a7_I20220731" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkzMA_74fd514c-4d50-481c-b28e-e5614d47901b">205,000</ix:nonFraction></ix:nonFraction> each, respectively.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company recognized rent expense associated with these leases of $<ix:nonFraction unitRef="usd" contextRef="ib656d8c6403f4dc78fd543334a957220_D20220501-20220731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjE5OTAyMzI2Mjc2NA_ead4c993-4676-412f-aa91-730e4368e195">23,000</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i4fa35d5bbbd94ab5a12de9c850a4deef_D20210501-20210731" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkyOA_d954167c-9034-4ee1-bd82-5796104a7d92">zero</ix:nonFraction> for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="csbr:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDYwNA_96e5f4bd-8bc6-441e-b8d8-a288bf1490f3" continuedAt="ib1b48a48b07549c8aa17625d230aa60b" escape="true">ROU assets and lease liabilities related to our current operating leases are as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center;text-indent:9pt"><ix:continuation id="ib1b48a48b07549c8aa17625d230aa60b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"></td><td style="width:49.822%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net<br/></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMS0xLTEtMS0xODgxMw_4087b9a3-bfd6-46e1-a7ae-4643e02d90ed">7,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMS0yLTEtMS0xODgxMw_fbb29892-fb2b-4645-8cab-36a960b9cffd">8,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMi0xLTEtMS0xODgxMw_8a0b620b-d9c2-4822-8736-5e7463396177">1,099</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMi0yLTEtMS0xODgxMw_172b8549-edb4-4174-aa7a-34a89e747716">1,054</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMy0xLTEtMS0xODgxMw_8becd7ac-95cb-47e0-8fa6-49925fb64a72">8,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMy0yLTEtMS0xODgxMw_9c05ad39-0e82-4d70-aa24-d8ba930904aa">8,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 31, 2022, the weighted average remaining operating lease term and the weighted average discount rate were&#160;<ix:nonNumeric contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkxMQ_97c0658f-d256-43e8-9a74-8f6336358650">6.42</ix:nonNumeric> years&#160;and&#160;<ix:nonFraction unitRef="number" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkxMw_703b9200-0796-4b9a-9f02-8f6837601a00">5.73</ix:nonFraction>%, respectively.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDYwNQ_42bfa9f8-7985-4972-a06a-308ec8e8520f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments due each fiscal year as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.385%"><tr><td style="width:1.0%"></td><td style="width:74.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMC0xLTEtMS0xODgxMw_38371987-5887-4039-a0a0-43012f5daaad">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMS0xLTEtMS0xODgxMw_498e752c-61f5-47cc-aecb-a09079c00979">2,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMi0xLTEtMS0xODgxMw_1eac9f07-bb47-4d10-b5e6-9eef2ad400e9">2,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMy0xLTEtMS0xODgxMw_6ee233ef-eee1-43f9-9070-011f0dcda34a">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNC0xLTEtMS0xODgxMw_f96fe49e-02ee-4bff-9f7e-5878413ff812">2,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="csbr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNS0xLTEtMS0xODgxMw_1a16e4b0-11da-477c-a869-e11ce88caeba">5,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total undiscounted liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNi0xLTEtMS0xODgxMw_e344b21b-5512-4158-8509-74725732386d">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNy0xLTEtMS0yMTkzNw_b7e4f583-861a-4c03-b2a6-1d3504a37bfc">9,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfOC0xLTEtMS0yMTkzNw_2ce0643e-04e8-41db-abd2-11f3b64b276d">9,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 5, Property and Equipment, for information on financing leases.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNzYy_122cffe8-c8f3-43a5-883a-905328ba4327" continuedAt="ie7c59211458645369135c53ecc8660ec" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="ie7c59211458645369135c53ecc8660ec" continuedAt="i8e756ffe85354088b7e9e12c8a52215a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related party transactions include transactions between the Company and its shareholders, management, or affiliates.&#160;&#160;The following transactions were in the normal course of operations and were measured and recorded at the exchange amount, which is the amount of consideration established and agreed to by the parties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consulting Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e756ffe85354088b7e9e12c8a52215a">During the three months ended July 31, 2022 and 2021, the Company paid an affiliate of a board member $<ix:nonFraction unitRef="usd" contextRef="ib6fed9c77e8f43daad4d3e42d103bedc_D20220501-20220731" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNDU1_2bb47487-9a8d-44b1-af27-8e969c373813">9,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i851e5a2ac2a74afc89c6b93db67bab8b_D20210501-20210731" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNDYy_d89e882a-94f5-41e9-b909-7a3f50c2d4b9">9,000</ix:nonFraction>, respectively, for consulting services unrelated to his duty as a board member. During the&#160;three months ended July 31, 2022 and 2021, the Company paid an affiliate of another board member $<ix:nonFraction unitRef="usd" contextRef="ie7dd96fbc4b344fc8421b1c148328401_D20220501-20220731" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNjIx_ab239d3e-20f2-4c3c-8dac-1493bae465ec">0</ix:nonFraction>&#160;and&#160;$<ix:nonFraction unitRef="usd" contextRef="i3b1cc212cb794f45b5fa375773a069c2_D20210501-20210731" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNjI4_8d5132d4-335c-4c9e-9499-04d051d049a3">3,000</ix:nonFraction>, respectively, for consulting services unrelated to their duties as a board member. As of July&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNzI1_8a330b29-e4a7-4b97-b02a-db74b99da307">0</ix:nonFraction> was due to these related parties.</ix:continuation>&#160;</span></div><div><span><br/></span></div><div id="i29549160a5144e4580af449aef8108b5_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMjExNg_4d485bf0-000a-4de3-bfb9-70fd3253c93e" continuedAt="i88a7424e4df14950a49d8ed688fc9d01" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i88a7424e4df14950a49d8ed688fc9d01"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently party to any legal matters to its knowledge. The Company is not aware of any other matters that would have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Payment Arrangements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into an Amended and Restated Registration Rights Agreement in connection with the March 2015 Private Placement. This Amended and Restated Registration Rights Agreement contains provisions that may call for the Company to pay penalties in certain circumstances. This registration payment arrangement primarily relates to the Company&#8217;s ability to file a registration statement within a particular time period, have a registration statement declared effective within a particular time period and to maintain the effectiveness of the registration statement for a particular time period. The Company has not accrued any liquidated damages associated with the Amended and Restated Registration Right Agreement as the Company has filed the required registration statement and anticipates continued compliance with the agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with third-party vendors to license tumor samples for development into PDX models and use in our TOS business. These types of arrangements have an upfront fee ranging from <ix:nonFraction unitRef="usd" contextRef="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731" decimals="INF" name="csbr:CollaborationArrangementRoyaltyFee" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMjE5OTAyMzI1NzY2OQ_100512a2-667a-4b1e-89dc-9b95162be16d">nil</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731" decimals="INF" name="csbr:CollaborationArrangementRoyaltyFee" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDA5Mg_532b8955-9e9c-41de-bcb4-b6a729ca5d22">30,000</ix:nonFraction> per tumor sample depending on the successful growth of the tumor model and ability to develop them into a sellable product. The upfront costs are expensed as incurred. In addition, under certain agreements, for a limited period of time, the Company is subject to royalty payments if the licensed tumor models are used for sale in our TOS business, ranging from <ix:nonFraction unitRef="number" contextRef="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731" decimals="INF" name="csbr:CollaborationArrangementRoyaltyFeePercentOfContractPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMjE5OTAyMzI1NzY5MQ_be56b94d-9ca8-4eda-b227-e7bb7d2ea224">2</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731" decimals="INF" name="csbr:CollaborationArrangementRoyaltyFeePercentOfContractPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDEwMQ_e2660ac3-d1ab-48a3-87b8-bee01d9249c9">20</ix:nonFraction>% of the contract price after recouping certain initiation costs. Some of these arrangements also set forth an annual minimum royalty due regardless of tumor models used for sale. For the quarter ended July 31, 2022 and 2021, we have recognized approximately $<ix:nonFraction unitRef="usd" contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDEwNg_467ed7e9-20d8-47dc-af2e-a8b46b2ad4d5">76,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDExNQ_853d77df-537a-4749-94a2-ec1f6f42a9b3">44,000</ix:nonFraction> in expense related to these royalty arrangements, respectively.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div id="i29549160a5144e4580af449aef8108b5_61"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion of our historical results of operations and our liquidity and capital resources should be read in conjunction with the condensed consolidated financial statements and related notes that appear elsewhere in this report and our most recent annual report for the year ended April&#160;30, 2022, as filed on Form 10-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains certain &#8220;forward-looking statements,&#8221; which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation, and availability of resources. These forward-looking statements include, without limitation, statements regarding: proposed new programs; expectations that regulatory developments or other matters will not have a material adverse effect on our financial position, results of operations, or liquidity; statements concerning projections, predictions, expectations, estimates, or forecasts as to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business, financial and operational results, and future economic performance; and statements of management&#8217;s goals and objectives and other similar expressions concerning matters that are not historical facts. Words such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;estimates&#8221; and similar expressions, as well as statements in future tense, identify forward-looking statements.</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made or management&#8217;s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements speak only as of the date the statements are made. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to, those described in &#8220;Risk Factors&#8221; in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended April&#160;30, 2022, as updated in our subsequent reports filed with the SEC, including any updates found in Part II, Item 1A of this or other reports on Form 10-Q, if any. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview and Recent Developments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. Our research center consists of a comprehensive set of computational and experimental research platforms. Our pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. We perform studies which we believe may predict the efficacy of experimental oncology drugs or approved drugs as stand-alone therapies or in combination with other drugs and can stimulate the results of human clinical trials. These studies include in vivo studies that rely on implanting multiple tumors from our TumorBank in mice and testing the therapy of interest on these tumors. Studies may also include bioinformatics analysis that reveal the differences in the genetic signatures of the tumors that responded to a therapy as compared to the tumors that did not respond. Additionally, we provide computational or experimental support to identify novel therapeutic targets, select appropriate patient populations for clinical evaluation, identify potential therapeutic combination strategies, and develop biomarker hypothesis of sensitivity or resistance. These studies include the use of our in vivo, ex vivo, analytical and computational platforms.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     We are engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through our Translational Oncology Solutions ("TOS"). This technology ranges from computational-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing our TumorGraft Technology Platform ("The Platform"), a comprehensive Bank of unique, well characterized models, we provide select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. By performing studies to predict the efficacy of oncology drugs, our Platform facilitates drug discovery with lower costs and increased speed of drug development as well as increased adoption of existing drugs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    As part of our growth strategy, we launched Lumin Bioinformatics ("Lumin"), a new oncology data-driven software program, during fiscal 2021. Our Lumin software contains comprehensive information derived from our research services and clinical studies. Lumin leverages our large Datacenter coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research. It is the combination of the Datacenter and the analytics that create a unique foundation for Lumin. Insights developed using Lumin can provide the basis for biomarker hypotheses, reveal potential mechanisms of therapeutic resistance, and guide the direction of additional preclinical evaluations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our drug discovery and development business leverages the computational and experimental capabilities within our platforms. Our discovery strategy utilizes our rich and unique Datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets. We then employ the use of our proprietary experimental platforms to rapidly validate these targets for further drug development efforts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    We have a rich pipeline of targets at various stages of discovery and validation, with a select group that has progressed to therapeutic development. Our commercial strategy for the validated targets and therapeutics established from this business is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">wide-ranging and still being developed. It will depend on many factors, and will be specific for each target or therapeutic area identified. Any expenses associated with this part of our business are research and development and are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     We regularly evaluate strategic options to create additional value from our drug discovery business, which may include, but are not limited to, potential spin-out transactions or capital raises.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity needs have typically arisen from the funding of our research and development programs and the launch of new products, working capital requirements, and other strategic initiatives. Recently, we have met these cash requirements through cash, working capital management, and sales of products and services.  In the past, we have also received proceeds from certain private placements and public offerings of our securities. For the three months ended July&#160;31, 2022, the Company had a net loss of approximately $319,000 and cash used in operations of $195,000. As of July&#160;31, 2022, the Company had an accumulated deficit of approximately $72.3 million, working capital of $1.8 million, and cash of $8.1 million. We believe that our cash on hand, together with expected positive cash flows from operations for fiscal year 2023, are adequate to fund operations through at least 12 months from the filing of this 10-Q. However, should our revenue expectations not materialize, we believe we have cost reduction strategies that could be implemented without disrupting the business or restructuring the Company. Should the Company be required to raise additional capital, there can be no assurance that management would be successful in raising such capital on terms acceptable to us, if at all.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our operating results for the periods presented below (dollars in thousands):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:44.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended July 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of<br/>Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of<br/>Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology services revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs and operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:44.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.225%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oncology Services Revenue</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oncology services revenue, which is primarily derived from pharmacology studies, was $13.7 million and $11.3 million for the three months ended July 31, 2022 and 2021, respectively, an increase of $2.5 million or 22.1%. The increase in revenue was primarily due to the expansion of our platform and offerings creating demand for our services and leading to larger pharmacology studies in both our in-vivo and ex-vivo platforms. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Oncology Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cost of oncology services for the three months ended July 31, 2022 and 2021 were $7.1 million and $5.4 million, respectively, an increase of $1.7 million or 30.7%.&#160; The increase in cost of oncology services was primarily from compensation, mice and supply expenses resulting from larger study sizes and compensation expense for our SaaS platform. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended July 31, 2022 and 2021, gross margins were 48.7% and 52.0%, respectively. The lower margin resulted from an </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">increase in study related expenses in advance of the revenue recognition. Additionally, SaaS costs were expensed during the three months ended July 31, 2022 compared to capitalized during the three months ended July 31, 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses for the three months ended July 31, 2022 and 2021 were $2.9 million and $2.3 million, respectively, an increase of approximately $583,000 or 25.3%. The increase for the three-month period was mainly due to compensation and lab supply expense related to the investment in our therapeutic drug discovery platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses for the three months ended July 31, 2022 and 2021 were $1.7 million and $1.6 million, respectively, an increase of $118,000, or 7.5%. The increase was mainly due to compensation expense. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses for the three months ended July 31, 2022 and 2021 were $2.4 million and $2.2 million, an increase of $244,000, or 11.3%. General and administrative expenses are primarily comprised of compensation, insurance, professional fees, IT, and depreciation and amortization expenses.  The increase was mainly due to an increase in IT related expenses to support the overall infrastructure growth of the company.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion relates to the major components of our cash flows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Operating Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in operating activities was $195,000 compared to net cash provided by operations of $216,000 for the three months ended July 31, 2022 and 2021, respectively. The cash used in operating activities during the current period was primarily due to reduction in accounts payable and accrued liability balances. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Investing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in investing activities was $754,000 and $907,000 for the three months ended July 31, 2022 and 2021, respectively.  The cash used in investing activities was primarily for the investment in additional lab and computer equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Financing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $0 for the three months ended July 31, 2022 compared to cash used by financing activities $2,000 for the three months ended July 31, 2021.  The decrease on cash provided by financing is related to decrease in stock options exercise activity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates and Policies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to apply methodologies and make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates of the Company include, among other things, accounts receivable realization, revenue recognition (replacement of licensed tumors), valuation allowance for deferred tax assets, valuation of goodwill, and stock compensation and warrant assumptions. Actual results could differ from those estimates. The Company&#8217;s critical accounting policies are summarized in the Company&#8217;s Annual Report on Form 10-K, filed with the SEC on July 22, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For detailed information regarding recently issued accounting pronouncements and the expected impact on our condensed consolidated financial statements, see Note 2, "Significant Accounting Policies" in the accompanying Notes to Condensed Consolidated Financial Statements included in Item 1 of this Report on Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Financing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no off-balance sheet debt or similar obligations.&#160;&#160;We have no transactions or obligations with related parties that are not disclosed, consolidated into or reflected in our reported results of operations or financial position.&#160;&#160;We do not guarantee any third-party debt.</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable to smaller reporting companies.</span></div><div><span><br/></span></div><div id="i29549160a5144e4580af449aef8108b5_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s responsibility to establish and maintain &#8220;disclosure controls and procedures&#8221; as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report. In designing and evaluating our disclosure controls and procedures. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the relationship between the benefit of desired controls and procedures and the cost of implementing new controls and procedures. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has assessed the effectiveness of our internal control over financial reporting as of July 31, 2022. Based on that assessment, our management, including our Chief Executive Officer and our Chief Financial Officer, have concluded that our disclosure controls and procedures were effective as of July 31, 2022 at the reasonable assurance level in ensuring that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure.  Further, management concluded that our consolidated financial statements in this quarterly report on Form 10-Q present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows as of the dates, and for the periods presented, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_70"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_76"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a smaller reporting company, we are not required to provide the information required by this Item; however, the discussion of our business and operations should be read together with the Risk Factors set forth in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on July 22, 2022. Such risks and uncertainties have the potential to affect our business, financial condition, results of operations, cash flow, strategies or prospects in a material and adverse manner.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i29549160a5144e4580af449aef8108b5_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbrq1731202210-qex311.htm">Section 302 Certification of Principal Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbrq1731202210-qex312.htm">Section 302 Certification of Principal Financial Officer </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbrq1731202210-qex321.htm">Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iXBRL Instance Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iXBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iXBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iXBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iXBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iXBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* filed herewith</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** furnished herewith</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i29549160a5144e4580af449aef8108b5_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHAMPIONS ONCOLOGY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: 9/12/022</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ronnie Morris</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronnie Morris</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(principal executive officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: 9/12/022</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David Miller</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Miller</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(principal financial and accounting officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>csbrq1731202210-qex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icde7b61e0f5e4dbd93299a6d387f7e97_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronnie Morris, certify that&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Champions Oncology, Inc., a Delaware corporation&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; September 12, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Ronnie Morris</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronnie Morris</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>csbrq1731202210-qex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if46e448cdbb74ac1be466678fe6ce71b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Miller, certify that&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Champions Oncology, Inc., a Delaware corporation&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; September 12, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;David Miller</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Miller</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>csbrq1731202210-qex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if3178a538f734d9e9626ef94a139e86f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Champions Oncology, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended July&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that to the best of our knowledge&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; September 12, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Ronnie Morris</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronnie Morris</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; September 12, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;David Miller</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Miller</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>csbr-20220731.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ec52204b-131e-4198-92e8-02fb9363ce20,g:7d91c0c2-82c1-4c83-ab39-3140ef69ee6c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:csbr="http://championsoncology.com/20220731" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://championsoncology.com/20220731">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20220731_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20220731_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20220731_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20220731_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://championsoncology.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL" roleURI="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
        <link:definition>1004005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationUseofEstimatesandBasisofPresentation" roleURI="http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Organization, Use of Estimates and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationUseofEstimatesandBasisofPresentationDetails" roleURI="http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentationDetails">
        <link:definition>2402401 - Disclosure - Organization, Use of Estimates and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://championsoncology.com/role/SignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1" roleURI="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails" roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails">
        <link:definition>2408404 - Disclosure - Significant Accounting Policies - Summary of Potentially Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableUnbilledServicesandDeferredRevenue" roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue">
        <link:definition>2109103 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableUnbilledServicesandDeferredRevenueTables" roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables">
        <link:definition>2310302 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails" roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails">
        <link:definition>2411405 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Accounts Receivable and Unbilled Services (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails" roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails">
        <link:definition>2412406 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomers" roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomers">
        <link:definition>2113104 - Disclosure - Revenue from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersTables" roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomersTables">
        <link:definition>2314303 - Disclosure - Revenue from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersDetails" roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomersDetails">
        <link:definition>2415407 - Disclosure - Revenue from Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://championsoncology.com/role/PropertyandEquipment">
        <link:definition>2116105 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://championsoncology.com/role/PropertyandEquipmentTables">
        <link:definition>2317304 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNarrativeDetails" roleURI="http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails">
        <link:definition>2418408 - Disclosure - Property and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentSummaryofPropertyandEquipmentDetails" roleURI="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails">
        <link:definition>2419409 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPayments" roleURI="http://championsoncology.com/role/ShareBasedPayments">
        <link:definition>2120106 - Disclosure - Share-Based Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsTables" roleURI="http://championsoncology.com/role/ShareBasedPaymentsTables">
        <link:definition>2321305 - Disclosure - Share-Based Payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails" roleURI="http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails">
        <link:definition>2422410 - Disclosure - Share-Based Payments - Allocation of Share Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsNarrativeDetails" roleURI="http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails">
        <link:definition>2423411 - Disclosure - Share-Based Payments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails" roleURI="http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails">
        <link:definition>2424412 - Disclosure - Share-Based Payments - Valuation Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsSummaryofStockOptionActivityDetails" roleURI="http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails">
        <link:definition>2425413 - Disclosure - Share-Based Payments - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://championsoncology.com/role/Leases">
        <link:definition>2126107 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://championsoncology.com/role/LeasesTables">
        <link:definition>2327306 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://championsoncology.com/role/LeasesNarrativeDetails">
        <link:definition>2428414 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesROUAssetsandLeaseLiabilitiesDetails" roleURI="http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails">
        <link:definition>2429415 - Disclosure - Leases - ROU Assets and Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails" roleURI="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails">
        <link:definition>2430416 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails_1" roleURI="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>2430416 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://championsoncology.com/role/RelatedPartyTransactions">
        <link:definition>2131108 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://championsoncology.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2432417 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://championsoncology.com/role/CommitmentsandContingencies">
        <link:definition>2133109 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://championsoncology.com/role/CommitmentandContingenciesDetails">
        <link:definition>2434418 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="csbr_BoardMemberOneMember" abstract="true" name="BoardMemberOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_ReversalOfProvisionForDoubtfulAccounts" abstract="false" name="ReversalOfProvisionForDoubtfulAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_FinanceLeaseDomain" abstract="true" name="FinanceLeaseDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_PersonalizedOncologyServicesMember" abstract="true" name="PersonalizedOncologyServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_PharmacologyServicesMember" abstract="true" name="PharmacologyServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="csbr_A2022FinanceLeaseMember" abstract="true" name="A2022FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_EquityIncentivePlan2021Member" abstract="true" name="EquityIncentivePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" abstract="false" name="CollaborationArrangementRoyaltyFeePercentOfContractPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="csbr_NumberOfOperatingSubsidiaries" abstract="false" name="NumberOfOperatingSubsidiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="csbr_PresentValueMinimumFutureObligationsInterestRate" abstract="false" name="PresentValueMinimumFutureObligationsInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="csbr_A2023FinanceLeaseMember" abstract="true" name="A2023FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_FewContractsMember" abstract="true" name="FewContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_CollaborationArrangementRoyaltyFee" abstract="false" name="CollaborationArrangementRoyaltyFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_AssetInProgressMember" abstract="true" name="AssetInProgressMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_RockvilleMDMember" abstract="true" name="RockvilleMDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_OperatingLeaseIncrementalRentExpense" abstract="false" name="OperatingLeaseIncrementalRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_BoardMemberTwoMember" abstract="true" name="BoardMemberTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_FinanceLeaseAxis" abstract="true" name="FinanceLeaseAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="csbr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_AdditionalExpansionPremisesMember" abstract="true" name="AdditionalExpansionPremisesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_EquityIncentivePlan2010Member" abstract="true" name="EquityIncentivePlan2010Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_FinanceLeaseDepreciationAndAmortizationExpenses" abstract="false" name="FinanceLeaseDepreciationAndAmortizationExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="csbr_MilanItalyMember" abstract="true" name="MilanItalyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_ProceedsFromExerciseOfOptionsAndWarrants" abstract="false" name="ProceedsFromExerciseOfOptionsAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_CorporateHeadquartersMember" abstract="true" name="CorporateHeadquartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="csbr_WorkingCapitalDeficit" abstract="false" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="csbr_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>csbr-20220731_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ec52204b-131e-4198-92e8-02fb9363ce20,g:7d91c0c2-82c1-4c83-ab39-3140ef69ee6c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="csbr-20220731.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6820701c-f2fc-42d3-8f13-de1a03d3797d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_40ef5df8-2180-4ad3-8f23-7ddc2d401a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6820701c-f2fc-42d3-8f13-de1a03d3797d" xlink:to="loc_us-gaap_LiabilitiesCurrent_40ef5df8-2180-4ad3-8f23-7ddc2d401a77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a54804ff-d391-45aa-bcaf-fa91f0704eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6820701c-f2fc-42d3-8f13-de1a03d3797d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a54804ff-d391-45aa-bcaf-fa91f0704eae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d7476e10-d814-48a2-b3f9-4422b1a0f0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6820701c-f2fc-42d3-8f13-de1a03d3797d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d7476e10-d814-48a2-b3f9-4422b1a0f0a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fbb2bfac-2aba-4910-a3f8-9ca6ab54499c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_438dc2d7-0888-475b-8d94-3c77ac4b534c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fbb2bfac-2aba-4910-a3f8-9ca6ab54499c" xlink:to="loc_us-gaap_CommonStockValue_438dc2d7-0888-475b-8d94-3c77ac4b534c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b4a6b262-b179-4a2d-8cac-489b07fa1441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fbb2bfac-2aba-4910-a3f8-9ca6ab54499c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b4a6b262-b179-4a2d-8cac-489b07fa1441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ebc3e85b-d821-4825-b454-c75d671f82a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fbb2bfac-2aba-4910-a3f8-9ca6ab54499c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ebc3e85b-d821-4825-b454-c75d671f82a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_36b2f064-8f9b-4590-885e-45595411967e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d4159ef2-b97c-4ad0-88f4-90c416ef72ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36b2f064-8f9b-4590-885e-45595411967e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d4159ef2-b97c-4ad0-88f4-90c416ef72ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ee96a111-0bab-4dae-83a8-d6b6bd53a255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36b2f064-8f9b-4590-885e-45595411967e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ee96a111-0bab-4dae-83a8-d6b6bd53a255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6422abcd-8f7c-46f3-b0c6-e0d80c7f3761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36b2f064-8f9b-4590-885e-45595411967e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6422abcd-8f7c-46f3-b0c6-e0d80c7f3761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_833227df-0f41-4cde-8baa-53ce98cf0d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ef31cc5b-19e4-49bf-9258-2e9cab36396d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_833227df-0f41-4cde-8baa-53ce98cf0d28" xlink:to="loc_us-gaap_AccountsPayableCurrent_ef31cc5b-19e4-49bf-9258-2e9cab36396d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2cc55066-7ce1-4af9-b51c-03c032da19e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_833227df-0f41-4cde-8baa-53ce98cf0d28" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2cc55066-7ce1-4af9-b51c-03c032da19e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9a1ba422-0053-4ee4-b9ab-7fb2c08e3fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_833227df-0f41-4cde-8baa-53ce98cf0d28" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9a1ba422-0053-4ee4-b9ab-7fb2c08e3fc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4e759c7b-0462-45e1-9899-fd569d9cd26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_833227df-0f41-4cde-8baa-53ce98cf0d28" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4e759c7b-0462-45e1-9899-fd569d9cd26a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_dac6a107-8bce-477d-ae15-26a1633a1bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_833227df-0f41-4cde-8baa-53ce98cf0d28" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_dac6a107-8bce-477d-ae15-26a1633a1bc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7688add5-c833-4389-93d1-c98091199701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_45de2e88-c4b8-409e-9485-49fe5feae16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7688add5-c833-4389-93d1-c98091199701" xlink:to="loc_us-gaap_Liabilities_45de2e88-c4b8-409e-9485-49fe5feae16b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0afcc288-af75-4c1f-a00a-847ec5e1368f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7688add5-c833-4389-93d1-c98091199701" xlink:to="loc_us-gaap_StockholdersEquity_0afcc288-af75-4c1f-a00a-847ec5e1368f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_94d9728e-d237-4cb7-b810-6587ea4b7302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_96c6da0b-d4a7-4cd1-99f9-fbe3249c9873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94d9728e-d237-4cb7-b810-6587ea4b7302" xlink:to="loc_us-gaap_AssetsCurrent_96c6da0b-d4a7-4cd1-99f9-fbe3249c9873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0586c686-8da3-453c-b6f9-271f4df46b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94d9728e-d237-4cb7-b810-6587ea4b7302" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0586c686-8da3-453c-b6f9-271f4df46b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a9d2c4d4-9186-4edf-90d7-64e6d3be69be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94d9728e-d237-4cb7-b810-6587ea4b7302" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a9d2c4d4-9186-4edf-90d7-64e6d3be69be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7b9817bf-42ab-4520-9d89-9249a6ede857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94d9728e-d237-4cb7-b810-6587ea4b7302" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7b9817bf-42ab-4520-9d89-9249a6ede857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bbb7635d-2322-4b31-89b9-61b95be9f12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94d9728e-d237-4cb7-b810-6587ea4b7302" xlink:to="loc_us-gaap_Goodwill_bbb7635d-2322-4b31-89b9-61b95be9f12b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="csbr-20220731.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f17dd845-0ca6-486c-9e2f-fa5289680209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a29da02b-035a-4b4b-926a-1ec09bea5719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f17dd845-0ca6-486c-9e2f-fa5289680209" xlink:to="loc_us-gaap_OperatingIncomeLoss_a29da02b-035a-4b4b-926a-1ec09bea5719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5e9bd218-5d67-405f-9e99-a33661262abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f17dd845-0ca6-486c-9e2f-fa5289680209" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5e9bd218-5d67-405f-9e99-a33661262abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_3d273075-e409-4c0a-a232-774093f34c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8aad9182-0ddc-4055-9aae-907298c7b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_3d273075-e409-4c0a-a232-774093f34c41" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8aad9182-0ddc-4055-9aae-907298c7b25f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4e7b6aa4-b213-446d-8e88-cf48702c1eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_3d273075-e409-4c0a-a232-774093f34c41" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4e7b6aa4-b213-446d-8e88-cf48702c1eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_144816a4-8744-4e94-9dfb-7033d7b3a825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_3d273075-e409-4c0a-a232-774093f34c41" xlink:to="loc_us-gaap_SellingAndMarketingExpense_144816a4-8744-4e94-9dfb-7033d7b3a825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_202583e6-9832-40db-acd8-5841582373e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_3d273075-e409-4c0a-a232-774093f34c41" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_202583e6-9832-40db-acd8-5841582373e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_76872940-72e9-4c59-bd5d-692742ee71b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_a4cbdbef-f06a-4339-ad0b-84ac29509e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_76872940-72e9-4c59-bd5d-692742ee71b2" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_a4cbdbef-f06a-4339-ad0b-84ac29509e4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23433ddc-5f22-4043-850c-87c4a90ca44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_76872940-72e9-4c59-bd5d-692742ee71b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23433ddc-5f22-4043-850c-87c4a90ca44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4cf84962-0744-48b3-93d5-2dbd7c8483b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d23e5b29-03e6-4997-8aad-c912488e5597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4cf84962-0744-48b3-93d5-2dbd7c8483b7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d23e5b29-03e6-4997-8aad-c912488e5597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_549674b5-2312-4819-a0bc-122b36d595fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4cf84962-0744-48b3-93d5-2dbd7c8483b7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_549674b5-2312-4819-a0bc-122b36d595fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="csbr-20220731.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12b6b994-b1a3-4f94-8273-62d5502b2e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c2b3db0-7356-414f-a063-340a89be588e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12b6b994-b1a3-4f94-8273-62d5502b2e0c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c2b3db0-7356-414f-a063-340a89be588e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2fe519cd-9a07-40d0-bd2b-f10266102b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12b6b994-b1a3-4f94-8273-62d5502b2e0c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2fe519cd-9a07-40d0-bd2b-f10266102b22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e658043-46b3-4d1d-a617-6014b4033206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12b6b994-b1a3-4f94-8273-62d5502b2e0c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e658043-46b3-4d1d-a617-6014b4033206" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8c94c8a-1601-4521-9e65-775cf5c526a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ProceedsFromExerciseOfOptionsAndWarrants_837bff0c-ebe0-4228-b9f1-02204913a0b6" xlink:href="csbr-20220731.xsd#csbr_ProceedsFromExerciseOfOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8c94c8a-1601-4521-9e65-775cf5c526a2" xlink:to="loc_csbr_ProceedsFromExerciseOfOptionsAndWarrants_837bff0c-ebe0-4228-b9f1-02204913a0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_895a1f33-aff0-4d55-b91c-d1655908fb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8f2122ea-b62c-45eb-a689-cbf36be91461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_895a1f33-aff0-4d55-b91c-d1655908fb39" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8f2122ea-b62c-45eb-a689-cbf36be91461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5f47f0e8-4174-48b1-b476-cef5b41afea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_NetIncomeLoss_5f47f0e8-4174-48b1-b476-cef5b41afea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_73dea5f4-1f62-4f2e-8a14-7c4a55fba42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_ShareBasedCompensation_73dea5f4-1f62-4f2e-8a14-7c4a55fba42c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_858d1822-64f7-4db3-955a-7ec6f7c0f5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_DepreciationAndAmortization_858d1822-64f7-4db3-955a-7ec6f7c0f5ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_79a9ea16-67f1-4670-82a6-77723c9f4b18" xlink:href="csbr-20220731.xsd#csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_79a9ea16-67f1-4670-82a6-77723c9f4b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ReversalOfProvisionForDoubtfulAccounts_f8240ad7-4ca0-4309-8a21-80ca65ad288b" xlink:href="csbr-20220731.xsd#csbr_ReversalOfProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_csbr_ReversalOfProvisionForDoubtfulAccounts_f8240ad7-4ca0-4309-8a21-80ca65ad288b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_97900962-f5ea-4c5d-b2b8-5f9263757350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_97900962-f5ea-4c5d-b2b8-5f9263757350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6ea10c1-6e51-43e8-be98-aba4d480deef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6ea10c1-6e51-43e8-be98-aba4d480deef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_394e3789-6843-4207-88a5-591fa6a56824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_394e3789-6843-4207-88a5-591fa6a56824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1769a1b4-8a07-4789-b1c7-cd2cecae8450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1769a1b4-8a07-4789-b1c7-cd2cecae8450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_d9c2e877-7d6a-4e40-932e-fc071c43589e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_d9c2e877-7d6a-4e40-932e-fc071c43589e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_f53d3d01-1751-4fdf-a57a-63c589e9de97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_f53d3d01-1751-4fdf-a57a-63c589e9de97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_252ab9d8-94aa-490e-b12d-16c32446f448" xlink:href="csbr-20220731.xsd#csbr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_252ab9d8-94aa-490e-b12d-16c32446f448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2194dcef-2016-407a-bbe2-bf30c6272b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2194dcef-2016-407a-bbe2-bf30c6272b3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b7ab7662-8938-4a68-9483-dc3f25411fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b7ab7662-8938-4a68-9483-dc3f25411fd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_050333a6-648b-41ad-81ab-1aeb9f9525ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41de7f14-027e-4589-b0e9-46b981bca997" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_050333a6-648b-41ad-81ab-1aeb9f9525ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cb987d10-ba0f-486b-9553-5b7b3a5427f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_a24e283a-ff1e-4e73-85ca-0be08e019060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cb987d10-ba0f-486b-9553-5b7b3a5427f4" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_a24e283a-ff1e-4e73-85ca-0be08e019060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b6a9e29d-91a6-4439-a1a1-9f4dca7c67d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cb987d10-ba0f-486b-9553-5b7b3a5427f4" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b6a9e29d-91a6-4439-a1a1-9f4dca7c67d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_ec1b4f68-4242-42e7-acf1-0321c10c8ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_b12088a3-cf00-49db-827f-0ff2ad810967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_ec1b4f68-4242-42e7-acf1-0321c10c8ebc" xlink:to="loc_us-gaap_AccountsReceivableGross_b12088a3-cf00-49db-827f-0ff2ad810967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_7af3790d-fa40-4edf-942b-654fd165167d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_ec1b4f68-4242-42e7-acf1-0321c10c8ebc" xlink:to="loc_us-gaap_UnbilledContractsReceivable_7af3790d-fa40-4edf-942b-654fd165167d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7e14320-8b59-449b-ae45-deef600c55f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_54f531f1-ff39-4bd0-8155-43f16bbf20c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7e14320-8b59-449b-ae45-deef600c55f0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_54f531f1-ff39-4bd0-8155-43f16bbf20c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0fe1a771-45ec-4c20-b227-fdbc79f27ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7e14320-8b59-449b-ae45-deef600c55f0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0fe1a771-45ec-4c20-b227-fdbc79f27ead" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1b672a9f-5cfa-48ac-9f40-34c7e90a9577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1b672a9f-5cfa-48ac-9f40-34c7e90a9577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1fc4a8b3-079a-40c8-af27-bcdb848d5d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1fc4a8b3-079a-40c8-af27-bcdb848d5d1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb5d79bf-0a45-442a-9002-7b9650a77404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb5d79bf-0a45-442a-9002-7b9650a77404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e15b8074-0d33-4bdc-851c-3958a12ae0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e15b8074-0d33-4bdc-851c-3958a12ae0ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6b17e633-bd4a-4871-ab76-7a7e2f1334b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6b17e633-bd4a-4871-ab76-7a7e2f1334b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_721af41b-f41b-47d7-92b0-5e03c0cafdfb" xlink:href="csbr-20220731.xsd#csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb836515-a02d-4f1a-b324-8bc6cb1be3f5" xlink:to="loc_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_721af41b-f41b-47d7-92b0-5e03c0cafdfb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2c249b7a-4522-425c-816f-123ab1cf3741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_00fb913b-7e26-41ba-98e5-0060e13e2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2c249b7a-4522-425c-816f-123ab1cf3741" xlink:to="loc_us-gaap_OperatingLeaseLiability_00fb913b-7e26-41ba-98e5-0060e13e2b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_87c4cd1a-1948-4b78-bb7a-b8f23c0ad6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2c249b7a-4522-425c-816f-123ab1cf3741" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_87c4cd1a-1948-4b78-bb7a-b8f23c0ad6aa" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>csbr-20220731_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ec52204b-131e-4198-92e8-02fb9363ce20,g:7d91c0c2-82c1-4c83-ab39-3140ef69ee6c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="csbr-20220731.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended" id="if27da01960a34049974d8026e546dda8_UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4fc2de6e-99d6-491e-9614-aa1689614427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4fc2de6e-99d6-491e-9614-aa1689614427" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a20f5552-ad0f-488e-b7ed-b746309f4654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a20f5552-ad0f-488e-b7ed-b746309f4654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88ab66bd-ab09-4bc1-a326-ca2c95183e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockholdersEquity_88ab66bd-ab09-4bc1-a326-ca2c95183e4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_da38692f-a8eb-4991-9763-70e9a1825f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_da38692f-a8eb-4991-9763-70e9a1825f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_b49b94d9-a74f-44f1-ba5a-ce749ae7ac82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_b49b94d9-a74f-44f1-ba5a-ce749ae7ac82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_f302e137-337f-47c6-bb25-bad0986a10af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_f302e137-337f-47c6-bb25-bad0986a10af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_711148aa-830b-4622-a14e-50a99b3059c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_NetIncomeLoss_711148aa-830b-4622-a14e-50a99b3059c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_27b4505a-68d1-4859-91f0-88d20dbc7390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_00ca5d07-f630-412f-9973-d6b6b2e69ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4fc2de6e-99d6-491e-9614-aa1689614427" xlink:to="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7eaf08a-3c9b-4088-98bb-b19391e29ca5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:to="loc_us-gaap_EquityComponentDomain_c7eaf08a-3c9b-4088-98bb-b19391e29ca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:to="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1f6625d1-6a53-4c06-ab4a-dd45485e567e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:to="loc_us-gaap_CommonStockMember_1f6625d1-6a53-4c06-ab4a-dd45485e567e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_63449bd2-e3d0-44e7-b176-fae947435d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_63449bd2-e3d0-44e7-b176-fae947435d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b0eb250c-fa66-4e5b-b8d6-c3041ea2137d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:to="loc_us-gaap_RetainedEarningsMember_b0eb250c-fa66-4e5b-b8d6-c3041ea2137d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended" id="ia417996b39774db8984b88d93ae740c0_SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b688de1-a3ef-4a0d-a8cd-df88bbef5a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b688de1-a3ef-4a0d-a8cd-df88bbef5a7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:to="loc_srt_ProductsAndServicesDomain_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:to="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FewContractsMember_6575b97f-791e-4954-86d6-480cb9aaf5e9" xlink:href="csbr-20220731.xsd#csbr_FewContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:to="loc_csbr_FewContractsMember_6575b97f-791e-4954-86d6-480cb9aaf5e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dcdfb9c2-68cf-411d-a3b3-65fee86623d0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:to="loc_srt_RangeMember_dcdfb9c2-68cf-411d-a3b3-65fee86623d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:to="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33595f15-11d5-452c-b484-1c9cd81d96bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:to="loc_srt_MaximumMember_33595f15-11d5-452c-b484-1c9cd81d96bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c0d1570-5031-4f0c-aded-3d1bc14215b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:to="loc_srt_MinimumMember_0c0d1570-5031-4f0c-aded-3d1bc14215b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23a57330-e30d-4133-8a9d-a0b73eee4a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23a57330-e30d-4133-8a9d-a0b73eee4a18" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1" xlink:type="simple" xlink:href="csbr-20220731.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1" xlink:type="extended" id="i9a13f3cba9494461b69ff71c86cafa4c_SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b688de1-a3ef-4a0d-a8cd-df88bbef5a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b688de1-a3ef-4a0d-a8cd-df88bbef5a7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:to="loc_srt_ProductsAndServicesDomain_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:to="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FewContractsMember_6575b97f-791e-4954-86d6-480cb9aaf5e9" xlink:href="csbr-20220731.xsd#csbr_FewContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:to="loc_csbr_FewContractsMember_6575b97f-791e-4954-86d6-480cb9aaf5e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dcdfb9c2-68cf-411d-a3b3-65fee86623d0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:to="loc_srt_RangeMember_dcdfb9c2-68cf-411d-a3b3-65fee86623d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:to="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33595f15-11d5-452c-b484-1c9cd81d96bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:to="loc_srt_MaximumMember_33595f15-11d5-452c-b484-1c9cd81d96bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c0d1570-5031-4f0c-aded-3d1bc14215b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:to="loc_srt_MinimumMember_0c0d1570-5031-4f0c-aded-3d1bc14215b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomersDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#RevenuefromContractswithCustomersDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/RevenuefromContractswithCustomersDetails" xlink:type="extended" id="id9925d0e4f54476f95146595bda6a1a9_RevenuefromContractswithCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b2254f54-b2e5-464b-b3a4-d50f57b26ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3dbf4a96-5d2b-45c8-926c-8510dd66c1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b2254f54-b2e5-464b-b3a4-d50f57b26ed0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3dbf4a96-5d2b-45c8-926c-8510dd66c1a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b2254f54-b2e5-464b-b3a4-d50f57b26ed0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:to="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fa9d489e-8301-4be3-8343-014cd7dfa127_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:to="loc_srt_ProductsAndServicesDomain_fa9d489e-8301-4be3-8343-014cd7dfa127_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:to="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PharmacologyServicesMember_ce0bca17-6fc5-46a6-af50-710816943bdb" xlink:href="csbr-20220731.xsd#csbr_PharmacologyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:to="loc_csbr_PharmacologyServicesMember_ce0bca17-6fc5-46a6-af50-710816943bdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_07e6aa8c-a685-4b68-941b-c7bc33609eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_07e6aa8c-a685-4b68-941b-c7bc33609eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PersonalizedOncologyServicesMember_9b981b6a-c1dd-4f5e-a4f4-dc3ea0903787" xlink:href="csbr-20220731.xsd#csbr_PersonalizedOncologyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:to="loc_csbr_PersonalizedOncologyServicesMember_9b981b6a-c1dd-4f5e-a4f4-dc3ea0903787" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended" id="i00e8add380a14ed986872a524cd3fbee_PropertyandEquipmentNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cafaea79-84b3-43ab-8eda-72c988e91985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cafaea79-84b3-43ab-8eda-72c988e91985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cdf241fe-f548-4c45-8368-be13b8ba6792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cdf241fe-f548-4c45-8368-be13b8ba6792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_61cb7613-43fe-4bb2-b791-3c294a922870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_61cb7613-43fe-4bb2-b791-3c294a922870" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_de77b606-fddc-4f66-b360-3bf572a75fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_de77b606-fddc-4f66-b360-3bf572a75fad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_130401e6-768a-4d67-96b8-fa77186b0f5f" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDepreciationAndAmortizationExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_130401e6-768a-4d67-96b8-fa77186b0f5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServicingAsset_42e2a442-74a7-453b-822b-4785a358b715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_ServicingAsset_42e2a442-74a7-453b-822b-4785a358b715" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServicingAssetAtAmortizedValue_fee3a1f8-7e15-449e-b5d0-6e2b1c32724c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAssetAtAmortizedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_ServicingAssetAtAmortizedValue_fee3a1f8-7e15-449e-b5d0-6e2b1c32724c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_1152f4d0-2669-4f56-ab35-a4acd292e667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_1152f4d0-2669-4f56-ab35-a4acd292e667" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseCost_0ed0edab-6ec7-4429-b6fe-59f70f099b0a" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_csbr_FinanceLeaseCost_0ed0edab-6ec7-4429-b6fe-59f70f099b0a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PresentValueMinimumFutureObligationsInterestRate_f905618e-2e2b-4b1d-8407-d85d09ca27fd" xlink:href="csbr-20220731.xsd#csbr_PresentValueMinimumFutureObligationsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_csbr_PresentValueMinimumFutureObligationsInterestRate_f905618e-2e2b-4b1d-8407-d85d09ca27fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6769b833-6d9f-4f3e-b2ee-085bac692af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6769b833-6d9f-4f3e-b2ee-085bac692af4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ffe49df1-877c-40f2-8c33-7728abb23455_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:to="loc_srt_RangeMember_ffe49df1-877c-40f2-8c33-7728abb23455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:to="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_270d4215-3f6f-4d0b-9deb-253e77232ff9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:to="loc_srt_MinimumMember_270d4215-3f6f-4d0b-9deb-253e77232ff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_53285104-c6f8-42cb-bb6e-eaf7c4a370f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:to="loc_srt_MaximumMember_53285104-c6f8-42cb-bb6e-eaf7c4a370f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f2e25ed-d064-421e-91ff-09ff572b0980_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f2e25ed-d064-421e-91ff-09ff572b0980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ba9da94-04a6-4a82-bbeb-0388e5c8946f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ba9da94-04a6-4a82-bbeb-0388e5c8946f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_b835317f-cfb9-43f8-bdf8-269e5523318b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ba9da94-04a6-4a82-bbeb-0388e5c8946f" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_b835317f-cfb9-43f8-bdf8-269e5523318b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDomain_4bca6a6c-6e7d-448c-a10f-88c2f6825f79_default" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:to="loc_csbr_FinanceLeaseDomain_4bca6a6c-6e7d-448c-a10f-88c2f6825f79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:to="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_A2022FinanceLeaseMember_872f8298-e583-4b20-a68c-c5410b859512" xlink:href="csbr-20220731.xsd#csbr_A2022FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:to="loc_csbr_A2022FinanceLeaseMember_872f8298-e583-4b20-a68c-c5410b859512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_A2023FinanceLeaseMember_96d696bf-bd85-49ef-b67d-5fae749b4b4a" xlink:href="csbr-20220731.xsd#csbr_A2023FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:to="loc_csbr_A2023FinanceLeaseMember_96d696bf-bd85-49ef-b67d-5fae749b4b4a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended" id="iaeebf5a77b8b4a4ebd26b716cced4f4f_PropertyandEquipmentSummaryofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_25361521-4595-4fb4-86bf-9be707630ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_25361521-4595-4fb4-86bf-9be707630ade" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_15d68a93-7628-462a-aab6-b3af5fe1d206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_15d68a93-7628-462a-aab6-b3af5fe1d206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a1a4c15a-edc2-4981-8f40-b386bb1e91e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a1a4c15a-edc2-4981-8f40-b386bb1e91e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_5e5e47e4-4158-414c-9459-0d72b3b032c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_5e5e47e4-4158-414c-9459-0d72b3b032c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb6d722-744f-4e32-ae18-bba189759eb4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb6d722-744f-4e32-ae18-bba189759eb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_392d9f2c-893a-4183-9652-e7b3de18b0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_392d9f2c-893a-4183-9652-e7b3de18b0f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_ee4c897a-698c-49dd-b439-9b81227bcd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_ComputerEquipmentMember_ee4c897a-698c-49dd-b439-9b81227bcd24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_cd8788fe-9698-4a54-a2a8-df885e277d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_cd8788fe-9698-4a54-a2a8-df885e277d03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_LaboratoryEquipmentMember_5e512890-1708-4cac-8c7c-380dc14305bd" xlink:href="csbr-20220731.xsd#csbr_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_csbr_LaboratoryEquipmentMember_5e512890-1708-4cac-8c7c-380dc14305bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AssetInProgressMember_03edca41-1a02-40e2-bfbc-5c700b16938d" xlink:href="csbr-20220731.xsd#csbr_AssetInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_csbr_AssetInProgressMember_03edca41-1a02-40e2-bfbc-5c700b16938d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_53e7237f-cb1c-4933-baf4-b6afe21e190b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_53e7237f-cb1c-4933-baf4-b6afe21e190b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails" xlink:type="extended" id="i521747b20a4f43e3bfbd288f3820604a_ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3f08aca7-0a3d-4dc3-afcf-d43178f0831f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_deedcd00-747c-4295-b0b3-e740364b95a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3f08aca7-0a3d-4dc3-afcf-d43178f0831f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_deedcd00-747c-4295-b0b3-e740364b95a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3f08aca7-0a3d-4dc3-afcf-d43178f0831f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_699d5a51-00b1-4bae-9dcb-5d60a40f28a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_699d5a51-00b1-4bae-9dcb-5d60a40f28a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0f88657e-c3cd-4ba4-b607-bfcbf3af59f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0f88657e-c3cd-4ba4-b607-bfcbf3af59f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_c844f8de-7359-4dd6-adb1-8316df871326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_c844f8de-7359-4dd6-adb1-8316df871326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b3afacb4-5cb2-4e9c-94d8-83c3dd45ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b3afacb4-5cb2-4e9c-94d8-83c3dd45ef75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_723a781d-c10e-416a-8e04-96848cafc227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_CostOfSalesMember_723a781d-c10e-416a-8e04-96848cafc227" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails" xlink:type="extended" id="i797bf7a2c3bb43ec898b04d836179c87_ShareBasedPaymentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5544c201-8fdc-4cc7-87ba-6a2fbb4b2bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5544c201-8fdc-4cc7-87ba-6a2fbb4b2bf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2a1c3846-add8-47a5-b104-ad7ad4ebe64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2a1c3846-add8-47a5-b104-ad7ad4ebe64d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_67af00a1-0bd7-4f22-afbd-2132d2fb60b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_67af00a1-0bd7-4f22-afbd-2132d2fb60b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7baeb194-3b08-4dad-9925-0ed6a81006b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7baeb194-3b08-4dad-9925-0ed6a81006b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_11adc6bf-c5ed-4ce3-8411-316e96a9f52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_11adc6bf-c5ed-4ce3-8411-316e96a9f52f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:to="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a8524d43-db8f-49d7-a55d-dba18453708b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:to="loc_us-gaap_PlanNameDomain_a8524d43-db8f-49d7-a55d-dba18453708b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:to="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_EquityIncentivePlan2021Member_1190e5ef-2f49-463a-abb7-542ca3b59e34" xlink:href="csbr-20220731.xsd#csbr_EquityIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:to="loc_csbr_EquityIncentivePlan2021Member_1190e5ef-2f49-463a-abb7-542ca3b59e34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_EquityIncentivePlan2010Member_8ae93d7e-231d-4676-bb2b-7b369c34f554" xlink:href="csbr-20220731.xsd#csbr_EquityIncentivePlan2010Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:to="loc_csbr_EquityIncentivePlan2010Member_8ae93d7e-231d-4676-bb2b-7b369c34f554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:to="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59d724b4-bb4d-4e88-b3bf-4c4578d5336d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:to="loc_srt_RangeMember_59d724b4-bb4d-4e88-b3bf-4c4578d5336d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_97c8af7e-37ae-4ecc-9996-1e5e45d96ba9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:to="loc_srt_RangeMember_97c8af7e-37ae-4ecc-9996-1e5e45d96ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_91d015a8-ea03-44f6-8781-b6a203441602" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_97c8af7e-37ae-4ecc-9996-1e5e45d96ba9" xlink:to="loc_srt_MaximumMember_91d015a8-ea03-44f6-8781-b6a203441602" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails" xlink:type="extended" id="i5132adc078f1499e9a16167c2d7c5c5a_ShareBasedPaymentsSummaryofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9095b0f8-0677-4e0a-9339-6b3b1891bf98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9095b0f8-0677-4e0a-9339-6b3b1891bf98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2f99a53b-24b9-4321-ba2d-73e170986328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2f99a53b-24b9-4321-ba2d-73e170986328" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_626bd756-8980-4777-ae9a-ff1d9705f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_626bd756-8980-4777-ae9a-ff1d9705f5da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_b86c9a2f-c07a-4399-8021-07ff2fd0e80a" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_b86c9a2f-c07a-4399-8021-07ff2fd0e80a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e6bc6a94-9fe4-4f98-88ba-85ea717c9b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e6bc6a94-9fe4-4f98-88ba-85ea717c9b2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8be8931-00de-4c55-b08a-034fde6fc079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_84cbad82-ae44-4feb-bd67-9980fc0584bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_84cbad82-ae44-4feb-bd67-9980fc0584bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6ee2f7d4-5507-4c3e-a4c3-f53497604214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6ee2f7d4-5507-4c3e-a4c3-f53497604214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56a8e9d9-4e68-464a-ab94-cebfe97c1c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56a8e9d9-4e68-464a-ab94-cebfe97c1c21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c458df70-0424-4baa-bfe6-a731465ac96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c458df70-0424-4baa-bfe6-a731465ac96b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fb4a62f1-f9e4-46dc-a360-54c8d414947a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fb4a62f1-f9e4-46dc-a360-54c8d414947a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_49d47b32-6c56-41cd-8350-a79ba1cbf716" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_49d47b32-6c56-41cd-8350-a79ba1cbf716" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_87b55688-0b85-4270-93c8-960b5fd9008c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_87b55688-0b85-4270-93c8-960b5fd9008c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_21aa372f-6719-4a76-9dd5-3f7e34282182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_13eeec6b-d89b-4eaf-9529-2663b47a938b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_13eeec6b-d89b-4eaf-9529-2663b47a938b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_02d0843c-0c51-4b3f-bba3-fc280d676d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_02d0843c-0c51-4b3f-bba3-fc280d676d44" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fe43003-e9f6-4e74-af5c-10975bbc858c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fe43003-e9f6-4e74-af5c-10975bbc858c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_68079f46-af28-4c2c-823c-31676e5986b9" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:to="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_68079f46-af28-4c2c-823c-31676e5986b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ce5133d6-2398-4541-9563-7abfa3c037f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ce5133d6-2398-4541-9563-7abfa3c037f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_23175aeb-ffb3-4be5-a589-4f3ab3ee62d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_23175aeb-ffb3-4be5-a589-4f3ab3ee62d5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_915cce99-7393-48a2-84ad-25b04648f9dd" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_915cce99-7393-48a2-84ad-25b04648f9dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9b802185-fdb6-4f79-b440-7383d187e114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_915cce99-7393-48a2-84ad-25b04648f9dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9b802185-fdb6-4f79-b440-7383d187e114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_63b8247b-582e-44ef-9b64-e585e489ab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_63b8247b-582e-44ef-9b64-e585e489ab4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9cb87723-0446-4031-ac4d-e8758976b924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9cb87723-0446-4031-ac4d-e8758976b924" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:to="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_8971c516-e274-4cac-8d7c-613e8ea88fc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:to="loc_us-gaap_GranteeStatusDomain_8971c516-e274-4cac-8d7c-613e8ea88fc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:to="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b7c27abf-0b7c-4f3b-bb47-00d9f5815131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b7c27abf-0b7c-4f3b-bb47-00d9f5815131" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_07037f48-fe6f-4473-9433-9c23315d72b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_07037f48-fe6f-4473-9433-9c23315d72b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i4493b93a4bab4aa591fc474671ad8133_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b21adc33-2a7a-4270-8e17-7a1b7e73ac82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseExpense_b21adc33-2a7a-4270-8e17-7a1b7e73ac82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f0270a38-cd02-4487-a24c-e1040d808b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f0270a38-cd02-4487-a24c-e1040d808b1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2efc545f-668b-495e-95ff-455ffd6a9c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2efc545f-668b-495e-95ff-455ffd6a9c10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_17602e34-e925-4bf5-839c-241c5b772122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseLiability_17602e34-e925-4bf5-839c-241c5b772122" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_OperatingLeaseIncrementalRentExpense_8eb2cb56-e915-4877-8047-060025524854" xlink:href="csbr-20220731.xsd#csbr_OperatingLeaseIncrementalRentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_csbr_OperatingLeaseIncrementalRentExpense_8eb2cb56-e915-4877-8047-060025524854" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0da65c7f-2e90-4101-bacd-a740e32cf6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0da65c7f-2e90-4101-bacd-a740e32cf6a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ab8044ee-886d-4868-b41a-325832532aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ab8044ee-886d-4868-b41a-325832532aac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CorporateHeadquartersMember_4aa7d297-f854-4121-951a-6eab20d66728" xlink:href="csbr-20220731.xsd#csbr_CorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_CorporateHeadquartersMember_4aa7d297-f854-4121-951a-6eab20d66728" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_RockvilleMDMember_92e6e87c-4a61-426a-bff1-64b7f504f0bc" xlink:href="csbr-20220731.xsd#csbr_RockvilleMDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_RockvilleMDMember_92e6e87c-4a61-426a-bff1-64b7f504f0bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AdditionalExpansionPremisesMember_b47b176c-30d4-48c6-848e-7e15e161f198" xlink:href="csbr-20220731.xsd#csbr_AdditionalExpansionPremisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_AdditionalExpansionPremisesMember_b47b176c-30d4-48c6-848e-7e15e161f198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_MilanItalyMember_0e30cbf8-71ba-4472-b438-125e861e91f2" xlink:href="csbr-20220731.xsd#csbr_MilanItalyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_MilanItalyMember_0e30cbf8-71ba-4472-b438-125e861e91f2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i410e01c892f24ab78f3318b85a7af115_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_6bc4e627-3813-47b9-af5d-baf0c7cf41ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_6bc4e627-3813-47b9-af5d-baf0c7cf41ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_86e12d51-3b10-4a34-8bca-95bad40fe216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_86e12d51-3b10-4a34-8bca-95bad40fe216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:to="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e73a3d-b6c4-4cc5-b520-53e64b0c1a86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e73a3d-b6c4-4cc5-b520-53e64b0c1a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_3612e1eb-a42e-4fec-b1f2-3d085c9a70ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e73a3d-b6c4-4cc5-b520-53e64b0c1a86" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_3612e1eb-a42e-4fec-b1f2-3d085c9a70ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:to="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d49bb763-c798-47d6-8c8f-bb9a63cf111c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d49bb763-c798-47d6-8c8f-bb9a63cf111c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_BoardMemberOneMember_b8c867c7-077b-4600-95d8-29d8a346eeed" xlink:href="csbr-20220731.xsd#csbr_BoardMemberOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:to="loc_csbr_BoardMemberOneMember_b8c867c7-077b-4600-95d8-29d8a346eeed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_BoardMemberTwoMember_e5267ccf-d306-451e-aec1-0ab7607ca218" xlink:href="csbr-20220731.xsd#csbr_BoardMemberTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:to="loc_csbr_BoardMemberTwoMember_e5267ccf-d306-451e-aec1-0ab7607ca218" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://championsoncology.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#CommitmentandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/CommitmentandContingenciesDetails" xlink:type="extended" id="idc2bf51495914c52ae4419ab49a933b5_CommitmentandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:href="csbr-20220731.xsd#csbr_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CollaborationArrangementRoyaltyFee_3ee260c4-12fb-4245-ae1f-3daa3facb757" xlink:href="csbr-20220731.xsd#csbr_CollaborationArrangementRoyaltyFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_csbr_CollaborationArrangementRoyaltyFee_3ee260c4-12fb-4245-ae1f-3daa3facb757" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_ac198934-0baa-4775-9386-9efe396ac021" xlink:href="csbr-20220731.xsd#csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_ac198934-0baa-4775-9386-9efe396ac021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_864d23c0-19b6-47db-b87d-1ab3ec98f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_us-gaap_RoyaltyExpense_864d23c0-19b6-47db-b87d-1ab3ec98f30e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:href="csbr-20220731.xsd#csbr_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:to="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd7a16d0-620f-4754-85ed-58a7c3799ca2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:to="loc_srt_RangeMember_fd7a16d0-620f-4754-85ed-58a7c3799ca2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:to="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9a26614c-0c54-4482-a87e-ce850622b4fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:to="loc_srt_MinimumMember_9a26614c-0c54-4482-a87e-ce850622b4fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a3382597-849b-47d5-88b1-99f9f257dfad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:to="loc_srt_MaximumMember_a3382597-849b-47d5-88b1-99f9f257dfad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>csbr-20220731_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ec52204b-131e-4198-92e8-02fb9363ce20,g:7d91c0c2-82c1-4c83-ab39-3140ef69ee6c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_csbr_MilanItalyMember_3193ccc8-7d94-4c48-a11f-327d355b37d9_terseLabel_en-US" xlink:label="lab_csbr_MilanItalyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milan Italy</link:label>
    <link:label id="lab_csbr_MilanItalyMember_label_en-US" xlink:label="lab_csbr_MilanItalyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milan Italy [Member]</link:label>
    <link:label id="lab_csbr_MilanItalyMember_documentation_en-US" xlink:label="lab_csbr_MilanItalyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milan Italy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_MilanItalyMember" xlink:href="csbr-20220731.xsd#csbr_MilanItalyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_MilanItalyMember" xlink:to="lab_csbr_MilanItalyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_302de89c-1ade-46b5-a73f-83558db7cd6a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_6c5d1a25-9baa-485b-94f1-dd276717505c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:to="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_7fb77a80-875e-439e-998e-717ed254fe26_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3f9a7ba2-7bed-4d70-a9b2-78ed31ac4eb8_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21032506-6a89-4bfe-9bbe-1851b4f70575_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_71cb07f6-edb2-4793-8e9f-3e123ed1ae3c_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total undiscounted liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_61a67198-a77e-4f26-9b87-5afdddef031d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a8a383ac-9370-4b74-b1df-3244fbe0cb28_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_78e3ac58-e604-4959-8824-1f523b25c03f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_134d55bc-e37f-4cbe-b13c-b9ed6765bd66_netLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_28012778-d593-4a87-a88a-419c795a1f08_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_92553bd6-769d-418c-9e51-55cedc5d1f1e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6334a912-6936-4dbc-b67a-0060be35992a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c3f06c59-69f1-486b-b391-e36098bfd2a8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_477b4e50-b1a9-48cb-b1b4-9b8caf782100_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9ff93e82-b4b5-4ba9-a6e7-3c6cbe67df63_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_105ff93c-ad0e-482f-aa3d-373f337b81d0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_b62ad0af-ad70-455c-93c2-141553fe0429_terseLabel_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6de18bfa-3e1e-4f96-b778-cf114aa621cf_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of oncology services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_14743e04-ebf3-49a0-aee1-1e39a110a12d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_819efeba-90dd-458a-aa8f-501cf061738b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_977b0051-df36-4862-a1ae-0e8d9e6ebfc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility rate minimum (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ae4c3ced-2fb4-48ff-b659-605c19b5e090_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1aebc0da-7b6f-40ae-8a4f-fab699e023b1_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_beff09e7-5a85-4de9-ad29-d7a0a7a6abae_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0045972b-4e13-4432-a7ba-6e22b644411b_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1634df6e-2c76-4ada-b736-cebb40d29eba_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $.001 par value; 200,000,000 shares authorized; 13,522,441 shares issued and outstanding as of July 31, 2022 and April 30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_CommitmentsAndContingenciesLineItems_7ed38690-97f6-417d-922d-79b0c8ac8ad4_terseLabel_en-US" xlink:label="lab_csbr_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Line Items]</link:label>
    <link:label id="lab_csbr_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_csbr_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Line Items]</link:label>
    <link:label id="lab_csbr_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_csbr_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CommitmentsAndContingenciesLineItems" xlink:href="csbr-20220731.xsd#csbr_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems" xlink:to="lab_csbr_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_FinanceLeaseAxis_6f07b01d-f1e6-4f22-be64-f15e1090fdcd_terseLabel_en-US" xlink:label="lab_csbr_FinanceLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Axis]</link:label>
    <link:label id="lab_csbr_FinanceLeaseAxis_label_en-US" xlink:label="lab_csbr_FinanceLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Axis]</link:label>
    <link:label id="lab_csbr_FinanceLeaseAxis_documentation_en-US" xlink:label="lab_csbr_FinanceLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseAxis" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_FinanceLeaseAxis" xlink:to="lab_csbr_FinanceLeaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_baf3f2ae-5589-40ba-849d-80c161fa1511_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3f20649a-fe08-4f0e-84b5-ed62fb9407a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of antidilutive securities excluded from earnings per share calculations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5d0ac193-ab7e-4601-aed3-3c25876c2f2c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_cccfe5ae-8f59-42ff-8dee-2bba41303840_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e29ecf2c-a491-41da-b1c8-db7c3ce19455_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_c3f769bb-504a-4574-85be-73ed6563981e_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe84df3b-3a11-409e-bb70-8d14cef5af13_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f1613d72-424c-4bfb-8ceb-31bd8851b91c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4114bd61-6b63-4644-a8ad-16d62737eaeb_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f3f4bfda-f496-4712-a68e-c47c72506b07_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_8192a7d7-8c6c-4493-95a0-68c253345ff9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3a84e85e-354f-47e1-89cf-d8bfd0e73155_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_CommitmentsAndContingenciesTable_8db2d985-15b0-49c5-973e-3c5f05b375a1_terseLabel_en-US" xlink:label="lab_csbr_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Table]</link:label>
    <link:label id="lab_csbr_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_csbr_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Table]</link:label>
    <link:label id="lab_csbr_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_csbr_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CommitmentsAndContingenciesTable" xlink:href="csbr-20220731.xsd#csbr_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_CommitmentsAndContingenciesTable" xlink:to="lab_csbr_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2e091b8f-13da-4935-8ed0-02bf0582dc4a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9a360dd8-119f-4751-a8f2-7362148f9fc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6cb0aa7e-2894-469e-93d3-c40fdd6ee953_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_e0ad1cff-1eaf-4801-8849-2cf46cb198cc_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0b2236c2-8547-408a-ac91-8a87fabae52a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ae1a8ab5-6457-47a5-be56-8bd1bee0abbe_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_daaa68e6-fc6d-4bef-b92d-68d77e8ed9cd_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_b5fc4e50-7aa9-4ac7-bda4-155fa067a1a2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_5cc35645-0acc-4dcf-ae26-8c2082991afc_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_BoardOfDirectorsChairmanMember_1ba367dd-ad78-4609-855b-b4720bfaddd0_terseLabel_en-US" xlink:label="lab_srt_BoardOfDirectorsChairmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member</link:label>
    <link:label id="lab_srt_BoardOfDirectorsChairmanMember_label_en-US" xlink:label="lab_srt_BoardOfDirectorsChairmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_BoardOfDirectorsChairmanMember" xlink:to="lab_srt_BoardOfDirectorsChairmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_376b3920-8077-4ef1-9e81-55b855c2b37c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_CollaborationArrangementRoyaltyFee_b0d5ca83-569d-4d2b-95f5-4fb82f73ba62_terseLabel_en-US" xlink:label="lab_csbr_CollaborationArrangementRoyaltyFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty fee per tumor sample</link:label>
    <link:label id="lab_csbr_CollaborationArrangementRoyaltyFee_label_en-US" xlink:label="lab_csbr_CollaborationArrangementRoyaltyFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement Royalty Fee</link:label>
    <link:label id="lab_csbr_CollaborationArrangementRoyaltyFee_documentation_en-US" xlink:label="lab_csbr_CollaborationArrangementRoyaltyFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement Royalty Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CollaborationArrangementRoyaltyFee" xlink:href="csbr-20220731.xsd#csbr_CollaborationArrangementRoyaltyFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_CollaborationArrangementRoyaltyFee" xlink:to="lab_csbr_CollaborationArrangementRoyaltyFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4d8a7d97-dcef-41ca-bd5f-d293faec33a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0a89502e-23aa-4070-b081-a946463beca7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_5cdfe6b9-58f2-486f-8ead-73f7ef148dec_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable and unbilled services</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e6f94f76-3ce0-4fa4-bef1-82baf106f47d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_07049cb0-11ae-4802-815c-3207a3fb07eb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_8c9fcb7c-ba46-40ed-be9d-28aeacccaf2c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_5cb77c7e-7e63-4936-962e-b8d1b98ba083_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting arrangement, amortization expense</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_dcedfc24-5204-4a83-8c97-59979958b92c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_PharmacologyServicesMember_412b5629-19fa-4d7f-9278-d468d35b7e0c_terseLabel_en-US" xlink:label="lab_csbr_PharmacologyServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacology services</link:label>
    <link:label id="lab_csbr_PharmacologyServicesMember_label_en-US" xlink:label="lab_csbr_PharmacologyServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacology Services [Member]</link:label>
    <link:label id="lab_csbr_PharmacologyServicesMember_documentation_en-US" xlink:label="lab_csbr_PharmacologyServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacology Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PharmacologyServicesMember" xlink:href="csbr-20220731.xsd#csbr_PharmacologyServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_PharmacologyServicesMember" xlink:to="lab_csbr_PharmacologyServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3ac2df2c-ba06-4cfa-8a58-f96e16221b07_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_0ebe8090-55d9-4ce6-a80e-60dcdc49962b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_0bbee035-3810-41c2-96f6-2c94cf75171b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_FinanceLeaseCost_bd7ebcb8-3cbb-4da2-b3c5-e55cdabd6cc4_terseLabel_en-US" xlink:label="lab_csbr_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease costs</link:label>
    <link:label id="lab_csbr_FinanceLeaseCost_label_en-US" xlink:label="lab_csbr_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_csbr_FinanceLeaseCost_documentation_en-US" xlink:label="lab_csbr_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseCost" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_FinanceLeaseCost" xlink:to="lab_csbr_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6005d39f-903e-436b-9ee3-14805adb4fce_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_24b7a87a-f565-44ed-9621-6ea772626b21_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liability</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_85029a6f-91a9-4267-8a1d-dadb6fda4d1a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7baa5bc5-7cfa-42a7-a6c3-bc200209cc7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0e417f8c-c7d4-454d-9c54-8978c2fe00f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_BoardMemberTwoMember_c376a974-1258-4829-b921-68b0582f85f8_terseLabel_en-US" xlink:label="lab_csbr_BoardMemberTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member Two</link:label>
    <link:label id="lab_csbr_BoardMemberTwoMember_label_en-US" xlink:label="lab_csbr_BoardMemberTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member Two [Member]</link:label>
    <link:label id="lab_csbr_BoardMemberTwoMember_documentation_en-US" xlink:label="lab_csbr_BoardMemberTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_BoardMemberTwoMember" xlink:href="csbr-20220731.xsd#csbr_BoardMemberTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_BoardMemberTwoMember" xlink:to="lab_csbr_BoardMemberTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3581acb7-0cea-4b26-8457-ffe78742f83f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_960f6bb0-fc14-4415-a67c-22592ebcb4f6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_53209e32-4dd6-4b10-9ebd-ccde95477d4b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">strike price as percent of market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5a608727-de86-486e-b1f9-21c4eef64827_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_acf2e9d6-532e-40d2-9c3a-d1e676ef8b3f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7aa1c959-0a29-4be5-b859-603492bbe346_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock_1fc7217f-9399-4789-a5b9-3eff6726d2ca_terseLabel_en-US" xlink:label="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of assets and liabilities</link:label>
    <link:label id="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="csbr-20220731.xsd#csbr_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_csbr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_50d31184-f6f4-4ae9-b86f-125ccce549e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4856ccda-5a5a-4615-84ab-0d5f822540ab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_6ebf50ea-3f91-48e5-8e33-6f88dc74fac4_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2d0dcc59-7f41-4e55-81f2-f89587e52679_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9546fa2d-72f9-4598-a619-f807b18e8cb2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7dc56adb-8384-4402-85fe-b8430301d14c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_313f521e-6c65-4331-a256-654d4e151c12_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8235a152-dbe2-425b-9ed7-b43bbe97c05c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_631fd73b-ee5f-404f-9a69-65f62db5be6e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_46f017bf-435a-4554-bf11-2cfd87b220c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_94e2b95e-b675-45b9-b864-e4462881be4e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8429703b-18f3-4b66-b6c0-0a3c349bdd56_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5812c44c-ad28-4eae-97f4-46fc43429202_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_897bf4f0-ff32-4828-9539-5d230634b5dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_55c11a84-004d-4f9e-884c-0d1896cb91b1_terseLabel_en-US" xlink:label="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payment, as percent of contract price</link:label>
    <link:label id="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_label_en-US" xlink:label="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Royalty Fee, Percent Of Contract Price</link:label>
    <link:label id="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_documentation_en-US" xlink:label="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Royalty Fee, Percent Of Contract Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" xlink:href="csbr-20220731.xsd#csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" xlink:to="lab_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_b4de0ba1-f31b-4a69-8861-4de6299f9ff7_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a611ff52-316d-440c-8f38-c9bf0f2beb5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_7b9d1485-eaec-4ee7-b398-2555b0a6922d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_85bdf844-283e-466e-a10d-176852cc0caf_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_4d2800f6-3998-46a4-b7e3-79bdd374cc9f_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServicingAssetAtAmortizedValue_4dc15017-694a-4a24-9b17-e3d51df87209_terseLabel_en-US" xlink:label="lab_us-gaap_ServicingAssetAtAmortizedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of servicing asset</link:label>
    <link:label id="lab_us-gaap_ServicingAssetAtAmortizedValue_label_en-US" xlink:label="lab_us-gaap_ServicingAssetAtAmortizedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Servicing Asset at Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServicingAssetAtAmortizedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAssetAtAmortizedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServicingAssetAtAmortizedValue" xlink:to="lab_us-gaap_ServicingAssetAtAmortizedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2748c2ec-cc0b-47fa-ac9c-5765f2a8e2e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_4b6f2458-b240-47b8-9e5c-90a85188b91e_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Unbilled Services and Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_OperatingLeaseIncrementalRentExpense_dad4067d-19f8-4435-a644-ece3b72a7b28_terseLabel_en-US" xlink:label="lab_csbr_OperatingLeaseIncrementalRentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental rent expense</link:label>
    <link:label id="lab_csbr_OperatingLeaseIncrementalRentExpense_label_en-US" xlink:label="lab_csbr_OperatingLeaseIncrementalRentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Incremental Rent Expense</link:label>
    <link:label id="lab_csbr_OperatingLeaseIncrementalRentExpense_documentation_en-US" xlink:label="lab_csbr_OperatingLeaseIncrementalRentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Incremental Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_OperatingLeaseIncrementalRentExpense" xlink:href="csbr-20220731.xsd#csbr_OperatingLeaseIncrementalRentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_OperatingLeaseIncrementalRentExpense" xlink:to="lab_csbr_OperatingLeaseIncrementalRentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7de21edd-fb8e-4651-bc57-5c35220be409_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5d9d46a0-c6de-4729-a48d-da39612ccf2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_48cd1a7f-1a87-4952-8071-bb632b51e4c4_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7afbe0f9-06cb-488a-86f1-e8d52654952c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e5b7bd7-a698-4155-a66e-720cf59fad52_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a65148b1-7e18-4dc0-9c25-4231c34135ef_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79426361-d672-4401-870f-df7ff05735fb_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_d1bfbc0b-1b67-4274-84d9-2ba3f95b1663_terseLabel_en-US" xlink:label="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of use assets</link:label>
    <link:label id="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right Of Use Assets</link:label>
    <link:label id="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:href="csbr-20220731.xsd#csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="lab_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f9f1dac4-c236-437b-a18f-17e3a817ba9a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_89be12bc-d94d-47c3-910d-4c21c3fe7f79_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb424434-97c1-4fb4-b4f3-1ce4a5df84fb_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6d49aef2-5fee-4e5e-b7c7-691dfb43160c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ded289e2-97b9-4fd5-8fdf-93de6e9423d4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a4bf94b7-4674-426a-9019-6ef4c54c4805_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_dd721f19-ea4b-43ec-89ab-6b4943a5981c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5d091905-f3a8-4054-b07d-f6c7fd3b6883_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b40a3f1-3d4c-4702-8601-13cc54906c82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_736d23c7-01f8-4d17-95bf-9bb60b5e7547_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_24e1ed46-e303-4251-8a23-cfdc29fc4ea0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8209f48e-368a-4cdc-9141-02fcb63e3144_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue arrangements by service contract period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_A2023FinanceLeaseMember_89473bd7-2bee-440c-bf96-1ffc48860161_terseLabel_en-US" xlink:label="lab_csbr_A2023FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Finance Lease</link:label>
    <link:label id="lab_csbr_A2023FinanceLeaseMember_label_en-US" xlink:label="lab_csbr_A2023FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Finance Lease [Member]</link:label>
    <link:label id="lab_csbr_A2023FinanceLeaseMember_documentation_en-US" xlink:label="lab_csbr_A2023FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Finance Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_A2023FinanceLeaseMember" xlink:href="csbr-20220731.xsd#csbr_A2023FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_A2023FinanceLeaseMember" xlink:to="lab_csbr_A2023FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_1c227a6f-6792-48ed-86e3-2d738c208d10_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8e606783-a651-43aa-b48a-12582caa5fb7_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_BoardMemberOneMember_74b117e8-fb66-4b08-a2c2-e3d894be44be_terseLabel_en-US" xlink:label="lab_csbr_BoardMemberOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member One</link:label>
    <link:label id="lab_csbr_BoardMemberOneMember_label_en-US" xlink:label="lab_csbr_BoardMemberOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member One [Member]</link:label>
    <link:label id="lab_csbr_BoardMemberOneMember_documentation_en-US" xlink:label="lab_csbr_BoardMemberOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_BoardMemberOneMember" xlink:href="csbr-20220731.xsd#csbr_BoardMemberOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_BoardMemberOneMember" xlink:to="lab_csbr_BoardMemberOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8a1ab3af-9d46-4224-b95e-4fdb03cdfa0e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1d92b217-e657-4233-b8a1-5d62da558a05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7dfdc091-b0e3-4383-b5b2-1e56e29fe21a_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_50f34297-6eee-4bff-a4cc-dc316a508f29_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e4f5b1b2-ba8d-4653-826e-3d77709d441c_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5044cccf-294c-48fc-ad77-3eb10f4e4129_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_33e1d65f-931d-4b42-98dc-a1d05f1c280b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_60acdbcf-2330-4942-af8e-d3447c60f62b_terseLabel_en-US" xlink:label="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, depreciation and amortization</link:label>
    <link:label id="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_label_en-US" xlink:label="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Depreciation And Amortization Expenses</link:label>
    <link:label id="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_documentation_en-US" xlink:label="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Depreciation And Amortization Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDepreciationAndAmortizationExpenses" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDepreciationAndAmortizationExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_FinanceLeaseDepreciationAndAmortizationExpenses" xlink:to="lab_csbr_FinanceLeaseDepreciationAndAmortizationExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_495f0840-5f89-44d1-848e-8b2a393abd77_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f5b8e03e-c830-4962-ab0d-bb263b817242_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3eea3061-7251-41a2-9c62-95871b05476a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Use of Estimates and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_0eb54d5c-c84a-45b3-8791-6f660e06215b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- Employees</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a982c306-034c-4d52-bc39-db56bdbb186d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of advanced billings</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_626f5eb8-24f8-47ec-a2fd-4cdb35733882_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_570108b9-87a9-4d8a-b71d-0dbc2677b60e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other TOS revenue</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b023c888-88ef-4b40-bd38-f2204861d89e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted, net of forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_5cd6b3b6-ca35-4cde-bb72-92ccc8ad4c2d_negatedTerseLabel_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_label_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_documentation_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" xlink:to="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_75ee4d1f-174b-4094-af0b-2217c5777b34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_EquityIncentivePlan2010Member_ffd5eb34-feb4-4a5a-a8a6-f01471cdc3c8_terseLabel_en-US" xlink:label="lab_csbr_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2010</link:label>
    <link:label id="lab_csbr_EquityIncentivePlan2010Member_label_en-US" xlink:label="lab_csbr_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2010 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_EquityIncentivePlan2010Member" xlink:href="csbr-20220731.xsd#csbr_EquityIncentivePlan2010Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_EquityIncentivePlan2010Member" xlink:to="lab_csbr_EquityIncentivePlan2010Member" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants_190ea843-49f6-4b7e-9cd6-bfd0a41e8099_terseLabel_en-US" xlink:label="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of options</link:label>
    <link:label id="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants_label_en-US" xlink:label="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Exercise Of Options And Warrants</link:label>
    <link:label id="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants_documentation_en-US" xlink:label="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options and warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ProceedsFromExerciseOfOptionsAndWarrants" xlink:href="csbr-20220731.xsd#csbr_ProceedsFromExerciseOfOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_ProceedsFromExerciseOfOptionsAndWarrants" xlink:to="lab_csbr_ProceedsFromExerciseOfOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_19fc44cb-1360-40a1-ba91-1d4f532a9b43_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_1307e627-3e45-42b1-a15b-485d14b03f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share outstanding</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_25efdb4c-1d79-48a3-ac14-0f680018ba65_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_8b29c930-5e70-40a0-8dd0-6e7627556fb7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_195a9354-b201-4577-8b1d-ee4cc0eb9671_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9bfc0582-db57-4a8c-b2b7-94ba14012bde_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_696c2ce3-c35b-407d-831c-9d7396b3ef52_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_d35ce4c6-c1b9-438b-a63c-67a2967dfcd9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_94c314e7-ebb0-490c-bb17-ffc90cec1347_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_111fb31b-d744-4640-84d9-19f3c003c778_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_WorkingCapitalDeficit_66d83f9d-e4bb-473a-aa1a-7d9372f0ce29_terseLabel_en-US" xlink:label="lab_csbr_WorkingCapitalDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_csbr_WorkingCapitalDeficit_label_en-US" xlink:label="lab_csbr_WorkingCapitalDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital (Deficit)</link:label>
    <link:label id="lab_csbr_WorkingCapitalDeficit_documentation_en-US" xlink:label="lab_csbr_WorkingCapitalDeficit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of reporting entity working capital (deficit) has reported.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_WorkingCapitalDeficit" xlink:href="csbr-20220731.xsd#csbr_WorkingCapitalDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_WorkingCapitalDeficit" xlink:to="lab_csbr_WorkingCapitalDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_fccbc59f-595e-4f8c-86e6-f85b84cc2eb1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3fafe379-6d95-453f-84e7-b699ef8fa349_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_57d3c25e-7386-4c6a-a29b-a11d83363613_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8918138e-df60-4d54-8869-0593765066c8_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_01b51685-c1d8-41ff-93b8-e7866de6eba5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9a8898dc-eefc-4c6e-95a6-f48f13257486_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of valuation assumptions for stock options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_FewContractsMember_e2ffdd36-2253-4344-85f2-60f19374f984_terseLabel_en-US" xlink:label="lab_csbr_FewContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Few Contracts</link:label>
    <link:label id="lab_csbr_FewContractsMember_label_en-US" xlink:label="lab_csbr_FewContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Few Contracts [Member]</link:label>
    <link:label id="lab_csbr_FewContractsMember_documentation_en-US" xlink:label="lab_csbr_FewContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Few contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FewContractsMember" xlink:href="csbr-20220731.xsd#csbr_FewContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_FewContractsMember" xlink:to="lab_csbr_FewContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8b6be67d-9672-4f14-ba3a-c0ac7625a43a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c5b05f3b-5089-45c6-8683-90e81e425450_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_8eb79372-d406-4275-ba70-f14c7779c50e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_701491be-b4cc-4b99-9b67-7b185f2298cc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_9776c9b6-944f-48ae-8ea4-a509c01abc0e_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2a374530-aa7e-4bcf-a982-961127a60381_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_36223134-b5d6-431e-a8c1-6c4a2c76ad3c_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4c7d8306-4152-4010-b7cd-da044ec74b12_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b12723ad-b684-4445-8999-a3dc9215fd3e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_16e20a9f-420f-48dc-b6c9-f6911910d119_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_827ca659-6573-48b4-80e4-aef6bc42d5fb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_831f977b-9ff3-423f-a0b6-713e1a1fd5c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_NumberOfOperatingSubsidiaries_5cfacff7-dfab-4ded-8584-eb4c172d765a_terseLabel_en-US" xlink:label="lab_csbr_NumberOfOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating subsidiaries</link:label>
    <link:label id="lab_csbr_NumberOfOperatingSubsidiaries_label_en-US" xlink:label="lab_csbr_NumberOfOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Subsidiaries</link:label>
    <link:label id="lab_csbr_NumberOfOperatingSubsidiaries_documentation_en-US" xlink:label="lab_csbr_NumberOfOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_NumberOfOperatingSubsidiaries" xlink:href="csbr-20220731.xsd#csbr_NumberOfOperatingSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_NumberOfOperatingSubsidiaries" xlink:to="lab_csbr_NumberOfOperatingSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0bd9bb2a-8c7f-4390-a2d6-0b4bd6e8f98c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_5f7b756e-92b9-470e-b8bb-00db2f06d530_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_968d005b-8a30-43e3-a0dd-266c0bbaa7ba_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9421370-630d-4b3e-ab0d-dc30d8778a4b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology services revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_84c9ec33-44b7-4c8a-84d4-66fa31829333_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_36d4a010-273e-46c1-acc7-92fa24698dec_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_65c6f552-36d8-434a-b19a-9c25a1867b5c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_32bdbe0e-18fd-4dc3-9a07-4dcf40b163da_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b4eac439-5859-407d-a7c3-dd0f10008830_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Employees</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_048d2348-46aa-48dc-94e3-15804285c408_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7d7b23a7-502f-44ed-907e-a6a01d90cf2d_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payments</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_b7f2a110-bdc1-465a-a695-31c589b228ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_981f8516-8ab3-44a4-9d59-94b1a15c54d8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_65695005-ad74-4e07-853a-6a117f1069d2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b1b3709e-6a31-4886-b4e3-59fb592cdecb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_33c1e911-e819-4119-9cdd-38f1967881f5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d0b40089-a743-4938-a517-ce3d33ff9733_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_98e659af-7cf4-4006-93c6-56d01cdf4cd7_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_050b34de-3c01-4a83-bbb9-2f4d2e3b4c62_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_90a0b25c-d398-41a3-a4c7-1992d797dfd2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_b93b6d31-6391-474c-bbb8-a3fd475fa7d1_terseLabel_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, granted (in years)</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:to="lab_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4b90e304-7944-4ef4-80cb-d3214fd347a2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4ac17a47-030f-42cd-9225-ce0f36654470_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1be610f1-1886-49d4-9183-20aa682cf461_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_09415715-9dcf-46b4-9474-cff775ea005f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_878fdd9d-c06e-4224-8ae0-72de3d845966_negatedLabel_en-US" xlink:label="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:label id="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="csbr-20220731.xsd#csbr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_csbr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_98273d56-085c-4862-96f7-c7021dec7b81_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bd523b81-ead4-49ef-8b62-a426d255b3c8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_de6c343a-1a74-496a-b3d8-0066ec74a985_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_08056aff-d193-4f29-8701-41f4310b87b2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_AssetInProgressMember_eed80eba-21c2-41ae-a11e-2933433ec4bf_terseLabel_en-US" xlink:label="lab_csbr_AssetInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets in progress</link:label>
    <link:label id="lab_csbr_AssetInProgressMember_label_en-US" xlink:label="lab_csbr_AssetInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset In Progress [Member]</link:label>
    <link:label id="lab_csbr_AssetInProgressMember_documentation_en-US" xlink:label="lab_csbr_AssetInProgressMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset In Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AssetInProgressMember" xlink:href="csbr-20220731.xsd#csbr_AssetInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_AssetInProgressMember" xlink:to="lab_csbr_AssetInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_A2022FinanceLeaseMember_dbdaf022-c784-43d4-a8ff-f79cb12135a1_terseLabel_en-US" xlink:label="lab_csbr_A2022FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Finance Lease</link:label>
    <link:label id="lab_csbr_A2022FinanceLeaseMember_label_en-US" xlink:label="lab_csbr_A2022FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Finance Lease [Member]</link:label>
    <link:label id="lab_csbr_A2022FinanceLeaseMember_documentation_en-US" xlink:label="lab_csbr_A2022FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Finance Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_A2022FinanceLeaseMember" xlink:href="csbr-20220731.xsd#csbr_A2022FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_A2022FinanceLeaseMember" xlink:to="lab_csbr_A2022FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_PersonalizedOncologyServicesMember_71f279bd-66cd-4346-b4a1-3064592c11a2_terseLabel_en-US" xlink:label="lab_csbr_PersonalizedOncologyServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized oncology services</link:label>
    <link:label id="lab_csbr_PersonalizedOncologyServicesMember_label_en-US" xlink:label="lab_csbr_PersonalizedOncologyServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized Oncology Services [Member]</link:label>
    <link:label id="lab_csbr_PersonalizedOncologyServicesMember_documentation_en-US" xlink:label="lab_csbr_PersonalizedOncologyServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized Oncology Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PersonalizedOncologyServicesMember" xlink:href="csbr-20220731.xsd#csbr_PersonalizedOncologyServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_PersonalizedOncologyServicesMember" xlink:to="lab_csbr_PersonalizedOncologyServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_CorporateHeadquartersMember_75e7a295-2d2f-432f-a5b3-8a82156eb061_terseLabel_en-US" xlink:label="lab_csbr_CorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Headquarters</link:label>
    <link:label id="lab_csbr_CorporateHeadquartersMember_label_en-US" xlink:label="lab_csbr_CorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CorporateHeadquartersMember" xlink:href="csbr-20220731.xsd#csbr_CorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_CorporateHeadquartersMember" xlink:to="lab_csbr_CorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_af34d3e0-ddbc-48bb-90d0-07452058ed45_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_340747dc-2d7d-467f-b2b8-dac63356e636_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_51481070-dafd-4731-a74b-de47def3f24a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share outstanding, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e7984443-104a-4f67-8b4b-797bb9681983_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_20c8832a-50cb-40bd-809f-30b48723f062_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_66c13dc9-c64d-4d3e-93ee-3cb402a9b79a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on disposal of equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8f16401-8547-4ebe-bb17-5cc4e7f790dc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_691d0453-d24f-4b3b-af4d-048ee600f8dc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_6ac329e9-e4dd-4f0f-95fe-7c380c05bb70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility Rate maximum (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9333529a-12a6-49e7-941e-3984bd3e19f6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_6069c4c8-eadf-440e-b5d8-457b9f923aac_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, asset, gross</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e061c830-5a23-4a5e-b1b6-83d57b573482_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of accounts receivable, unbilled services, and advanced billings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_e113cabf-bbc8-499a-aa03-15196704d256_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1f54ae86-4fb9-4791-8c17-313efe9e2b99_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_cc3ea9b4-5820-4b86-bf13-05311da251cf_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_911d09cc-9de7-4e82-9727-95c86dcce7e5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d6c29996-eabb-4c53-b01b-ac2e4fe0452d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share outstanding, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_207ddff0-2a54-41af-9f24-01dce3127542_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_223fb210-5aa6-4682-a6a0-fdcde9100c55_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration term of awards</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_b2264493-10ed-437c-b2c5-71637ff2160d_terseLabel_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in dollars per share)</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price</link:label>
    <link:label id="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" xlink:to="lab_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6e24d027-451a-4209-a77c-6e6a0d280332_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future operating lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_281035d2-2957-44c9-94be-d59eb0477ea8_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits anticipated during the next 12 months</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5a2f662d-7d9f-45f4-ad15-e64184ca56e9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_64df345d-09fc-4c9f-9813-49419af9dd13_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_RockvilleMDMember_366e1757-42d6-461c-8a03-a4ef8b2471e4_terseLabel_en-US" xlink:label="lab_csbr_RockvilleMDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rockville, MD</link:label>
    <link:label id="lab_csbr_RockvilleMDMember_label_en-US" xlink:label="lab_csbr_RockvilleMDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rockville, MD [Member]</link:label>
    <link:label id="lab_csbr_RockvilleMDMember_documentation_en-US" xlink:label="lab_csbr_RockvilleMDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rockville, MD [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_RockvilleMDMember" xlink:href="csbr-20220731.xsd#csbr_RockvilleMDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_RockvilleMDMember" xlink:to="lab_csbr_RockvilleMDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_7e86407c-2430-42e5-a4e8-8ccbcc069936_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_31e723f4-7b99-46ea-b200-8f27b139a239_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_5c0aee4f-9d03-40a4-b57e-5adccdf6b83f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_effe3e5a-17a3-4e9e-b226-4cedcdd5a270_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ccbe38c7-2152-44c8-9c55-3baeae211046_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_18100e54-4e31-4d5f-8461-4f3bef0010e5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_cc5acb27-0177-44e6-a99a-cda723901af5_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled services</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_74f7ccbb-e4c2-470b-9759-b8a222a71a6d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_AdditionalExpansionPremisesMember_ca28e041-7ff2-4217-b4fc-d8f443ea99c9_terseLabel_en-US" xlink:label="lab_csbr_AdditionalExpansionPremisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Expansion Premises</link:label>
    <link:label id="lab_csbr_AdditionalExpansionPremisesMember_label_en-US" xlink:label="lab_csbr_AdditionalExpansionPremisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Expansion Premises [Member]</link:label>
    <link:label id="lab_csbr_AdditionalExpansionPremisesMember_documentation_en-US" xlink:label="lab_csbr_AdditionalExpansionPremisesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Expansion Premises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AdditionalExpansionPremisesMember" xlink:href="csbr-20220731.xsd#csbr_AdditionalExpansionPremisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_AdditionalExpansionPremisesMember" xlink:to="lab_csbr_AdditionalExpansionPremisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b9e7d59d-0dcb-43e6-8dd1-cc43b7793c60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ed588ed2-9be9-4c12-bea0-dbf95eaa86f5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, amounts of transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_93a4da85-eb64-43a5-b891-d5af2ce7e29b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_LaboratoryEquipmentMember_311187d3-2c13-4da0-a0e8-e36574a2698b_terseLabel_en-US" xlink:label="lab_csbr_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_csbr_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_csbr_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_csbr_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_csbr_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_LaboratoryEquipmentMember" xlink:href="csbr-20220731.xsd#csbr_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_LaboratoryEquipmentMember" xlink:to="lab_csbr_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_510462fd-e8f4-4de2-b7b7-88eb8dbbc905_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_ed656be4-168a-43d4-8242-0ced684cfd46_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c58281b5-3bad-4348-a993-d91a610e202b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of allocation of share based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e2872c0e-e8e6-4d66-b7b7-9aad1a7181c1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_c17f1b91-e90d-4b53-96c9-d323384e6969_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_36f11887-cecb-4279-bae9-365861110bd9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9316f47a-be50-4a32-bb41-71ba1c18a65a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_478c3835-40c2-47f6-b61a-7710843b77a3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_cf221873-ef8c-4bd8-8d67-a1f62bc1b7d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ee83f3b3-dd8d-4960-8e5f-83c61d997466_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_b0cbc0ef-02e8-4dc3-8f8d-3066a14e0b20_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4e6e350c-8214-4596-b9e3-4837dc2a0093_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_0e1e5cce-7f07-47f6-ad59-ee2cd014c59f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock on exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_89d86a71-1c22-4bc3-8b2a-8e5bcd375886_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_284046af-6257-46ef-ba16-6f8bf3a02ec8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_486870c2-bf15-440e-98b1-0904723ae9f8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_309401a1-92a6-492f-bb74-483547c4d6ce_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d0a29d9d-144e-44a0-b1a0-397edaa22011_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_c00d9ebb-a736-4a1c-ae50-916f59ee3214_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_1902f570-33ea-4b36-9e41-d106d94bb157_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c0d7427f-6a57-41b8-b65e-abeaaa0a7ee1_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_314fb16d-ab82-47bf-96ce-8a46bdb9e3a4_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_EquityIncentivePlan2021Member_3f723f25-88bd-4746-b8ae-72bde85c21ab_terseLabel_en-US" xlink:label="lab_csbr_EquityIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2021</link:label>
    <link:label id="lab_csbr_EquityIncentivePlan2021Member_label_en-US" xlink:label="lab_csbr_EquityIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2021 [Member]</link:label>
    <link:label id="lab_csbr_EquityIncentivePlan2021Member_documentation_en-US" xlink:label="lab_csbr_EquityIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_EquityIncentivePlan2021Member" xlink:href="csbr-20220731.xsd#csbr_EquityIncentivePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_EquityIncentivePlan2021Member" xlink:to="lab_csbr_EquityIncentivePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_0b503c58-4bfc-43a6-a46d-3ffd231384fa_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_9270772e-0ec0-4e2e-8772-5dae1fae99f6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e1cc09e0-0301-41ce-ad1d-0ef27f3e4708_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_92e0ce9e-11b8-4830-9cd1-75a6f8f96a79_terseLabel_en-US" xlink:label="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="csbr-20220731.xsd#csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_31161a10-3efb-433d-8527-f896fa0a1d72_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_93b96404-c1ef-4743-8c9e-a215daf7d8ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5d96d7a7-0ea5-4d9b-92bb-41bdbf92cb30_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_f3d0fb7b-ee14-4a14-96dc-411598b2ba9a_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2ab1299a-a10b-4cd3-a529-38f45bd9092a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88c3b212-2478-4d76-9ac0-042c31759fdf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_8509debf-cb60-4364-829c-7fb93439f11a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_ReversalOfProvisionForDoubtfulAccounts_da6d9343-05aa-4d36-a2ca-333146dd50e4_terseLabel_en-US" xlink:label="lab_csbr_ReversalOfProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_csbr_ReversalOfProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_csbr_ReversalOfProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal Of Provision For Doubtful Accounts</link:label>
    <link:label id="lab_csbr_ReversalOfProvisionForDoubtfulAccounts_documentation_en-US" xlink:label="lab_csbr_ReversalOfProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal Of Provision For Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ReversalOfProvisionForDoubtfulAccounts" xlink:href="csbr-20220731.xsd#csbr_ReversalOfProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_ReversalOfProvisionForDoubtfulAccounts" xlink:to="lab_csbr_ReversalOfProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fa7c8dbb-d115-43b9-af6d-83bb1eac7071_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ab80de46-0c89-4bce-ae5f-034d27b8c1d6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_39d5a876-0c0f-4431-8ce8-f712c52abe7e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_44fd617a-44a7-4ebe-afe0-54f0aff0a6b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_713842e2-fca4-456a-9a1e-e6c5e3e97b5f_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4dadf85a-6fa2-4623-bf8c-beb31fa2e23f_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServicingAsset_732b9af0-0936-4673-a6a5-dfd462de96ed_terseLabel_en-US" xlink:label="lab_us-gaap_ServicingAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Servicing asset</link:label>
    <link:label id="lab_us-gaap_ServicingAsset_label_en-US" xlink:label="lab_us-gaap_ServicingAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Servicing Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServicingAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServicingAsset" xlink:to="lab_us-gaap_ServicingAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ae5d27e8-ee6c-42ac-b7e4-aef79217c789_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_25a4a511-5c28-4b57-a50c-1b0192c5a569_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17505574-a857-40cc-b6a3-403f278da2ec_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_286aceba-1ff8-402c-9112-695f7b6537d9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ce317094-4fcf-4341-98de-71494082ffb8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_d5b8db9e-10c3-4812-9eb8-08805b868835_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f181d2be-2dd6-49a2-8de5-628e295ff3b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_64b4654e-c3f4-4250-8563-e05953d9d37e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_20298a8e-3884-44cc-a82c-bac4b6b03035_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock on exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_PresentValueMinimumFutureObligationsInterestRate_426ea775-5aee-4fc5-87bc-a40c056ec6f8_terseLabel_en-US" xlink:label="lab_csbr_PresentValueMinimumFutureObligationsInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of minimum future obligations interest rate</link:label>
    <link:label id="lab_csbr_PresentValueMinimumFutureObligationsInterestRate_label_en-US" xlink:label="lab_csbr_PresentValueMinimumFutureObligationsInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present Value Minimum Future Obligations Interest Rate</link:label>
    <link:label id="lab_csbr_PresentValueMinimumFutureObligationsInterestRate_documentation_en-US" xlink:label="lab_csbr_PresentValueMinimumFutureObligationsInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present Value Minimum Future Obligations Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PresentValueMinimumFutureObligationsInterestRate" xlink:href="csbr-20220731.xsd#csbr_PresentValueMinimumFutureObligationsInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_PresentValueMinimumFutureObligationsInterestRate" xlink:to="lab_csbr_PresentValueMinimumFutureObligationsInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_239a403c-ec67-4a8d-a07b-1d9430e824c4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_e54d6f7a-6883-4a4e-bcd3-7a3c12e18526_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_02abcd57-39a0-4500-a266-26e2a094677b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6c7f57f2-fcff-490a-bd7a-3d073da3ec10_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b07d7cf1-1c40-432d-9e3d-c9ab6c020a7a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e0968caf-11b8-44d1-ab5b-d79a4191581d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9d465fb8-7a3a-44de-a453-484209289441_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ac623b9c-2ce0-49bb-a778-f7b31bc5aafd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_d1d79d26-0ad2-4568-a38d-75e2d5204972_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_9d1b5768-017a-4c8d-85eb-6bf36ad474b7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bbc0fbe7-0a4a-4d60-beee-80750be68e9a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Being Evaluated/Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_csbr_FinanceLeaseDomain_ae85f9f3-089b-4970-ac83-6f03b9154d9c_terseLabel_en-US" xlink:label="lab_csbr_FinanceLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Domain]</link:label>
    <link:label id="lab_csbr_FinanceLeaseDomain_label_en-US" xlink:label="lab_csbr_FinanceLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Domain]</link:label>
    <link:label id="lab_csbr_FinanceLeaseDomain_documentation_en-US" xlink:label="lab_csbr_FinanceLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDomain" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_csbr_FinanceLeaseDomain" xlink:to="lab_csbr_FinanceLeaseDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_b30dec74-e2f9-4430-978a-1681a21edfac_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of oncology services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_252fe9c8-b4e4-4d11-a766-6078f36c3193_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_78e4b28e-a155-473c-8339-d77b1d3e286a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2523393c-ed39-45b8-945b-11651dab117d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4afd6be5-d33f-44fe-be75-ae1e47fa63e9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a3eec3b4-4cd6-4dc5-8f5a-619ed2485b86_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>csbr-20220731_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ec52204b-131e-4198-92e8-02fb9363ce20,g:7d91c0c2-82c1-4c83-ab39-3140ef69ee6c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://championsoncology.com/role/Cover" xlink:type="simple" xlink:href="csbr-20220731.xsd#Cover"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fa25c28d-b699-4e4d-b938-df03d0df01c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_DocumentType_fa25c28d-b699-4e4d-b938-df03d0df01c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_74610dd3-900b-47bf-88ee-a85f56013715" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_DocumentQuarterlyReport_74610dd3-900b-47bf-88ee-a85f56013715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9d853766-c0b0-4ceb-a165-0c2d1716c17b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_DocumentPeriodEndDate_9d853766-c0b0-4ceb-a165-0c2d1716c17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b0bd4003-6479-4ebf-8f7d-bd3d0197ea67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_DocumentTransitionReport_b0bd4003-6479-4ebf-8f7d-bd3d0197ea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_953b5925-7393-43b8-b6ad-674f84220ba6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityFileNumber_953b5925-7393-43b8-b6ad-674f84220ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bb462d7d-a3e5-4f89-ae6d-fa443e2822ac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityRegistrantName_bb462d7d-a3e5-4f89-ae6d-fa443e2822ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0907f4f5-ce57-4567-bc7b-0d9cf14c8235" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0907f4f5-ce57-4567-bc7b-0d9cf14c8235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fb49b846-bd60-455f-8d6a-7e5133e5223f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityTaxIdentificationNumber_fb49b846-bd60-455f-8d6a-7e5133e5223f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_11cda76d-8547-441b-8cf6-4a7e8cf333bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityAddressAddressLine1_11cda76d-8547-441b-8cf6-4a7e8cf333bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_02dbaecb-c858-49aa-a29f-3a3d22e7f206" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityAddressPostalZipCode_02dbaecb-c858-49aa-a29f-3a3d22e7f206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_144ebd3b-0dd5-422f-a005-bbbac9b99dee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityAddressCityOrTown_144ebd3b-0dd5-422f-a005-bbbac9b99dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_60d74a5f-ee18-41fb-8666-f338912fd048" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityAddressStateOrProvince_60d74a5f-ee18-41fb-8666-f338912fd048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2f00dd31-e223-4bf7-91c0-fc992b89337a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_CityAreaCode_2f00dd31-e223-4bf7-91c0-fc992b89337a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a4b052ef-f67a-4c83-b27a-9bb2296199ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_LocalPhoneNumber_a4b052ef-f67a-4c83-b27a-9bb2296199ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_557651ef-ded2-4df9-a6e8-385f1a257b23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_Security12bTitle_557651ef-ded2-4df9-a6e8-385f1a257b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8c009b9e-cf31-4b81-898b-1ff6ae9215db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_TradingSymbol_8c009b9e-cf31-4b81-898b-1ff6ae9215db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d8002868-0f4f-4ffd-b99c-71d061ae4e35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_SecurityExchangeName_d8002868-0f4f-4ffd-b99c-71d061ae4e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_907259d0-d94f-4abc-a754-3b54aea06815" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityCurrentReportingStatus_907259d0-d94f-4abc-a754-3b54aea06815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ac9e80ab-71e2-41eb-a90f-4b71914d4e97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityInteractiveDataCurrent_ac9e80ab-71e2-41eb-a90f-4b71914d4e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2676cde7-0f99-4222-aa23-1ed7409f46bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityFilerCategory_2676cde7-0f99-4222-aa23-1ed7409f46bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_822aecaa-b8aa-4bf5-826b-4436db919c2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntitySmallBusiness_822aecaa-b8aa-4bf5-826b-4436db919c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_afacd30b-96c1-41a2-a5db-d0e2c68a4912" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityEmergingGrowthCompany_afacd30b-96c1-41a2-a5db-d0e2c68a4912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_717c12dc-4170-4016-b5df-be146ce5a1b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityShellCompany_717c12dc-4170-4016-b5df-be146ce5a1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ef4f72b5-bda2-4640-b808-0144c7ad093a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ef4f72b5-bda2-4640-b808-0144c7ad093a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_30517cd6-0bee-4e9a-8272-e754cdced472" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_AmendmentFlag_30517cd6-0bee-4e9a-8272-e754cdced472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e26e5a8e-9254-4df8-82be-bcad927b0e06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_DocumentFiscalYearFocus_e26e5a8e-9254-4df8-82be-bcad927b0e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9bcab53d-ae62-47ab-b764-0ff0302c059c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9bcab53d-ae62-47ab-b764-0ff0302c059c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0ff8884a-38d3-47df-bc30-c47f47dff8c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_EntityCentralIndexKey_0ff8884a-38d3-47df-bc30-c47f47dff8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_294376f2-00db-40cf-90f9-722f96b91eb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6e5f146-3ac1-43d3-b50f-ed25a34ec9af" xlink:to="loc_dei_CurrentFiscalYearEndDate_294376f2-00db-40cf-90f9-722f96b91eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="csbr-20220731.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_971777c6-6eea-4aee-ad75-4aaa77103943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_971777c6-6eea-4aee-ad75-4aaa77103943" xlink:to="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c595fcb2-575e-4d7b-87e6-41865a3b8967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c595fcb2-575e-4d7b-87e6-41865a3b8967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fd27053d-9ccf-4f46-be29-d0f00a0befcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c595fcb2-575e-4d7b-87e6-41865a3b8967" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fd27053d-9ccf-4f46-be29-d0f00a0befcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a6723817-9d18-458f-81c1-3721599b8965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c595fcb2-575e-4d7b-87e6-41865a3b8967" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a6723817-9d18-458f-81c1-3721599b8965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_89fddfdb-35ae-4af5-a194-e5156c641876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c595fcb2-575e-4d7b-87e6-41865a3b8967" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_89fddfdb-35ae-4af5-a194-e5156c641876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_98f9fa23-d2d1-4026-8c15-71a03453a79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c595fcb2-575e-4d7b-87e6-41865a3b8967" xlink:to="loc_us-gaap_AssetsCurrent_98f9fa23-d2d1-4026-8c15-71a03453a79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9b327e85-0c7a-4dd7-a57e-8185b880d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9b327e85-0c7a-4dd7-a57e-8185b880d4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_86e5129d-38b4-46b5-a3b0-bef4e8f2310b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_86e5129d-38b4-46b5-a3b0-bef4e8f2310b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_03be1f1d-6221-4ab2-a6d0-da8ad4c09d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_03be1f1d-6221-4ab2-a6d0-da8ad4c09d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6036ef8e-5309-4c52-bbd7-4e90cc21a747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:to="loc_us-gaap_Goodwill_6036ef8e-5309-4c52-bbd7-4e90cc21a747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b2f142fe-f6ba-405b-a08a-0b820263f7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_618d1db5-5479-4428-9feb-671b282b2d6a" xlink:to="loc_us-gaap_Assets_b2f142fe-f6ba-405b-a08a-0b820263f7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_971777c6-6eea-4aee-ad75-4aaa77103943" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4de87d09-7415-4d95-8f8d-2f467f637a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:to="loc_us-gaap_AccountsPayableCurrent_4de87d09-7415-4d95-8f8d-2f467f637a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1f4e6730-e3ca-4f83-a581-d016b56587c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1f4e6730-e3ca-4f83-a581-d016b56587c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_17b53654-2110-4afb-9df9-1af5e1411400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_17b53654-2110-4afb-9df9-1af5e1411400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_38107f40-ee8d-4945-a869-53a951b9aa34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_38107f40-ee8d-4945-a869-53a951b9aa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f7fec0bc-9577-4b09-81e8-82fe98ecd211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f7fec0bc-9577-4b09-81e8-82fe98ecd211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2b38c075-ffe4-4840-97ed-2cf0a7e823bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6b2af5f-5b8d-4508-948f-17adb57c39f1" xlink:to="loc_us-gaap_LiabilitiesCurrent_2b38c075-ffe4-4840-97ed-2cf0a7e823bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_23b12d75-1c33-4121-b53e-b8d972ac6c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_23b12d75-1c33-4121-b53e-b8d972ac6c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fc235cd1-a3a3-4873-a4a0-47ac20fb2364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fc235cd1-a3a3-4873-a4a0-47ac20fb2364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f9de10f1-0a42-4f0a-bec6-2f07b5c89962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:to="loc_us-gaap_Liabilities_f9de10f1-0a42-4f0a-bec6-2f07b5c89962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5b7d1bf5-3f26-4f1f-a03d-dab65de329c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5b7d1bf5-3f26-4f1f-a03d-dab65de329c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5ac7a737-b540-4c42-8d19-2ef239a4ac70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5b7d1bf5-3f26-4f1f-a03d-dab65de329c8" xlink:to="loc_us-gaap_CommonStockValue_5ac7a737-b540-4c42-8d19-2ef239a4ac70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d09f63b4-78d6-4ae9-a849-a635288e2310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5b7d1bf5-3f26-4f1f-a03d-dab65de329c8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d09f63b4-78d6-4ae9-a849-a635288e2310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_09171b86-4207-4339-8a09-32db71d70e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5b7d1bf5-3f26-4f1f-a03d-dab65de329c8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_09171b86-4207-4339-8a09-32db71d70e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_55fb6aac-959c-47e4-b427-4be1fed411e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5b7d1bf5-3f26-4f1f-a03d-dab65de329c8" xlink:to="loc_us-gaap_StockholdersEquity_55fb6aac-959c-47e4-b427-4be1fed411e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fa01b92f-4993-482e-aa38-889df296b7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_99fc8d39-f0bf-4a57-82ac-df5224224ff3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fa01b92f-4993-482e-aa38-889df296b7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL" xlink:type="simple" xlink:href="csbr-20220731.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0a5c4b13-47df-4d26-b30f-d17aff64bead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ecd0d3ba-5f9e-48b1-a9ed-5ab7bca39b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a5c4b13-47df-4d26-b30f-d17aff64bead" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ecd0d3ba-5f9e-48b1-a9ed-5ab7bca39b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bf855411-3448-4fde-9ff4-f3175b72b21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a5c4b13-47df-4d26-b30f-d17aff64bead" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bf855411-3448-4fde-9ff4-f3175b72b21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1e71a647-fe96-45b9-b658-1869b32c9d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a5c4b13-47df-4d26-b30f-d17aff64bead" xlink:to="loc_us-gaap_CommonStockSharesIssued_1e71a647-fe96-45b9-b658-1869b32c9d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_24c27603-7594-47eb-b786-46eae04d21e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a5c4b13-47df-4d26-b30f-d17aff64bead" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_24c27603-7594-47eb-b786-46eae04d21e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="csbr-20220731.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c0c5837c-05e8-419c-a8ae-5f98ada54963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c0c5837c-05e8-419c-a8ae-5f98ada54963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9a59c081-0a7c-470b-8715-d1735f4f83e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9a59c081-0a7c-470b-8715-d1735f4f83e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c60060d1-c5e3-4a34-a845-618a78c6452d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c60060d1-c5e3-4a34-a845-618a78c6452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_787c6436-26d5-4c46-84dd-f83d3dc77c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:to="loc_us-gaap_SellingAndMarketingExpense_787c6436-26d5-4c46-84dd-f83d3dc77c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_44244b7e-898b-4c11-8ac7-f76c7a5244af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_44244b7e-898b-4c11-8ac7-f76c7a5244af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ab6bf208-503a-4f3c-b958-a689246815f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f21cef1-5371-4844-b114-fba51dd70e60" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ab6bf208-503a-4f3c-b958-a689246815f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ae6f50bc-7cad-4beb-adb7-5116357c97ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_OperatingIncomeLoss_ae6f50bc-7cad-4beb-adb7-5116357c97ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_be42bd99-984f-473f-91f4-6502d44a21f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_be42bd99-984f-473f-91f4-6502d44a21f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e6efccd-a4d9-43fa-81bc-04de1e52ffc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e6efccd-a4d9-43fa-81bc-04de1e52ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_869cb91a-acab-47ea-bf91-7129eb8c6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_869cb91a-acab-47ea-bf91-7129eb8c6f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6a13233-a896-458b-993d-6b882cd4cfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_NetIncomeLoss_c6a13233-a896-458b-993d-6b882cd4cfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a9911f6c-27b2-4400-93d8-3210944170ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_EarningsPerShareAbstract_a9911f6c-27b2-4400-93d8-3210944170ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f700f840-f255-4bc4-8ef7-67ca7083ed8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a9911f6c-27b2-4400-93d8-3210944170ec" xlink:to="loc_us-gaap_EarningsPerShareBasic_f700f840-f255-4bc4-8ef7-67ca7083ed8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d93ded13-dd6c-4d27-b606-715a79e01c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a9911f6c-27b2-4400-93d8-3210944170ec" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d93ded13-dd6c-4d27-b606-715a79e01c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bee75edf-0f14-4b0c-abe9-699a15c291bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bee75edf-0f14-4b0c-abe9-699a15c291bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96f549f0-1869-427d-a1c1-cbd4287922f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bee75edf-0f14-4b0c-abe9-699a15c291bc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96f549f0-1869-427d-a1c1-cbd4287922f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0bbfb81-32df-4445-9228-a47d0ca53bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bee75edf-0f14-4b0c-abe9-699a15c291bc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0bbfb81-32df-4445-9228-a47d0ca53bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_ea88149e-cf30-412e-a73b-4cf7a185c981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_TypeOfRevenueExtensibleList_ea88149e-cf30-412e-a73b-4cf7a185c981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_224003b8-6856-4115-8fb7-f0a83791d48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da9aa746-d150-4d03-b0fe-312c2dc95bcb" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_224003b8-6856-4115-8fb7-f0a83791d48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="csbr-20220731.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fc0681d4-f127-467b-879a-f77ec94ecf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fc0681d4-f127-467b-879a-f77ec94ecf6a" xlink:to="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c7eaf08a-3c9b-4088-98bb-b19391e29ca5" xlink:to="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1f6625d1-6a53-4c06-ab4a-dd45485e567e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:to="loc_us-gaap_CommonStockMember_1f6625d1-6a53-4c06-ab4a-dd45485e567e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_63449bd2-e3d0-44e7-b176-fae947435d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_63449bd2-e3d0-44e7-b176-fae947435d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b0eb250c-fa66-4e5b-b8d6-c3041ea2137d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e06f6ca2-0fdb-4f91-bdad-c3664be78a2b" xlink:to="loc_us-gaap_RetainedEarningsMember_b0eb250c-fa66-4e5b-b8d6-c3041ea2137d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4fc2de6e-99d6-491e-9614-aa1689614427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_890cb087-34e2-42ff-9b48-51c250ecea49" xlink:to="loc_us-gaap_StatementLineItems_4fc2de6e-99d6-491e-9614-aa1689614427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4fc2de6e-99d6-491e-9614-aa1689614427" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a20f5552-ad0f-488e-b7ed-b746309f4654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a20f5552-ad0f-488e-b7ed-b746309f4654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88ab66bd-ab09-4bc1-a326-ca2c95183e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockholdersEquity_88ab66bd-ab09-4bc1-a326-ca2c95183e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_da38692f-a8eb-4991-9763-70e9a1825f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_da38692f-a8eb-4991-9763-70e9a1825f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_b49b94d9-a74f-44f1-ba5a-ce749ae7ac82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_b49b94d9-a74f-44f1-ba5a-ce749ae7ac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_f302e137-337f-47c6-bb25-bad0986a10af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_f302e137-337f-47c6-bb25-bad0986a10af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_711148aa-830b-4622-a14e-50a99b3059c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_NetIncomeLoss_711148aa-830b-4622-a14e-50a99b3059c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_27b4505a-68d1-4859-91f0-88d20dbc7390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_27b4505a-68d1-4859-91f0-88d20dbc7390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_00ca5d07-f630-412f-9973-d6b6b2e69ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_546885e8-c78d-42d0-84a7-de67b2c11e89" xlink:to="loc_us-gaap_StockholdersEquity_00ca5d07-f630-412f-9973-d6b6b2e69ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="csbr-20220731.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c74daca6-bcf3-4ce6-9ada-125484fdfd62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c74daca6-bcf3-4ce6-9ada-125484fdfd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01b1705c-5bba-4988-847e-57e533f0eb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c74daca6-bcf3-4ce6-9ada-125484fdfd62" xlink:to="loc_us-gaap_NetIncomeLoss_01b1705c-5bba-4988-847e-57e533f0eb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c74daca6-bcf3-4ce6-9ada-125484fdfd62" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_aca6aa69-e619-4551-800b-4aad572dfb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:to="loc_us-gaap_ShareBasedCompensation_aca6aa69-e619-4551-800b-4aad572dfb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_dab415c0-cea4-4779-b0ee-dc335100256e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:to="loc_us-gaap_DepreciationAndAmortization_dab415c0-cea4-4779-b0ee-dc335100256e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0bb017b7-349d-455a-8a46-3ae02358c925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0bb017b7-349d-455a-8a46-3ae02358c925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_9bef4ff3-944b-4a56-8340-d98bf74533c1" xlink:href="csbr-20220731.xsd#csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:to="loc_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_9bef4ff3-944b-4a56-8340-d98bf74533c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ReversalOfProvisionForDoubtfulAccounts_b854f1a3-62a2-44eb-9a3b-af760d896c63" xlink:href="csbr-20220731.xsd#csbr_ReversalOfProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:to="loc_csbr_ReversalOfProvisionForDoubtfulAccounts_b854f1a3-62a2-44eb-9a3b-af760d896c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_adb9c80b-3808-4614-aa40-e9276d9153a3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5e9cc764-2d26-46ce-ae5d-18a20c6add66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5e9cc764-2d26-46ce-ae5d-18a20c6add66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3b74d48a-b76f-4850-aae8-b15909990761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3b74d48a-b76f-4850-aae8-b15909990761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d35f2b75-6091-4b62-b227-31dfee5a471d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d35f2b75-6091-4b62-b227-31dfee5a471d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6326bd27-54bf-4d2e-b80b-46166c8d03b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6326bd27-54bf-4d2e-b80b-46166c8d03b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b3297e66-35d1-4fe4-afc0-e82779376fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b3297e66-35d1-4fe4-afc0-e82779376fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a8e5bb35-705d-43ab-8338-9cb44f3926a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a8e5bb35-705d-43ab-8338-9cb44f3926a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_565fdde1-022e-49ee-b814-b286a06816c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_565fdde1-022e-49ee-b814-b286a06816c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_2eae8d7c-4cf3-4e11-8fd6-e30d718cb426" xlink:href="csbr-20220731.xsd#csbr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_csbr_IncreaseDecreaseInOperatingLeaseLiabilities_2eae8d7c-4cf3-4e11-8fd6-e30d718cb426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_535a432f-07ce-4d86-89f6-f3b711bf4e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_380ab4fb-b1cf-4532-a114-8e8b92878fc0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_535a432f-07ce-4d86-89f6-f3b711bf4e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cb87cf20-564b-4595-a472-ecbc7729e0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c74daca6-bcf3-4ce6-9ada-125484fdfd62" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cb87cf20-564b-4595-a472-ecbc7729e0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_227e4291-6eea-48ba-a203-d447e18182ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_227e4291-6eea-48ba-a203-d447e18182ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_53dcabb2-442e-451e-a7fc-4de27e2072c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_227e4291-6eea-48ba-a203-d447e18182ee" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_53dcabb2-442e-451e-a7fc-4de27e2072c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_97764f12-8f0c-4733-89a1-0c082c7f796d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_227e4291-6eea-48ba-a203-d447e18182ee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_97764f12-8f0c-4733-89a1-0c082c7f796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6f2f1ff2-7d20-446d-b30e-afc8b1b5ecee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6f2f1ff2-7d20-446d-b30e-afc8b1b5ecee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ProceedsFromExerciseOfOptionsAndWarrants_d9cffc1c-c76a-4fab-9ef9-fc329d4f43bf" xlink:href="csbr-20220731.xsd#csbr_ProceedsFromExerciseOfOptionsAndWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6f2f1ff2-7d20-446d-b30e-afc8b1b5ecee" xlink:to="loc_csbr_ProceedsFromExerciseOfOptionsAndWarrants_d9cffc1c-c76a-4fab-9ef9-fc329d4f43bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3e2712a-12ee-44b2-8c05-b008e6fa868a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6f2f1ff2-7d20-446d-b30e-afc8b1b5ecee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3e2712a-12ee-44b2-8c05-b008e6fa868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6aa9bc93-ca63-4d83-9bf5-b516d8d3f140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6aa9bc93-ca63-4d83-9bf5-b516d8d3f140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_81f67a5d-e947-44a2-bcde-5b25b4ad808c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_81f67a5d-e947-44a2-bcde-5b25b4ad808c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1119e4df-477c-491f-91c2-1ca368d25817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7f504459-0f0f-480d-b0a9-6d885675783a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1119e4df-477c-491f-91c2-1ca368d25817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation" xlink:type="simple" xlink:href="csbr-20220731.xsd#OrganizationUseofEstimatesandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_28393e4b-1b63-4221-bbec-032ba1f5e5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_84382cd5-2fd0-468c-80c8-ed8779569a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_28393e4b-1b63-4221-bbec-032ba1f5e5b9" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_84382cd5-2fd0-468c-80c8-ed8779569a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentationDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#OrganizationUseofEstimatesandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_00b7be7f-7121-4936-b579-11f51ef074bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_NumberOfOperatingSubsidiaries_d7a2fcef-619e-407a-bfe7-3fefd6c45f58" xlink:href="csbr-20220731.xsd#csbr_NumberOfOperatingSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_00b7be7f-7121-4936-b579-11f51ef074bd" xlink:to="loc_csbr_NumberOfOperatingSubsidiaries_d7a2fcef-619e-407a-bfe7-3fefd6c45f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="csbr-20220731.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fa812f2c-d9c4-46cf-bcad-cbc6b91070ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6c0c46fc-c5a2-49e9-8e70-c285719c9e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fa812f2c-d9c4-46cf-bcad-cbc6b91070ad" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6c0c46fc-c5a2-49e9-8e70-c285719c9e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="csbr-20220731.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0dff999d-c19e-4696-95ce-7f53460f97bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0dff999d-c19e-4696-95ce-7f53460f97bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_3e9d1b1e-d140-42a7-a9ee-4ef45ce17936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_3e9d1b1e-d140-42a7-a9ee-4ef45ce17936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_08c3d441-d6d0-4b2a-8634-a2cfadc15dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_08c3d441-d6d0-4b2a-8634-a2cfadc15dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_d591d1e0-0de8-468a-a048-52c5c8703b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_d591d1e0-0de8-468a-a048-52c5c8703b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_51f463e6-a0a5-4607-89df-f09d1657affa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_51f463e6-a0a5-4607-89df-f09d1657affa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0aaf7459-a1f7-47bb-8700-47e6aeb2d72a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e9194e2-3a87-4c55-b70e-69568bf746f8" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0aaf7459-a1f7-47bb-8700-47e6aeb2d72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="csbr-20220731.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b1e600d9-8af3-4630-b06b-0a42bc76a466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2750d4f8-1002-4ef7-b74e-69cf5ed4bf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e600d9-8af3-4630-b06b-0a42bc76a466" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2750d4f8-1002-4ef7-b74e-69cf5ed4bf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_6a83e2ec-9ad0-4bb4-87d2-b6209cb8571d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_6a83e2ec-9ad0-4bb4-87d2-b6209cb8571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0fe9ed66-d26a-48c8-a4f2-51bd07d769d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_NetIncomeLoss_0fe9ed66-d26a-48c8-a4f2-51bd07d769d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6162d121-0454-4cdc-a6c7-97aa8819ccfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6162d121-0454-4cdc-a6c7-97aa8819ccfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_489cb8f9-ee90-499e-a76b-08110ec2ef7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_489cb8f9-ee90-499e-a76b-08110ec2ef7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_WorkingCapitalDeficit_b50371fc-613d-4d16-b12b-c90f735e2805" xlink:href="csbr-20220731.xsd#csbr_WorkingCapitalDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_csbr_WorkingCapitalDeficit_b50371fc-613d-4d16-b12b-c90f735e2805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4c67b41-e655-4876-9067-d79d63312b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4c67b41-e655-4876-9067-d79d63312b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_c3c6049b-e7fb-4683-af79-77cdf657407e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_c3c6049b-e7fb-4683-af79-77cdf657407e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3c5d7740-5e61-4d36-99df-831e56ad0e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3c5d7740-5e61-4d36-99df-831e56ad0e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_4367269f-b26a-4d61-86dc-6f656b8239dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_4367269f-b26a-4d61-86dc-6f656b8239dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_758c6f6b-c4fb-44dc-b734-2d4275ae163c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cccfe649-c087-4dd9-908e-a1b7b0a72d28" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_758c6f6b-c4fb-44dc-b734-2d4275ae163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_02e623cf-d14e-470e-afd8-b1397d13a1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02e623cf-d14e-470e-afd8-b1397d13a1dd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a9d29a56-a318-4a9e-a7ef-0fa1c15b7da2" xlink:to="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FewContractsMember_6575b97f-791e-4954-86d6-480cb9aaf5e9" xlink:href="csbr-20220731.xsd#csbr_FewContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c66ec46a-81e4-4c3b-b362-6ab58cb3d7af" xlink:to="loc_csbr_FewContractsMember_6575b97f-791e-4954-86d6-480cb9aaf5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dcdfb9c2-68cf-411d-a3b3-65fee86623d0" xlink:to="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33595f15-11d5-452c-b484-1c9cd81d96bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:to="loc_srt_MaximumMember_33595f15-11d5-452c-b484-1c9cd81d96bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c0d1570-5031-4f0c-aded-3d1bc14215b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4f460752-6ecb-45d7-9234-53f503a4f9ab" xlink:to="loc_srt_MinimumMember_0c0d1570-5031-4f0c-aded-3d1bc14215b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23a57330-e30d-4133-8a9d-a0b73eee4a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23a57330-e30d-4133-8a9d-a0b73eee4a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0f0fd794-a281-4c0d-b5a9-fce73a821067" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b688de1-a3ef-4a0d-a8cd-df88bbef5a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_3cfee4e2-a80c-46cd-8c94-47e904b91bbe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b688de1-a3ef-4a0d-a8cd-df88bbef5a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1" xlink:type="simple" xlink:href="csbr-20220731.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://championsoncology.com/role/SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ffba35f5-e68f-449d-a066-f0c5a9bc6253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_619c1635-fdae-4f1e-8f59-81b2c0a4a4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffba35f5-e68f-449d-a066-f0c5a9bc6253" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_619c1635-fdae-4f1e-8f59-81b2c0a4a4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue" xlink:type="simple" xlink:href="csbr-20220731.xsd#AccountsReceivableUnbilledServicesandDeferredRevenue"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_d61c6ec7-00c3-4f21-a459-540af61b6091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_49a3fa19-e607-4fb2-9f6d-06aec94dc16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_d61c6ec7-00c3-4f21-a459-540af61b6091" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_49a3fa19-e607-4fb2-9f6d-06aec94dc16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables" xlink:type="simple" xlink:href="csbr-20220731.xsd#AccountsReceivableUnbilledServicesandDeferredRevenueTables"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_15146b99-69a1-442f-88b1-24ed5ab9169a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_611e70aa-a376-4f6b-82a9-9647abe8c53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_15146b99-69a1-442f-88b1-24ed5ab9169a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_611e70aa-a376-4f6b-82a9-9647abe8c53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_54c1a65f-d9e8-4f91-b4f5-dba8e6061548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_15146b99-69a1-442f-88b1-24ed5ab9169a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_54c1a65f-d9e8-4f91-b4f5-dba8e6061548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_9cfb4ac0-d7c6-4222-a8bb-055c6bc150f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_c0c34fc7-e23f-4dd3-9ed2-088ade406302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_9cfb4ac0-d7c6-4222-a8bb-055c6bc150f5" xlink:to="loc_us-gaap_AccountsReceivableGross_c0c34fc7-e23f-4dd3-9ed2-088ade406302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_579b4da9-3d75-4045-a996-2e957bfc16c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_9cfb4ac0-d7c6-4222-a8bb-055c6bc150f5" xlink:to="loc_us-gaap_UnbilledContractsReceivable_579b4da9-3d75-4045-a996-2e957bfc16c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_739a447b-9212-4d6e-8665-5218cfa25052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_9cfb4ac0-d7c6-4222-a8bb-055c6bc150f5" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_739a447b-9212-4d6e-8665-5218cfa25052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_28572af6-5d93-4efb-a15f-9b6c06cf6b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_9cfb4ac0-d7c6-4222-a8bb-055c6bc150f5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_28572af6-5d93-4efb-a15f-9b6c06cf6b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_403d8eeb-4339-42f0-9bd2-77285446b5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_9cfb4ac0-d7c6-4222-a8bb-055c6bc150f5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_403d8eeb-4339-42f0-9bd2-77285446b5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_398aceae-a446-4367-bcdd-0f46f5b58f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e983111b-3b8b-4dc9-bf0b-ecbc33f85c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_398aceae-a446-4367-bcdd-0f46f5b58f9c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e983111b-3b8b-4dc9-bf0b-ecbc33f85c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomers" xlink:type="simple" xlink:href="csbr-20220731.xsd#RevenuefromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/RevenuefromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ce04d763-84f9-485f-a5e6-2490cb7ebb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_6fc5df3e-9318-4225-a627-79bcc8646ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ce04d763-84f9-485f-a5e6-2490cb7ebb67" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_6fc5df3e-9318-4225-a627-79bcc8646ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomersTables" xlink:type="simple" xlink:href="csbr-20220731.xsd#RevenuefromContractswithCustomersTables"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/RevenuefromContractswithCustomersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a8f24ac8-dee3-4020-aa7f-c3c786a270ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0c8286aa-96da-46d3-8a7d-a32628e73799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a8f24ac8-dee3-4020-aa7f-c3c786a270ce" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0c8286aa-96da-46d3-8a7d-a32628e73799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/RevenuefromContractswithCustomersDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#RevenuefromContractswithCustomersDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/RevenuefromContractswithCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d0b77308-6235-48b2-bd3b-c3b319193e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d0b77308-6235-48b2-bd3b-c3b319193e3e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:to="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_fa9d489e-8301-4be3-8343-014cd7dfa127" xlink:to="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PharmacologyServicesMember_ce0bca17-6fc5-46a6-af50-710816943bdb" xlink:href="csbr-20220731.xsd#csbr_PharmacologyServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:to="loc_csbr_PharmacologyServicesMember_ce0bca17-6fc5-46a6-af50-710816943bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_07e6aa8c-a685-4b68-941b-c7bc33609eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_07e6aa8c-a685-4b68-941b-c7bc33609eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PersonalizedOncologyServicesMember_9b981b6a-c1dd-4f5e-a4f4-dc3ea0903787" xlink:href="csbr-20220731.xsd#csbr_PersonalizedOncologyServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_693b56e8-e079-4916-8484-2bb68aa334a6" xlink:to="loc_csbr_PersonalizedOncologyServicesMember_9b981b6a-c1dd-4f5e-a4f4-dc3ea0903787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b2254f54-b2e5-464b-b3a4-d50f57b26ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c0a6e457-8c0d-49b2-8e8f-5f461ad64659" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_b2254f54-b2e5-464b-b3a4-d50f57b26ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3dbf4a96-5d2b-45c8-926c-8510dd66c1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b2254f54-b2e5-464b-b3a4-d50f57b26ed0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3dbf4a96-5d2b-45c8-926c-8510dd66c1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6016882f-27e6-4fae-ab8e-8b55879d8c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_78dcf2a2-586d-467f-857b-54499054cff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6016882f-27e6-4fae-ab8e-8b55879d8c8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_78dcf2a2-586d-467f-857b-54499054cff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_08d313b4-4fb4-4e89-8709-086a2d561eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9d39d0ce-86c4-4d38-922e-1d20eb0d648a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_08d313b4-4fb4-4e89-8709-086a2d561eeb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9d39d0ce-86c4-4d38-922e-1d20eb0d648a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_86b3b6bd-c2c4-4321-a6cf-74dc86cd59e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_86b3b6bd-c2c4-4321-a6cf-74dc86cd59e6" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ffe49df1-877c-40f2-8c33-7728abb23455" xlink:to="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_270d4215-3f6f-4d0b-9deb-253e77232ff9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:to="loc_srt_MinimumMember_270d4215-3f6f-4d0b-9deb-253e77232ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_53285104-c6f8-42cb-bb6e-eaf7c4a370f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cf037b11-73cb-4ef3-aac9-77839e519d2c" xlink:to="loc_srt_MaximumMember_53285104-c6f8-42cb-bb6e-eaf7c4a370f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ba9da94-04a6-4a82-bbeb-0388e5c8946f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4f2e25ed-d064-421e-91ff-09ff572b0980" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ba9da94-04a6-4a82-bbeb-0388e5c8946f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_b835317f-cfb9-43f8-bdf8-269e5523318b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ba9da94-04a6-4a82-bbeb-0388e5c8946f" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_b835317f-cfb9-43f8-bdf8-269e5523318b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_FinanceLeaseAxis_4bca6a6c-6e7d-448c-a10f-88c2f6825f79" xlink:to="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_A2022FinanceLeaseMember_872f8298-e583-4b20-a68c-c5410b859512" xlink:href="csbr-20220731.xsd#csbr_A2022FinanceLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:to="loc_csbr_A2022FinanceLeaseMember_872f8298-e583-4b20-a68c-c5410b859512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_A2023FinanceLeaseMember_96d696bf-bd85-49ef-b67d-5fae749b4b4a" xlink:href="csbr-20220731.xsd#csbr_A2023FinanceLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_FinanceLeaseDomain_914cc6ed-58ca-4f33-96d4-4097c648d3d6" xlink:to="loc_csbr_A2023FinanceLeaseMember_96d696bf-bd85-49ef-b67d-5fae749b4b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_822de510-90d2-46fe-8745-31e0da09264d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cafaea79-84b3-43ab-8eda-72c988e91985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cafaea79-84b3-43ab-8eda-72c988e91985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cdf241fe-f548-4c45-8368-be13b8ba6792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cdf241fe-f548-4c45-8368-be13b8ba6792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_61cb7613-43fe-4bb2-b791-3c294a922870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_61cb7613-43fe-4bb2-b791-3c294a922870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_de77b606-fddc-4f66-b360-3bf572a75fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_de77b606-fddc-4f66-b360-3bf572a75fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_130401e6-768a-4d67-96b8-fa77186b0f5f" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseDepreciationAndAmortizationExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_csbr_FinanceLeaseDepreciationAndAmortizationExpenses_130401e6-768a-4d67-96b8-fa77186b0f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServicingAsset_42e2a442-74a7-453b-822b-4785a358b715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_ServicingAsset_42e2a442-74a7-453b-822b-4785a358b715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServicingAssetAtAmortizedValue_fee3a1f8-7e15-449e-b5d0-6e2b1c32724c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAssetAtAmortizedValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_ServicingAssetAtAmortizedValue_fee3a1f8-7e15-449e-b5d0-6e2b1c32724c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_1152f4d0-2669-4f56-ab35-a4acd292e667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_1152f4d0-2669-4f56-ab35-a4acd292e667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_FinanceLeaseCost_0ed0edab-6ec7-4429-b6fe-59f70f099b0a" xlink:href="csbr-20220731.xsd#csbr_FinanceLeaseCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_csbr_FinanceLeaseCost_0ed0edab-6ec7-4429-b6fe-59f70f099b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_PresentValueMinimumFutureObligationsInterestRate_f905618e-2e2b-4b1d-8407-d85d09ca27fd" xlink:href="csbr-20220731.xsd#csbr_PresentValueMinimumFutureObligationsInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_csbr_PresentValueMinimumFutureObligationsInterestRate_f905618e-2e2b-4b1d-8407-d85d09ca27fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6769b833-6d9f-4f3e-b2ee-085bac692af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_181a6d69-1934-4bd2-b8e8-4816928f4431" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6769b833-6d9f-4f3e-b2ee-085bac692af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b6b65372-eca0-4b1e-94c3-ca4b82cb23b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b6b65372-eca0-4b1e-94c3-ca4b82cb23b0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bb6d722-744f-4e32-ae18-bba189759eb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_392d9f2c-893a-4183-9652-e7b3de18b0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_392d9f2c-893a-4183-9652-e7b3de18b0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_ee4c897a-698c-49dd-b439-9b81227bcd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_ComputerEquipmentMember_ee4c897a-698c-49dd-b439-9b81227bcd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_cd8788fe-9698-4a54-a2a8-df885e277d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_cd8788fe-9698-4a54-a2a8-df885e277d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_LaboratoryEquipmentMember_5e512890-1708-4cac-8c7c-380dc14305bd" xlink:href="csbr-20220731.xsd#csbr_LaboratoryEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_csbr_LaboratoryEquipmentMember_5e512890-1708-4cac-8c7c-380dc14305bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AssetInProgressMember_03edca41-1a02-40e2-bfbc-5c700b16938d" xlink:href="csbr-20220731.xsd#csbr_AssetInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_csbr_AssetInProgressMember_03edca41-1a02-40e2-bfbc-5c700b16938d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_53e7237f-cb1c-4933-baf4-b6afe21e190b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1608df4e-c4bb-4ec3-a249-b3e69a57928d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_53e7237f-cb1c-4933-baf4-b6afe21e190b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5e42a7f-5fc0-4c8c-a6db-715434597dbf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_25361521-4595-4fb4-86bf-9be707630ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_25361521-4595-4fb4-86bf-9be707630ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_15d68a93-7628-462a-aab6-b3af5fe1d206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_15d68a93-7628-462a-aab6-b3af5fe1d206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a1a4c15a-edc2-4981-8f40-b386bb1e91e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a1a4c15a-edc2-4981-8f40-b386bb1e91e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_5e5e47e4-4158-414c-9459-0d72b3b032c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_16a13483-013e-4389-88fa-a5c34dfab07b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_5e5e47e4-4158-414c-9459-0d72b3b032c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPayments" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPayments"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/ShareBasedPayments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_289476f4-41ca-47f1-b51d-01513ef2e5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8e64595b-7a22-448f-bbce-45918f34e62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_289476f4-41ca-47f1-b51d-01513ef2e5e2" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8e64595b-7a22-448f-bbce-45918f34e62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsTables" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsTables"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4aca5cef-3834-4aba-aa12-d8ba3ccf3672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7dc18ad6-8518-4d6b-bc3a-e43bd4fa7ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4aca5cef-3834-4aba-aa12-d8ba3ccf3672" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7dc18ad6-8518-4d6b-bc3a-e43bd4fa7ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_79971010-0509-40d9-a0c2-8825ef2d6bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4aca5cef-3834-4aba-aa12-d8ba3ccf3672" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_79971010-0509-40d9-a0c2-8825ef2d6bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_876630d9-3339-4888-848d-2a4a13459a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4aca5cef-3834-4aba-aa12-d8ba3ccf3672" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_876630d9-3339-4888-848d-2a4a13459a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a9aeafc-1d11-426f-93ab-84697b2e7d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a9aeafc-1d11-426f-93ab-84697b2e7d0a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_699d5a51-00b1-4bae-9dcb-5d60a40f28a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0f88657e-c3cd-4ba4-b607-bfcbf3af59f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0f88657e-c3cd-4ba4-b607-bfcbf3af59f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_c844f8de-7359-4dd6-adb1-8316df871326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_c844f8de-7359-4dd6-adb1-8316df871326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b3afacb4-5cb2-4e9c-94d8-83c3dd45ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b3afacb4-5cb2-4e9c-94d8-83c3dd45ef75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_723a781d-c10e-416a-8e04-96848cafc227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffd7c5aa-fa93-4a5d-9f71-61c0d1bc46f8" xlink:to="loc_us-gaap_CostOfSalesMember_723a781d-c10e-416a-8e04-96848cafc227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3f08aca7-0a3d-4dc3-afcf-d43178f0831f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e242c33a-6027-4f2d-b505-fe5178b127ae" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3f08aca7-0a3d-4dc3-afcf-d43178f0831f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_deedcd00-747c-4295-b0b3-e740364b95a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3f08aca7-0a3d-4dc3-afcf-d43178f0831f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_deedcd00-747c-4295-b0b3-e740364b95a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c191e234-6374-4a8b-82da-aba1707dd648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c191e234-6374-4a8b-82da-aba1707dd648" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:to="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_a8524d43-db8f-49d7-a55d-dba18453708b" xlink:to="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_EquityIncentivePlan2021Member_1190e5ef-2f49-463a-abb7-542ca3b59e34" xlink:href="csbr-20220731.xsd#csbr_EquityIncentivePlan2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:to="loc_csbr_EquityIncentivePlan2021Member_1190e5ef-2f49-463a-abb7-542ca3b59e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_EquityIncentivePlan2010Member_8ae93d7e-231d-4676-bb2b-7b369c34f554" xlink:href="csbr-20220731.xsd#csbr_EquityIncentivePlan2010Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b67cf45c-fd73-430f-b0bc-978fa0f67c4d" xlink:to="loc_csbr_EquityIncentivePlan2010Member_8ae93d7e-231d-4676-bb2b-7b369c34f554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:to="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_97c8af7e-37ae-4ecc-9996-1e5e45d96ba9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_59d724b4-bb4d-4e88-b3bf-4c4578d5336d" xlink:to="loc_srt_RangeMember_97c8af7e-37ae-4ecc-9996-1e5e45d96ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_91d015a8-ea03-44f6-8781-b6a203441602" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_97c8af7e-37ae-4ecc-9996-1e5e45d96ba9" xlink:to="loc_srt_MaximumMember_91d015a8-ea03-44f6-8781-b6a203441602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f35901-249f-41e2-ba1f-422f57f9e211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5544c201-8fdc-4cc7-87ba-6a2fbb4b2bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5544c201-8fdc-4cc7-87ba-6a2fbb4b2bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2a1c3846-add8-47a5-b104-ad7ad4ebe64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2a1c3846-add8-47a5-b104-ad7ad4ebe64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_67af00a1-0bd7-4f22-afbd-2132d2fb60b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_67af00a1-0bd7-4f22-afbd-2132d2fb60b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7baeb194-3b08-4dad-9925-0ed6a81006b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7baeb194-3b08-4dad-9925-0ed6a81006b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_11adc6bf-c5ed-4ce3-8411-316e96a9f52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c12cf2e-d02f-4e06-bcdd-feecd36f1747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_11adc6bf-c5ed-4ce3-8411-316e96a9f52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0170a219-42fa-4b7f-a412-4b2f0d5aad0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b3b3e2f8-1979-41dd-b091-2291dc019122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0170a219-42fa-4b7f-a412-4b2f0d5aad0c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b3b3e2f8-1979-41dd-b091-2291dc019122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40b9fd42-b366-423c-8ef4-402bc0ff101c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0170a219-42fa-4b7f-a412-4b2f0d5aad0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40b9fd42-b366-423c-8ef4-402bc0ff101c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_eb7eb687-3841-4f87-ad17-2bf72f4434d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0170a219-42fa-4b7f-a412-4b2f0d5aad0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_eb7eb687-3841-4f87-ad17-2bf72f4434d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0abbd5c7-569a-4879-b97b-2b78c9019443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0170a219-42fa-4b7f-a412-4b2f0d5aad0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0abbd5c7-569a-4879-b97b-2b78c9019443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_641614cc-5c52-4544-bc98-4edb9db9c48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0170a219-42fa-4b7f-a412-4b2f0d5aad0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_641614cc-5c52-4544-bc98-4edb9db9c48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#ShareBasedPaymentsSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7f30ec7-820c-4754-87a3-509fa7c922a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7f30ec7-820c-4754-87a3-509fa7c922a1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:to="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_8971c516-e274-4cac-8d7c-613e8ea88fc2" xlink:to="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b7c27abf-0b7c-4f3b-bb47-00d9f5815131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b7c27abf-0b7c-4f3b-bb47-00d9f5815131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_07037f48-fe6f-4473-9433-9c23315d72b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_2c02a0a7-9b41-4125-941f-1f96058625b5" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_07037f48-fe6f-4473-9433-9c23315d72b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcf7721-6468-495f-9165-1179a0c5e856" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9095b0f8-0677-4e0a-9339-6b3b1891bf98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9095b0f8-0677-4e0a-9339-6b3b1891bf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2f99a53b-24b9-4321-ba2d-73e170986328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2f99a53b-24b9-4321-ba2d-73e170986328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_626bd756-8980-4777-ae9a-ff1d9705f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_626bd756-8980-4777-ae9a-ff1d9705f5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_b86c9a2f-c07a-4399-8021-07ff2fd0e80a" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod_b86c9a2f-c07a-4399-8021-07ff2fd0e80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e6bc6a94-9fe4-4f98-88ba-85ea717c9b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e6bc6a94-9fe4-4f98-88ba-85ea717c9b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8be8931-00de-4c55-b08a-034fde6fc079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d4b750b4-935f-44bd-a6f9-574467995b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8be8931-00de-4c55-b08a-034fde6fc079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_84cbad82-ae44-4feb-bd67-9980fc0584bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_84cbad82-ae44-4feb-bd67-9980fc0584bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6ee2f7d4-5507-4c3e-a4c3-f53497604214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6ee2f7d4-5507-4c3e-a4c3-f53497604214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56a8e9d9-4e68-464a-ab94-cebfe97c1c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56a8e9d9-4e68-464a-ab94-cebfe97c1c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c458df70-0424-4baa-bfe6-a731465ac96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c458df70-0424-4baa-bfe6-a731465ac96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fb4a62f1-f9e4-46dc-a360-54c8d414947a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fb4a62f1-f9e4-46dc-a360-54c8d414947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_49d47b32-6c56-41cd-8350-a79ba1cbf716" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice_49d47b32-6c56-41cd-8350-a79ba1cbf716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_87b55688-0b85-4270-93c8-960b5fd9008c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_87b55688-0b85-4270-93c8-960b5fd9008c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_21aa372f-6719-4a76-9dd5-3f7e34282182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5902f15a-048f-43ce-9ae2-970b8c2d6cd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_21aa372f-6719-4a76-9dd5-3f7e34282182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_13eeec6b-d89b-4eaf-9529-2663b47a938b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_13eeec6b-d89b-4eaf-9529-2663b47a938b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_02d0843c-0c51-4b3f-bba3-fc280d676d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_02d0843c-0c51-4b3f-bba3-fc280d676d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fe43003-e9f6-4e74-af5c-10975bbc858c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fe43003-e9f6-4e74-af5c-10975bbc858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_68079f46-af28-4c2c-823c-31676e5986b9" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_70f90a90-d2f6-4a90-921c-48f660bdc35b" xlink:to="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_68079f46-af28-4c2c-823c-31676e5986b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ce5133d6-2398-4541-9563-7abfa3c037f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ce5133d6-2398-4541-9563-7abfa3c037f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_23175aeb-ffb3-4be5-a589-4f3ab3ee62d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_23175aeb-ffb3-4be5-a589-4f3ab3ee62d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_915cce99-7393-48a2-84ad-25b04648f9dd" xlink:href="csbr-20220731.xsd#csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_915cce99-7393-48a2-84ad-25b04648f9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9b802185-fdb6-4f79-b440-7383d187e114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_915cce99-7393-48a2-84ad-25b04648f9dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9b802185-fdb6-4f79-b440-7383d187e114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_63b8247b-582e-44ef-9b64-e585e489ab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_63b8247b-582e-44ef-9b64-e585e489ab4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9cb87723-0446-4031-ac4d-e8758976b924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74439a04-9b68-4d57-b280-6dd0a55d5de9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9cb87723-0446-4031-ac4d-e8758976b924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/Leases" xlink:type="simple" xlink:href="csbr-20220731.xsd#Leases"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_67573664-a755-487b-a001-b200212ac88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5a2dcef7-4ee9-4ab1-8133-d169f69d16f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67573664-a755-487b-a001-b200212ac88b" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5a2dcef7-4ee9-4ab1-8133-d169f69d16f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesTables" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d0bc7986-8ab9-4365-a8f9-9b8291260b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AssetsAndLiabilitiesLesseeTableTextBlock_e6d54f9a-7d55-42f1-860e-147321f69928" xlink:href="csbr-20220731.xsd#csbr_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d0bc7986-8ab9-4365-a8f9-9b8291260b14" xlink:to="loc_csbr_AssetsAndLiabilitiesLesseeTableTextBlock_e6d54f9a-7d55-42f1-860e-147321f69928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_45093ec4-efe1-40de-a328-5f0a90dc16c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d0bc7986-8ab9-4365-a8f9-9b8291260b14" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_45093ec4-efe1-40de-a328-5f0a90dc16c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_57034f04-4e47-42ff-8cb7-6fed10f9529b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_57034f04-4e47-42ff-8cb7-6fed10f9529b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6dbef26d-3bb6-4d73-b27d-a9cf5e66f8e6" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CorporateHeadquartersMember_4aa7d297-f854-4121-951a-6eab20d66728" xlink:href="csbr-20220731.xsd#csbr_CorporateHeadquartersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_CorporateHeadquartersMember_4aa7d297-f854-4121-951a-6eab20d66728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_RockvilleMDMember_92e6e87c-4a61-426a-bff1-64b7f504f0bc" xlink:href="csbr-20220731.xsd#csbr_RockvilleMDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_RockvilleMDMember_92e6e87c-4a61-426a-bff1-64b7f504f0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_AdditionalExpansionPremisesMember_b47b176c-30d4-48c6-848e-7e15e161f198" xlink:href="csbr-20220731.xsd#csbr_AdditionalExpansionPremisesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_AdditionalExpansionPremisesMember_b47b176c-30d4-48c6-848e-7e15e161f198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_MilanItalyMember_0e30cbf8-71ba-4472-b438-125e861e91f2" xlink:href="csbr-20220731.xsd#csbr_MilanItalyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4e88990e-15e5-41f7-b086-8d9c205731f3" xlink:to="loc_csbr_MilanItalyMember_0e30cbf8-71ba-4472-b438-125e861e91f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d9568d38-8e98-402d-aa51-0b25cca4a0c2" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b21adc33-2a7a-4270-8e17-7a1b7e73ac82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseExpense_b21adc33-2a7a-4270-8e17-7a1b7e73ac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f0270a38-cd02-4487-a24c-e1040d808b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f0270a38-cd02-4487-a24c-e1040d808b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2efc545f-668b-495e-95ff-455ffd6a9c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2efc545f-668b-495e-95ff-455ffd6a9c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_17602e34-e925-4bf5-839c-241c5b772122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseLiability_17602e34-e925-4bf5-839c-241c5b772122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_OperatingLeaseIncrementalRentExpense_8eb2cb56-e915-4877-8047-060025524854" xlink:href="csbr-20220731.xsd#csbr_OperatingLeaseIncrementalRentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_csbr_OperatingLeaseIncrementalRentExpense_8eb2cb56-e915-4877-8047-060025524854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0da65c7f-2e90-4101-bacd-a740e32cf6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0da65c7f-2e90-4101-bacd-a740e32cf6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ab8044ee-886d-4868-b41a-325832532aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d393dda3-26e9-40ed-9401-aa3fba66614e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ab8044ee-886d-4868-b41a-325832532aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesROUAssetsandLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ad9b0692-5956-4121-8f78-a18ddad174c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e6405397-bf2a-42fc-8bb4-0ddcf434cca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad9b0692-5956-4121-8f78-a18ddad174c3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e6405397-bf2a-42fc-8bb4-0ddcf434cca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a32190c2-3d07-4bb5-933b-08d4294f6f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad9b0692-5956-4121-8f78-a18ddad174c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a32190c2-3d07-4bb5-933b-08d4294f6f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f1719e66-9422-44c7-a744-0f0cf99768eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad9b0692-5956-4121-8f78-a18ddad174c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f1719e66-9422-44c7-a744-0f0cf99768eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a9b4d774-4945-4337-8021-6fca3c7b5d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a9b4d774-4945-4337-8021-6fca3c7b5d9c" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4692379e-3fa8-405f-99b6-ff979af5ae6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4692379e-3fa8-405f-99b6-ff979af5ae6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_627e7a42-73e5-46dd-9dd1-983a546f2892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_627e7a42-73e5-46dd-9dd1-983a546f2892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b6edb346-d0db-4f25-9d48-703e70551373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b6edb346-d0db-4f25-9d48-703e70551373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_295ebd0c-a39d-40c0-bc7e-89d34e495afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_295ebd0c-a39d-40c0-bc7e-89d34e495afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ffc2c4e-e6d0-42ea-b234-3a7e8bb3bc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ffc2c4e-e6d0-42ea-b234-3a7e8bb3bc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_7d60878e-f125-4fd3-b748-9cc1286593e6" xlink:href="csbr-20220731.xsd#csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_7d60878e-f125-4fd3-b748-9cc1286593e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4cdf8ce5-dcd0-4df1-92f1-1fa7bc2a8a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4cdf8ce5-dcd0-4df1-92f1-1fa7bc2a8a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f9d344fb-fb4b-4ad2-9c51-8093a892efcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f9d344fb-fb4b-4ad2-9c51-8093a892efcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d1922ff6-bb63-40a6-bbbf-6ce14b8e078b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2cd26a2-144a-4afb-9929-37d117173d92" xlink:to="loc_us-gaap_OperatingLeaseLiability_d1922ff6-bb63-40a6-bbbf-6ce14b8e078b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="csbr-20220731.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://championsoncology.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="csbr-20220731.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e9538ae1-5bcb-48fa-8b39-49ea5b069f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_774fe604-3ef8-42f5-973b-2757dbf4fe10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e9538ae1-5bcb-48fa-8b39-49ea5b069f80" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_774fe604-3ef8-42f5-973b-2757dbf4fe10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ea4a0dbb-2465-4d50-b4fc-a7e8f8f32a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ea4a0dbb-2465-4d50-b4fc-a7e8f8f32a0f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:to="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e73a3d-b6c4-4cc5-b520-53e64b0c1a86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_d6b6a3e5-d8f3-4f39-85eb-c5947bf7e661" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e73a3d-b6c4-4cc5-b520-53e64b0c1a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_3612e1eb-a42e-4fec-b1f2-3d085c9a70ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e73a3d-b6c4-4cc5-b520-53e64b0c1a86" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_3612e1eb-a42e-4fec-b1f2-3d085c9a70ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:to="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d49bb763-c798-47d6-8c8f-bb9a63cf111c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_BoardMemberOneMember_b8c867c7-077b-4600-95d8-29d8a346eeed" xlink:href="csbr-20220731.xsd#csbr_BoardMemberOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:to="loc_csbr_BoardMemberOneMember_b8c867c7-077b-4600-95d8-29d8a346eeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_BoardMemberTwoMember_e5267ccf-d306-451e-aec1-0ab7607ca218" xlink:href="csbr-20220731.xsd#csbr_BoardMemberTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3b388d2e-93b3-48b7-8be6-a49257ffbc74" xlink:to="loc_csbr_BoardMemberTwoMember_e5267ccf-d306-451e-aec1-0ab7607ca218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0025fd54-29d8-41aa-adbd-7f87c468a062" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_6bc4e627-3813-47b9-af5d-baf0c7cf41ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_6bc4e627-3813-47b9-af5d-baf0c7cf41ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_86e12d51-3b10-4a34-8bca-95bad40fe216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_15747ace-5298-462c-b929-fd817a9b5e97" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_86e12d51-3b10-4a34-8bca-95bad40fe216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="csbr-20220731.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_991eab5c-4f43-4788-98e0-82292a37dc92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2361f187-31ac-40e3-9fd5-5ffa9551ab92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_991eab5c-4f43-4788-98e0-82292a37dc92" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2361f187-31ac-40e3-9fd5-5ffa9551ab92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://championsoncology.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="csbr-20220731.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6034019d-88ad-4eb9-96bf-cf5512a2ebf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:href="csbr-20220731.xsd#csbr_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6034019d-88ad-4eb9-96bf-cf5512a2ebf2" xlink:to="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:to="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fd7a16d0-620f-4754-85ed-58a7c3799ca2" xlink:to="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9a26614c-0c54-4482-a87e-ce850622b4fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:to="loc_srt_MinimumMember_9a26614c-0c54-4482-a87e-ce850622b4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a3382597-849b-47d5-88b1-99f9f257dfad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11437e51-b126-40ca-8c28-e4f27e2f2842" xlink:to="loc_srt_MaximumMember_a3382597-849b-47d5-88b1-99f9f257dfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:href="csbr-20220731.xsd#csbr_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_CommitmentsAndContingenciesTable_a472692c-999f-410a-9fb6-15d5d8c2fde8" xlink:to="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CollaborationArrangementRoyaltyFee_3ee260c4-12fb-4245-ae1f-3daa3facb757" xlink:href="csbr-20220731.xsd#csbr_CollaborationArrangementRoyaltyFee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_csbr_CollaborationArrangementRoyaltyFee_3ee260c4-12fb-4245-ae1f-3daa3facb757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_ac198934-0baa-4775-9386-9efe396ac021" xlink:href="csbr-20220731.xsd#csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice_ac198934-0baa-4775-9386-9efe396ac021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_864d23c0-19b6-47db-b87d-1ab3ec98f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_csbr_CommitmentsAndContingenciesLineItems_ab49b753-7d10-4f5a-950b-e4cd281f48ef" xlink:to="loc_us-gaap_RoyaltyExpense_864d23c0-19b6-47db-b87d-1ab3ec98f30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982050288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Sep. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHAMPIONS ONCOLOGY, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1401755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One University Plaza, Suite 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hackensack<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">808-8400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CSBR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,522,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982705520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 8,058<span></span>
</td>
<td class="nump">$ 9,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">9,355<span></span>
</td>
<td class="nump">9,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">18,371<span></span>
</td>
<td class="nump">19,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">7,971<span></span>
</td>
<td class="nump">8,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,698<span></span>
</td>
<td class="nump">7,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">34,390<span></span>
</td>
<td class="nump">35,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,537<span></span>
</td>
<td class="nump">2,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">1,957<span></span>
</td>
<td class="nump">2,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,099<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liability</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">10,885<span></span>
</td>
<td class="nump">11,071<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">16,620<span></span>
</td>
<td class="nump">17,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">8,127<span></span>
</td>
<td class="nump">8,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">25,407<span></span>
</td>
<td class="nump">26,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value; 200,000,000 shares authorized; 13,522,441 shares issued and outstanding as of July 31, 2022 and April 30, 2022, respectively</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">81,270<span></span>
</td>
<td class="nump">81,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(72,301)<span></span>
</td>
<td class="num">(71,982)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">8,983<span></span>
</td>
<td class="nump">9,096<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 34,390<span></span>
</td>
<td class="nump">$ 35,378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982734816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - $ / shares<br></strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">13,522,441<span></span>
</td>
<td class="nump">13,522,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">13,522,441<span></span>
</td>
<td class="nump">13,522,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330981243008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Oncology services revenue</a></td>
<td class="nump">$ 13,745<span></span>
</td>
<td class="nump">$ 11,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Costs and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of oncology services</a></td>
<td class="nump">7,052<span></span>
</td>
<td class="nump">5,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,887<span></span>
</td>
<td class="nump">2,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,398<span></span>
</td>
<td class="nump">2,154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total costs and operating expenses</a></td>
<td class="nump">14,029<span></span>
</td>
<td class="nump">11,428<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(284)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(302)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (319)<span></span>
</td>
<td class="num">$ (172)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per common share outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share outstanding, basic (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share outstanding, diluted (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">13,522,433<span></span>
</td>
<td class="nump">13,401,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">13,522,433<span></span>
</td>
<td class="nump">13,401,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Revenue, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977657296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,414,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 30, 2021</a></td>
<td class="nump">$ 7,428<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 79,945<span></span>
</td>
<td class="num">$ (72,530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock on exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock on exercise of stock options</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(172)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Jul. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,415,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jul. 31, 2021</a></td>
<td class="nump">$ 7,538<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">80,227<span></span>
</td>
<td class="num">(72,702)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 30, 2022</a></td>
<td class="nump">13,522,441<span></span>
</td>
<td class="nump">13,522,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 30, 2022</a></td>
<td class="nump">$ 9,096<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">81,064<span></span>
</td>
<td class="num">(71,982)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (319)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Jul. 31, 2022</a></td>
<td class="nump">13,522,441<span></span>
</td>
<td class="nump">13,522,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jul. 31, 2022</a></td>
<td class="nump">$ 8,983<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 81,270<span></span>
</td>
<td class="num">$ (72,301)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977661392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (319)<span></span>
</td>
<td class="num">$ (172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Net gain on disposal of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Operating lease right-of use assets</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ReversalOfProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">158<span></span>
</td>
<td class="num">(825)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(331)<span></span>
</td>
<td class="nump">1,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(775)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(195)<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(754)<span></span>
</td>
<td class="num">(907)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(754)<span></span>
</td>
<td class="num">(907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ProceedsFromExerciseOfOptionsAndWarrants', window );">Proceeds from exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash</a></td>
<td class="num">(949)<span></span>
</td>
<td class="num">(689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at beginning of period</a></td>
<td class="nump">9,007<span></span>
</td>
<td class="nump">4,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at end of period</a></td>
<td class="nump">$ 8,058<span></span>
</td>
<td class="nump">$ 3,998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_ProceedsFromExerciseOfOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_ProceedsFromExerciseOfOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_ReversalOfProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reversal Of Provision For Doubtful Accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_ReversalOfProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985509584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Use of Estimates and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Use of Estimates and Basis of Presentation</a></td>
<td class="text">Organization, Use of Estimates and Basis of Presentation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Champions Oncology, Inc is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The Company has three operating subsidiaries: Champions Oncology (Israel), Limited, Champions Biotechnology U.K., Limited, and Champions Oncology, S.R.L. (Italy). For the three months ended July 31, 2022 and 2021, there were no revenues earned by these subsidiaries.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s foreign subsidiaries functional currency is the U.S. dollar. Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company&#8217;s international operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC. All significant intercompany transactions and accounts have been eliminated. Certain information related to the Company&#8217;s organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, or GAAP, has been condensed or omitted. The accounting policies followed in the preparation of these unaudited condensed consolidated financial statements are consistent with those followed in the Company&#8217;s annual consolidated financial statements for the year ended April&#160;30, 2022, as filed on Form 10-K. In the opinion of management, these unaudited condensed consolidated financial statements contain all material adjustments necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended April&#160;30, 2022. The results of operations for the interim periods are not necessarily indicative of the results of operations for a full fiscal year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985728816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only those investments which are highly liquid, readily convertible to cash, and with original maturities of three months or less to be cash equivalents. As of July&#160;31, 2022 and April 30, 2022 the Company had no cash equivalents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity needs have typically arisen from the funding of our research and development programs and the launch of new products, working capital requirements, and other strategic initiatives. Recently, we have met these cash requirements through our cash on hand, working capital management, and sales of products and services. In the past, we have also received proceeds from certain private placements and public offerings of our securities. For the three months ended July&#160;31, 2022, the Company had a net loss of approximately $319,000 and cash used in operations of $195,000. As of July&#160;31, 2022, the Company had an accumulated deficit of approximately $72.3 million, working capital of $1.8 million and cash of $8.1 million. We believe that our cash on hand, together with expected net positive cash provided by operations for fiscal year 2023, are adequate to fund operations through at least 12 months from the filing of this 10-Q.  However, should our revenue expectations not materialize, we believe we have cost reduction strategies that could be implemented without disrupting the business or restructuring the Company. Should the Company be required to raise additional capital, there can be no assurance that management would be successful in raising such capital on terms acceptable to us, if at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its leases under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease, if applicable, or the Company&#8217;s incremental borrowing rate. As the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line rent expense over the lease term. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income or loss per share is computed by dividing the net income or loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. Such dilutive shares consist of incremental shares that would be issued upon exercise of the Company&#8217;s common stock options. </span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 31, 2022 and 2021, all of the Company's potential common stock is considered anti-dilutive. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.666%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.896%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.896%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.899%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the total potential share-based instruments outstanding at July&#160;31, 2022 and 2021 that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"><tr><td style="width:1.0%"/><td style="width:71.552%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total common stock equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734,428&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#160;&#160;&#160;&#160;Deferred income taxes have been provided to show the effect of temporary differences between the recognition of expenses for financial and income tax reporting purposes and between the tax basis of assets and liabilities, and their reported amounts in the consolidated financial statements.  In assessing the realizability of deferred tax assets, the Company assesses the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">likelihood that deferred tax assets will be recovered through tax planning strategies or from future taxable income, and to the extent that recovery is not likely or there is insufficient earnings history, a valuation allowance is established. The Company's ability to utilize net operating losses (&#8220;NOL&#8221;) carryforwards to offset future taxable income would be limited if the Company had undergone or were to undergo an &#8220;ownership change&#8221; within the meaning of Section 382 of the Internal Revenue Code (the &#8220;IRC&#8221;). The Company adjusts the valuation allowance in the period management determines it is more likely than not that deferred tax assets will or will not be realized.  Changes in valuation allowances from period to period are included in the tax provision in the period of change.  As of&#160;July&#160;31, 2022 and April&#160;30, 2022, the Company provided a valuation allowance for all net deferred tax assets, as recovery is not more likely than not based on an insufficient history of earnings.</span></div><div style="padding-left:11.25pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reflects tax benefits only if it is more likely than not that the Company will be able to sustain the tax position, based on its technical merits.&#160;&#160;If a tax benefit meets this criterion, it is measured and recognized based on the largest amount of benefit that is cumulatively greater than 50% likely to be realized.&#160;&#160;The Company recorded $181,000 of liabilities related to uncertain tax positions relative to one of its foreign operations as of July&#160;31, 2022 and April&#160;30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company did not recognize interest or penalties on its consolidated statements of operations during the three-month periods ended July 31, 2022 and 2021. The Company does not anticipate unrecognized tax benefits will be recorded during the next 12 months.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the three months ended July 31, 2022 and 2021 was $17,000 and $14,000, respectively, mainly attributable to taxable income earned in Israel and/or Italy relating to transfer pricing. &#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The objective of the standard is to establish a single comprehensive revenue recognition model that is designed to create greater comparability of financial statements across industries and jurisdictions.  Under this standard, companies recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      All revenue is generated from contracts with customers. The Company's arrangements are service type contracts that mainly have a duration of less than a year. The Company recognizes revenue when control of these services is transferred to the customer in an amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange for those services.  The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when, or as, the Company transfers control of the product or service for each performance obligation. The Company records revenues net of any tax assessments by governmental authorities, such as value added taxes, that are imposed on and concurrent with specific revenue generating transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The majority of the Company's revenue arrangements are service contracts that are completed within a year or less. There are a few contracts that range in duration between 1 and 3 years. Substantially all of the Company's performance obligations, and associated revenue, are transferred to the customer over time. Most of the Company's contracts can be terminated by the customer without cause. In the event of termination, the Company's contracts provide that the customer pay the Company for services rendered through the termination date. The Company generally receives compensation based on a predetermined invoicing schedule relating to specific milestones for that contract.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Amendments to contracts are common. The Company evaluates each amendment which meets the criteria of a contract modification under ASC 606. Each modification is further evaluated to determine whether the contract modification should be accounted for as a separate contract or as a continuation of the original agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The Company accounts for amendments as a separate contract as they meet the criteria under ASC 606-10-25-12.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pharmacology Study and Other Services</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally enters into contracts with customers to provide oncology services with payments based on fixed-fee arrangements. At contract inception, the Company assesses the services promised in the contracts with customers to identify the performance obligations in the arrangement. The Company's fixed-fee arrangements for oncology services are considered a single performance obligation because the Company provides a highly-integrated service.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time using a progress-based input method since there is no single output measure that would fairly depict the transfer of control over the life of the performance obligation. Revenue is recognized for the single performance obligation over time due to the Company's right to payment for work performed to date and the performance does not create an asset with an alternative use. The Company recognizes revenue as portions of the overall performance obligation are completed as this best depicts the progress of the performance obligation.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incremental Costs of Obtaining a Contract (Sales Commissions)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">       Under ASC 606, the costs of obtaining a contract can be expensed immediately, rather than capitalized and amortized, if the amortization period is one year or shorter. Sales commissions for the Company represent contract costs with a term of one year or less. Therefore, under ASC 606, the Company elected the practical expedient to expense these costs as incurred.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Consideration</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, contracts provide for variable consideration that is contingent upon the occurrence of uncertain future events, such as the success of the initial performance obligation. Variable consideration is estimated at the expected value or at the most likely amount depending on the type of consideration. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimate of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of its anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables, Unbilled Services and Deferred Revenue</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, billings and payments are established by contractual provisions including predetermined payment schedules, which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. In general, the Company's intention in its invoicing (payment terms) is to maintain cash neutrality over the life of the contract. Upfront payments, when they occur, are intended to cover certain expenses the Company incurs at the beginning of the contract. Neither the Company nor its customers view such upfront payments and contracted payment schedules as a means of financing. Unbilled services primarily arise when the revenue recognized exceeds the amount billed to the customer. Such situations occur due to divergences between revenue recognition and the invoicing milestones which are based on predetermined payment terms.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of unearned payments received in excess of revenue recognized. As the contracted services are subsequently performed and the associated revenue is recognized, the deferred revenue balance is reduced by the amount of the revenue recognized during the period. Deferred revenue is classified as a current liability on the condensed consolidated balance sheet as the Company expects to recognize the associated revenue in less than one year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Being Evaluated</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, "Financial Instruments - Credit Losses".  This update requires immediate recognition of management&#8217;s estimates of current expected credit losses ("CECL").  Under the prior model, losses were recognized only as they were incurred.  The new model is applicable to all financial instruments that are not accounted for at fair value through net income.  The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies.  Early adoption is permitted.   The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330987059568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, Unbilled Services and Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Accounts Receivable, Unbilled Services and Deferred Revenue</a></td>
<td class="text">Accounts Receivable, Unbilled Services and Deferred Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable and unbilled services were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:71.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable and unbilled services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,355&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred revenue was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:71.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue is shown as a current liability on the Company's condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330987014064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contracts with Customers</a></td>
<td class="text">Revenue from Contracts with Customers<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oncology Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents disaggregated revenue for the three months ended July 31, 2022 and 2021:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:70.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.014%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacology services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other TOS revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personalized oncology services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oncology services revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,745&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other TOS revenue represents additional services provided to the Company's pharmaceutical and biotechnology customers, specifically flow cytometry services and SaaS provided via our Lumin Bioinformatics software ("Lumin").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div>Contract assets include unbilled amounts typically resulting from revenue recognized in excess of the amounts billed to the customer for which the right to payment is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are classified as current. Contract liabilities consist of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period. Contract assets and liabilities are presented on the balance sheet on a net contract-by-contract basis at the end of each reporting period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985530816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is recorded at cost and primarily consists of laboratory equipment, computer equipment and software, capitalized software development costs, and furniture and fixtures. Depreciation and amortization is calculated on a straight-line basis over the estimated useful lives of the various assets ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzI3_71ed8872-0f98-4a2c-950c-1fa4fcc01343">three</span> to nine years. Property and equipment consisted of the following (table in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233">Property and equipment, net</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was $528,000 and $317,000 for the three months ended July 31, 2022 and 2021, respectively. Depreciation and amortization expense, excluding expense recorded under finances leases, was $499,000 and $317,000 for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;31, 2022 and April&#160;30, 2022, property, plant and equipment included gross assets held under finance leases of $1,081,000 and $713,000, respectively. Related depreciation expense was approximately $29,000 and $0 for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized software development costs under a hosting arrangement</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the cost of computer software obtained or developed for internal use as well as the software development and implementation costs associated with a hosting arrangement ("internal-use software") that is a service contract in accordance and with ASC 350, Intangibles - Goodwill and Other ("ASC-350"). We capitalize certain costs in the development of our internal-use software when the preliminary project stage is completed and it is probable that the project itself will be completed and the software will perform as intended. These capitalized costs include personnel and related expenses for employees and costs of third-party consultants who are directly associated with and who devote time to these internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended purpose. Costs incurred for significant upgrades, increased functionality, and enhancements to the Company's internal-use software solutions are also capitalized. Costs incurred for training, maintenance, and minor modifications are expensed as incurred. Capitalized software development costs are amortized using the straight-line method over an estimated useful economic life of three years.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has capitalized development and implementation costs in accordance with accounting guidance for its Lumin platform. Lumin is the Company's oncology data-driven software program and data tool which operates as Software as a Service. These capitalized costs represent salaries, including direct payroll-related costs, certain software development consultant expenses and molecular sequencing programming costs incurred in the engineering and coding of the software development. Capitalized costs are classified as assets in progress during the development process until development is complete and the asset is available for sale. The initial version of the Lumin platform was launched during fiscal year 2021, at which time initial capitalization ceased and amortization commenced. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continued to develop increased functionality, expand product design and usability, and add enhancements to the Lumin platform. In accordance with accounting guidance, these costs were capitalized. This developmental work did not render the initial released version to be obsolete or diminished in value but, rather, added to the base functionality of the existing platform. During the third quarter of fiscal year 2022, these capitalized costs were placed into service as the enhanced version was launched and made available for sale. The total cost of the Lumin asset placed into service and available for sale was $1.9&#160;million. As of July&#160;31, 2022, the carrying value of the asset net of accumulated amortization was $1.3&#160;million. Amortization expense related to this asset was $157,000 and $40,000 for the three months ended July 31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Lease</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2022, the Company recognized a finance lease for laboratory equipment. This equipment was obtained as the result of a laboratory supplies purchase commitment with costs of approximately $370,000 at inception through December 2025. Cash payments for this lease are in the form of consideration for purchasing lab supplies under a purchase commitment agreement. At the commencement of the commitment, the present value of the minimum future obligations of $370,000 was calculated based on an interest rate of 3.25%. Depreciation and amortization expense related to this finance lease was $18,000 and zero for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2023, the Company recognized a finance lease for laboratory equipment. This equipment was obtained as the result of a laboratory supplies purchase commitment with costs of approximately $368,000 at inception through June 2027. Cash payments for this lease are in the form of consideration for purchasing lab supplies under a purchase commitment agreement. The present value of the minimum future obligations of $368,000 was calculated based on an interest rate of 3.5%. Depreciation and amortization expense related to this finance lease was $11,250 and zero for the three months ended July 31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985810496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Payments</a></td>
<td class="text">Share-Based Payments<div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was recognized as follows (table in thousands):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.011%"><tr><td style="width:1.0%"/><td style="width:65.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.960%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.961%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has in place a 2021 Equity Incentive Plan and 2010 Equity Incentive Plan ("the Plans"). In general, these plans provide for stock-based compensation to the Company&#8217;s employees, directors and non-employees. The plans also provide for limits on the aggregate number of shares that may be granted, the term of grants and the strike price of option awards. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Equity Incentive Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the 2021 Annual Shareholders Meeting, shareholders approved the adoption of the 2021 Equity Incentive Plan (&#8220;2021 Equity Plan&#8221;). The purpose of the 2021 Equity Plan is to grant (i) Non-statutory Stock Options; (ii) Incentive Stock Options; (iii) Restricted Stock Awards; and/or (iv) Stock Appreciation Rights (collectively, stock-based compensation) to its employees, directors and non-employees. Total stock awards under the 2021 Equity Plan shall not exceed 2&#160;million shares of common stock. Options and Stock Appreciation Rights expire no later than ten years from the date of grant and the awards vest as determined by the Board of Directors. Options and Stock Appreciation Rights have a strike price not less than 100% of the fair market value of the common stock subject to the option or right at the date of grant. As of July&#160;31, 2022, approximately 1.7&#160;million shares were left to issue under this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2010 Equity Incentive Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2011, shareholders owning a majority of the issued and outstanding shares of the Company executed a written consent approving the 2010 Equity Incentive Plan (&#8220;2010 Equity Plan&#8221;). The purpose of the 2010 Equity Plan is to grant (i) Non-statutory Stock Options; (ii) Restricted Stock Awards; and (iii) Stock Appreciation Rights (collectively, stock-based compensation) to its employees, directors and non-employees. Total stock awards under the 2010 Equity Plan shall not exceed 30 million shares of common stock. Options and Stock Appreciation Rights expire no later than ten years from the date of grant and the awards vest as determined by the Board of Directors. Options and Stock Appreciation Rights have a strike price not less than 100% of the fair market value of the common stock subject to the option or right at the date of grant. After February 2021, no more shares were available to be issued from this plan.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Grants</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.192%"><tr><td style="width:1.0%"/><td style="width:35.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.200%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.200%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.204%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.58%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.94% - 66.21%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the three months ended July 31, 2022 and 2021 was $4.50 and $5.33, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock options activity for the three months ended July 31, 2022 was a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s follows:</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:28.795%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.904%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.864%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors<br/>and<br/>Employees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-<br/>Employees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, April 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.90</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,462,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,462,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,846,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985699264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently leases certain office equipment and its office and laboratory facilities under non-cancelable operating leases. Rent expense for operating leases is recognized on a straight-line basis over the lease term from the lease commencement date through the scheduled expiration date. Rent expense totaled $467,000 and $452,000 for the three months ended July 31, 2022 and 2021, respectively. The Company considers its facilities adequate for its current operational needs.</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the following facilities:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">One University Plaza, Suite 307, Hackensack, New Jersey 07601, which, since November 2011, serves as the Company&#8217;s corporate headquarters. The lease was renewed during fiscal year 2022 and expires in November 2026. The Company recognized $21,000 and $24,000 of rent expense relative to this lease for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1330 Piccard Drive Suite 025, Rockville, MD 20850, which consists of laboratory and office space where the Company conducts operations related to its primary service offerings. The Company executed this lease (the "Original Premises") on January 11, 2017. The operating commencement date was August&#160;11, 2017. This lease was originally set to expire in August 2028. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">On March 30, 2020, the Company executed the first amendment to this lease to expand the existing premises at 1330 Piccard Drive, Suite 025 ("Expansion Premises") to add on Suites 050 and 104.  This amendment also extended the current lease term by six months.  The Expansion Premises operating lease commencement date was June 1, 2020 and, under the amendment, both leases expire February 28, 2029.  </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In accordance with ASC 842, "Leases", the Company evaluated the first amendment and also performed a reassessment of the existing lease for Suite 025 to determine the impact of the six-month term extension.  As a result of this assessment, the Company recognized an additional operating ROU asset and related operating lease liability for Suite 025 of $118,000 and $125,000, respectively, as well as an incremental net rent expense of $8,000 during the three months ended July 31, 2020 related to fiscal year 2021.  </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Upon the Expansion Premises operating lease commencement date (June 1, 2020), the Company recognized an operating ROU asset and related operating lease liability for Suites 050 and 104 of $3.8 million, each, respectively.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">On December 22, 2020, the Company executed the second amendment to this lease to expand the existing premises at 1330 Piccard Drive, Suites 025, 050, and 104 ("Additional Expansion Premises") to add on Suite 201.  The Additional Expansion Premises operating lease commencement date is April 1, 2021 and, under the second amendment, reaffirms that all three leases expire February 28, 2029.  Upon the Additional Expansion Premises operating lease commencement date (April 1, 2021), the Company also recognized an operating ROU asset and related operating lease liability for Suite 201 of $3.3&#160;million, each, respectively.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">For the leases related to the premises at Piccard Drive, the Company recognized $422,000 for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">VIA LEONE XIII, 14, Milan, Italy, which consists of laboratory and office space where the Company conducts operations related to its flow cytometry service offerings. The Company executed the lease for its laboratory space in June 2021, and commenced occupancy during the three months ended October 31, 2021. This lease expires May 2023. The Company executed the lease for its office space on October 1, 2021. This lease expires September 2027.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company recognized an operating ROU asset and related operating lease liability for the lab and office space of $205,000 each, respectively.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company recognized rent expense associated with these leases of $23,000 and zero for the three months ended July 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ROU assets and lease liabilities related to our current operating leases are as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:49.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.440%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net<br/></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 31, 2022, the weighted average remaining operating lease term and the weighted average discount rate were&#160;6.42 years&#160;and&#160;5.73%, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments due each fiscal year as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.385%"><tr><td style="width:1.0%"/><td style="width:74.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total undiscounted liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 5, Property and Equipment, for information on financing leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985699264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related party transactions include transactions between the Company and its shareholders, management, or affiliates.&#160;&#160;The following transactions were in the normal course of operations and were measured and recorded at the exchange amount, which is the amount of consideration established and agreed to by the parties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consulting Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>During the three months ended July 31, 2022 and 2021, the Company paid an affiliate of a board member $9,000 and $9,000, respectively, for consulting services unrelated to his duty as a board member. During the&#160;three months ended July 31, 2022 and 2021, the Company paid an affiliate of another board member $0&#160;and&#160;$3,000, respectively, for consulting services unrelated to their duties as a board member. As of July&#160;31, 2022, $0 was due to these related parties.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330987014064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently party to any legal matters to its knowledge. The Company is not aware of any other matters that would have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Payment Arrangements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into an Amended and Restated Registration Rights Agreement in connection with the March 2015 Private Placement. This Amended and Restated Registration Rights Agreement contains provisions that may call for the Company to pay penalties in certain circumstances. This registration payment arrangement primarily relates to the Company&#8217;s ability to file a registration statement within a particular time period, have a registration statement declared effective within a particular time period and to maintain the effectiveness of the registration statement for a particular time period. The Company has not accrued any liquidated damages associated with the Amended and Restated Registration Right Agreement as the Company has filed the required registration statement and anticipates continued compliance with the agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with third-party vendors to license tumor samples for development into PDX models and use in our TOS business. These types of arrangements have an upfront fee ranging from nil to $30,000 per tumor sample depending on the successful growth of the tumor model and ability to develop them into a sellable product. The upfront costs are expensed as incurred. In addition, under certain agreements, for a limited period of time, the Company is subject to royalty payments if the licensed tumor models are used for sale in our TOS business, ranging from 2% to 20% of the contract price after recouping certain initiation costs. Some of these arrangements also set forth an annual minimum royalty due regardless of tumor models used for sale. For the quarter ended July 31, 2022 and 2021, we have recognized approximately $76,000 and $44,000 in expense related to these royalty arrangements, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982027120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash EquivalentsThe Company considers only those investments which are highly liquid, readily convertible to cash, and with original maturities of three months or less to be cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">LeasesThe Company accounts for its leases under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease, if applicable, or the Company&#8217;s incremental borrowing rate. As the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line rent expense over the lease term.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>Basic net income or loss per share is computed by dividing the net income or loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. Such dilutive shares consist of incremental shares that would be issued upon exercise of the Company&#8217;s common stock options.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#160;&#160;&#160;&#160;Deferred income taxes have been provided to show the effect of temporary differences between the recognition of expenses for financial and income tax reporting purposes and between the tax basis of assets and liabilities, and their reported amounts in the consolidated financial statements.  In assessing the realizability of deferred tax assets, the Company assesses the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">likelihood that deferred tax assets will be recovered through tax planning strategies or from future taxable income, and to the extent that recovery is not likely or there is insufficient earnings history, a valuation allowance is established. The Company's ability to utilize net operating losses (&#8220;NOL&#8221;) carryforwards to offset future taxable income would be limited if the Company had undergone or were to undergo an &#8220;ownership change&#8221; within the meaning of Section 382 of the Internal Revenue Code (the &#8220;IRC&#8221;). The Company adjusts the valuation allowance in the period management determines it is more likely than not that deferred tax assets will or will not be realized.  Changes in valuation allowances from period to period are included in the tax provision in the period of change.  As of&#160;July&#160;31, 2022 and April&#160;30, 2022, the Company provided a valuation allowance for all net deferred tax assets, as recovery is not more likely than not based on an insufficient history of earnings.</span></div><div style="padding-left:11.25pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reflects tax benefits only if it is more likely than not that the Company will be able to sustain the tax position, based on its technical merits.&#160;&#160;If a tax benefit meets this criterion, it is measured and recognized based on the largest amount of benefit that is cumulatively greater than 50% likely to be realized.&#160;&#160;The Company recorded $181,000 of liabilities related to uncertain tax positions relative to one of its foreign operations as of July&#160;31, 2022 and April&#160;30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company did not recognize interest or penalties on its consolidated statements of operations during the three-month periods ended July 31, 2022 and 2021. The Company does not anticipate unrecognized tax benefits will be recorded during the next 12 months.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The objective of the standard is to establish a single comprehensive revenue recognition model that is designed to create greater comparability of financial statements across industries and jurisdictions.  Under this standard, companies recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      All revenue is generated from contracts with customers. The Company's arrangements are service type contracts that mainly have a duration of less than a year. The Company recognizes revenue when control of these services is transferred to the customer in an amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange for those services.  The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when, or as, the Company transfers control of the product or service for each performance obligation. The Company records revenues net of any tax assessments by governmental authorities, such as value added taxes, that are imposed on and concurrent with specific revenue generating transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The majority of the Company's revenue arrangements are service contracts that are completed within a year or less. There are a few contracts that range in duration between 1 and 3 years. Substantially all of the Company's performance obligations, and associated revenue, are transferred to the customer over time. Most of the Company's contracts can be terminated by the customer without cause. In the event of termination, the Company's contracts provide that the customer pay the Company for services rendered through the termination date. The Company generally receives compensation based on a predetermined invoicing schedule relating to specific milestones for that contract.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Amendments to contracts are common. The Company evaluates each amendment which meets the criteria of a contract modification under ASC 606. Each modification is further evaluated to determine whether the contract modification should be accounted for as a separate contract or as a continuation of the original agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The Company accounts for amendments as a separate contract as they meet the criteria under ASC 606-10-25-12.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pharmacology Study and Other Services</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally enters into contracts with customers to provide oncology services with payments based on fixed-fee arrangements. At contract inception, the Company assesses the services promised in the contracts with customers to identify the performance obligations in the arrangement. The Company's fixed-fee arrangements for oncology services are considered a single performance obligation because the Company provides a highly-integrated service.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time using a progress-based input method since there is no single output measure that would fairly depict the transfer of control over the life of the performance obligation. Revenue is recognized for the single performance obligation over time due to the Company's right to payment for work performed to date and the performance does not create an asset with an alternative use. The Company recognizes revenue as portions of the overall performance obligation are completed as this best depicts the progress of the performance obligation.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incremental Costs of Obtaining a Contract (Sales Commissions)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">       Under ASC 606, the costs of obtaining a contract can be expensed immediately, rather than capitalized and amortized, if the amortization period is one year or shorter. Sales commissions for the Company represent contract costs with a term of one year or less. Therefore, under ASC 606, the Company elected the practical expedient to expense these costs as incurred.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Consideration</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, contracts provide for variable consideration that is contingent upon the occurrence of uncertain future events, such as the success of the initial performance obligation. Variable consideration is estimated at the expected value or at the most likely amount depending on the type of consideration. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimate of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of its anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables, Unbilled Services and Deferred Revenue</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, billings and payments are established by contractual provisions including predetermined payment schedules, which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. In general, the Company's intention in its invoicing (payment terms) is to maintain cash neutrality over the life of the contract. Upfront payments, when they occur, are intended to cover certain expenses the Company incurs at the beginning of the contract. Neither the Company nor its customers view such upfront payments and contracted payment schedules as a means of financing. Unbilled services primarily arise when the revenue recognized exceeds the amount billed to the customer. Such situations occur due to divergences between revenue recognition and the invoicing milestones which are based on predetermined payment terms.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of unearned payments received in excess of revenue recognized. As the contracted services are subsequently performed and the associated revenue is recognized, the deferred revenue balance is reduced by the amount of the revenue recognized during the period. Deferred revenue is classified as a current liability on the condensed consolidated balance sheet as the Company expects to recognize the associated revenue in less than one year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Being Evaluated/Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Being Evaluated</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, "Financial Instruments - Credit Losses".  This update requires immediate recognition of management&#8217;s estimates of current expected credit losses ("CECL").  Under the prior model, losses were recognized only as they were incurred.  The new model is applicable to all financial instruments that are not accounted for at fair value through net income.  The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies.  Early adoption is permitted.   The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330986948720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of antidilutive securities excluded from earnings per share calculations</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the total potential share-based instruments outstanding at July&#160;31, 2022 and 2021 that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"><tr><td style="width:1.0%"/><td style="width:71.552%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total common stock equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734,428&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985701936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, Unbilled Services and Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Summary of accounts receivable, unbilled services, and advanced billings</a></td>
<td class="text">Accounts receivable and unbilled services were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:71.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable and unbilled services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,355&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of advanced billings</a></td>
<td class="text">Deferred revenue was as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:71.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982023456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of disaggregation of revenue</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents disaggregated revenue for the three months ended July 31, 2022 and 2021:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:70.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.014%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacology services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other TOS revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personalized oncology services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oncology services revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,745&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985595152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of property and equipment</a></td>
<td class="text">Property and equipment consisted of the following (table in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233">Property and equipment, net</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330981894512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of allocation of share based compensation expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was recognized as follows (table in thousands):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.011%"><tr><td style="width:1.0%"/><td style="width:65.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.960%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.961%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of valuation assumptions for stock options</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.192%"><tr><td style="width:1.0%"/><td style="width:35.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.200%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.200%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.204%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>July 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.58%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.94% - 66.21%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock options activity for the three months ended July 31, 2022 was a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s follows:</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:28.795%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.615%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.904%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.864%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors<br/>and<br/>Employees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-<br/>Employees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, April 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.90</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,462,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,462,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,846,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330985500320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Summary of assets and liabilities</a></td>
<td class="text">ROU assets and lease liabilities related to our current operating leases are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:49.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.440%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net<br/></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future operating lease payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments due each fiscal year as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.385%"><tr><td style="width:1.0%"/><td style="width:74.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total undiscounted liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330988669520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Use of Estimates and Basis of Presentation (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jul. 31, 2022 </div>
<div>subsidiary</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_NumberOfOperatingSubsidiaries', window );">Number of operating subsidiaries</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_NumberOfOperatingSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Operating Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_NumberOfOperatingSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330981245872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(319)<span></span>
</td>
<td class="num">$ (172)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(195)<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">72,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_WorkingCapitalDeficit', window );">Working capital</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">8,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax penalties and interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Unrecognized tax benefits anticipated during the next 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reporting entity working capital (deficit) has reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330981972832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - Few Contracts - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-08-01<br></strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=csbr_FewContractsMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue arrangements by service contract period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=csbr_FewContractsMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue arrangements by service contract period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=csbr_FewContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=csbr_FewContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-08-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-08-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977692752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Summary of Potentially Antidilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents (in shares)</a></td>
<td class="nump">1,722,155<span></span>
</td>
<td class="nump">1,734,428<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982575648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Accounts Receivable and Unbilled Services (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable</a></td>
<td class="nump">$ 5,619<span></span>
</td>
<td class="nump">$ 6,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled services</a></td>
<td class="nump">4,366<span></span>
</td>
<td class="nump">4,106<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Total accounts receivable and unbilled services</a></td>
<td class="nump">9,985<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less allowance for doubtful accounts</a></td>
<td class="num">(630)<span></span>
</td>
<td class="num">(630)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 9,355<span></span>
</td>
<td class="nump">$ 9,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982049152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 10,885<span></span>
</td>
<td class="nump">$ 11,071<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977682592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Oncology services revenue</a></td>
<td class="nump">$ 13,745<span></span>
</td>
<td class="nump">$ 11,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=csbr_PharmacologyServicesMember', window );">Pharmacology services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Oncology services revenue</a></td>
<td class="nump">12,756<span></span>
</td>
<td class="nump">10,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other TOS revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Oncology services revenue</a></td>
<td class="nump">948<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=csbr_PersonalizedOncologyServicesMember', window );">Personalized oncology services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Oncology services revenue</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=csbr_PharmacologyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=csbr_PharmacologyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=csbr_PersonalizedOncologyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=csbr_PersonalizedOncologyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330980365472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 528,000<span></span>
</td>
<td class="nump">$ 317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">499,000<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Finance lease, asset, gross</a></td>
<td class="nump">1,081,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 713,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_FinanceLeaseDepreciationAndAmortizationExpenses', window );">Finance lease, depreciation and amortization</a></td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingAsset', window );">Servicing asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingAssetAtAmortizedValue', window );">Carrying value of servicing asset</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization', window );">Hosting arrangement, amortization expense</a></td>
<td class="nump">157,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_FinanceLeaseAxis=csbr_A2022FinanceLeaseMember', window );">2022 Finance Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_FinanceLeaseCost', window );">Finance lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_PresentValueMinimumFutureObligationsInterestRate', window );">Present value of minimum future obligations interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease, amortization</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_FinanceLeaseAxis=csbr_A2023FinanceLeaseMember', window );">2023 Finance Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_FinanceLeaseCost', window );">Finance lease costs</a></td>
<td class="nump">$ 368,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_PresentValueMinimumFutureObligationsInterestRate', window );">Present value of minimum future obligations interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease, amortization</a></td>
<td class="nump">$ 11,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_FinanceLeaseDepreciationAndAmortizationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Depreciation And Amortization Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_FinanceLeaseDepreciationAndAmortizationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_PresentValueMinimumFutureObligationsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present Value Minimum Future Obligations Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_PresentValueMinimumFutureObligationsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of servicing assets that are subsequently measured at fair value and servicing assets that are subsequently measured using the amortization method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122501-111745<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingAssetAtAmortizedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized amount of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122739-111746<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122492-111745<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122501-111745<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingAssetAtAmortizedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_FinanceLeaseAxis=csbr_A2022FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_FinanceLeaseAxis=csbr_A2022FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_FinanceLeaseAxis=csbr_A2023FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_FinanceLeaseAxis=csbr_A2023FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330980340608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 13,803<span></span>
</td>
<td class="nump">$ 12,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(6,105)<span></span>
</td>
<td class="num">(5,577)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">$ 7,698<span></span>
</td>
<td class="nump">$ 7,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property, Plant and Equipment, Net<span></span>
</td>
<td class="text">Property, Plant and Equipment, Net<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">$ 246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,953<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,888<span></span>
</td>
<td class="nump">1,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=csbr_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">9,073<span></span>
</td>
<td class="nump">8,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=csbr_AssetInProgressMember', window );">Assets in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=csbr_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=csbr_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=csbr_AssetInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=csbr_AssetInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330980356432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Allocation of Share Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of oncology services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330980326624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 18, 2011</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="nump">$ 5.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2021Member', window );">Equity Incentive Plan 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">strike price as percent of market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2010Member', window );">Equity Incentive Plan 2010</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">strike price as percent of market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2010Member', window );">Equity Incentive Plan 2010 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Shares granted, net of forfeitures (in shares)</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=csbr_EquityIncentivePlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330982235520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Valuation Assumptions for Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (in percent)</a></td>
<td class="nump">2.87%<span></span>
</td>
<td class="nump">0.82%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility rate minimum (in percent)</a></td>
<td class="nump">62.58%<span></span>
</td>
<td class="nump">65.94%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility Rate maximum (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.21%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330980860752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Summary of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">1,658,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(7,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(1,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(4,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">1,722,155<span></span>
</td>
<td class="nump">1,658,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">1,722,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">1,380,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 4.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">7.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">7.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice', window );">Canceled (in dollars per share)</a></td>
<td class="nump">4.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share)</a></td>
<td class="nump">5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">4.64<span></span>
</td>
<td class="nump">$ 4.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 4.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding (in years)</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm', window );">Outstanding, granted (in years)</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest (in years)</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 7,462<span></span>
</td>
<td class="nump">$ 6,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">7,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">$ 6,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Directors and Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">1,617,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(7,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod', window );">Canceled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(4,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">1,683,115<span></span>
</td>
<td class="nump">1,617,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">1,683,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">1,380,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember', window );">Non- Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">40,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(1,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">39,040<span></span>
</td>
<td class="nump">40,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">39,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement by Share Based Payment Award, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330981154288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Jun. 01, 2020</div></th>
<th class="th"><div>Mar. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating leases, rent expense</a></td>
<td class="nump">$ 467<span></span>
</td>
<td class="nump">$ 452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">7,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 9,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">6 years 5 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, percent</a></td>
<td class="nump">5.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_CorporateHeadquartersMember', window );">Corporate Headquarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating leases, rent expense</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_RockvilleMDMember', window );">Rockville, MD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating leases, rent expense</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_OperatingLeaseIncrementalRentExpense', window );">Incremental rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_AdditionalExpansionPremisesMember', window );">Additional Expansion Premises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_MilanItalyMember', window );">Milan Italy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating leases, rent expense</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_OperatingLeaseIncrementalRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Incremental Rent Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_OperatingLeaseIncrementalRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_CorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_CorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_RockvilleMDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_RockvilleMDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_AdditionalExpansionPremisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_AdditionalExpansionPremisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_MilanItalyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=csbr_MilanItalyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977662016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - ROU Assets and Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">$ 7,971<span></span>
</td>
<td class="nump">$ 8,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,099<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current portion of operating lease liabilities</a></td>
<td class="nump">$ 8,127<span></span>
</td>
<td class="nump">$ 8,412<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330980305504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 2,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">5,164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">&#160;Total undiscounted liabilities</a></td>
<td class="nump">18,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(9,415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 9,226<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977685568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board Member | Board Member One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amounts of transaction</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board Member | Board Member Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amounts of transaction</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=csbr_BoardMemberOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=csbr_BoardMemberOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=csbr_BoardMemberTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=csbr_BoardMemberTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140330977606464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">$ 76,000<span></span>
</td>
<td class="nump">$ 44,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CollaborationArrangementRoyaltyFee', window );">Royalty fee per tumor sample</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice', window );">Royalty payment, as percent of contract price</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CollaborationArrangementRoyaltyFee', window );">Royalty fee per tumor sample</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice', window );">Royalty payment, as percent of contract price</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_CollaborationArrangementRoyaltyFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement Royalty Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_CollaborationArrangementRoyaltyFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement, Royalty Fee, Percent Of Contract Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_csbr_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">csbr_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>csbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>csbr-20220731_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:csbr="http://championsoncology.com/20220731"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="csbr-20220731.xsd" xlink:type="simple"/>
    <context id="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i7162da0ccfc34694a9c545f0084622ec_I20220909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2022-09-09</instant>
        </period>
    </context>
    <context id="i577c8b3d14454bb0b350f284ca6c1329_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="ic065ecda714549d8b9539d3a70cf972f_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i17924741f22b459ca3fec613390b6179_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iaa96ae2b58864431a19fca9982f05809_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i74b4dfd18191429c9ceb14b3f8c13d1f_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iaf29f85b5bd541b7a5f20864ebcdbfe0_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i9898920fb7064f9fb12fba471bc4597c_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i8d47b40f944a4de88ffdac21c78c982d_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i288a79b1b3d641ffa7490e0d5672f7f7_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i9c77242238dc46cfa4a8582a2c07efca_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i73be74dc4a704955a13d4a6e605014c1_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="if98b46a595474311b3a3c697506f8d81_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i40a87370111849e4b06dd3c5817bbbb1_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="iffa6bb1922094929b2d547692aefd75c_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i2585e39e17d7472a892cc1d2e2e61c94_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="idb484428e98e40b38348d54e643addb7_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ia61c6e91da644288a202775dd72f34f0_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i085ec6b98bf6466f8ea58b578ad7c55d_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="ie7278dee4bfc4f0db784f5737bf65204_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i06a3076d34d446dfa338a23dc5b09cac_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i12ebeded0a02450a9d446437bbbc576c_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i6eca0785cd844297b787bca9c17b7117_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:FewContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-08-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="ie70d8f70a5944b69be752032e3c823a4_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:FewContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-08-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i91fabe7ea07840b0ad07eea382c68f2c_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PharmacologyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ia438aed8edee4499a8c76234ae8091b1_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PharmacologyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i98127e2a2ada454e83135bf30e7094f4_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i2f5707fdf6d74465854a45083439a864_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ia0cd432221fb46c5b2ff6c3f14dae6c0_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PersonalizedOncologyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ia7484f64f1cd4b20ba501dd09db89691_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">csbr:PersonalizedOncologyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ia612a5a694ed4a2aab99e2c1b7c1e7b9_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i1b2bd8d2bae64d3a8a1229b5763b483f_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i99022b6aeb5849f68381125e8cdb97ea_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i11effbe8666d492bb6247738f880f0a4_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i6b5212cdfd144c8188adcfed3bf2b746_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i1ee763a8872248559a69477fb7ba51ef_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i7470cfb3a4e24c169da0a95c73f21990_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="iba47105892b84c23a2e865ef51894ed5_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ib57b0077fa424cfa9994c70df2820ec2_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:AssetInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="id7446b75d7234b01989cb3824d3109aa_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">csbr:AssetInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ic7b897b038814dab831bf20fd743486c_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="id123ab3740ed4938a93cc09d1793ca01_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i6dfc15decd0849a7ba09ebc4e674af89_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ibc1695cc594a4e7cad70f212f82cb391_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2022FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i9b610a04f8314e00a08a6a9b91c33292_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2022FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="id7396db6674049dd925725f824b27e50_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2022FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2023FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="id42bfc0d6ba246b783fdd25ce27859cb_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="csbr:FinanceLeaseAxis">csbr:A2023FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i4ca13514049f49afa46dab0656a44d2a_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i3bab8e5b86cc43df8e6b97165cdc5f3c_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ia3752fc3c3d8408694ab9b64622ad170_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i5753fa1a19a74139a0f74c566b7aa853_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ia8e1fd8a290f4d44b5e8552f71eede35_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i51dcfb3a899c4a8e813069354ef8efcd_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ifb0d823f162b4a5193235bd46686af4b_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="if3f6897bc8834b8f904bba44f16469a8_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i4ac79db879ea4f6eb1f558ff7ea89f1d_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i45d9fcd2385f4e39a7cbdd2d532819d7_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i0ce03b4537c94cf7b7799c4e749ac6bc_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i080c253670fa426ea429272a7273cf12_D20110218-20110218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-02-18</startDate>
            <endDate>2011-02-18</endDate>
        </period>
    </context>
    <context id="i86bc626a809147259f5f564000ed6a2d_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">csbr:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i1b9d5525af9d4411bcbf399d302cd535_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ifd81da0b91f449c284d6c5416e74f934_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i96b45f148ed94f2b987822093a127b64_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i8b2c162c0b10404093ec52141324084c_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="id6e0ef2a12e441258eba05a1fce64ef5_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="iafaf30d9b4bb4f1a9ecbae72caf1fb8f_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:CorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ib1ac3aca3d2e4e09a8d672880d693ede_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:CorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i53b7f92a0f504fe8a62ea065fb7de171_I20200330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <instant>2020-03-30</instant>
        </period>
    </context>
    <context id="if0a29219b6d948bfb1a15242e7e2ee28_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i1318dfe0a0ec49f5acc43f0ba736b4ba_D20200501-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i708a863763c143c7b34dd9a365f1231f_I20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="idf77001db0284d6e948b1a45819dd957_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:AdditionalExpansionPremisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i900f808a09d14b639e4c9009b851f365_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i1bf7db3dbce34511bf24eb8231dc9fb6_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:RockvilleMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i3b3db1ffdd35458cb1b2797cc1c3e7a7_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:MilanItalyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="ib656d8c6403f4dc78fd543334a957220_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:MilanItalyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i4fa35d5bbbd94ab5a12de9c850a4deef_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">csbr:MilanItalyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ib6fed9c77e8f43daad4d3e42d103bedc_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i851e5a2ac2a74afc89c6b93db67bab8b_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ie7dd96fbc4b344fc8421b1c148328401_D20220501-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i3b1cc212cb794f45b5fa375773a069c2_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">csbr:BoardMemberTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="subsidiary">
        <measure>csbr:subsidiary</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF8zLTEtMS0xLTE4ODEz_df90eceb-59ca-4101-a626-453dde1f6219">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF82LTEtMS0xLTE4ODEz_85c72ed4-f5a5-40a4-8d05-5a20064eb03d">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF83LTEtMS0xLTE4ODEz_2287ddf1-ef09-4013-9285-cf79ee05969d">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF84LTEtMS0xLTE4ODEz_406e4708-5291-4976-8de4-6913e019d3fa">0000771856</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80L2ZyYWc6Y2RjNWJkZTNlMmQwNGZmYmEzZDlhYTY3ZWVhMGEwNTkvdGFibGU6YzI3YmMxYWIwOGFmNGEwZmFiMDNiMjlkYTc5NmE0YjQvdGFibGVyYW5nZTpjMjdiYzFhYjA4YWY0YTBmYWIwM2IyOWRhNzk2YTRiNF85LTEtMS0xLTE4ODEz_28e4fa94-ba4f-4185-ba19-656e2b8ae19f">--04-30</dei:CurrentFiscalYearEndDate>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0wLTEtMS0xODgxMw_1a314bab-bc49-462d-9774-0a2a9e532563">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0wLTEtMS0xODgxMw_b5d3071c-49b2-43e4-8afd-750cbba73f89">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0wLTEtMS0xODgxMw_24738fed-0e57-44c5-8ac4-6f88cd052e09">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0wLTEtMS0xODgxMw_4e771243-6a18-4c99-aa0e-f31efb2e55ca">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzI3_71ed8872-0f98-4a2c-950c-1fa4fcc01343">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc2_66272536-2705-4a24-8891-46d5bb52d75a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MjUzNTA3MTRjMDIyNDZjMGFjZjAwZTgzNjk3ZWM0MWEvdGFibGVyYW5nZToyNTM1MDcxNGMwMjI0NmMwYWNmMDBlODM2OTdlYzQxYV8wLTAtMS0xLTE4ODEz_3ea80d7c-7671-468a-b55f-d0a50fe585f0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MjUzNTA3MTRjMDIyNDZjMGFjZjAwZTgzNjk3ZWM0MWEvdGFibGVyYW5nZToyNTM1MDcxNGMwMjI0NmMwYWNmMDBlODM2OTdlYzQxYV8xLTEtMS0xLTE4ODEzL3RleHRyZWdpb246YzA2MWM1NzgwZTEzNGRlYWE1NjMyM2M2NzE1ZmQxY2ZfMzU_e114e1aa-b881-49d8-988e-424940428b89">2022-07-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZGI1Y2E3YWY5N2U2NDA2OWI0NTA1MjI3NzM2ZWU1YWIvdGFibGVyYW5nZTpkYjVjYTdhZjk3ZTY0MDY5YjQ1MDUyMjc3MzZlZTVhYl8wLTAtMS0xLTE4ODEz_91c08457-0042-49c4-b025-144808c8d2a7">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc3_346554ba-2293-40f8-b696-c32dcf365c2c">001-11504</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc4_e15618b5-d906-4ac5-9eeb-3836bf2c19f3">CHAMPIONS ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8wLTAtMS0xLTE4ODEz_f79ca3a6-213f-47ae-ba59-0e723a8f0f81">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8wLTEtMS0xLTE4ODEz_100ff35c-0590-40d8-9934-e4774f8ef970">52-1401755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8zLTAtMS0xLTE4ODEz_ac4e357c-e319-456b-9c07-e727aea28571">One University Plaza, Suite 307</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV8zLTEtMS0xLTE4ODEz_71bc240d-5727-495e-bb38-e5323548357d">07601</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV80LTAtMS0xLTE4ODEzL3RleHRyZWdpb246MDA2ZTRjNDJmZjg1NDcwY2FlMjYwYTY3YmU0YmJmMWZfNA_8037ed1c-95f1-4dfd-8737-1866b098262f">Hackensack</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6NzcyODk2MGIwNjE2NDYzMGE5NjA4NTNmOGJkZjk4YTkvdGFibGVyYW5nZTo3NzI4OTYwYjA2MTY0NjMwYTk2MDg1M2Y4YmRmOThhOV80LTAtMS0xLTE4ODEzL3RleHRyZWdpb246MDA2ZTRjNDJmZjg1NDcwY2FlMjYwYTY3YmU0YmJmMWZfOA_a24fb280-739c-4491-9709-bd5c9710fd7b">NJ</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDcx_e610ad8a-d5b6-4da0-aa33-b05385f2dbbf">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDcy_27a45650-6791-4fb5-a92e-68d566bedd59">808-8400</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MTllMGExMGI1YWFjNGZjNTk1MWFjNTkxNGUzZmU4ODcvdGFibGVyYW5nZToxOWUwYTEwYjVhYWM0ZmM1OTUxYWM1OTE0ZTNmZTg4N18xLTAtMS0xLTE4ODEz_e47dc286-ec0d-41e0-ba80-f436be75a028">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MTllMGExMGI1YWFjNGZjNTk1MWFjNTkxNGUzZmU4ODcvdGFibGVyYW5nZToxOWUwYTEwYjVhYWM0ZmM1OTUxYWM1OTE0ZTNmZTg4N18xLTItMS0xLTE4ODEz_22be72fa-a4a1-4176-820b-c405d50f5fda">CSBR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6MTllMGExMGI1YWFjNGZjNTk1MWFjNTkxNGUzZmU4ODcvdGFibGVyYW5nZToxOWUwYTEwYjVhYWM0ZmM1OTUxYWM1OTE0ZTNmZTg4N18xLTQtMS0xLTE4ODEzL3RleHRyZWdpb246N2YzZDc0YTFiZGJjNDUwN2E4OTFlZTYzMzkzNzk2ODNfOA_c0c69e28-6ba8-4524-8ae5-e9a9e58128e3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDcz_30ea8013-b262-4d01-8203-b337e143d477">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc0_21305b40-1ed6-4fd3-88b3-74b6fbed7ef3">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZTAzZGQxNGNlYmY0NDRlNTkyZjJjMmJmNGNkYzBhZTYvdGFibGVyYW5nZTplMDNkZDE0Y2ViZjQ0NGU1OTJmMmMyYmY0Y2RjMGFlNl8wLTItMS0xLTE4ODEzL3RleHRyZWdpb246YWE1NTg3MDI4OGFlNDIxNzllNDkzZTlmZDhjMWYwODFfNA_d2b19260-e5c8-477b-a8f7-057cd0eabe54">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZTAzZGQxNGNlYmY0NDRlNTkyZjJjMmJmNGNkYzBhZTYvdGFibGVyYW5nZTplMDNkZDE0Y2ViZjQ0NGU1OTJmMmMyYmY0Y2RjMGFlNl8wLTMtMS0xLTE4ODEzL3RleHRyZWdpb246ZTgxMDdhNzY2MmQ1NGQxN2JlYzEyNGYwYjNjZjUyODRfMzA_84854e34-9cd4-4043-bc03-e497f83c10d1">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGFibGU6ZTAzZGQxNGNlYmY0NDRlNTkyZjJjMmJmNGNkYzBhZTYvdGFibGVyYW5nZTplMDNkZDE0Y2ViZjQ0NGU1OTJmMmMyYmY0Y2RjMGFlNl8xLTMtMS0xLTE4ODEzL3RleHRyZWdpb246MmE1NzlkNTRmYTE2NDRiMGFhZDYxZDEzZWFlNmQ5ZjVfMjg_b228c16e-3ae9-4abd-ad83-1e91de8a31cf">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF8yMDc1_9d026bdc-50af-432b-b1b4-417ea4426d55">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i7162da0ccfc34694a9c545f0084622ec_I20220909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xL2ZyYWc6YmUxOWYwYzRjYzdmNDM5NGFiYzJiOGMzZWE2MTg1ZmQvdGV4dHJlZ2lvbjpiZTE5ZjBjNGNjN2Y0Mzk0YWJjMmI4YzNlYTYxODVmZF81NDk3NTU4MTU5OTM_9beea35c-bf42-471f-ae75-552b28858dd4"
      unitRef="shares">13522441</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNC0xLTEtMS0xODgxMw_92f6a24a-5bd2-4993-a911-73ab0d1ce4d9"
      unitRef="usd">8058000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNC0zLTEtMS0xODgxMw_751b8fed-1d18-488a-bfcf-61596a58f458"
      unitRef="usd">9007000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNS0xLTEtMS0xODgxMw_de6e222c-bf78-4f67-a821-705888a5a9a3"
      unitRef="usd">9355000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNS0zLTEtMS0xODgxMw_177f998e-98b3-46f5-9f3d-30ca460e7287"
      unitRef="usd">9513000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNi0xLTEtMS0xODgxMw_09160e28-bba6-41ea-a028-e357f956b9de"
      unitRef="usd">958000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNi0zLTEtMS0xODgxMw_4fdf2d90-6d07-4d2d-8303-331a74e735db"
      unitRef="usd">1144000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfOC0xLTEtMS0xODgxMw_a790da13-dd3d-42ae-a695-98adb0cee25f"
      unitRef="usd">18371000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfOC0zLTEtMS0xODgxMw_12c1111a-41d4-485c-8cea-b9b0b4f42908"
      unitRef="usd">19664000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTEtMS0xLTEtMTg4MTM_b7716579-abb6-483e-82ab-e8de7440020a"
      unitRef="usd">7971000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTEtMy0xLTEtMTg4MTM_f479680b-e76d-4b43-be4e-7b322ab311ac"
      unitRef="usd">8230000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTItMS0xLTEtMTg4MTM_2245aa85-b00c-4c6a-8904-7be766e45c5a"
      unitRef="usd">7698000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTItMy0xLTEtMTg4MTM_bc2dcf7c-f84e-4886-b5e9-59d89a8c208d"
      unitRef="usd">7134000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTMtMS0xLTEtMTg4MTM_1fca41b1-714b-4ad7-81dc-bdfe820b8e4c"
      unitRef="usd">15000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTMtMy0xLTEtMTg4MTM_07aa8dcd-dff9-4f5e-9694-319ab4811840"
      unitRef="usd">15000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTQtMS0xLTEtMTg4MTM_76b0d4f8-4fc3-45d7-9a63-5744a5a81623"
      unitRef="usd">335000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTQtMy0xLTEtMTg4MTM_988a264a-3aa4-46af-ac1b-a65f3af9f77f"
      unitRef="usd">335000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTYtMS0xLTEtMTg4MTM_551acbbf-324d-433e-b885-723e397eca73"
      unitRef="usd">34390000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMTYtMy0xLTEtMTg4MTM_b36eee9d-76f2-46ab-864d-52e358705495"
      unitRef="usd">35378000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjEtMS0xLTEtMTg4MTM_88e73bf2-ed42-44d5-8322-65cadde1b820"
      unitRef="usd">2537000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjEtMy0xLTEtMTg4MTM_6b518760-bed5-4c50-be6e-a71ac80988f7"
      unitRef="usd">2868000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjItMS0xLTEtMTg4MTM_63409165-5959-476b-bbea-b3cc87825112"
      unitRef="usd">1957000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjItMy0xLTEtMTg4MTM_d67be8e4-4c04-4288-bf3f-edc19434980a"
      unitRef="usd">2414000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjQtMS0xLTEtMTg4MTM_3b8250a0-3a15-4c5c-bc3b-b2c4db0c8a37"
      unitRef="usd">1099000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjQtMy0xLTEtMTg4MTM_7768062d-b059-4900-8987-d40c918ff454"
      unitRef="usd">1054000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjUtMS0xLTEtMTg4MTM_01177a0b-0a4c-4b33-a291-f828fecf7857"
      unitRef="usd">142000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjUtMy0xLTEtMTg4MTM_a07979cf-b016-4378-b0db-9981b7bf8e29"
      unitRef="usd">72000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjYtMS0xLTEtMTg4MTM_c7b123b2-2530-4582-8d98-bc534b3501e5"
      unitRef="usd">10885000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjYtMy0xLTEtMTg4MTM_c963a410-ed58-49a4-ba46-94fd34a43741"
      unitRef="usd">11071000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjgtMS0xLTEtMTg4MTM_86faf195-c19c-421d-a3cf-12bef25893da"
      unitRef="usd">16620000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMjgtMy0xLTEtMTg4MTM_72eb6194-c500-4952-8256-b8b02b887165"
      unitRef="usd">17479000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzAtMS0xLTEtMTg4MTM_e8e05f41-20e8-48c1-9adf-86d939df5aa6"
      unitRef="usd">8127000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzAtMy0xLTEtMTg4MTM_b2bd8c6f-0bef-40c5-9fa4-3e61f3a03243"
      unitRef="usd">8412000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzItMS0xLTEtMTg4MTM_ecb82038-e477-4099-a5cb-63153d6f5f4c"
      unitRef="usd">660000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzItMy0xLTEtMTg4MTM_c9b1eaff-21ee-4af0-a465-d021c7382a99"
      unitRef="usd">391000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzQtMS0xLTEtMTg4MTM_5ff07f03-5c6f-4435-8a25-0aef27fd7700"
      unitRef="usd">25407000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzQtMy0xLTEtMTg4MTM_fed93668-6fe4-41fa-be93-98e91e4267dc"
      unitRef="usd">26282000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8xOA_79f11c41-bf79-413a-9bcd-2fc8e1d4b37f"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8xOA_a10fc626-949b-40b7-ad85-70b111eb15da"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8zMg_1ed0637d-6bc2-48e0-9a23-8d8b9a08cd23"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF8zMg_3587a112-714f-48f1-b596-9dcea28a0ab5"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_02f5d3a3-9e46-4964-b709-88a39c89879b"
      unitRef="shares">13522441</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_403fb7de-48dd-4e0e-825f-fb326b5dcd47"
      unitRef="shares">13522441</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_415b40ac-ff8a-4060-a182-9c4d76330304"
      unitRef="shares">13522441</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMC0xLTEtMTg4MTMvdGV4dHJlZ2lvbjo3NjJiOWZmYTdkYjc0NzhjOTRkMDc2NDQ0ZTM0M2NiNF81NA_c5bd30c5-8388-4b61-8e17-4370927e02de"
      unitRef="shares">13522441</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMS0xLTEtMTg4MTM_da066e6e-916c-4ec0-986a-4af12934e516"
      unitRef="usd">14000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzctMy0xLTEtMTg4MTM_69740329-c1ca-461a-b093-bef63e529375"
      unitRef="usd">14000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzktMS0xLTEtMTg4MTM_1b6a3c34-99fd-46a8-9866-86707cf941bf"
      unitRef="usd">81270000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfMzktMy0xLTEtMTg4MTM_9d37cc61-b865-40b0-95b3-09ed346931f0"
      unitRef="usd">81064000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDAtMS0xLTEtMTg4MTM_d957e3cb-0c38-4175-b63b-f6618cd4b3d5"
      unitRef="usd">-72301000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDAtMy0xLTEtMTg4MTM_d24ffd21-c0ee-4d30-8971-b27737c474ed"
      unitRef="usd">-71982000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDItMS0xLTEtMTg4MTM_fe7faa3b-218b-471b-a45f-4325c88c06d6"
      unitRef="usd">8983000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDItMy0xLTEtMTg4MTM_bc1bf99d-4cae-4d97-85d6-f5cc9d137ba5"
      unitRef="usd">9096000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDQtMS0xLTEtMTg4MTM_a496b477-c414-4bc0-a0a2-2f3304f0c063"
      unitRef="usd">34390000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8xNi9mcmFnOjFmN2M3Y2EzY2I1ZDQxZDY4MTk3Y2UzMDk2NzJjYWExL3RhYmxlOjFjNDI4OWNiMjNiNzRmYjY4ZGMzOTczY2IwZDI2Zjk0L3RhYmxlcmFuZ2U6MWM0Mjg5Y2IyM2I3NGZiNjhkYzM5NzNjYjBkMjZmOTRfNDQtMy0xLTEtMTg4MTM_82c9c687-0bda-473e-a6e2-6acbf86eb3b1"
      unitRef="usd">35378000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0xLTEtMS0xODgxMw_f7118e87-87c4-4033-ba2f-ef4785ea3df8"
      unitRef="usd">13745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMy0zLTEtMS0xODgxMw_11ab57b6-7371-4897-90a9-a8d2bda927f3"
      unitRef="usd">11253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0xLTEtMS0xODgxMw_1f10d309-5af5-413a-abcd-68d1a4ee5e81"
      unitRef="usd">7052000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNi0zLTEtMS0xODgxMw_088a5caa-249b-4430-90e0-2a840e23ba08"
      unitRef="usd">5396000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNy0xLTEtMS0xODgxMw_3d6bec5e-5943-45ab-a24a-f2cc67c41d6b"
      unitRef="usd">2887000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfNy0zLTEtMS0xODgxMw_41277ca6-5624-44d2-94f4-cfd02de0b84d"
      unitRef="usd">2304000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOC0xLTEtMS0xODgxMw_639efffb-0093-413e-b396-36c59f76df7b"
      unitRef="usd">1692000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOC0zLTEtMS0xODgxMw_03748802-acd2-4aea-918e-dcac18114d64"
      unitRef="usd">1574000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOS0xLTEtMS0xODgxMw_1865ad4e-81c3-4e10-9e22-ce2008ee6f35"
      unitRef="usd">2398000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfOS0zLTEtMS0xODgxMw_b481eab0-1e77-4faa-a6e6-3a7ccd806a13"
      unitRef="usd">2154000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTEtMS0xLTEtMTg4MTM_5cb0f818-655b-40d4-80af-a88535c78468"
      unitRef="usd">14029000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTEtMy0xLTEtMTg4MTM_3fe51a63-7e64-4ae9-8e00-4b26e8a7ae5a"
      unitRef="usd">11428000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTMtMS0xLTEtMTg4MTM_2ab39b52-be31-44d4-9a2c-b5bb56efb2a9"
      unitRef="usd">-284000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTMtMy0xLTEtMTg4MTM_a8cac567-390c-4a0e-95f2-98005fa55b83"
      unitRef="usd">-175000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTYtMS0xLTEtMTg4MTM_573d71b2-cf63-46ff-a2b0-5e7aa4332dbe"
      unitRef="usd">-18000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTYtMy0xLTEtMTg4MTM_5590cc7a-2c69-44b4-aa7a-aa029503fdf0"
      unitRef="usd">17000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTgtMS0xLTEtMTg4MTM_29610426-286a-4f1e-9c32-a9b913023080"
      unitRef="usd">-302000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTgtMy0xLTEtMTg4MTM_a94aea05-3b20-4fd8-9e21-d8c2882f81b8"
      unitRef="usd">-158000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTktMS0xLTEtMTg4MTM_9d58388b-cc7d-4584-92f8-d978c2ce7aed"
      unitRef="usd">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMTktMy0xLTEtMTg4MTM_e64394ee-6095-4ab1-936f-6d0ff32c8fea"
      unitRef="usd">14000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjEtMS0xLTEtMTg4MTM_a6206146-1a50-41af-bc23-9b9ca8d92fc6"
      unitRef="usd">-319000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjEtMy0xLTEtMTg4MTM_9684cb09-d4c8-4c2a-b528-e973ae70a726"
      unitRef="usd">-172000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjQtMS0xLTEtMTg4MTM_43bdab28-e65e-4308-82ec-05e071e4eb5e"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjQtMy0xLTEtMTg4MTM_95c6965f-51bb-4e31-a52a-14a76c5bef77"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjUtMS0xLTEtMTg4MTM_663311ce-bee4-4116-87db-9839dacb09ca"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjUtMy0xLTEtMTg4MTM_5b0ba707-4f8b-43b6-81f1-63f0d369a3a8"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjgtMS0xLTEtMTg4MTM_febe507d-d009-4fec-a1dc-88d610aa00fe"
      unitRef="shares">13522433</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjgtMy0xLTEtMTg4MTM_7755bc3b-4be9-4dba-ab01-b08b3820e1de"
      unitRef="shares">13401929</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjktMS0xLTEtMTg4MTM_59f78b56-28b5-461e-a2ba-f035813bf358"
      unitRef="shares">13522433</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yMi9mcmFnOjQ4OWU5ODQ4YWZiODQzMzE4MmE3NzA0YWUxYmQ0MDQ3L3RhYmxlOjQxNWE3ZDM3NmIzMjQyYWQ4YmY0YTE3ZWZmZTYxYzg2L3RhYmxlcmFuZ2U6NDE1YTdkMzc2YjMyNDJhZDhiZjRhMTdlZmZlNjFjODZfMjktMy0xLTEtMTg4MTM_d195bd01-53a6-45b2-945b-d24b0ed1a26c"
      unitRef="shares">13401929</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i17924741f22b459ca3fec613390b6179_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0xLTEtMS0xODgxMw_68cbabcb-9d8c-4651-8c15-3bd585a54196"
      unitRef="shares">13522441</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i17924741f22b459ca3fec613390b6179_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0zLTEtMS0xODgxMw_a2e779a5-5132-488f-a831-e52db1000ab1"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa96ae2b58864431a19fca9982f05809_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi05LTEtMS0xODgxMw_bac38e31-3d19-4d1f-a8c2-276dd4e78ea9"
      unitRef="usd">81064000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i74b4dfd18191429c9ceb14b3f8c13d1f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0xMS0xLTEtMTg4MTM_558fbdc4-b461-47f5-99b1-cda66ba09f93"
      unitRef="usd">-71982000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMi0xNS0xLTEtMTg4MTM_65746780-5aae-4a29-a572-4c4ca87896dd"
      unitRef="usd">9096000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaf29f85b5bd541b7a5f20864ebcdbfe0_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMy05LTEtMS0xODgxMw_f977ba4e-a089-4a48-a44f-841768bea348"
      unitRef="usd">206000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMy0xNS0xLTEtMTg4MTM_4a4be7e8-6ca6-44df-876e-d2e2050527e7"
      unitRef="usd">206000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i9898920fb7064f9fb12fba471bc4597c_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTAtMTEtMS0xLTE4ODEz_29d85fdf-5602-404b-9c44-1c8d8ec5c21b"
      unitRef="usd">-319000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTAtMTUtMS0xLTE4ODEz_552053d5-22f3-4eb4-870b-6768648c127f"
      unitRef="usd">-319000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8d47b40f944a4de88ffdac21c78c982d_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMS0xLTEtMTg4MTM_a9cf53b9-6da2-4648-ad2e-f8f2f2990785"
      unitRef="shares">13522441</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8d47b40f944a4de88ffdac21c78c982d_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMy0xLTEtMTg4MTM_8b07b0b6-3767-40fe-8752-2d2616889229"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i288a79b1b3d641ffa7490e0d5672f7f7_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtOS0xLTEtMTg4MTM_47c13cda-ed8d-4f30-9a10-d68a8bbec35c"
      unitRef="usd">81270000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c77242238dc46cfa4a8582a2c07efca_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMTEtMS0xLTE4ODEz_f552847f-822a-4e1c-95c2-525f64971eca"
      unitRef="usd">-72301000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMTEtMTUtMS0xLTE4ODEz_188b059b-db98-4e22-b362-f9e323947564"
      unitRef="usd">8983000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i73be74dc4a704955a13d4a6e605014c1_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMS0xLTEtMTg4MTM_1e50bd65-99fe-4516-999e-1af69c8b6f26"
      unitRef="shares">13414066</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i73be74dc4a704955a13d4a6e605014c1_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMy0xLTEtMTg4MTM_54515e6e-9294-4154-919f-a01c3f266d38"
      unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if98b46a595474311b3a3c697506f8d81_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtOS0xLTEtMTg4MTM_89db9241-cda7-4549-ac66-276cf9eaceea"
      unitRef="usd">79945000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i40a87370111849e4b06dd3c5817bbbb1_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMTEtMS0xLTE4ODEz_a449d7dd-3f30-4267-ba4b-0aafea0a9d2a"
      unitRef="usd">-72530000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iffa6bb1922094929b2d547692aefd75c_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjgtMTUtMS0xLTE4ODEz_1dcc2983-8c62-4222-b438-e0f61a73a4d8"
      unitRef="usd">7428000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2585e39e17d7472a892cc1d2e2e61c94_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjktOS0xLTEtMTg4MTM_3d785673-78d9-4cbc-9b11-a34309aa92d1"
      unitRef="usd">280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMjktMTUtMS0xLTE4ODEz_ace51c78-2235-406c-8182-aa8ea26a9637"
      unitRef="usd">280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="idb484428e98e40b38348d54e643addb7_D20210501-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzEtMS0xLTEtMTg4MTM_19b49e48-c5a0-4190-9273-bab6f95175a0"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i2585e39e17d7472a892cc1d2e2e61c94_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzEtOS0xLTEtMTg4MTM_9973722e-449d-467f-a013-e147f14cd971"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzEtMTUtMS0xLTE4ODEz_99be71bd-c3b0-4fd6-b3ab-64bdc8d5a8fa"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss
      contextRef="ia61c6e91da644288a202775dd72f34f0_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzItMTEtMS0xLTE4ODEz_bbf5cf67-230d-482f-8e51-da79d5dd07de"
      unitRef="usd">-172000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzItMTUtMS0xLTE4ODEz_251f1a25-50d6-4e5a-8d86-44a4d6f68887"
      unitRef="usd">-172000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i085ec6b98bf6466f8ea58b578ad7c55d_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMS0xLTEtMTg4MTM_e72f7923-2083-4eef-8f52-1dcd551e9c1e"
      unitRef="shares">13415066</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i085ec6b98bf6466f8ea58b578ad7c55d_I20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMy0xLTEtMTg4MTM_919367ae-0054-434a-af5f-15643b6ff735"
      unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7278dee4bfc4f0db784f5737bf65204_I20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtOS0xLTEtMTg4MTM_c7ae09ed-cecd-4822-9eef-f9e382623816"
      unitRef="usd">80227000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i06a3076d34d446dfa338a23dc5b09cac_I20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMTEtMS0xLTE4ODEz_7cdaf7a3-73b2-4160-9d36-a7aec971d227"
      unitRef="usd">-72702000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i12ebeded0a02450a9d446437bbbc576c_I20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yNS9mcmFnOjBjYzFjZGMyM2NkZjRmNzVhODBiYjQ0ZWI0ZDU5ZWY1L3RhYmxlOmZhZjkwOWRjZmI3MTQzMTFiMzJjYzhkZDY5OTlhNDFlL3RhYmxlcmFuZ2U6ZmFmOTA5ZGNmYjcxNDMxMWIzMmNjOGRkNjk5OWE0MWVfMzMtMTUtMS0xLTE4ODEz_39873705-3952-4342-9d3e-fbb957e795a4"
      unitRef="usd">7538000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMy0xLTEtMS0xODgxMw_aac5de13-fd66-47f6-93bd-188297be0fd0"
      unitRef="usd">-319000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMy0zLTEtMS0xODgxMw_b266182e-f780-4dcd-b6dc-6f63f7cb262d"
      unitRef="usd">-172000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNi0xLTEtMS0xODgxMw_054a9208-73c7-4c9b-9657-42f081a3c136"
      unitRef="usd">206000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNi0zLTEtMS0xODgxMw_11fa73fd-ba13-4a1d-a74a-7b7a4bb41c65"
      unitRef="usd">280000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfOC0xLTEtMS0xODgxMw_8c93aead-060b-4747-86a0-d03fb69f11f6"
      unitRef="usd">528000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfOC0zLTEtMS0xODgxMw_1a53aa3e-d2e4-41e8-9a90-b2c6c1a76c72"
      unitRef="usd">317000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTAtMS0xLTEtMTg4MTM_9702388d-96d8-4f9e-bf4d-f917b69d818e"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTAtMy0xLTEtMTg4MTM_0003d266-1438-49b8-ae5b-3a91b7a5b709"
      unitRef="usd">4000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <csbr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTItMS0xLTEtMTg4MTM_589f68b5-1157-4906-a560-0ad4c326c2b4"
      unitRef="usd">269000</csbr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <csbr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTItMy0xLTEtMTg4MTM_12ca6637-f30b-45d9-9f15-a96eb2474ecf"
      unitRef="usd">245000</csbr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <csbr:ReversalOfProvisionForDoubtfulAccounts
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTMtMS0xLTEtMTg4MTM_cc117a6c-e801-4e75-b4b9-5d8a98735ba0"
      unitRef="usd">0</csbr:ReversalOfProvisionForDoubtfulAccounts>
    <csbr:ReversalOfProvisionForDoubtfulAccounts
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTMtMy0xLTEtMTg4MTM_12c0b7d2-0999-449e-aa88-a082db2ad73b"
      unitRef="usd">78000</csbr:ReversalOfProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTYtMS0xLTEtMTg4MTM_79f1e75e-b772-4813-86f8-b5dabb89b431"
      unitRef="usd">-158000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTYtMy0xLTEtMTg4MTM_edfa6abc-6835-4e4d-8a15-43a656f997d0"
      unitRef="usd">825000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTctMS0xLTEtMTg4MTM_c69b3400-22c4-45ac-8a0f-41853c60b9ac"
      unitRef="usd">-186000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTctMy0xLTEtMTg4MTM_e08211a0-b7d5-42e6-88dc-6a5d1bb0bff6"
      unitRef="usd">-93000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTgtMS0xLTEtMTg4MTM_cd44c358-692b-44c2-859b-61e16ed8b6d5"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTgtMy0xLTEtMTg4MTM_0f84eaaf-3bfd-4aba-98a5-6d08f240e358"
      unitRef="usd">70000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTktMS0xLTEtMTg4MTM_a36fcb50-bd32-4947-9b33-7fc8a4fc1211"
      unitRef="usd">-331000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMTktMy0xLTEtMTg4MTM_86369483-dde1-4feb-ae70-041e86abfe82"
      unitRef="usd">1372000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjAtMS0xLTEtMTg4MTM_eae1dd5c-3ead-442f-96be-93381aa48599"
      unitRef="usd">-456000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjAtMy0xLTEtMTg4MTM_87123160-f864-47b7-9cdb-209381b8bf2e"
      unitRef="usd">-250000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjItMS0xLTEtMTg4MTM_5fd92f28-00b2-4cff-bc00-53874eaaf12f"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjItMy0xLTEtMTg4MTM_b5c83b9b-e8a4-4324-a709-651ab8f51d6c"
      unitRef="usd">15000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjMtMS0xLTEtMTg4MTM_8e5f68bb-6684-4feb-beea-54da27fbaea5"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjMtMy0xLTEtMTg4MTM_41866dad-acb8-40bd-9385-b2debaaa8c54"
      unitRef="usd">62000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <csbr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjQtMS0xLTEtMTg4MTM_2cb3404c-0c17-47e3-94f6-5ad065b795b0"
      unitRef="usd">250000</csbr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <csbr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjQtMy0xLTEtMTg4MTM_c2fcefb4-f78e-475a-a4aa-f65bb8d00b40"
      unitRef="usd">150000</csbr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjUtMS0xLTEtMTg4MTM_def365f1-2b6e-4cc9-b3a4-1d4d57344fa6"
      unitRef="usd">-186000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjUtMy0xLTEtMTg4MTM_869efaf9-2446-455b-afbb-ab26d2ea27a3"
      unitRef="usd">-775000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjctMS0xLTEtMTg4MTM_6d3b617c-6e7c-415b-b296-76eda8b608cf"
      unitRef="usd">-195000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMjctMy0xLTEtMTg4MTM_e5525745-3987-4a89-96b3-f343eae90d49"
      unitRef="usd">216000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzAtMS0xLTEtMTg4MTM_4aeccccc-9920-47c6-91cb-dc3360be389e"
      unitRef="usd">754000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzAtMy0xLTEtMTg4MTM_9ff24112-3dd3-4075-af16-7f151fbabdb9"
      unitRef="usd">907000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzUtMS0xLTEtMTg4MTM_5e9f81bf-9777-4539-83bb-3cd5954ce880"
      unitRef="usd">-754000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzUtMy0xLTEtMTg4MTM_7c9adad5-cbf7-412a-928e-fdccd3308a4a"
      unitRef="usd">-907000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <csbr:ProceedsFromExerciseOfOptionsAndWarrants
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzktMS0xLTEtMTg4MTM_717c6a01-ec8b-4cbe-8661-4b231da28938"
      unitRef="usd">0</csbr:ProceedsFromExerciseOfOptionsAndWarrants>
    <csbr:ProceedsFromExerciseOfOptionsAndWarrants
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfMzktMy0xLTEtMTg4MTM_35d50d61-51b4-44a3-abe1-10273cea64c5"
      unitRef="usd">2000</csbr:ProceedsFromExerciseOfOptionsAndWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDUtMS0xLTEtMTg4MTM_48cb7cde-51b5-42d0-a120-2c9eb31a141c"
      unitRef="usd">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDUtMy0xLTEtMTg4MTM_9164a351-abf8-4a80-9768-2bc9e7a99c47"
      unitRef="usd">2000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDctMS0xLTEtMTg4MTM_229356dc-a442-4a30-b35e-161c81b6db46"
      unitRef="usd">-949000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDctMy0xLTEtMTg4MTM_59be240c-2305-46ff-b189-8cae48b7d003"
      unitRef="usd">-689000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDgtMS0xLTEtMTg4MTM_07969cfa-1a1e-4b15-873b-3cfcb5dee347"
      unitRef="usd">9007000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iffa6bb1922094929b2d547692aefd75c_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNDgtMy0xLTEtMTg4MTM_a9a02016-1709-4048-962a-e657060459f7"
      unitRef="usd">4687000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNTAtMS0xLTEtMTg4MTM_d0393124-a390-42e0-98da-5920064db3c1"
      unitRef="usd">8058000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i12ebeded0a02450a9d446437bbbc576c_I20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8yOC9mcmFnOmZlYzFkMWYwYjQ1MjQ3YzBhNzA0NDY0YTc0MDg0NzRjL3RhYmxlOjljM2M4NGQ1OWVhYjRhOTZhMzJiOGU0YzY4NzQyNDAwL3RhYmxlcmFuZ2U6OWMzYzg0ZDU5ZWFiNGE5NmEzMmI4ZTRjNjg3NDI0MDBfNTAtMy0xLTEtMTg4MTM_05ba20b1-da0b-434b-98c7-f4144d2aba34"
      unitRef="usd">3998000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNC9mcmFnOjIxMzU0ZDNmNDUxNjRkNTI5OTA3YmZjYWE0YWZkMWZjL3RleHRyZWdpb246MjEzNTRkM2Y0NTE2NGQ1Mjk5MDdiZmNhYTRhZmQxZmNfNDE1MA_c149cb49-987b-44cb-a918-f28e288c7e19">Organization, Use of Estimates and Basis of Presentation&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Champions Oncology, Inc is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     The Company has three operating subsidiaries: Champions Oncology (Israel), Limited, Champions Biotechnology U.K., Limited, and Champions Oncology, S.R.L. (Italy). For the three months ended July 31, 2022 and 2021, there were no revenues earned by these subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s foreign subsidiaries functional currency is the U.S. dollar. Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company&#x2019;s international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC. All significant intercompany transactions and accounts have been eliminated. Certain information related to the Company&#x2019;s organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, or GAAP, has been condensed or omitted. The accounting policies followed in the preparation of these unaudited condensed consolidated financial statements are consistent with those followed in the Company&#x2019;s annual consolidated financial statements for the year ended April&#160;30, 2022, as filed on Form 10-K. In the opinion of management, these unaudited condensed consolidated financial statements contain all material adjustments necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the year ended April&#160;30, 2022. The results of operations for the interim periods are not necessarily indicative of the results of operations for a full fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <csbr:NumberOfOperatingSubsidiaries
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNC9mcmFnOjIxMzU0ZDNmNDUxNjRkNTI5OTA3YmZjYWE0YWZkMWZjL3RleHRyZWdpb246MjEzNTRkM2Y0NTE2NGQ1Mjk5MDdiZmNhYTRhZmQxZmNfMTk2MA_a6fb67dd-aa64-4789-8e13-b9d7de81ab14"
      unitRef="subsidiary">3</csbr:NumberOfOperatingSubsidiaries>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDI_4bbfbcdc-4c9e-46d7-ae9e-5c5494933080">Significant Accounting Policies &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only those investments which are highly liquid, readily convertible to cash, and with original maturities of three months or less to be cash equivalents. As of July&#160;31, 2022 and April 30, 2022 the Company had no cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our liquidity needs have typically arisen from the funding of our research and development programs and the launch of new products, working capital requirements, and other strategic initiatives. Recently, we have met these cash requirements through our cash on hand, working capital management, and sales of products and services. In the past, we have also received proceeds from certain private placements and public offerings of our securities. For the three months ended July&#160;31, 2022, the Company had a net loss of approximately $319,000 and cash used in operations of $195,000. As of July&#160;31, 2022, the Company had an accumulated deficit of approximately $72.3 million, working capital of $1.8 million and cash of $8.1 million. We believe that our cash on hand, together with expected net positive cash provided by operations for fiscal year 2023, are adequate to fund operations through at least 12 months from the filing of this 10-Q.  However, should our revenue expectations not materialize, we believe we have cost reduction strategies that could be implemented without disrupting the business or restructuring the Company. Should the Company be required to raise additional capital, there can be no assurance that management would be successful in raising such capital on terms acceptable to us, if at all.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its leases under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease, if applicable, or the Company&#x2019;s incremental borrowing rate. As the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line rent expense over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income or loss per share is computed by dividing the net income or loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. Such dilutive shares consist of incremental shares that would be issued upon exercise of the Company&#x2019;s common stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 31, 2022 and 2021, all of the Company's potential common stock is considered anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects the total potential share-based instruments outstanding at July&#160;31, 2022 and 2021 that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#160;&#160;&#160;&#160;Deferred income taxes have been provided to show the effect of temporary differences between the recognition of expenses for financial and income tax reporting purposes and between the tax basis of assets and liabilities, and their reported amounts in the consolidated financial statements.  In assessing the realizability of deferred tax assets, the Company assesses the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;likelihood that deferred tax assets will be recovered through tax planning strategies or from future taxable income, and to the extent that recovery is not likely or there is insufficient earnings history, a valuation allowance is established. The Company's ability to utilize net operating losses (&#x201c;NOL&#x201d;) carryforwards to offset future taxable income would be limited if the Company had undergone or were to undergo an &#x201c;ownership change&#x201d; within the meaning of Section 382 of the Internal Revenue Code (the &#x201c;IRC&#x201d;). The Company adjusts the valuation allowance in the period management determines it is more likely than not that deferred tax assets will or will not be realized.  Changes in valuation allowances from period to period are included in the tax provision in the period of change.  As of&#160;July&#160;31, 2022 and April&#160;30, 2022, the Company provided a valuation allowance for all net deferred tax assets, as recovery is not more likely than not based on an insufficient history of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:11.25pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reflects tax benefits only if it is more likely than not that the Company will be able to sustain the tax position, based on its technical merits.&#160;&#160;If a tax benefit meets this criterion, it is measured and recognized based on the largest amount of benefit that is cumulatively greater than 50% likely to be realized.&#160;&#160;The Company recorded $181,000 of liabilities related to uncertain tax positions relative to one of its foreign operations as of July&#160;31, 2022 and April&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company did not recognize interest or penalties on its consolidated statements of operations during the three-month periods ended July 31, 2022 and 2021. The Company does not anticipate unrecognized tax benefits will be recorded during the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes for the three months ended July 31, 2022 and 2021 was $17,000 and $14,000, respectively, mainly attributable to taxable income earned in Israel and/or Italy relating to transfer pricing. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The objective of the standard is to establish a single comprehensive revenue recognition model that is designed to create greater comparability of financial statements across industries and jurisdictions.  Under this standard, companies recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;      All revenue is generated from contracts with customers. The Company's arrangements are service type contracts that mainly have a duration of less than a year. The Company recognizes revenue when control of these services is transferred to the customer in an amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange for those services.  The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when, or as, the Company transfers control of the product or service for each performance obligation. The Company records revenues net of any tax assessments by governmental authorities, such as value added taxes, that are imposed on and concurrent with specific revenue generating transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     The majority of the Company's revenue arrangements are service contracts that are completed within a year or less. There are a few contracts that range in duration between 1 and 3 years. Substantially all of the Company's performance obligations, and associated revenue, are transferred to the customer over time. Most of the Company's contracts can be terminated by the customer without cause. In the event of termination, the Company's contracts provide that the customer pay the Company for services rendered through the termination date. The Company generally receives compensation based on a predetermined invoicing schedule relating to specific milestones for that contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     Amendments to contracts are common. The Company evaluates each amendment which meets the criteria of a contract modification under ASC 606. Each modification is further evaluated to determine whether the contract modification should be accounted for as a separate contract or as a continuation of the original agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     The Company accounts for amendments as a separate contract as they meet the criteria under ASC 606-10-25-12.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pharmacology Study and Other Services&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally enters into contracts with customers to provide oncology services with payments based on fixed-fee arrangements. At contract inception, the Company assesses the services promised in the contracts with customers to identify the performance obligations in the arrangement. The Company's fixed-fee arrangements for oncology services are considered a single performance obligation because the Company provides a highly-integrated service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue over time using a progress-based input method since there is no single output measure that would fairly depict the transfer of control over the life of the performance obligation. Revenue is recognized for the single performance obligation over time due to the Company's right to payment for work performed to date and the performance does not create an asset with an alternative use. The Company recognizes revenue as portions of the overall performance obligation are completed as this best depicts the progress of the performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incremental Costs of Obtaining a Contract (Sales Commissions)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;       Under ASC 606, the costs of obtaining a contract can be expensed immediately, rather than capitalized and amortized, if the amortization period is one year or shorter. Sales commissions for the Company represent contract costs with a term of one year or less. Therefore, under ASC 606, the Company elected the practical expedient to expense these costs as incurred.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some cases, contracts provide for variable consideration that is contingent upon the occurrence of uncertain future events, such as the success of the initial performance obligation. Variable consideration is estimated at the expected value or at the most likely amount depending on the type of consideration. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimate of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of its anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Receivables, Unbilled Services and Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, billings and payments are established by contractual provisions including predetermined payment schedules, which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. In general, the Company's intention in its invoicing (payment terms) is to maintain cash neutrality over the life of the contract. Upfront payments, when they occur, are intended to cover certain expenses the Company incurs at the beginning of the contract. Neither the Company nor its customers view such upfront payments and contracted payment schedules as a means of financing. Unbilled services primarily arise when the revenue recognized exceeds the amount billed to the customer. Such situations occur due to divergences between revenue recognition and the invoicing milestones which are based on predetermined payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of unearned payments received in excess of revenue recognized. As the contracted services are subsequently performed and the associated revenue is recognized, the deferred revenue balance is reduced by the amount of the revenue recognized during the period. Deferred revenue is classified as a current liability on the condensed consolidated balance sheet as the Company expects to recognize the associated revenue in less than one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Being Evaluated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, "Financial Instruments - Credit Losses".  This update requires immediate recognition of management&#x2019;s estimates of current expected credit losses ("CECL").  Under the prior model, losses were recognized only as they were incurred.  The new model is applicable to all financial instruments that are not accounted for at fair value through net income.  The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies.  Early adoption is permitted.   The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MTU_ba154dbd-8d1d-49c4-a0c6-9767d5f4002f">Cash and Cash EquivalentsThe Company considers only those investments which are highly liquid, readily convertible to cash, and with original maturities of three months or less to be cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjk0_30ebaa08-4c4c-4923-99a3-97a1a4678237"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjk0_5d176159-ac47-4730-b981-be3d97ca7edf"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:NetIncomeLoss
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfODE1_dfbf829a-6ecb-4910-9e51-78f8dc5a8366"
      unitRef="usd">-319000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfODUz_df847133-9251-4681-baae-40b0cfc45db8"
      unitRef="usd">-195000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfOTIz_6ed93604-b766-46f1-92de-4c66f537b341"
      unitRef="usd">-72300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <csbr:WorkingCapitalDeficit
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfOTQ2_a73fe660-d9e8-449b-8049-261850178b39"
      unitRef="usd">1800000</csbr:WorkingCapitalDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfOTYx_acbcecba-2225-4d97-8a19-408a0307f620"
      unitRef="usd">8100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTMzOTg_8e970e6e-f548-44d0-bd37-958ed12c6069">LeasesThe Company accounts for its leases under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease, if applicable, or the Company&#x2019;s incremental borrowing rate. As the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line rent expense over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDk_49d30e93-08bf-4f96-aa3c-6b663a0a6d22">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;Basic net income or loss per share is computed by dividing the net income or loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. Such dilutive shares consist of incremental shares that would be issued upon exercise of the Company&#x2019;s common stock options.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDQ_04d64c5b-3a26-419d-9442-0eb0a01c54ce">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects the total potential share-based instruments outstanding at July&#160;31, 2022 and 2021 that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RhYmxlOjM0ZTU0YjQzOWZhMzRiZDI5YTVmZDNjY2IyNDJiMWM3L3RhYmxlcmFuZ2U6MzRlNTRiNDM5ZmEzNGJkMjlhNWZkM2NjYjI0MmIxYzdfNS0xLTEtMS0xODgxMw_49b530fc-459f-47ad-952b-9b4d6dfe71ee"
      unitRef="shares">1722155</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RhYmxlOjM0ZTU0YjQzOWZhMzRiZDI5YTVmZDNjY2IyNDJiMWM3L3RhYmxlcmFuZ2U6MzRlNTRiNDM5ZmEzNGJkMjlhNWZkM2NjYjI0MmIxYzdfNS0zLTEtMS0xODgxMw_b41ba699-c390-4c9f-a28e-5fef47f10b83"
      unitRef="shares">1734428</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MTM_20fad32b-20cc-4fed-b998-5d07ab5a355c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#160;&#160;&#160;&#160;Deferred income taxes have been provided to show the effect of temporary differences between the recognition of expenses for financial and income tax reporting purposes and between the tax basis of assets and liabilities, and their reported amounts in the consolidated financial statements.  In assessing the realizability of deferred tax assets, the Company assesses the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;likelihood that deferred tax assets will be recovered through tax planning strategies or from future taxable income, and to the extent that recovery is not likely or there is insufficient earnings history, a valuation allowance is established. The Company's ability to utilize net operating losses (&#x201c;NOL&#x201d;) carryforwards to offset future taxable income would be limited if the Company had undergone or were to undergo an &#x201c;ownership change&#x201d; within the meaning of Section 382 of the Internal Revenue Code (the &#x201c;IRC&#x201d;). The Company adjusts the valuation allowance in the period management determines it is more likely than not that deferred tax assets will or will not be realized.  Changes in valuation allowances from period to period are included in the tax provision in the period of change.  As of&#160;July&#160;31, 2022 and April&#160;30, 2022, the Company provided a valuation allowance for all net deferred tax assets, as recovery is not more likely than not based on an insufficient history of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:11.25pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reflects tax benefits only if it is more likely than not that the Company will be able to sustain the tax position, based on its technical merits.&#160;&#160;If a tax benefit meets this criterion, it is measured and recognized based on the largest amount of benefit that is cumulatively greater than 50% likely to be realized.&#160;&#160;The Company recorded $181,000 of liabilities related to uncertain tax positions relative to one of its foreign operations as of July&#160;31, 2022 and April&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company did not recognize interest or penalties on its consolidated statements of operations during the three-month periods ended July 31, 2022 and 2021. The Company does not anticipate unrecognized tax benefits will be recorded during the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNTY4Mw_9e835435-a74c-434c-a050-ef9c22a9401e"
      unitRef="usd">181000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNTY4Mw_c024fcae-ff57-4a04-9db7-4a96314cf006"
      unitRef="usd">181000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjA1Ng_5c871b9d-30af-49cd-a971-b77c308ff598"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjA1Ng_79a28594-0040-4121-ad35-24a2638ee78e"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjIxNQ_b4a6d6f2-73cb-43a2-9057-8cd29268cf61"
      unitRef="usd">0</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjM1NQ_f94be35d-a380-4f98-9e75-2c95bcdf53da"
      unitRef="usd">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfNjM2Mg_0c54d1b0-2c60-499d-8774-315cdcfa14d0"
      unitRef="usd">14000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MTQ_0a85f1ec-7d70-486e-98f1-59747cc15310">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The objective of the standard is to establish a single comprehensive revenue recognition model that is designed to create greater comparability of financial statements across industries and jurisdictions.  Under this standard, companies recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;      All revenue is generated from contracts with customers. The Company's arrangements are service type contracts that mainly have a duration of less than a year. The Company recognizes revenue when control of these services is transferred to the customer in an amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange for those services.  The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when, or as, the Company transfers control of the product or service for each performance obligation. The Company records revenues net of any tax assessments by governmental authorities, such as value added taxes, that are imposed on and concurrent with specific revenue generating transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     The majority of the Company's revenue arrangements are service contracts that are completed within a year or less. There are a few contracts that range in duration between 1 and 3 years. Substantially all of the Company's performance obligations, and associated revenue, are transferred to the customer over time. Most of the Company's contracts can be terminated by the customer without cause. In the event of termination, the Company's contracts provide that the customer pay the Company for services rendered through the termination date. The Company generally receives compensation based on a predetermined invoicing schedule relating to specific milestones for that contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     Amendments to contracts are common. The Company evaluates each amendment which meets the criteria of a contract modification under ASC 606. Each modification is further evaluated to determine whether the contract modification should be accounted for as a separate contract or as a continuation of the original agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     The Company accounts for amendments as a separate contract as they meet the criteria under ASC 606-10-25-12.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pharmacology Study and Other Services&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally enters into contracts with customers to provide oncology services with payments based on fixed-fee arrangements. At contract inception, the Company assesses the services promised in the contracts with customers to identify the performance obligations in the arrangement. The Company's fixed-fee arrangements for oncology services are considered a single performance obligation because the Company provides a highly-integrated service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue over time using a progress-based input method since there is no single output measure that would fairly depict the transfer of control over the life of the performance obligation. Revenue is recognized for the single performance obligation over time due to the Company's right to payment for work performed to date and the performance does not create an asset with an alternative use. The Company recognizes revenue as portions of the overall performance obligation are completed as this best depicts the progress of the performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incremental Costs of Obtaining a Contract (Sales Commissions)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;       Under ASC 606, the costs of obtaining a contract can be expensed immediately, rather than capitalized and amortized, if the amortization period is one year or shorter. Sales commissions for the Company represent contract costs with a term of one year or less. Therefore, under ASC 606, the Company elected the practical expedient to expense these costs as incurred.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some cases, contracts provide for variable consideration that is contingent upon the occurrence of uncertain future events, such as the success of the initial performance obligation. Variable consideration is estimated at the expected value or at the most likely amount depending on the type of consideration. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimate of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of its anticipated performance and all information (historical, current and forecasted) that is reasonably available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Receivables, Unbilled Services and Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, billings and payments are established by contractual provisions including predetermined payment schedules, which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. In general, the Company's intention in its invoicing (payment terms) is to maintain cash neutrality over the life of the contract. Upfront payments, when they occur, are intended to cover certain expenses the Company incurs at the beginning of the contract. Neither the Company nor its customers view such upfront payments and contracted payment schedules as a means of financing. Unbilled services primarily arise when the revenue recognized exceeds the amount billed to the customer. Such situations occur due to divergences between revenue recognition and the invoicing milestones which are based on predetermined payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of unearned payments received in excess of revenue recognized. As the contracted services are subsequently performed and the associated revenue is recognized, the deferred revenue balance is reduced by the amount of the revenue recognized during the period. Deferred revenue is classified as a current liability on the condensed consolidated balance sheet as the Company expects to recognize the associated revenue in less than one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6eca0785cd844297b787bca9c17b7117_I20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjE5OTAyMzI3MjM3MQ_a0d1618b-4439-4a44-a352-a01fdca49248">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ie70d8f70a5944b69be752032e3c823a4_I20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMjE5OTAyMzI3MjM3NQ_34549f65-16df-420c-8ec8-b0f924f7eb1c">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV8zNy9mcmFnOmVjZTVlMzk3Yjg4ZTQ2MzQ4YjEwOWYxYjMxMTcwNDQ4L3RleHRyZWdpb246ZWNlNWUzOTdiODhlNDYzNDhiMTA5ZjFiMzExNzA0NDhfMTM0MDc_d6ebf3f8-b24b-427b-924b-6e38540b6c20">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Being Evaluated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, "Financial Instruments - Credit Losses".  This update requires immediate recognition of management&#x2019;s estimates of current expected credit losses ("CECL").  Under the prior model, losses were recognized only as they were incurred.  The new model is applicable to all financial instruments that are not accounted for at fair value through net income.  The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies.  Early adoption is permitted.   The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RleHRyZWdpb246ZDA2N2JjMWFlYTcxNDhkZjk1OTEzZWNiODA2OTE2YzNfMzE2_20087b8f-5653-4fbe-863e-5768f628bdf5">Accounts Receivable, Unbilled Services and Deferred Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled services were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable and unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred revenue was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue is shown as a current liability on the Company's condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RleHRyZWdpb246ZDA2N2JjMWFlYTcxNDhkZjk1OTEzZWNiODA2OTE2YzNfMzE4_a0d0bed4-cad2-4ad8-bccc-79ebda4fd9a6">Accounts receivable and unbilled services were as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable and unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMS0xLTEtMS0xODgxMw_310aa7ea-318a-4a01-9c9a-67558b8ef9b8"
      unitRef="usd">5619000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMS0zLTEtMS0xODgxMw_d274830c-5cbb-4922-8a9d-8845047c5307"
      unitRef="usd">6037000</us-gaap:AccountsReceivableGross>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMi0xLTEtMS0xODgxMw_44d5a84d-d340-4f05-bfd3-791820f6ca27"
      unitRef="usd">4366000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMi0zLTEtMS0xODgxMw_15362270-3b4f-461b-8fe9-13209e35b0e5"
      unitRef="usd">4106000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMy0xLTEtMS0xODgxMw_15e74baf-54bc-46e9-9d21-ef5707e070eb"
      unitRef="usd">9985000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfMy0zLTEtMS0xODgxMw_a5c946c7-3b7b-4068-b5e1-683bc412be1d"
      unitRef="usd">10143000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNC0xLTEtMS0xODgxMw_81a0248d-1216-4aac-816e-52c86204eb02"
      unitRef="usd">630000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNC0zLTEtMS0xODgxMw_202473de-68b7-48e7-8ada-b11a1376598b"
      unitRef="usd">630000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNS0xLTEtMS0xODgxMw_b10c2e46-5e75-486f-aab5-fa9ad0e9a451"
      unitRef="usd">9355000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjBmMzhjNTRhNmI0NTQxNTFiOGEyYTY3MGNlZWYxNjE0L3RhYmxlcmFuZ2U6MGYzOGM1NGE2YjQ1NDE1MWI4YTJhNjcwY2VlZjE2MTRfNS0zLTEtMS0xODgxMw_da2a21f3-1f9b-4320-b1f6-a82caefdeffe"
      unitRef="usd">9513000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RleHRyZWdpb246ZDA2N2JjMWFlYTcxNDhkZjk1OTEzZWNiODA2OTE2YzNfMzE1_25fff69c-499d-46ee-aa9e-d42bf9360db6">Deferred revenue was as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjQ2ZjNhMjNmYzU3ZDQ0NTNiZDYzMGNiMmZlMmMzMTJmL3RhYmxlcmFuZ2U6NDZmM2EyM2ZjNTdkNDQ1M2JkNjMwY2IyZmUyYzMxMmZfMS0xLTEtMS0xODgxMw_240261d4-0538-4246-b7f2-e84ef9fdbb15"
      unitRef="usd">10885000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80MC9mcmFnOmQwNjdiYzFhZWE3MTQ4ZGY5NTkxM2VjYjgwNjkxNmMzL3RhYmxlOjQ2ZjNhMjNmYzU3ZDQ0NTNiZDYzMGNiMmZlMmMzMTJmL3RhYmxlcmFuZ2U6NDZmM2EyM2ZjNTdkNDQ1M2JkNjMwY2IyZmUyYzMxMmZfMS0zLTEtMS0xODgxMw_920202f7-dbee-467c-9333-4bc853dc4788"
      unitRef="usd">11071000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RleHRyZWdpb246Njg1NzBjZjJkMmI2NDY3NGI2ZjNhMDdiYTNiZjJkNTVfMzEzMg_592b6863-ac3c-49d9-828c-569e02efb6b3">Revenue from Contracts with Customers&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Oncology Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables represents disaggregated revenue for the three months ended July 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacology services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other TOS revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personalized oncology services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total oncology services revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other TOS revenue represents additional services provided to the Company's pharmaceutical and biotechnology customers, specifically flow cytometry services and SaaS provided via our Lumin Bioinformatics software ("Lumin").&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;Contract assets include unbilled amounts typically resulting from revenue recognized in excess of the amounts billed to the customer for which the right to payment is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are classified as current. Contract liabilities consist of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period. Contract assets and liabilities are presented on the balance sheet on a net contract-by-contract basis at the end of each reporting period.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RleHRyZWdpb246Njg1NzBjZjJkMmI2NDY3NGI2ZjNhMDdiYTNiZjJkNTVfMzEzNg_03e234a9-0619-4dac-9ebe-11885ee3aec1">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables represents disaggregated revenue for the three months ended July 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacology services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other TOS revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personalized oncology services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total oncology services revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91fabe7ea07840b0ad07eea382c68f2c_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMi0xLTEtMS0xODgxMw_14a6075f-db56-4c45-8113-545768246603"
      unitRef="usd">12756000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia438aed8edee4499a8c76234ae8091b1_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMi0zLTEtMS0xODgxMw_bbf042b6-7019-4a39-93ed-6c809a9a0d21"
      unitRef="usd">10703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98127e2a2ada454e83135bf30e7094f4_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMy0xLTEtMS0xODgxMw_14f54c4c-b8a5-47eb-8014-5b86961c4ebe"
      unitRef="usd">948000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f5707fdf6d74465854a45083439a864_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfMy0zLTEtMS0xODgxMw_9279008b-410b-4b00-922d-1271b37ae498"
      unitRef="usd">526000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0cd432221fb46c5b2ff6c3f14dae6c0_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNC0xLTEtMS0xODgxMw_bfb5a387-0f5d-47af-aaa1-8967a80c513a"
      unitRef="usd">41000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7484f64f1cd4b20ba501dd09db89691_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNC0zLTEtMS0xODgxMw_c1d31b4d-e0bf-4788-8d68-f88b726f87fa"
      unitRef="usd">24000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNS0xLTEtMS0xODgxMw_0ea7f1b0-feff-4e6a-9b31-9985a2e0d78d"
      unitRef="usd">13745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80My9mcmFnOjY4NTcwY2YyZDJiNjQ2NzRiNmYzYTA3YmEzYmYyZDU1L3RhYmxlOjJhZWY0YjhhZjg0MTRlY2RiOWFmZDdmOWYzMWQyNWY1L3RhYmxlcmFuZ2U6MmFlZjRiOGFmODQxNGVjZGI5YWZkN2Y5ZjMxZDI1ZjVfNS0zLTEtMS0xODgxMw_3fd14d05-2bf4-4b88-8476-fc6332b815f4"
      unitRef="usd">11253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTMyMg_e25e043f-8eb3-4667-b4e0-70b080b28e2a">Property and Equipment&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is recorded at cost and primarily consists of laboratory equipment, computer equipment and software, capitalized software development costs, and furniture and fixtures. Depreciation and amortization is calculated on a straight-line basis over the estimated useful lives of the various assets ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzI3_71ed8872-0f98-4a2c-950c-1fa4fcc01343"&gt;three&lt;/span&gt; to nine years. Property and equipment consisted of the following (table in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense was $528,000 and $317,000 for the three months ended July 31, 2022 and 2021, respectively. Depreciation and amortization expense, excluding expense recorded under finances leases, was $499,000 and $317,000 for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July&#160;31, 2022 and April&#160;30, 2022, property, plant and equipment included gross assets held under finance leases of $1,081,000 and $713,000, respectively. Related depreciation expense was approximately $29,000 and $0 for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized software development costs under a hosting arrangement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for the cost of computer software obtained or developed for internal use as well as the software development and implementation costs associated with a hosting arrangement ("internal-use software") that is a service contract in accordance and with ASC 350, Intangibles - Goodwill and Other ("ASC-350"). We capitalize certain costs in the development of our internal-use software when the preliminary project stage is completed and it is probable that the project itself will be completed and the software will perform as intended. These capitalized costs include personnel and related expenses for employees and costs of third-party consultants who are directly associated with and who devote time to these internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended purpose. Costs incurred for significant upgrades, increased functionality, and enhancements to the Company's internal-use software solutions are also capitalized. Costs incurred for training, maintenance, and minor modifications are expensed as incurred. Capitalized software development costs are amortized using the straight-line method over an estimated useful economic life of three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has capitalized development and implementation costs in accordance with accounting guidance for its Lumin platform. Lumin is the Company's oncology data-driven software program and data tool which operates as Software as a Service. These capitalized costs represent salaries, including direct payroll-related costs, certain software development consultant expenses and molecular sequencing programming costs incurred in the engineering and coding of the software development. Capitalized costs are classified as assets in progress during the development process until development is complete and the asset is available for sale. The initial version of the Lumin platform was launched during fiscal year 2021, at which time initial capitalization ceased and amortization commenced. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continued to develop increased functionality, expand product design and usability, and add enhancements to the Lumin platform. In accordance with accounting guidance, these costs were capitalized. This developmental work did not render the initial released version to be obsolete or diminished in value but, rather, added to the base functionality of the existing platform. During the third quarter of fiscal year 2022, these capitalized costs were placed into service as the enhanced version was launched and made available for sale. The total cost of the Lumin asset placed into service and available for sale was $1.9&#160;million. As of July&#160;31, 2022, the carrying value of the asset net of accumulated amortization was $1.3&#160;million. Amortization expense related to this asset was $157,000 and $40,000 for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year 2022, the Company recognized a finance lease for laboratory equipment. This equipment was obtained as the result of a laboratory supplies purchase commitment with costs of approximately $370,000 at inception through December 2025. Cash payments for this lease are in the form of consideration for purchasing lab supplies under a purchase commitment agreement. At the commencement of the commitment, the present value of the minimum future obligations of $370,000 was calculated based on an interest rate of 3.25%. Depreciation and amortization expense related to this finance lease was $18,000 and zero for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal year 2023, the Company recognized a finance lease for laboratory equipment. This equipment was obtained as the result of a laboratory supplies purchase commitment with costs of approximately $368,000 at inception through June 2027. Cash payments for this lease are in the form of consideration for purchasing lab supplies under a purchase commitment agreement. The present value of the minimum future obligations of $368,000 was calculated based on an interest rate of 3.5%. Depreciation and amortization expense related to this finance lease was $11,250 and zero for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMzMz_f9d6074e-5c21-4823-88c2-8668a40dcb2a">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTMxOQ_a28cb09a-c31d-4cd6-a372-4517f5c0d77f">Property and equipment consisted of the following (table in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_099c344f-8a57-410b-a972-10749c4bcf0a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMC0xLTEtMTg4MTM_dae58af9-7839-44aa-bf9d-c508b491f233"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia612a5a694ed4a2aab99e2c1b7c1e7b9_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMS0xLTEtMS0xODgxMw_26c9f620-cf46-48bf-b1f3-8fba852a5860"
      unitRef="usd">246000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1b2bd8d2bae64d3a8a1229b5763b483f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMS0zLTEtMS0xODgxMw_93b7742c-dce6-4c7b-a1be-a1cd191a0aeb"
      unitRef="usd">246000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i99022b6aeb5849f68381125e8cdb97ea_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMi0xLTEtMS0xODgxMw_8bf7024e-1942-422e-af87-b91a792ee61a"
      unitRef="usd">1953000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i11effbe8666d492bb6247738f880f0a4_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMi0zLTEtMS0xODgxMw_c3578cc2-0379-445b-8ea0-95fae876bfbf"
      unitRef="usd">1667000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6b5212cdfd144c8188adcfed3bf2b746_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMy0xLTEtMS0xODgxMw_3af0cbca-a22b-466f-8f98-a2b6bac26dae"
      unitRef="usd">1888000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ee763a8872248559a69477fb7ba51ef_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMy0zLTEtMS0xODgxMw_65943223-9579-4435-9053-017aebd891af"
      unitRef="usd">1888000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7470cfb3a4e24c169da0a95c73f21990_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNC0xLTEtMS0xODgxMw_b6f8cc72-c258-4dbe-82dc-e675382f42b3"
      unitRef="usd">9073000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iba47105892b84c23a2e865ef51894ed5_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNC0zLTEtMS0xODgxMw_86215522-32bc-4e3d-8ac7-cd99c8886f8a"
      unitRef="usd">8618000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib57b0077fa424cfa9994c70df2820ec2_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNS0xLTEtMS0xODgxMw_88eda126-2c21-4bf9-b755-1961ec65107b"
      unitRef="usd">532000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id7446b75d7234b01989cb3824d3109aa_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNS0zLTEtMS0xODgxMw_ce2d4206-93e5-4ade-8b2c-893b5513331b"
      unitRef="usd">181000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic7b897b038814dab831bf20fd743486c_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNi0xLTEtMS0xODgxMw_f0a45050-2cc5-467e-bbe3-c454e7e73b28"
      unitRef="usd">111000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id123ab3740ed4938a93cc09d1793ca01_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfNi0zLTEtMS0xODgxMw_beeb9d93-7645-4dd0-81ca-a909ea0819e0"
      unitRef="usd">111000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOC0xLTEtMS0xODgxMw_96991f6d-1039-4588-9a2d-1ca35b2e897a"
      unitRef="usd">13803000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOC0zLTEtMS0xODgxMw_39ecd58a-191d-415d-a411-e4da1a3aeb05"
      unitRef="usd">12711000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOS0xLTEtMS0xODgxMw_06138550-3fc3-4c2f-8a7a-38339f876c22"
      unitRef="usd">6105000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfOS0zLTEtMS0xODgxMw_cc4c7596-7a7f-4e45-b290-c0e661c2b467"
      unitRef="usd">5577000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMS0xLTEtMTg4MTM_5afda43b-f8f8-4ffa-8f3e-ff6b507b8365"
      unitRef="usd">7698000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RhYmxlOjU4NWM2ODM0YTBhNDRmZDdhYWZmZDllMjlkMDQ4YmZiL3RhYmxlcmFuZ2U6NTg1YzY4MzRhMGE0NGZkN2FhZmZkOWUyOWQwNDhiZmJfMTEtMy0xLTEtMTg4MTM_b8fbabf9-95f1-4e70-9e85-eab2fa526b6d"
      unitRef="usd">7134000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTEw_9c22f49b-3d49-4dc8-8f13-f7c19be6818d"
      unitRef="usd">528000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i12ebeded0a02450a9d446437bbbc576c_I20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTE3_81bac4f4-c851-4b4a-a2f7-1b668cdc6810"
      unitRef="usd">317000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMDY1OQ_eeabdbfa-d439-4f17-84b7-c6128189537e"
      unitRef="usd">499000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMDY2OA_4f408684-262b-4249-b882-621f09556c25"
      unitRef="usd">317000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNjU4_00cfbdef-b56d-43c9-aa11-c44400d526ae"
      unitRef="usd">1081000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTg2MQ_ef2f9962-68d9-4897-baae-a6f97471a693"
      unitRef="usd">713000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <csbr:FinanceLeaseDepreciationAndAmortizationExpenses
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNzA5_4cb4bab1-1534-4c1c-ab97-9ee44967cfed"
      unitRef="usd">29000</csbr:FinanceLeaseDepreciationAndAmortizationExpenses>
    <csbr:FinanceLeaseDepreciationAndAmortizationExpenses
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNzE2_669641d1-01fe-4ae9-9bbb-d3cea5ecb33d"
      unitRef="usd">0</csbr:FinanceLeaseDepreciationAndAmortizationExpenses>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6dfc15decd0849a7ba09ebc4e674af89_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMjA5MA_50ad1c6c-2e63-4662-af02-177d0fd5865b">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ServicingAsset
      contextRef="ibc1695cc594a4e7cad70f212f82cb391_I20220131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTgyMg_e9120e9d-5a3e-4bff-b394-79bebd9c5e86"
      unitRef="usd">1900000</us-gaap:ServicingAsset>
    <us-gaap:ServicingAssetAtAmortizedValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNTQ5NzU1ODI2NzQy_90daa031-b6b2-4d65-b17e-a38ba1e3e262"
      unitRef="usd">1300000</us-gaap:ServicingAssetAtAmortizedValue>
    <us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMzczMA_b19f0d40-256a-4185-8042-60eff0c88a36"
      unitRef="usd">157000</us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzMzc0MQ_9fd090d2-c61c-4dbc-8b80-5621f88b0806"
      unitRef="usd">40000</us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization>
    <csbr:FinanceLeaseCost
      contextRef="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc3Mg_ee0e6733-3558-43fd-b45f-0e98da1f4f65"
      unitRef="usd">370000</csbr:FinanceLeaseCost>
    <csbr:FinanceLeaseCost
      contextRef="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc2Mg_903ddc57-f888-4310-9156-a594c7a1beb4"
      unitRef="usd">370000</csbr:FinanceLeaseCost>
    <csbr:PresentValueMinimumFutureObligationsInterestRate
      contextRef="i59309deaf04948b9952be42efe20ca6a_D20210501-20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc1NQ_59fc5895-bf6d-4e84-b524-d6f5b2a5875c"
      unitRef="number">0.0325</csbr:PresentValueMinimumFutureObligationsInterestRate>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i9b610a04f8314e00a08a6a9b91c33292_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfNDk0NzgwMjMzNjU2Nw_a90c29b9-d580-4531-b5b0-da9f1dd244c8"
      unitRef="usd">18000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id7396db6674049dd925725f824b27e50_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc1Mw_0f7e180a-f5a2-4810-ad6d-2e30473129d7"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <csbr:FinanceLeaseCost
      contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTc0NA_92c6ebf5-5caa-4212-832d-d72273ef9544"
      unitRef="usd">368000</csbr:FinanceLeaseCost>
    <csbr:FinanceLeaseCost
      contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTczNA_25f69b4d-2226-424c-9e05-ce24617fa7f7"
      unitRef="usd">368000</csbr:FinanceLeaseCost>
    <csbr:PresentValueMinimumFutureObligationsInterestRate
      contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTcyOA_5d8753a8-b006-4e32-b304-cf5357678c2b"
      unitRef="number">0.035</csbr:PresentValueMinimumFutureObligationsInterestRate>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id1484475bbaf40b7bdccdf9f53235ca0_D20220501-20220731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTgxMQ_2e6c8699-b44a-4d1a-9d8a-9a4895f70f7f"
      unitRef="usd">11250</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id42bfc0d6ba246b783fdd25ce27859cb_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80Ni9mcmFnOjc3MDE2NDhiZDZiNzQwYjY5Mzc3ZjMxOWU0MmVmZDI4L3RleHRyZWdpb246NzcwMTY0OGJkNmI3NDBiNjkzNzdmMzE5ZTQyZWZkMjhfMTA5OTUxMTYzOTcyNg_dfd72023-bc83-439a-8a58-014471c13862"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1OQ_ecaf7f2e-613b-4c22-8cbe-639eee9f61da">Share-Based Payments&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was recognized as follows (table in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.011%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.749%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of oncology services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has in place a 2021 Equity Incentive Plan and 2010 Equity Incentive Plan ("the Plans"). In general, these plans provide for stock-based compensation to the Company&#x2019;s employees, directors and non-employees. The plans also provide for limits on the aggregate number of shares that may be granted, the term of grants and the strike price of option awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the 2021 Annual Shareholders Meeting, shareholders approved the adoption of the 2021 Equity Incentive Plan (&#x201c;2021 Equity Plan&#x201d;). The purpose of the 2021 Equity Plan is to grant (i) Non-statutory Stock Options; (ii) Incentive Stock Options; (iii) Restricted Stock Awards; and/or (iv) Stock Appreciation Rights (collectively, stock-based compensation) to its employees, directors and non-employees. Total stock awards under the 2021 Equity Plan shall not exceed 2&#160;million shares of common stock. Options and Stock Appreciation Rights expire no later than ten years from the date of grant and the awards vest as determined by the Board of Directors. Options and Stock Appreciation Rights have a strike price not less than 100% of the fair market value of the common stock subject to the option or right at the date of grant. As of July&#160;31, 2022, approximately 1.7&#160;million shares were left to issue under this plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2010 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 18, 2011, shareholders owning a majority of the issued and outstanding shares of the Company executed a written consent approving the 2010 Equity Incentive Plan (&#x201c;2010 Equity Plan&#x201d;). The purpose of the 2010 Equity Plan is to grant (i) Non-statutory Stock Options; (ii) Restricted Stock Awards; and (iii) Stock Appreciation Rights (collectively, stock-based compensation) to its employees, directors and non-employees. Total stock awards under the 2010 Equity Plan shall not exceed 30 million shares of common stock. Options and Stock Appreciation Rights expire no later than ten years from the date of grant and the awards vest as determined by the Board of Directors. Options and Stock Appreciation Rights have a strike price not less than 100% of the fair market value of the common stock subject to the option or right at the date of grant. After February 2021, no more shares were available to be issued from this plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Option Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.192%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.87%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.82%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.58%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.94% - 66.21%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of stock options granted during the three months ended July 31, 2022 and 2021 was $4.50 and $5.33, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock options activity for the three months ended July 31, 2022 was a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.904%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Directors&lt;br/&gt;and&lt;br/&gt;Employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-&lt;br/&gt;Employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,131,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,462,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,462,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,846,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1MQ_6464855f-7bdb-4cc8-a24d-8e134f227864">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was recognized as follows (table in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.011%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.749%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of oncology services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4ca13514049f49afa46dab0656a44d2a_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMi0xLTEtMS0xODgxMw_1e14b17d-b344-488f-9383-5b77fb3addfd"
      unitRef="usd">123000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3bab8e5b86cc43df8e6b97165cdc5f3c_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMi0zLTEtMS0xODgxMw_6b20d405-0413-41fc-bf2c-3a2d21b50067"
      unitRef="usd">171000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia3752fc3c3d8408694ab9b64622ad170_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMy0xLTEtMS0xODgxMw_fb785f99-9bd3-42d4-81cf-0a6947e8c619"
      unitRef="usd">48000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5753fa1a19a74139a0f74c566b7aa853_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfMy0zLTEtMS0xODgxMw_ad8d690a-445e-418c-93fe-b86c7058cc1b"
      unitRef="usd">51000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia8e1fd8a290f4d44b5e8552f71eede35_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNC0xLTEtMS0xODgxMw_ca7ab1ff-f7d8-4f68-8201-79dfe14af3aa"
      unitRef="usd">3000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i51dcfb3a899c4a8e813069354ef8efcd_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNC0zLTEtMS0xODgxMw_d4239d2e-939e-4262-a53e-538a0abe9a8d"
      unitRef="usd">6000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifb0d823f162b4a5193235bd46686af4b_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNS0xLTEtMS0xODgxMw_c13768a8-f2d4-492e-a222-a734fd66e2fe"
      unitRef="usd">32000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if3f6897bc8834b8f904bba44f16469a8_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNS0zLTEtMS0xODgxMw_65bcc66b-cfe1-4051-a938-8958d8a65345"
      unitRef="usd">52000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNi0xLTEtMS0xODgxMw_5c26faca-a967-4224-bb95-5b5c05583700"
      unitRef="usd">206000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmUyNTk4OWZmOTEwZDQzNWI5YTMwNDdjMWQ5MGI1YzY4L3RhYmxlcmFuZ2U6ZTI1OTg5ZmY5MTBkNDM1YjlhMzA0N2MxZDkwYjVjNjhfNi0zLTEtMS0xODgxMw_77893e46-2156-4e98-a7f9-af3b1fe692db"
      unitRef="usd">280000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4ac79db879ea4f6eb1f558ff7ea89f1d_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0Mjg5OA_0571aa4f-5273-467a-847a-5fdac699ddae"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i45d9fcd2385f4e39a7cbdd2d532819d7_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkwOA_a2b79001-cf6f-47ff-b263-dbe3010df7ab">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i45d9fcd2385f4e39a7cbdd2d532819d7_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkxMA_2b0ea322-1238-41e5-b28f-14355d68cae3"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i0ce03b4537c94cf7b7799c4e749ac6bc_I20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkxNg_1c31a694-ac08-467f-8023-100c2c812422"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i080c253670fa426ea429272a7273cf12_D20110218-20110218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0MjkyOQ_b3a3e423-19b1-4801-8e31-9163c3e762be"
      unitRef="shares">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i86bc626a809147259f5f564000ed6a2d_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0Mjk0MA_24ff7cf1-fcdc-4b7e-ac2f-e019ef71ef98">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i86bc626a809147259f5f564000ed6a2d_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA5OTUxMTY0Mjk0Mg_e826adb7-fa27-41a8-a6c8-c71ddef8c0cf"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1Mg_995d0a05-a874-4f0c-84e5-0da391777b1b">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.192%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;July 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.87%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.82%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.58%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.94% - 66.21%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMi0xLTEtMS0xODgxMy90ZXh0cmVnaW9uOmMxYjM4NDQzOGVhNDQzN2NhYmM0MjZkMzI0ZmI4Y2ZiXzQ_f302694d-7bd6-42ff-a3b1-c43dae2a5d45">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMi0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOmIwNzc5NGE4NTMyNjQ0ZDJiMzA3ZGQ3NzNiZGExOTYzXzU0OTc1NTgxMzg4ODY_f775e16d-8a93-43f4-9fad-7313dd8d8159">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMy0xLTEtMS0xODgxMy90ZXh0cmVnaW9uOjFjYjUxYjhhMTZmNTQ2ZmZiZDgwZjM5ZWQ0Yjk5ZWQ2XzQ_d3a4a2a7-2e3a-4598-95b5-017ce92eca02"
      unitRef="number">0.0287</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfMy0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOjczOWYxN2VkYmU5YTRmZGZiY2Q3ZjFkMjhlNmQzODdkXzQ_8179ea08-d121-459a-8c4d-4a75643211a0"
      unitRef="number">0.0082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNC0xLTEtMS0xODgxMy90ZXh0cmVnaW9uOmUxZjU5ZTQ2MGFiNTQwZDM4NWRlZjc2YmI1MTg0MzYxXzQ_52ccfc61-08a0-43ab-b6d7-2a90f869c201"
      unitRef="number">0.6258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNC0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOmFjZDZlNTM5ODhmZTRiZWM5YjhlMzBiNDhiOTk4YjBmXzQ_6085c2e2-4403-491f-9179-7d8b449661a7"
      unitRef="number">0.6594</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNC0zLTEtMS0xODgxMy90ZXh0cmVnaW9uOmFjZDZlNTM5ODhmZTRiZWM5YjhlMzBiNDhiOTk4YjBmXzU0OTc1NTgxMzg4ODk_6d585173-7840-46b0-9e9f-0619759f7d75"
      unitRef="number">0.6621</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNS0xLTEtMS0xODgxMw_70588a4e-00fb-4828-8e61-0d5a318e6ef9"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOmRlNTYxMDI1YTExYzRiNTc4M2FkMDg1MGM0N2UxYzVhL3RhYmxlcmFuZ2U6ZGU1NjEwMjVhMTFjNGI1NzgzYWQwODUwYzQ3ZTFjNWFfNS0zLTEtMS0xODgxMw_c23f5c6e-f4f2-476a-984d-b428e1af598f"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfOTQ2_578a39c0-c781-4246-a487-39f642d7e1f9"
      unitRef="usdPerShare">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfOTUz_a9516a49-018d-40d2-8e1a-a86f27eafd25"
      unitRef="usdPerShare">5.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RleHRyZWdpb246MWQyOTgzYWU3YjVmNDBkMTlkMjkwYWE0MDAyZGYyM2RfMTA1Mw_ab08cb70-1967-48ae-80e4-8789e01fa7be">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock options activity for the three months ended July 31, 2022 was a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.904%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Directors&lt;br/&gt;and&lt;br/&gt;Employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-&lt;br/&gt;Employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,131,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,462,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,462,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,846,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1b9d5525af9d4411bcbf399d302cd535_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS0xLTEtMS0xODgxMw_85db92a8-7cd3-4638-b480-3930a35118e9"
      unitRef="shares">1617324</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifd81da0b91f449c284d6c5416e74f934_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS0yLTEtMS0xODgxMw_22eec4e4-32e6-4457-a270-12f0be99e9cd"
      unitRef="shares">40915</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS01LTEtMS0xODgxMw_97a2c8eb-a026-4c55-91b1-83d267cfd45c"
      unitRef="shares">1658239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS03LTEtMS0xODgxMw_2b68c66a-ce46-4a5f-a5a1-9f78ea169a13"
      unitRef="usdPerShare">4.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i96b45f148ed94f2b987822093a127b64_D20210501-20220430"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS05LTEtMS0xODgxMw_69aeb27f-646f-4376-a2c8-2cab6a269016">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMS0xMS0xLTEtMTg4MTM_dbab6dd0-204a-48ee-8198-74b38f0c6b14"
      unitRef="usd">6131000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi0xLTEtMS0xODgxMw_a2aaa03c-91b7-4439-925a-a8d3c77e200c"
      unitRef="shares">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi0yLTEtMS0xODgxMw_9b2731fa-5803-4b54-8ece-e29ecf0cba78"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi01LTEtMS0xODgxMw_d73dc64a-5ae5-4b30-9a70-bf93ff7fd59a"
      unitRef="shares">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi03LTEtMS0xODgxMw_7785f9be-8799-420a-8f55-d41fc94eacbe"
      unitRef="usdPerShare">7.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMi05LTEtMS0xODgxMw_01884120-2a83-45a7-981d-68aed0ac28c5">P9Y10M24D</csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC0xLTEtMS0xODgxMw_839a9472-1a77-4f6e-ac6b-21c76b9c7918"
      unitRef="shares">7625</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC0yLTEtMS0xODgxMw_937f9650-79da-4488-ac5f-bbbae654cdb5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC01LTEtMS0xODgxMw_cb558559-19c2-4212-95bd-8aa8c29d4f49"
      unitRef="shares">7625</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNC03LTEtMS0xODgxMw_127110c6-07dc-4261-90aa-f5e1c35fb9bc"
      unitRef="usdPerShare">7.73</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod
      contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS0xLTEtMS0xODgxMw_64479959-0d01-4b83-a798-82a9317a5f5b"
      unitRef="shares">0</csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod>
    <csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod
      contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS0yLTEtMS0xODgxMw_cb0c816d-2c76-4ebd-8df6-1e655efa136e"
      unitRef="shares">1875</csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod>
    <csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS01LTEtMS0xODgxMw_e368351d-e36f-4c8e-9847-285a24bcdbce"
      unitRef="shares">1875</csbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod>
    <csbr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNS03LTEtMS0xODgxMw_00e2dc4d-8b63-4242-8f62-dd39b6d40cd6"
      unitRef="usdPerShare">4.63</csbr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i8b2c162c0b10404093ec52141324084c_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi0xLTEtMS0xODgxMw_90d076a6-9e25-4ad1-a003-65585c5b8d94"
      unitRef="shares">4584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i2835fdca251141ffb245a9c9652d2ff6_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi0yLTEtMS0xODgxMw_eee16b58-f110-4a99-824d-be140be4f555"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi01LTEtMS0xODgxMw_655bd1e2-f0c8-407f-b653-8798e4be9f98"
      unitRef="shares">4584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfNi03LTEtMS0xODgxMw_41d08153-3792-49c4-8e52-0f69ca63c82b"
      unitRef="usdPerShare">5.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id6e0ef2a12e441258eba05a1fce64ef5_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC0xLTEtMS0xODgxMw_2f5b1301-dc29-4077-be0a-a6039897abc3"
      unitRef="shares">1683115</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC0yLTEtMS0xODgxMw_733daa80-9f6e-497c-a757-2c9aefbfeaf2"
      unitRef="shares">39040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC01LTEtMS0xODgxMw_eeef82a9-b8a1-4521-86ce-d21c698a8d7b"
      unitRef="shares">1722155</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC03LTEtMS0xODgxMw_b8a6aca1-3e38-48d7-bd08-deec9e4919b6"
      unitRef="usdPerShare">4.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC05LTEtMS0xODgxMw_faa81b3c-7d3c-490d-a050-f925cb7e8697">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfOC0xMS0xLTEtMTg4MTM_62f84bd2-d015-437d-82a2-488969749907"
      unitRef="usd">7462000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="id6e0ef2a12e441258eba05a1fce64ef5_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtMS0xLTEtMTg4MTM_4de18112-a3d9-4d24-afde-a2dc117a7a02"
      unitRef="shares">1683115</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtMi0xLTEtMTg4MTM_8ef141dd-4c0a-4bfd-99f6-28264bedbe22"
      unitRef="shares">39040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtNS0xLTEtMTg4MTM_2b42f1dd-b4b5-4650-b079-c25c5b91e8ad"
      unitRef="shares">1722155</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtNy0xLTEtMTg4MTM_908abc1f-c498-4862-b04e-3deae7be0ce9"
      unitRef="usdPerShare">4.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtOS0xLTEtMTg4MTM_80a57f51-6b1f-41d8-a48c-4d2b5525916d">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTAtMTEtMS0xLTE4ODEz_0c2c76a4-7af8-4cc6-90f5-909a33fbdac8"
      unitRef="usd">7462000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="id6e0ef2a12e441258eba05a1fce64ef5_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItMS0xLTEtMTg4MTM_ff8690f1-d8dc-4c17-9b64-46fa843e5b0d"
      unitRef="shares">1380775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i8287b98ae5e5404cb8ad892c62bc2e0d_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItMi0xLTEtMTg4MTM_b223cf40-313c-4f4e-8e2a-8ccc488c1d68"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItNS0xLTEtMTg4MTM_2cb4eccf-a9ed-4c36-8ff9-7bdd07d2a1e4"
      unitRef="shares">1380775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItNy0xLTEtMTg4MTM_096706d6-2ac0-4c3d-ae06-7b3d6fe537f0"
      unitRef="usdPerShare">4.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItOS0xLTEtMTg4MTM_54b7babb-9b1b-497b-bfbe-e52721b49ad5">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV80OS9mcmFnOjFkMjk4M2FlN2I1ZjQwZDE5ZDI5MGFhNDAwMmRmMjNkL3RhYmxlOjEwNTI5ZDA3MDQ4MTRkZmY4YzExYmU2Y2ZhZTlhYTgzL3RhYmxlcmFuZ2U6MTA1MjlkMDcwNDgxNGRmZjhjMTFiZTZjZmFlOWFhODNfMTItMTEtMS0xLTE4ODEz_b4e76031-c3bd-4b77-af34-3a646fe2580e"
      unitRef="usd">6846000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDU5Ng_2ad9a436-b868-406d-bf0a-18081a97eff0">Leases&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently leases certain office equipment and its office and laboratory facilities under non-cancelable operating leases. Rent expense for operating leases is recognized on a straight-line basis over the lease term from the lease commencement date through the scheduled expiration date. Rent expense totaled $467,000 and $452,000 for the three months ended July 31, 2022 and 2021, respectively. The Company considers its facilities adequate for its current operational needs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the following facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;One University Plaza, Suite 307, Hackensack, New Jersey 07601, which, since November 2011, serves as the Company&#x2019;s corporate headquarters. The lease was renewed during fiscal year 2022 and expires in November 2026. The Company recognized $21,000 and $24,000 of rent expense relative to this lease for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;1330 Piccard Drive Suite 025, Rockville, MD 20850, which consists of laboratory and office space where the Company conducts operations related to its primary service offerings. The Company executed this lease (the "Original Premises") on January 11, 2017. The operating commencement date was August&#160;11, 2017. This lease was originally set to expire in August 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;On March 30, 2020, the Company executed the first amendment to this lease to expand the existing premises at 1330 Piccard Drive, Suite 025 ("Expansion Premises") to add on Suites 050 and 104.  This amendment also extended the current lease term by six months.  The Expansion Premises operating lease commencement date was June 1, 2020 and, under the amendment, both leases expire February 28, 2029.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;In accordance with ASC 842, "Leases", the Company evaluated the first amendment and also performed a reassessment of the existing lease for Suite 025 to determine the impact of the six-month term extension.  As a result of this assessment, the Company recognized an additional operating ROU asset and related operating lease liability for Suite 025 of $118,000 and $125,000, respectively, as well as an incremental net rent expense of $8,000 during the three months ended July 31, 2020 related to fiscal year 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Upon the Expansion Premises operating lease commencement date (June 1, 2020), the Company recognized an operating ROU asset and related operating lease liability for Suites 050 and 104 of $3.8 million, each, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;On December 22, 2020, the Company executed the second amendment to this lease to expand the existing premises at 1330 Piccard Drive, Suites 025, 050, and 104 ("Additional Expansion Premises") to add on Suite 201.  The Additional Expansion Premises operating lease commencement date is April 1, 2021 and, under the second amendment, reaffirms that all three leases expire February 28, 2029.  Upon the Additional Expansion Premises operating lease commencement date (April 1, 2021), the Company also recognized an operating ROU asset and related operating lease liability for Suite 201 of $3.3&#160;million, each, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;For the leases related to the premises at Piccard Drive, the Company recognized $422,000 for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;VIA LEONE XIII, 14, Milan, Italy, which consists of laboratory and office space where the Company conducts operations related to its flow cytometry service offerings. The Company executed the lease for its laboratory space in June 2021, and commenced occupancy during the three months ended October 31, 2021. This lease expires May 2023. The Company executed the lease for its office space on October 1, 2021. This lease expires September 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;The Company recognized an operating ROU asset and related operating lease liability for the lab and office space of $205,000 each, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;The Company recognized rent expense associated with these leases of $23,000 and zero for the three months ended July 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ROU assets and lease liabilities related to our current operating leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets, net&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 31, 2022, the weighted average remaining operating lease term and the weighted average discount rate were&#160;6.42 years&#160;and&#160;5.73%, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments due each fiscal year as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.385%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total undiscounted liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 5, Property and Equipment, for information on financing leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDg3NA_1868e1e5-c425-4c63-988e-e02123ada6d8"
      unitRef="usd">467000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDg4NA_0a9d7abc-9a2f-4a56-a6dd-254c8d74c7d9"
      unitRef="usd">452000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="iafaf30d9b4bb4f1a9ecbae72caf1fb8f_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDg5NA_071a5e84-f8ca-45d4-8890-563f94cd4e6d"
      unitRef="usd">21000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib1ac3aca3d2e4e09a8d672880d693ede_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkwMw_8717ad0c-0415-407c-a962-f25b3dcd59b8"
      unitRef="usd">24000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i53b7f92a0f504fe8a62ea065fb7de171_I20200330"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTUxMQ_345d3397-4963-483d-bd0f-184f11b7e262">P6M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i53b7f92a0f504fe8a62ea065fb7de171_I20200330"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDU5Nw_4805de50-e780-4131-9418-66d50c9f9243">P6M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if0a29219b6d948bfb1a15242e7e2ee28_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjAwNw_df4dda9c-b69f-49ca-9e77-7b95758c2c5b"
      unitRef="usd">118000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="if0a29219b6d948bfb1a15242e7e2ee28_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjAxNA_c4fada49-b6af-4c25-bc4f-c7c3ab547838"
      unitRef="usd">125000</us-gaap:OperatingLeaseLiability>
    <csbr:OperatingLeaseIncrementalRentExpense
      contextRef="i1318dfe0a0ec49f5acc43f0ba736b4ba_D20200501-20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjA3OA_8bf1de5f-5426-4421-a8b0-184b1f4b7072"
      unitRef="usd">8000</csbr:OperatingLeaseIncrementalRentExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i708a863763c143c7b34dd9a365f1231f_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjMxNg_242bfdb8-31c0-457e-8de6-e3a7f48e4b15"
      unitRef="usd">3800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i708a863763c143c7b34dd9a365f1231f_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjMxNg_3d349e46-a743-4b54-9c14-8d09dc3d329e"
      unitRef="usd">3800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="idf77001db0284d6e948b1a45819dd957_I20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMzEyMA_8c738813-01af-412c-9b05-66cd7e691011"
      unitRef="usd">3300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idf77001db0284d6e948b1a45819dd957_I20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMzEyMA_fa13b3b6-3607-4108-a76e-04c44e338791"
      unitRef="usd">3300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseExpense
      contextRef="i900f808a09d14b639e4c9009b851f365_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDk0MA_3a170ef1-5d1f-42ea-ad7f-c71e5a8aee09"
      unitRef="usd">422000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i1bf7db3dbce34511bf24eb8231dc9fb6_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDk0MA_c2e3c17e-6834-4aee-b604-b582ae702732"
      unitRef="usd">422000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseLiability
      contextRef="i3b3db1ffdd35458cb1b2797cc1c3e7a7_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkzMA_2aa51f56-7e07-4767-addc-d18b244c22f9"
      unitRef="usd">205000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3b3db1ffdd35458cb1b2797cc1c3e7a7_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkzMA_74fd514c-4d50-481c-b28e-e5614d47901b"
      unitRef="usd">205000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib656d8c6403f4dc78fd543334a957220_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMjE5OTAyMzI2Mjc2NA_ead4c993-4676-412f-aa91-730e4368e195"
      unitRef="usd">23000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i4fa35d5bbbd94ab5a12de9c850a4deef_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkyOA_d954167c-9034-4ee1-bd82-5796104a7d92"
      unitRef="usd">0</us-gaap:OperatingLeaseExpense>
    <csbr:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDYwNA_96e5f4bd-8bc6-441e-b8d8-a288bf1490f3">ROU assets and lease liabilities related to our current operating leases are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets, net&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</csbr:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMS0xLTEtMS0xODgxMw_4087b9a3-bfd6-46e1-a7ae-4643e02d90ed"
      unitRef="usd">7971000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMS0yLTEtMS0xODgxMw_fbb29892-fb2b-4645-8cab-36a960b9cffd"
      unitRef="usd">8230000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMi0xLTEtMS0xODgxMw_8a0b620b-d9c2-4822-8736-5e7463396177"
      unitRef="usd">1099000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMi0yLTEtMS0xODgxMw_172b8549-edb4-4174-aa7a-34a89e747716"
      unitRef="usd">1054000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMy0xLTEtMS0xODgxMw_8becd7ac-95cb-47e0-8fa6-49925fb64a72"
      unitRef="usd">8127000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic065ecda714549d8b9539d3a70cf972f_I20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOjBmMDRlNmZiNmJjMDQyMWFhMTgwMmJmOWM5NTQ2ZGYwL3RhYmxlcmFuZ2U6MGYwNGU2ZmI2YmMwNDIxYWExODAyYmY5Yzk1NDZkZjBfMy0yLTEtMS0xODgxMw_9c05ad39-0e82-4d70-aa24-d8ba930904aa"
      unitRef="usd">8412000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkxMQ_97c0658f-d256-43e8-9a74-8f6336358650">P6Y5M1D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfMTA5OTUxMTYzNDkxMw_703b9200-0796-4b9a-9f02-8f6837601a00"
      unitRef="number">0.0573</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RleHRyZWdpb246MDNkNmI3NDgzNTQwNDQ4Y2FiNjUyODFmYjc0ZjVkNTVfNDYwNQ_42bfa9f8-7985-4972-a06a-308ec8e8520f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments due each fiscal year as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.385%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total undiscounted liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMC0xLTEtMS0xODgxMw_38371987-5887-4039-a0a0-43012f5daaad"
      unitRef="usd">2060000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMS0xLTEtMS0xODgxMw_498e752c-61f5-47cc-aecb-a09079c00979"
      unitRef="usd">2811000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMi0xLTEtMS0xODgxMw_1eac9f07-bb47-4d10-b5e6-9eef2ad400e9"
      unitRef="usd">2850000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfMy0xLTEtMS0xODgxMw_6ee233ef-eee1-43f9-9070-011f0dcda34a"
      unitRef="usd">2896000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNC0xLTEtMS0xODgxMw_f96fe49e-02ee-4bff-9f7e-5878413ff812"
      unitRef="usd">2860000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <csbr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNS0xLTEtMS0xODgxMw_1a16e4b0-11da-477c-a869-e11ce88caeba"
      unitRef="usd">5164000</csbr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNi0xLTEtMS0xODgxMw_e344b21b-5512-4158-8509-74725732386d"
      unitRef="usd">18641000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfNy0xLTEtMS0yMTkzNw_b7e4f583-861a-4c03-b2a6-1d3504a37bfc"
      unitRef="usd">9415000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81Mi9mcmFnOjAzZDZiNzQ4MzU0MDQ0OGNhYjY1MjgxZmI3NGY1ZDU1L3RhYmxlOmQ4ZmNjNGQwNTg3MTRlNTlhYWQ0NDk4ZmFiMTc4NGFhL3RhYmxlcmFuZ2U6ZDhmY2M0ZDA1ODcxNGU1OWFhZDQ0OThmYWIxNzg0YWFfOC0xLTEtMS0yMTkzNw_2ce0643e-04e8-41db-abd2-11f3b64b276d"
      unitRef="usd">9226000</us-gaap:OperatingLeaseLiability>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNzYy_122cffe8-c8f3-43a5-883a-905328ba4327">Related Party Transactions&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Related party transactions include transactions between the Company and its shareholders, management, or affiliates.&#160;&#160;The following transactions were in the normal course of operations and were measured and recorded at the exchange amount, which is the amount of consideration established and agreed to by the parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consulting Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;During the three months ended July 31, 2022 and 2021, the Company paid an affiliate of a board member $9,000 and $9,000, respectively, for consulting services unrelated to his duty as a board member. During the&#160;three months ended July 31, 2022 and 2021, the Company paid an affiliate of another board member $0&#160;and&#160;$3,000, respectively, for consulting services unrelated to their duties as a board member. As of July&#160;31, 2022, $0 was due to these related parties.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ib6fed9c77e8f43daad4d3e42d103bedc_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNDU1_2bb47487-9a8d-44b1-af27-8e969c373813"
      unitRef="usd">9000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i851e5a2ac2a74afc89c6b93db67bab8b_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNDYy_d89e882a-94f5-41e9-b909-7a3f50c2d4b9"
      unitRef="usd">9000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ie7dd96fbc4b344fc8421b1c148328401_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNjIx_ab239d3e-20f2-4c3c-8dac-1493bae465ec"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i3b1cc212cb794f45b5fa375773a069c2_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNjI4_8d5132d4-335c-4c9e-9499-04d051d049a3"
      unitRef="usd">3000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i577c8b3d14454bb0b350f284ca6c1329_I20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81NS9mcmFnOjlhNzc2MzJhODQ0ZjQxZjU5Y2NlYTUyZjhhOGM2OTBmL3RleHRyZWdpb246OWE3NzYzMmE4NDRmNDFmNTljY2VhNTJmOGE4YzY5MGZfNzI1_8a330b29-e4a7-4b97-b02a-db74b99da307"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMjExNg_4d485bf0-000a-4de3-bfb9-70fd3253c93e">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not currently party to any legal matters to its knowledge. The Company is not aware of any other matters that would have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Registration Payment Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into an Amended and Restated Registration Rights Agreement in connection with the March 2015 Private Placement. This Amended and Restated Registration Rights Agreement contains provisions that may call for the Company to pay penalties in certain circumstances. This registration payment arrangement primarily relates to the Company&#x2019;s ability to file a registration statement within a particular time period, have a registration statement declared effective within a particular time period and to maintain the effectiveness of the registration statement for a particular time period. The Company has not accrued any liquidated damages associated with the Amended and Restated Registration Right Agreement as the Company has filed the required registration statement and anticipates continued compliance with the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contracts with third-party vendors to license tumor samples for development into PDX models and use in our TOS business. These types of arrangements have an upfront fee ranging from nil to $30,000 per tumor sample depending on the successful growth of the tumor model and ability to develop them into a sellable product. The upfront costs are expensed as incurred. In addition, under certain agreements, for a limited period of time, the Company is subject to royalty payments if the licensed tumor models are used for sale in our TOS business, ranging from 2% to 20% of the contract price after recouping certain initiation costs. Some of these arrangements also set forth an annual minimum royalty due regardless of tumor models used for sale. For the quarter ended July 31, 2022 and 2021, we have recognized approximately $76,000 and $44,000 in expense related to these royalty arrangements, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <csbr:CollaborationArrangementRoyaltyFee
      contextRef="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMjE5OTAyMzI1NzY2OQ_100512a2-667a-4b1e-89dc-9b95162be16d"
      unitRef="usd">0</csbr:CollaborationArrangementRoyaltyFee>
    <csbr:CollaborationArrangementRoyaltyFee
      contextRef="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDA5Mg_532b8955-9e9c-41de-bcb4-b6a729ca5d22"
      unitRef="usd">30000</csbr:CollaborationArrangementRoyaltyFee>
    <csbr:CollaborationArrangementRoyaltyFeePercentOfContractPrice
      contextRef="ia2ad90db9eff47f2861297d6ffa4f5c4_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMjE5OTAyMzI1NzY5MQ_be56b94d-9ca8-4eda-b227-e7bb7d2ea224"
      unitRef="number">0.02</csbr:CollaborationArrangementRoyaltyFeePercentOfContractPrice>
    <csbr:CollaborationArrangementRoyaltyFeePercentOfContractPrice
      contextRef="i06aa5a25d79b48c8b08f7bec7edd398e_D20220501-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDEwMQ_e2660ac3-d1ab-48a3-87b8-bee01d9249c9"
      unitRef="number">0.20</csbr:CollaborationArrangementRoyaltyFeePercentOfContractPrice>
    <us-gaap:RoyaltyExpense
      contextRef="ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDEwNg_467ed7e9-20d8-47dc-af2e-a8b46b2ad4d5"
      unitRef="usd">76000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="ied549d81234c4cff83f83c9215b34f63_D20210501-20210731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTQ5MTYwYTUxNDRlNDU4MGFmNDQ5YWVmODEwOGI1L3NlYzoyOTU0OTE2MGE1MTQ0ZTQ1ODBhZjQ0OWFlZjgxMDhiNV81OC9mcmFnOjE3MjRjNTVlOTVjMDRkMzliZGNiYWEzMzc3MDhkZDg4L3RleHRyZWdpb246MTcyNGM1NWU5NWMwNGQzOWJkY2JhYTMzNzcwOGRkODhfMTA5OTUxMTYzMDExNQ_853d77df-537a-4749-94a2-ec1f6f42a9b3"
      unitRef="usd">44000</us-gaap:RoyaltyExpense>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>51
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MR(0.@/=3SM7V1G^@.)+L_@]02P,$%     @ @88L5>HP@PCF!   81D  !@
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MC/CY(P3X^Q4A[.U&? //_U49_0M02P,$%     @ @88L51(7O S-!0  BQ@
M !@   !X;"]W;W)K<VAE971S+W-H965T-BYX;6RM66UOXC@0_BL6MSKM2D>)
M'<)+CR)1:+5=[99J:6\_F\2 KTF<M1VZO5]_=I(FD#BF*R&MEL3,#,_,>.89
MNY,7QI_%CA )?D5A+*XZ.RF3RUY/^#L287'!$A*K;S:,1UBJ5[[MB803'&1*
M4=A#CC/H19C&G>DD6WO@TPE+94AC\L"!2*,(\]=K$K*7JP[LO"U\I]N=U N]
MZ23!6[(B\BEYX.JM5UH):$1B05D,.-E<=6;P<NXZ6B&3^(>2%W'P#+0K:\:>
M]<M=<-5Q-"(2$E]J$UA][,F<A*&VI'#\+(QVRM_4BH?/;]9O,^>5,VLLR)R%
M/V@@=U>=40<$9(/34'YG+Y])X9"G[?DL%-G_X*60=3K 3X5D4:&L$$0TSC_Q
MKR(0!PK*CED!%0JHKM!O47 +!3=S-$>6N;7 $D\GG+T KJ65-?V0Q2;35M[0
M6*=Q);GZEBH].7VZGSTM[AYO%F"^O%_<W*_RI]7RZ]UBII=7C^KCV\W]XPHL
M;\%\MOH,;K\N?ZQ %SRM%N#CAT_@ Z Q>-RQ5. X$).>5+BT]9Y?8+C.,: 6
M#"[XQF*Y$^ F#DAPK-]3_I1.H3>GKI'5X)<TO  N_ L@!R$#GOG[U:$%CEO&
MV,WLN2WVE@GA6-)XFV]:*BD1EZ8PY6;Z9C.ZH"]%@GURU5$5*PC?D\[TSS_@
MP/G;Y..9C!UYW"\][MNL3^]5_PF9,.Z%7'.0:>HFLY]V73B>]/:'X U"<(A*
MH2-07@G*LZ9A%ORKZDFU("F 9*H'^2SV:4A 7*#5J_K9QV('$L[V5&U'L'X%
M'U.A'FC\";#WIM([9RK/9.PH:H,R:@-K*E>2^<]=W2D#X+-(T8? N@&;G,XM
M>0=90\Z@EEF#S,@Q)W980AQ:(2Z(\MNG..>%.  X8ES2__(%\DMC)B:\PP86
M#XUJ>)LR+AR:\8Y*O*.3U;%5# L4NH"*A D< K8!Y&=*$[T_35A'#1Q.#6E3
MHMLW QV70,=6H%7C"HG: (!K3NPJI*H> !:"2&.%CYLI'M0+W"#3]\QHH5-Q
MF6/%^Z!K-ALPU'P# I:NY28-5:GZ+(W-6 N+MK@:1(:C%J@'M NMS6B^P_&6
M",V<!STE"VFVA4.*US1L[R^%^3,UF'-9.PX&JH*!K'F;%0G2/9G0/5Z'QG(M
MK!PF GKU>C4(=4>H;6M5% ZM?*FV%DDP#=ZZ29XD)G>$JRF-<U6TEH(H;!\!
M']4;HT%H[+; KG@8VHEXF2$,F=I<DO#(AK%_NA":(MUA2^^&%2M#*WU5R4_P
M:VOFO>8ONRZLXVM*0;=M:H 5 4([ RJ /"5')6G$V&2V;M]K9-D@A;RV(%8,
M".T4N#S:B:>0-CFMD>JF"&RKH8KVH)WW<I QB[OO!7J:] PB@[:,5[0'?X_W
M3L%LDME13@ND!BG8EGE4<1ZR<]Z";(@*9J!ZYY[$J;%\4)/!NLT&9)(:#ENR
MCBJF0U;RR*:=;**NINC#V=HT41M]@ 8?QE[=AZ84@H,6%RI^0LA*UG?QGHCW
M3/W(RG._R\KGLG;L=45YZ 3EI=S?Z>VO!CZ5,94G^9K1GG5.14T:ZPZ]?CU/
M!JFQTS)7HXKNT.ES9[;7BJVF_C4S9T1MHK8F:H-4.^J* 9']8'I+8ZQ.HN_8
M7F<]59[+VK'7%:TB.ZVJ8=TG)!!@PUFDYBK"?9IO-I;H@YLY3TWZK/=9@T@+
M(:"*7I&=7N]-MP(;0]J,F$_3K4&D#7/%MLC.M@OB\XR]5!EH[$9HAC/CN%\_
MJYFD!J-Q"\"*99&=9><ZH%B"-=G2.-9QU(V&<,H"(]8F?XZ=@^(KL#:E^H-1
M2XFZ%<NZ=I9]PTKTU&]#6=@YO+D:.8U#BD'*'8_KA\K>P;5N1/@VN^T6(!N7
M\\O0<K6\49]E]\BU]6MX.<_OQ2LS^37]-\Q5\(6:<S;*I',Q5('C^<UW_B)9
MDET>KYF4+,H>=P0'A&L!]?V&,?GVHG^@_/O#]']02P,$%     @ @88L5>[N
M($1S!@  )!   !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6RU6&UOVS80
M_BN$"W0KX,J.D[X@30(X6;ME;=$@6;8/PS[0TLEB(Y$J2<5Q?_V>(VG9#IRT
M0+<OL43QWIZ[>X[,T<+8&U<1>7'7U-H=#RKOV\/1R.45-=)EIB6-+Z6QC?1X
MM?.1:RW)(@@U]6@R'K\<-5+IP<E16+NP)T>F\[72=&&%ZYI&VN4IU69Q/-@;
MK!8NU;SRO# Z.6KEG*[(7[<7%F^C7DNA&M).&2TLE<>#Z=[AZ0'O#QO^5+1P
M&\^"(YD9<\,OY\7Q8,P.44VY9PT2/[=T1G7-BN#&EZ1ST)MDP<WGE?9W(7;$
M,I..SDS]ERI\=3QX/1 %E;*K_:59_$8IGA>L+S>U"W_%(NT=#T3>.6^:) P/
M&J7CK[Q+.'R/P"0)3(+?T5#P\A?IY<F1-0MA>3>T\4,(-4C#.:4Y*5?>XJN"
MG#_Y9.=2JZ^2(1J*:T?"E.*M\PH!DQ-2%^)4.N5X^<*2(^W#WJ.1AW76,<J3
MI=-H:?* I7WQT6A?.?%6%U1LRX_@=>_Z9.7ZZ>11A;]W=2;V]X9B,IY,'M&W
MWT.Q'_3M?Q<49T8[4ZM"QN(!#IOA,QSOE)8Z5[(65U@D5*IWXN_IS'F+6OMG
M%T+1@8/=#G#_';I6YG0\:-F6O:7!R=,G>R_';QX)[Z /[^ Q[?]IIO\?2^*L
MDDV+!R<^:12VF2^'XESG ENE\)17.BP^)RUG-16"9:7-*V$V+ K2<]!)(906
M.7C**ST72(EVD<)  ANZ!)+<^6#3&S$C@9=:?8WBA>WFHE N-[=DE\'Q@FY!
M9"TG.Q-_5(0Z:5JIES^YM3<Y/I(5($X; H:FF?$5-LR[6GJ35&FCGV\LD;Y5
MUNA81OP]AU/*^0"3Q%N#HJB8#A&  UUCF1>["![*D(7H#E:9-3T6>H]:V.#H
M72;.H;"M))!8(3Q3!GQ\0W88(P2-K 6$M(2@G9IK8 *(2ID#("[X;\ CI!>@
M? "1&Y="4IHSXJ#)M42%VX)05!))J"Q1@HX3Y[J94X625I$[W%$@XN=S9R75
MSX;B@VJ4IV*XL>M4F8U47V?OLXUM[-"NBKO*+K,/&10#PN6S3(#]X18EUYI(
M8L0D)D!!RYZ"@D(\X!7; =N"_VB#--R2[E (2 :C.%OR!K3%9G!;4#Q]\GJR
M]^J-$\@!YHK>VBG*3N<IY7EG+>E\R2W"/EYG5YDH3%U+"X5<]#).OSGF<\Q!
M;9RCF%=+N9GK5;6S=X#\7E*@&,8_8XB&["=_Z"ZOI)Y#!1="67>Y[V1L(VX[
MHW6:N@N%PO<[(E/<(WI5NBGAD _6@4VG95=PHEA;@;*/3XF3\5+V].O6]%M)
M-,>,2 LT2XL8"]%VUG52!_?9$=O5B812\P6OT4S\\8J J/(J[7B["A/>-\JY
M0&BI'*[>GF5B6L,\ %&ERME&B"I/T/DU_E&=S'/3;;M)-<I1<T"9."/KD28H
M24P5SCUUB#8Y?Q]%LT6UFYXD6]Q#+3#+5R&5QGAMN'O1N*B%#B2!(H6]&K6,
M!JV[(M;#3H![6)4.)FR!/133O&G20I-J&>DY:>26E>,[M3[*AF+5(;]A>KJ
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M.(OB5AD>*_0#6=Z [SP95B]LH/_'P,F_4$L#!!0    ( (&&+%4"6D#;210
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MNK"G\V&*TD_-77Z#)NC^]"X':;E3P\:J==*:,PWZ<E'F:P[1'FZ/4[>R;;=
MQ=IT='2^?:R:]E'Z]O%1B6I[*UPC#82^'?V#SO,CFCO/*-^4J"Y=QOC[HNS]
MZ9SW*EAC.#70DP)6$DXG1Q2%T^2(OFI@424G^#@)1],C&H_"L^R(3FD\#I/X
M" G#K1.LVRE9%N1;L>3\:/_ Q6+K7QNY+&W0\"V>.J:)^G_&/7#-NRP<17[J
MW2A,TP"-O%UUM2$\;&[[QO&Q!?XEFC%S0_BF\_E8D& ?E9Y'OO"U9>37S@W]
MPW7?7W[>U_8 1#.J1/%HM<?!.)X$:9)1%@5G\8@G1M,@2<_0KP-LC!]^' <Q
M+(JBJ,E7Z)],_; -1C><A*,)G85G$>&=?RX52QY/@G$R.NE%N_$DG*3T0>"*
M*&6Q7XV#Z02KW?\L'*><;$ -55DPFF8'JMKQ*,RBQS@?.Q&HIFD0 U]Z%D20
MC8,);N=X-&+]60MR$F3CQ,/XBIQM;T;9Y[GNJ]S3:_Y?UO_Q09I<65\JGM>7
M3J-@,AGU2/<S68B7J2R,?52FV=@K?.Y%>7CP5:.29N&_W5C4PW7MF@\<_6S_
M>>BZ^2JR%V^^+7T29J&0OMRG7 ZB<#(:-!6S&SB]\M](9MHY7?G'I12XS5@
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MNA:\Z$TWJ>C>>+KX&;H>^Z@*.S?LLDA%VJ;O0H=:D7BMR)MX)\/W97;(>E'
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M1Y!C(5I%6]-]Q7T_EYXO,\J%7^CZW"DG9ZTC4^_!K*"6NG^*Y_T]' &NQZ\
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M^EQ\&(7J)#HPU'M\_$.)#A&@"#&&I75"F>#Z\MN??_F1/UU]>XK\9.T.QO/
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M9,8?UPK8SM(+^'UIC$]?:(/\'T%>_0=02P,$%     @ @88L58!,>K34 @
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M_'(:@6T;4SL@4X=FL#7$K26$)?=RM'X#KQ>&;ZH;^ /Z?X?T%U!+ P04
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M6VV"10 %EJP5]EX=?L6^'D\P5\+X+QPZWRP+(&^-574?3 QJ+KL_^][OPU'
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MZPGWZ%H9:0HEM;AC)_#X$HH?YRLDQP/X\Z5F]01F+Q/P2WF&K2Q@'K6^EMM
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MV=#$VX!O!'9R;XR,DQ7G]V;R*9LXGA$$%%)E&+!^;&$&E!HB+>-7P^FTKS3
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MSGMR][#\5) /!%WJQOJ1"MDGZ\M(GJ2 J0!Y?T&IV S4 N79S/\'4$L#!!0
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M 'U]Q;EZ6I@;U%]CXO\ 4$L#!!0    ( (&&+%4*,LE;>@0   <;   9
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M&ELH@BTN$OZ%''^#:D(#R;<A"5/_T;$<.[JVT*9@G*056'B0QEGYB1^K0#0
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M'P8FW@8\,]BJDS8Q3A9"K$WG4SQR/",(.$3:,%!\;. !.#=$*./G@=.IIC3
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M2M\HMKG2=S@(,T&_7W"NMAUSK;3_"K+?4$L#!!0    ( (&&+%6=[D(;ZP(
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MA\:Y 1XN21J*&=U\QEQ01_$M:,CU+VRRO5W;@$7*!8URL,P@"N+LGSSF1I0
MDJ<>8.< >Q_0?@;@Y !'"\TRT[(F1!!WP.@&F-HMV=1 >Z/14DT0JV.\%4P^
M#21.N#,,B4 /IH2))[AC).9$&\SA>(*"!"$_@0]P?SN!XZ,3.((@ACN?IIS$
M'A^80J:@B,Q%'FZ4A;.?">? #8V%S^%3[*%7Q9LR]2)_>YO_R&XD_)*&9^"T
M3L&V;+LFG_'_PUL-Z3B%G8[F<UYJ)_S\*K?"M<"(_ZKS+>-MU_.JRWS!$[+
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M1:8VR.=+2L5VH@(4#;3[%U!+ P04    " "!ABQ5=NRSE1D#  #N#   &0
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MOD%IZ,CPQ3R5]A>MBKG]$P?%N52<EF"M@!)6_.-U&8@:0/,T X(2$.P#^D\
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M@B.R:7]G*5_F23OJ!A:B'K5I?X/I=>/V'&AS<9FR%4LG=5?/IU4SL V;M;Z
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "!ABQ5<6LT^[H#   Z&P  #P
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M4$L! A0#%     @ @88L50=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "!ABQ5<6;G]>X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "!ABQ5F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( (&&+%6U+R]6X@4  -<>   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "!ABQ5[U0+JE\%  #Z%0  &               @($E#@  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ @88L53_-ODFQ @  <@<  !@
M             ("!NA,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( (&&+%76(K4?  4  )X4   8              " @:$6  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "!ABQ5ZC"#".8$  !A
M&0  &               @('7&P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ @88L51(7O S-!0  BQ@  !@              ("!\R
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( (&&+%7N[B!$
M<P8  "00   8              " @?8F  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " "!ABQ5 EI VTD4  !/.0  &
M@(&?+0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ @88L
M5;Q5AK/K @  - <  !@              ("!'D(  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( (&&+%41 ,.7%@,  "L'   9
M      " @3]%  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ @88L5?!Y[4\R"0  [!H  !D              ("!C$@  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "!ABQ5:J.(:  '  ! $P
M&0              @('U40  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( (&&+%72P], '@@  %,7   9              " @2Q9  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ @88L5?HE.?*G
M @  *08  !D              ("!@6$  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " "!ABQ5!,*(:F0%  #=#   &0
M@(%?9   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( (&&
M+%4> ATP3!$  !0R   9              " @?II  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ @88L58!,>K34 @  *08  !D
M         ("!?7L  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " "!ABQ5M_'T >H"  !A!P  &0              @(&(?@  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( (&&+%7U/_&[J0(   (&
M   9              " @:F!  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ @88L5;V_^!4  P  B08  !D              ("!B80
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "!ABQ57AP=
M!I@$    "P  &0              @(' AP  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( (&&+%6GDN2@/0,  *L'   9
M  " @8^,  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
M@88L5<%$)G-0 @  ^@0  !D              ("! Y   'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " "!ABQ5E2,H* 0$  #-#P  &0
M            @(&*D@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( (&&+%5U8YZ]F (  -0'   9              " @<66  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ @88L5?@Q,CQZ @
M[ 4  !D              ("!E)D  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " "!ABQ5:>\6/<X"   ,"   &0              @(%%
MG   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( (&&+%5/
M4,?(00(  #L%   9              " @4J?  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ @88L58%5'10] P  IPT  !D
M     ("!PJ$  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M" "!ABQ5:.3C'=4%   (+0  &0              @($VI0  >&PO=V]R:W-H
M965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( (&&+%504P"N?P0  /,7   9
M              " @4*K  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L!
M A0#%     @ @88L54:]>$&S P  F1$  !D              ("!^*\  'AL
M+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "!ABQ5"C+)6WH$
M   '&P  &0              @('BLP  >&PO=V]R:W-H965T<R]S:&5E=#,S
M+GAM;%!+ 0(4 Q0    ( (&&+%6U]FXG\@(  -<(   9              "
M@9.X  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ @88L
M53#D?@.@!@  @2P  !D              ("!O+L  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " "!ABQ5OL)00[(&  #400  &0
M        @(&3P@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( (&&+%7;+Z@^@P(  )8&   9              " @7S)  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ @88L52C7E\?J @  (0@
M !D              ("!-LP  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " "!ABQ5G>Y"&^L"  !,"P  &0              @(%7SP
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( (&&+%5V[+.5
M&0,  .X,   9              " @7G2  !X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ @88L51G1W LK P  [A(   T
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;72YX;6Q02P4&     #  ,  '#0  A^$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>89</ContextCount>
  <ElementCount>201</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>33</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization, Use of Estimates and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation</Role>
      <ShortName>Organization, Use of Estimates and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue</Role>
      <ShortName>Accounts Receivable, Unbilled Services and Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Revenue from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/RevenuefromContractswithCustomers</Role>
      <ShortName>Revenue from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Share-Based Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/ShareBasedPayments</Role>
      <ShortName>Share-Based Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2133109 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://championsoncology.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://championsoncology.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables</Role>
      <ShortName>Accounts Receivable, Unbilled Services and Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Revenue from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/RevenuefromContractswithCustomersTables</Role>
      <ShortName>Revenue from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://championsoncology.com/role/RevenuefromContractswithCustomers</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://championsoncology.com/role/PropertyandEquipment</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2321305 - Disclosure - Share-Based Payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/ShareBasedPaymentsTables</Role>
      <ShortName>Share-Based Payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://championsoncology.com/role/ShareBasedPayments</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2327306 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://championsoncology.com/role/Leases</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization, Use of Estimates and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentationDetails</Role>
      <ShortName>Organization, Use of Estimates and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Significant Accounting Policies - Summary of Potentially Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails</Role>
      <ShortName>Significant Accounting Policies - Summary of Potentially Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Accounts Receivable and Unbilled Services (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails</Role>
      <ShortName>Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Accounts Receivable and Unbilled Services (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails</Role>
      <ShortName>Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Revenue from Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/RevenuefromContractswithCustomersDetails</Role>
      <ShortName>Revenue from Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://championsoncology.com/role/RevenuefromContractswithCustomersTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Property and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails</Role>
      <ShortName>Property and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Share-Based Payments - Allocation of Share Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Payments - Allocation of Share Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Share-Based Payments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails</Role>
      <ShortName>Share-Based Payments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Share-Based Payments - Valuation Assumptions for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails</Role>
      <ShortName>Share-Based Payments - Valuation Assumptions for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Share-Based Payments - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Payments - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Leases - ROU Assets and Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - ROU Assets and Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Leases - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://championsoncology.com/role/RelatedPartyTransactions</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="csbr-20220731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:PropertyPlantAndEquipmentUsefulLife -  csbr-20220731.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="csbr-20220731.htm">csbr-20220731.htm</File>
    <File>csbr-20220731.xsd</File>
    <File>csbr-20220731_cal.xml</File>
    <File>csbr-20220731_def.xml</File>
    <File>csbr-20220731_lab.xml</File>
    <File>csbr-20220731_pre.xml</File>
    <File>csbrq1731202210-qex311.htm</File>
    <File>csbrq1731202210-qex312.htm</File>
    <File>csbrq1731202210-qex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="360">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>57
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "csbr-20220731.htm": {
   "axisCustom": 1,
   "axisStandard": 11,
   "contextCount": 89,
   "dts": {
    "calculationLink": {
     "local": [
      "csbr-20220731_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "csbr-20220731_def.xml"
     ]
    },
    "inline": {
     "local": [
      "csbr-20220731.htm"
     ]
    },
    "labelLink": {
     "local": [
      "csbr-20220731_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "csbr-20220731_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "csbr-20220731.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 307,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 7,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 12
   },
   "keyCustom": 17,
   "keyStandard": 184,
   "memberCustom": 15,
   "memberStandard": 18,
   "nsprefix": "csbr",
   "nsuri": "http://championsoncology.com/20220731",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://championsoncology.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Revenue from Contracts with Customers",
     "role": "http://championsoncology.com/role/RevenuefromContractswithCustomers",
     "shortName": "Revenue from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Property and Equipment",
     "role": "http://championsoncology.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Share-Based Payments",
     "role": "http://championsoncology.com/role/ShareBasedPayments",
     "shortName": "Share-Based Payments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Leases",
     "role": "http://championsoncology.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - Related Party Transactions",
     "role": "http://championsoncology.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - Commitments and Contingencies",
     "role": "http://championsoncology.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://championsoncology.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue (Tables)",
     "role": "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables",
     "shortName": "Accounts Receivable, Unbilled Services and Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Revenue from Contracts with Customers (Tables)",
     "role": "http://championsoncology.com/role/RevenuefromContractswithCustomersTables",
     "shortName": "Revenue from Contracts with Customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Property and Equipment (Tables)",
     "role": "http://championsoncology.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321305 - Disclosure - Share-Based Payments (Tables)",
     "role": "http://championsoncology.com/role/ShareBasedPaymentsTables",
     "shortName": "Share-Based Payments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "csbr:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - Leases (Tables)",
     "role": "http://championsoncology.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "csbr:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "csbr:NumberOfOperatingSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "subsidiary",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization, Use of Estimates and Basis of Presentation (Details)",
     "role": "http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentationDetails",
     "shortName": "Organization, Use of Estimates and Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "csbr:NumberOfOperatingSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "subsidiary",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CashEquivalentsAtCarryingValue",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CashEquivalentsAtCarryingValue",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ie70d8f70a5944b69be752032e3c823a4_I20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "role": "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ie70d8f70a5944b69be752032e3c823a4_I20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Significant Accounting Policies - Summary of Potentially Antidilutive Securities (Details)",
     "role": "http://championsoncology.com/role/SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails",
     "shortName": "Significant Accounting Policies - Summary of Potentially Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Accounts Receivable and Unbilled Services (Details)",
     "role": "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails",
     "shortName": "Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Accounts Receivable and Unbilled Services (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Deferred Revenue (Details)",
     "role": "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails",
     "shortName": "Accounts Receivable, Unbilled Services and Deferred Revenue - Summary of Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Revenue from Contracts with Customers (Details)",
     "role": "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails",
     "shortName": "Revenue from Contracts with Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i91fabe7ea07840b0ad07eea382c68f2c_D20220501-20220731",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)",
     "role": "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Property and Equipment - Narrative (Details)",
     "role": "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
     "shortName": "Property and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)",
     "role": "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails",
     "shortName": "Property and Equipment - Summary of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Share-Based Payments - Allocation of Share Based Compensation Expense (Details)",
     "role": "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Payments - Allocation of Share Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Share-Based Payments - Narrative (Details)",
     "role": "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails",
     "shortName": "Share-Based Payments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Share-Based Payments - Valuation Assumptions for Stock Options (Details)",
     "role": "http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails",
     "shortName": "Share-Based Payments - Valuation Assumptions for Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ic065ecda714549d8b9539d3a70cf972f_I20220430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Share-Based Payments - Summary of Stock Option Activity (Details)",
     "role": "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails",
     "shortName": "Share-Based Payments - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Leases - Narrative (Details)",
     "role": "http://championsoncology.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Leases - ROU Assets and Lease Liabilities (Details)",
     "role": "http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails",
     "shortName": "Leases - ROU Assets and Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Leases - Future Minimum Lease Payments (Details)",
     "role": "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails",
     "shortName": "Leases - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Related Party Transactions (Details)",
     "role": "http://championsoncology.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i577c8b3d14454bb0b350f284ca6c1329_I20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Commitment and Contingencies (Details)",
     "role": "http://championsoncology.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i73be74dc4a704955a13d4a6e605014c1_I20210430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS\u2019 EQUITY",
     "role": "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "i73be74dc4a704955a13d4a6e605014c1_I20210430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization, Use of Estimates and Basis of Presentation",
     "role": "http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation",
     "shortName": "Organization, Use of Estimates and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Significant Accounting Policies",
     "role": "http://championsoncology.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Accounts Receivable, Unbilled Services and Deferred Revenue",
     "role": "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue",
     "shortName": "Accounts Receivable, Unbilled Services and Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220731.htm",
      "contextRef": "ia065d7a8613841d5a8e1479cee6bfeda_D20220501-20220731",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 33,
   "tag": {
    "csbr_A2022FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Finance Lease",
        "label": "2022 Finance Lease [Member]",
        "terseLabel": "2022 Finance Lease"
       }
      }
     },
     "localname": "A2022FinanceLeaseMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_A2023FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Finance Lease",
        "label": "2023 Finance Lease [Member]",
        "terseLabel": "2023 Finance Lease"
       }
      }
     },
     "localname": "A2023FinanceLeaseMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_AdditionalExpansionPremisesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Expansion Premises",
        "label": "Additional Expansion Premises [Member]",
        "terseLabel": "Additional Expansion Premises"
       }
      }
     },
     "localname": "AdditionalExpansionPremisesMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_AssetInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset In Progress",
        "label": "Asset In Progress [Member]",
        "terseLabel": "Assets in progress"
       }
      }
     },
     "localname": "AssetInProgressMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Summary of assets and liabilities"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "csbr_BoardMemberOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Member One [Member]",
        "label": "Board Member One [Member]",
        "terseLabel": "Board Member One"
       }
      }
     },
     "localname": "BoardMemberOneMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_BoardMemberTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Member Two [Member]",
        "label": "Board Member Two [Member]",
        "terseLabel": "Board Member Two"
       }
      }
     },
     "localname": "BoardMemberTwoMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_CollaborationArrangementRoyaltyFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement Royalty Fee",
        "label": "Collaboration Arrangement Royalty Fee",
        "terseLabel": "Royalty fee per tumor sample"
       }
      }
     },
     "localname": "CollaborationArrangementRoyaltyFee",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_CollaborationArrangementRoyaltyFeePercentOfContractPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement, Royalty Fee, Percent Of Contract Price",
        "label": "Collaboration Arrangement, Royalty Fee, Percent Of Contract Price",
        "terseLabel": "Royalty payment, as percent of contract price"
       }
      }
     },
     "localname": "CollaborationArrangementRoyaltyFeePercentOfContractPrice",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "csbr_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies [Line Items]",
        "label": "Commitments and Contingencies [Line Items]",
        "terseLabel": "Commitments and Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "csbr_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies",
        "label": "Commitments and Contingencies [Table]",
        "terseLabel": "Commitments and Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "csbr_CorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Headquarters [Member]",
        "terseLabel": "Corporate Headquarters"
       }
      }
     },
     "localname": "CorporateHeadquartersMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_EquityIncentivePlan2010Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Incentive Plan 2010 [Member]",
        "terseLabel": "Equity Incentive Plan 2010"
       }
      }
     },
     "localname": "EquityIncentivePlan2010Member",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_EquityIncentivePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan 2021",
        "label": "Equity Incentive Plan 2021 [Member]",
        "terseLabel": "Equity Incentive Plan 2021"
       }
      }
     },
     "localname": "EquityIncentivePlan2021Member",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_FewContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Few contracts.",
        "label": "Few Contracts [Member]",
        "terseLabel": "Few Contracts"
       }
      }
     },
     "localname": "FewContractsMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_FinanceLeaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease",
        "label": "Finance Lease [Axis]",
        "terseLabel": "Finance Lease [Axis]"
       }
      }
     },
     "localname": "FinanceLeaseAxis",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "csbr_FinanceLeaseCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "terseLabel": "Finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_FinanceLeaseDepreciationAndAmortizationExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Depreciation And Amortization Expenses",
        "label": "Finance Lease, Depreciation And Amortization Expenses",
        "terseLabel": "Finance lease, depreciation and amortization"
       }
      }
     },
     "localname": "FinanceLeaseDepreciationAndAmortizationExpenses",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_FinanceLeaseDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease [Domain]",
        "label": "Finance Lease [Domain]",
        "terseLabel": "Finance Lease [Domain]"
       }
      }
     },
     "localname": "FinanceLeaseDomain",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Liabilities",
        "label": "Increase (Decrease) In Operating Lease Liabilities",
        "negatedLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Right Of Use Assets",
        "label": "Increase (Decrease) In Operating Lease, Right Of Use Assets",
        "terseLabel": "Operating lease right-of use assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_MilanItalyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milan Italy",
        "label": "Milan Italy [Member]",
        "terseLabel": "Milan Italy"
       }
      }
     },
     "localname": "MilanItalyMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_NumberOfOperatingSubsidiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Operating Subsidiaries",
        "label": "Number Of Operating Subsidiaries",
        "terseLabel": "Number of operating subsidiaries"
       }
      }
     },
     "localname": "NumberOfOperatingSubsidiaries",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "csbr_OperatingLeaseIncrementalRentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Incremental Rent Expense",
        "label": "Operating Lease, Incremental Rent Expense",
        "terseLabel": "Incremental rent expense"
       }
      }
     },
     "localname": "OperatingLeaseIncrementalRentExpense",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_PersonalizedOncologyServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Personalized Oncology Services [Member]",
        "label": "Personalized Oncology Services [Member]",
        "terseLabel": "Personalized oncology services"
       }
      }
     },
     "localname": "PersonalizedOncologyServicesMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_PharmacologyServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacology Services [Member]",
        "label": "Pharmacology Services [Member]",
        "terseLabel": "Pharmacology services"
       }
      }
     },
     "localname": "PharmacologyServicesMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_PresentValueMinimumFutureObligationsInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present Value Minimum Future Obligations Interest Rate",
        "label": "Present Value Minimum Future Obligations Interest Rate",
        "terseLabel": "Present value of minimum future obligations interest rate"
       }
      }
     },
     "localname": "PresentValueMinimumFutureObligationsInterestRate",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "csbr_ProceedsFromExerciseOfOptionsAndWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options and warrants.",
        "label": "Proceeds From Exercise Of Options And Warrants",
        "terseLabel": "Proceeds from exercise of options"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptionsAndWarrants",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_ReversalOfProvisionForDoubtfulAccounts": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal Of Provision For Doubtful Accounts",
        "label": "Reversal Of Provision For Doubtful Accounts",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ReversalOfProvisionForDoubtfulAccounts",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "csbr_RockvilleMDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rockville, MD [Member]",
        "label": "Rockville, MD [Member]",
        "terseLabel": "Rockville, MD"
       }
      }
     },
     "localname": "RockvilleMDMember",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement by Share Based Payment Award, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period",
        "negatedTerseLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "csbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, granted (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "csbr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price",
        "terseLabel": "Canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "csbr_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reporting entity working capital (deficit) has reported.",
        "label": "Working Capital (Deficit)",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://championsoncology.com/20220731",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://championsoncology.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Board Member"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r29",
      "r31",
      "r60",
      "r61",
      "r152",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r151",
      "r153",
      "r189",
      "r190",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r307",
      "r332",
      "r334",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails",
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails",
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r151",
      "r153",
      "r189",
      "r190",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r307",
      "r332",
      "r334",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails",
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r103",
      "r134",
      "r135",
      "r177",
      "r180",
      "r311",
      "r331",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails",
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r103",
      "r134",
      "r135",
      "r177",
      "r180",
      "r311",
      "r331",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails",
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r128",
      "r133",
      "r134",
      "r135",
      "r136",
      "r151",
      "r153",
      "r188",
      "r189",
      "r190",
      "r221",
      "r222",
      "r223",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r307",
      "r332",
      "r334",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails",
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails",
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r128",
      "r133",
      "r134",
      "r135",
      "r136",
      "r151",
      "r153",
      "r188",
      "r189",
      "r190",
      "r221",
      "r222",
      "r223",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r307",
      "r332",
      "r334",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails",
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails",
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r30",
      "r31",
      "r60",
      "r61",
      "r152",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r106",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r22",
      "r296"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGross": {
     "auth_ref": [
      "r14",
      "r107"
     ],
     "calculation": {
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r4",
      "r14",
      "r107",
      "r108"
     ],
     "calculation": {
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "totalLabel": "Total accounts receivable and unbilled services"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r107",
      "r108"
     ],
     "calculation": {
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Total accounts receivable, net",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails",
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r9",
      "r124"
     ],
     "calculation": {
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r63",
      "r64",
      "r65",
      "r231",
      "r232",
      "r233",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r192",
      "r235",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r20",
      "r109",
      "r114",
      "r115",
      "r116"
     ],
     "calculation": {
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Less allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total common stock equivalents (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesSummaryofPotentiallyAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r12",
      "r57",
      "r92",
      "r95",
      "r101",
      "r112",
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r254",
      "r256",
      "r262",
      "r294",
      "r296",
      "r314",
      "r322"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r21",
      "r57",
      "r112",
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r254",
      "r256",
      "r262",
      "r294",
      "r296"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r7",
      "r52"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r47",
      "r52",
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash at end of period",
        "periodStartLabel": "Cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r47",
      "r263"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r137",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r63",
      "r64",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r13",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r13",
      "r296"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $.001 par value; 200,000,000 shares authorized; 13,522,441 shares issued and outstanding as of July 31, 2022 and April 30, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of advanced billings"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r157",
      "r158",
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r157",
      "r158",
      "r178"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r42",
      "r311"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of oncology services"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of oncology services"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r50",
      "r122"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r50",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r177",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r194",
      "r195",
      "r227",
      "r228",
      "r229",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Payments"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPayments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r59",
      "r141",
      "r143",
      "r144",
      "r148",
      "r149",
      "r150",
      "r288",
      "r316",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net loss per common share outstanding"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r40",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r76",
      "r78",
      "r80",
      "r81",
      "r82",
      "r85",
      "r86",
      "r260",
      "r261",
      "r319",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share outstanding, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r40",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r78",
      "r80",
      "r81",
      "r82",
      "r85",
      "r86",
      "r260",
      "r261",
      "r319",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share outstanding, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r83",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r35",
      "r36",
      "r37",
      "r63",
      "r64",
      "r65",
      "r67",
      "r73",
      "r75",
      "r87",
      "r113",
      "r155",
      "r156",
      "r231",
      "r232",
      "r233",
      "r250",
      "r251",
      "r259",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r284",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r273",
      "r278",
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease, amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Finance lease, asset, gross"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Net gain on disposal of equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r10",
      "r117",
      "r118",
      "r119",
      "r120",
      "r296",
      "r313"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r191",
      "r193",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r191",
      "r193",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization": {
     "auth_ref": [
      "r121",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization",
        "terseLabel": "Hosting arrangement, amortization expense"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostExpenseAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r38",
      "r92",
      "r94",
      "r97",
      "r100",
      "r102",
      "r312",
      "r317",
      "r320",
      "r329"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r126",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax penalties and interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r58",
      "r74",
      "r75",
      "r91",
      "r242",
      "r252",
      "r253",
      "r330"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "netLabel": "Provision for income taxes",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r240",
      "r241",
      "r246",
      "r247",
      "r248",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r49",
      "r308"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Liabilities [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other long term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of future operating lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Extension term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r23",
      "r57",
      "r96",
      "r112",
      "r138",
      "r139",
      "r140",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r255",
      "r256",
      "r257",
      "r262",
      "r294",
      "r295"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r19",
      "r57",
      "r112",
      "r262",
      "r296",
      "r315",
      "r324"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r25",
      "r57",
      "r112",
      "r138",
      "r139",
      "r140",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r255",
      "r256",
      "r257",
      "r262",
      "r294",
      "r295",
      "r296"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Accounts Receivable, Unbilled Services and Deferred Revenue"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r47",
      "r48",
      "r51"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Net cash provided by (used in) operating activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r32",
      "r33",
      "r37",
      "r39",
      "r51",
      "r57",
      "r66",
      "r68",
      "r69",
      "r70",
      "r71",
      "r74",
      "r75",
      "r79",
      "r92",
      "r94",
      "r97",
      "r100",
      "r102",
      "r112",
      "r138",
      "r139",
      "r140",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r261",
      "r262",
      "r318",
      "r327"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements Being Evaluated/Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total costs and operating expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Costs and operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r92",
      "r94",
      "r97",
      "r100",
      "r102"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating leases, rent expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesFutureMinimumLeasePaymentsDetails",
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liabilities",
        "verboseLabel": "Non-current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets, net",
        "verboseLabel": "Operating lease right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://championsoncology.com/role/LeasesNarrativeDetails",
      "http://championsoncology.com/role/LeasesROUAssetsandLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r280",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate, percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r279",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Use of Estimates and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/OrganizationUseofEstimatesandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r24",
      "r296"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liability"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (loss)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other TOS revenue"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r125",
      "r278"
     ],
     "calculation": {
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r12",
      "r123",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r127",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r8",
      "r123"
     ],
     "calculation": {
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r125",
      "r296",
      "r321",
      "r325"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Summary of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r287",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related party transaction, amounts of transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r285",
      "r286",
      "r288",
      "r292",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r238",
      "r310",
      "r355"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r156",
      "r296",
      "r323",
      "r338",
      "r339"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r63",
      "r64",
      "r65",
      "r67",
      "r73",
      "r75",
      "r113",
      "r231",
      "r232",
      "r233",
      "r250",
      "r251",
      "r259",
      "r335",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r88",
      "r89",
      "r93",
      "r98",
      "r99",
      "r103",
      "r104",
      "r105",
      "r176",
      "r177",
      "r311"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Oncology services revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomersDetails",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r56",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r179",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RevenuefromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue arrangements by service contract period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Summary of accounts receivable, unbilled services, and advanced billings"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "verboseLabel": "Summary of antidilutive securities excluded from earnings per share calculations"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r225",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "verboseLabel": "Summary of allocation of share based compensation expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r289",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r191",
      "r193",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails",
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r198",
      "r213",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Summary of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Summary of valuation assumptions for stock options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "verboseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "verboseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsAllocationofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServicingAsset": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of servicing assets that are subsequently measured at fair value and servicing assets that are subsequently measured using the amortization method.",
        "label": "Servicing Asset",
        "terseLabel": "Servicing asset"
       }
      }
     },
     "localname": "ServicingAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServicingAssetAtAmortizedValue": {
     "auth_ref": [
      "r303",
      "r304",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized amount of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.",
        "label": "Servicing Asset at Amortized Cost",
        "terseLabel": "Carrying value of servicing asset"
       }
      }
     },
     "localname": "ServicingAssetAtAmortizedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Volatility Rate maximum (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Volatility rate minimum (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails",
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Life (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Shares granted, net of forfeitures (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r193",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Directors and Employees"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r191",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "verboseLabel": "Non- Employees"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration term of awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Vested and expected to vest (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "strike price as percent of market value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/ShareBasedPaymentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r55",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Unrecognized tax benefits anticipated during the next 12 months"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Capitalized software development costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/PropertyandEquipmentNarrativeDetails",
      "http://championsoncology.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r27",
      "r35",
      "r36",
      "r37",
      "r63",
      "r64",
      "r65",
      "r67",
      "r73",
      "r75",
      "r87",
      "r113",
      "r155",
      "r156",
      "r231",
      "r232",
      "r233",
      "r250",
      "r251",
      "r259",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r284",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r63",
      "r64",
      "r65",
      "r87",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Issuance of common stock on exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Issuance of common stock on exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r13",
      "r17",
      "r18",
      "r57",
      "r110",
      "r112",
      "r262",
      "r296"
     ],
     "calculation": {
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_TypeOfRevenueExtensibleList": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfRevenueExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled services"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/AccountsReceivableUnbilledServicesandDeferredRevenueSummaryofAccountsReceivableandUnbilledServicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r239",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r77",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r76",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://championsoncology.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118198657&loc=SL118198666-228104"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "50",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=6469459&loc=d3e122492-111745"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "50",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=6469459&loc=d3e122501-111745"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=6469459&loc=d3e122501-111745"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r356": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r357": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r358": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r359": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r360": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r361": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>58
<FILENAME>0001628280-22-024751-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-024751-xbrl.zip
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M,3QY N\"?P#\D=B7SC^A&F5[,_<%AM7&$:\VJE^P4I9Q\ 2DCJJ?8(.T LX
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M<:U5A?%!6^4C4J5-WNSL=NJ-X^/Z0PN\ 4BDF4X0)2P@GFJ/C!8*89]2IF4
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M?KP+NJ/GIB^EXWYTVO_CQP:0X)7UCZ X2SO@P&SMU#9JFSL;'\#-B09@(QY
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M9EQN;%/\8!EGA6'K13+]BAXN-=RO%-P_O/UQ#?>K#/=S6BT@O/'"2Y3;6 N
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M.AW"?,+%,QUDMQ=MRGD6ZGXK"@UP#YGTS2>>.*'QK#C19^<QM;IQT(G//+Z
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M_QY1@NNF8[(\VE-!@6H*\<)IC7-8+.LU#X+U[(]7>C) 6'_7K78Z6LKW+5;
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MJJO[5#Y#R\G%)9]N:L,W@^5*!V%8GAEJ'?=.J,QZJ8T#4<D('&M7+W[.C6?
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M?,>'6(\X-7L$[KV)C">WND+1JDYY'UY:3U)<>?IOCC<K/FK@[4DGZKF-*(2
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ML0DCSLZ' SB1Q[>-MZB$;!B@SY-$&T_0D>CMX'1M=XOA\;$@ZL>KPK#7:0V
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M5A2*W1\>H_Q1QMBC3#:[W81>>YN&Q*MUJX:R5</BU7@-.0A_+M07ZQHI=5&
MFR+D<D)!V\P5]PZ45ZV-4IY:8H0E7IA;-VVX4COYJ]?M]U<F^N*>.DH9??&)
M-S_OTX/=?7QT^,<)S"U&79P<??X"?[?;^Z?M;_N[__"CLR^MN4+EA\?DZ/*(
M[U]^.(%YXN9?,>KBSQ.X\AL\Z^+@\S\_TES._E[8F"&W*H#$A&S@.2BG)L2F
M>:"A@H E,]A F>,8GEU7.:D![94#&C'4..FHT3[G48?5A%)E,I$SPR6[=5>&
M&M"6"6AS2;?,",&I1<[Z6+E)&*2)\?"'=401C;4W:P5HKR&7X\WU'HZZK,>5
M93T40([)@:8SR>$@ETP20C,OK3-*>+TL(6L=XE_7 K#F2\V!R"4PY1X1Q2GB
ME )6!2F0 ; 2BGJ?$[VQ33;5TL)?5S&&]=5S,B%PFA@O\]A'0E%C<LJ%8#)(
MB0/6?%G21<W)2^/DN517E@EI+468"84XSPR27F.DLJ"]%+D))D1.SG.Q0IS\
M&HQ8;VX5(%$7U+@*G'*344*MBZD:W$HBI78V>,=,H$;PO!8S5@R<YHN',1VP
M-58C#0)CC&4+2,:X$@WB(U US9WV$9RD?'#YL+JDQNIR,O%>Y,G_3BF76::B
M@5:(8(31&8@@M9BQ<IP\*V;DF8K%C1C(%4G,8!E2.&,($P%ZH).@-X35X^37
M8,9XMR!\L[9=7 5%@L=^MH9I[BFW)%=.8ZTR*UB@1"E<"Q6K!46+BG3E 10>
M09&EF43<&8\D=1;Y7&1,TL"I81O;:A,V<84TGMIVL61.-IH+@C.IJ)'<4J:I
MEWGF0T9D]/YFM5"Q<IP\*U3(G)(LHQ0Q:BSBGCDDM17(.J4L2!+ Z'IC6V[F
M9)6J"[\&V\5.E>0:<Z^/>[Y?VRFN!J),&(Q!G=$<1(J@E5+<"NP"E11[2^N8
MDZ?'FOF8$RF]TX3FB*:$"!,4,B++$%$Y\3;/"!9F8SMC=(74E]H0L616367-
M8=N=B*G]F"BIK &9D3M&L-*ZCJ9X#E:=<VEXZCC%>6SWDB&N'0CXAEHD%3-9
M1AAC!%B5R%4JP_LJ+ U>]_U)M^T:K;-8DL6G2@VUK>$JM+'"2 6R 9.2I-P0
MH-M <0 48ESFMA8,GAYMYD,AHI\[PQD&P< "VN3"(V,\0S9VK!%>,$-E+ 7V
M8+2IC0FKRZJ.4*8-$QQ[QQ636C%KL7)$P >-22T8/ >KSG6$\]XHIQ@2.0=6
M=0XC2:)W46'E-99$>;QJK%H*!C-YGX0G1ERV@'^+>RRM7?9J3?(UR%]%\?'S
MA<G;M11V%;1G0EAI6 PBR;@QV+ ,!RJYU;DEC"XM):BV$R\']P_F/3XJ5XJ$
MW"&"F4(\DQ(I'7M:6<TR0SU(V3J5Q98/[P1:2VFKR\H6YYFW3@O"4WUFHS*F
M'-/1I:L$K>-(5H^5YPHO*]C 3&I$5"QO0OY_]MZT*8XD61?^*VG<,_?M-B.8
MC,B(S CU,9G1C:2CN0.TU*AUX L6*R2JA:E%"'[]ZQZ9M5>QJ8 "JF<,054N
ML;@_OH:[<$1S2HD' YGJ3'N3BJK'^2IJ<2\ZYO-OW^V^2;:M[3?KDEMNK#S7
M*XO__/($&L;8TH\71H/?&QY_ :3:'JN/MA#%U@"V- ";TZ(#:UX)D9(LV(QP
MRP*1NM DDUFF@BQRR]C&VWR3IK,=.GY=!Y%> K\O2PU9\_L*\OM,,,IR6PB5
MDT(7V)*'"V*82HE-?9Y3RPS/BXVW8A.$P&KP^U(<3G?O G%3WXL'<#@]Z2!?
M@T;XDLJB/FX"/6+(P(]Q<,)W#W:/4Z5LQCFJ"Z*HNG-KD!:$I@57EAL;4KU>
M\J4NN=,>3,V@2"'1;\2U)B8HX$B12L,5#2S+%E7#C T#AO@]^<_=JC0L[OCS
M>DJVW'(-5EM'7"6G,_S^OFQA0XF8E?$9A[D?OG1]S-S<QL*9"]3+*:URK3PN
M%8'^FD0@H8/3/#,DR" )#T$3&3)/0LB-2 LCLUQLO"TV<[6L8U-W8KCG4>]J
M#:"O#T ?W-6_!M#5!-#+20 U6!,0D[65"!3,[R(ERDM!O#8L:,%RDSL$4)HM
MJYG[HP#H9"_#V3KBJ]8:J3M327S%.J%<WTG$_SCWK:Y/+G0W^:_GH\;][@%:
M_#)A*'V>,/03317>71PKRUC@RI#,<3 #G96@A-&,A,)297PN*7;5%DQN HW.
MH$BDIKL0#67>>.==JE/&1:J5XSSG66&,L:*HTWYOT3-X331/1S39L:0@(7C@
MQ$J!YX4X%C$)!:$FSZ5U%J@FW7B;T6(^T6"G1FRA$3OE)$V@C],N=O+S+AD4
M.T\0.R)U(3UL8KO(<V^Q^4/C\J;62#6@;6+/PZIS]!#CAIV?0+1AR\B*4KI)
M VFENWEG#+Q7KY?KZ/HVL8XU8<XES)UOZ=[5R<7NV>[5[LXAW?]T[$$1<@;,
M2L?1Q15H020W!;$Y98!KH#47?N,M5VHYV+;TQNAK8E@2,;#][6. JU3FDA.6
M8[DE!M+.2,E(SFA(E1"Y9>(!,6L):N.=NV6NBOZY'?O,X3)55L?$6L6.#O7G
M:?7YYC"/%WY# 3_=PJ]J+^R2$TQ)&S2M._6-*5RO81U?_A2*[5WTD#5+W\C2
M8&@?IUB?QOE C,@=X8"N1&M*B>4<2,^!R5O53$LE70ZF+\O5LJ:%I7;Q.]@6
M,+X?</W5_L$)VP59'UA0*@<\EPYDO50%,5I[HG/8)UY0G:MLXVU!L[ET,:U@
M?O:S27X3AK(^!XCZ$3MJ O@_B<IHNZ8S05?7V#+OJJ'?,GWWM9'3WM6V..;6
M<*,-)51DG'!++=$&J$AYS[G*"ZRNN?&6K9JN>#\J>+4;_8X=Y[G*@?$H26GP
MA&NOB#+&$)=9KP'L39;!1K\0%?#A-+[XQ#>QB*^]10OUVQ7\K?4WG9S"7VBX
MZP[V(O83I[@F_;_/5BL^ %+"-@NZ=9EH:]O]%LQ_0&.Q+37HK<-.T\,U:YN>
MAF>Y!*ZLUP_^P/M*[-;6T@WL\ Q*<7+A&PW\%Y\W=\F13LLFV)7X5R7CJET
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M,D7C;,V5G(,BI$!)3AWL+#<R([I0DDBF548++8(PJYY=]C+9]X[V[O*\9X_
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MHH0MV?[KCT1RMIEL5&&LC2GT^JX;?;T(OA!#(EP I2!?8A5<$*P:6+C;C5>
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MLE 497%VLRRN J9K@?Q4 OE]>^S4P42('3\=EZ130G2!X7475%9I&B2HU*#
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MXBD[?7_0'J,T&'1=:G:[Y<;+R[U6&KKZ2(^ESK+4,$4\UP76%2J(24$ .E/
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M12?F=-1EQ 8\6]?X,Q.U-H!V\='1V8E.XB$= >?Z&):TF$(1,R0PT:-;)96
M#&\TEE'4[Y'#Z4]^(&=ZF/,5@+M$_9](1QDVZ$SJ@X6K-.07EL WU9*I2E?J
M-[%HW\"AU1YNQR!0/G =5-5IT!,1NP1CWA,H(1?)+P[+=73J8'*[#P-TW5_?
MW&9YGM1POV$785' 7HT=0ZL^A_5R#1P6L9^HQ:F?=_V;P2^_ 6Z#KG'YIFS%
M-\:;?JN?57LYT*R?ZB4:UZ3ZNK;X5;Z5<8%&?]UTNGYQ[0_8BOZ J?:HU7><
M;[&"+OPZW5K\W76/55N,RGL]]?KOA+C?4]=C78_UAK$R<:NGWM#:_9H.[A5^
MK52+[?G]DX?3PAZ2*SZO&34AK7//HQ0ZB-;8;J7+OYLH\S,QZ5MN:HI3WYBS
M4*-+[](Z>L47$2W&A:1QQQF_KI7#HEC1Z?>Y,@;7JWA/^J/KE7LE](>MQ!>N
MX6K9 ]42KY#%,I\(_HBG6*:B?K<0=D;;;QA.;CE2#]5:[T.X$Q4L>L;_W]ZS
M-[=M._E5,+GTINW0C$A)EN3<=<9QDM:_2^S43N;N_KJA2,A"0Y$J'W;<3W^[
M"_"A!VW1EBU21F?BVA((+O;] O!0]HAP86URG30^-3XU/C4^-3XWQV=MPS2A
M_Q[L5NQBV7DK?]YE&ZWWT>HLNL/:L/37CUIBL[G9ZAJ#7G^]CJC)OJSF<FNI
MD:575JHBNY[4K67 !E*ITS$[.R'2;D.4+7*(5DNM4DN68?>[6BTUG$I:+6D.
MN1-GMFU:+Y1!5%"0 9&-[,DJ^_-'8'H./4?M.9X@LLV:A9I4=SC)MQ07C4'9
M[HFC;:C]5BCK1V2*-K5R&F5/B;*FS*%)]V)0]MB:7-F]&\B]@$V.N=%0+!QC
MD65#JUN1ZN&B)7[]P.CT[9J._1V4?ZKP?%/W:#^)U+?,NBD43:/GII'1'1UJ
M(C6;2+UA[327IM$STZC;,0>[H]&6XN2VN$$7%=MT'^0%M3B[:0R'=9E.%RF>
MFTC6CFH4FD8U!*G;Z6DB-9Q('5,WBC2=1OW:(=\6:?3"DD&7=)X'ND!T2B)6
M#5Y8&L@R#D<Z#=1T(MDZ#=1X&AG]05T'2!/IN8G4TVF@IM-H4-M'U5F@A^+Z
M=Q[P2)TZ['@S$0@Z^TE<5^_;W%.OV^B.ACHT:C:1K(&I4PP-IY%M6'U-I(83
MR1KMJ*=7TZC&_HD&Y($:T_J\M3,B-) :2-UN_6CM]#6DNTGN:+I^80&$U3,Z
M]D@;U893J;.KW4R:2'5VCO9L'8PWG4H=RZS;]JB)]-S1N&WN4)"V5$QNNB]T
M&KCAC"]?"% W>ZU<7G7T<A=0[H4I'N2<+6#C\W?V[>R#[2.HV4+[LSWL_;([
M[+2HNO7$,M-$UC"M=K'&+K#TL&,>[N%+K;^U_MY02*U!OUU"JO7WL[&&>=@N
MUM@;_;WG73.'NVH1W#V#4)CYABZP^6W#RYCT%3EMNAY%PZIAK7=%SG+=NG]'
MW;I&*5 /?<:A]V0/,^4<A &_>_9U(Y]T<CU2$^O%CM3$:M%(3:P6C=3$:M%(
M3:P6C=3$:M%(3:P6C=3$:M%(3:P6C=3$:M%(3:P6C7Q /0FGS0:XCRV"#;,:
M&$UX)!)XF[M0%5LY M_&W#G;Y%[819A_HZMZZS^WM;46!;^:B\TOL[O,+K-;
MOG#X_L7((J<(/!XD1R/*/#_1XJJJF?::,[EKPFT-=P&X9?]TQX6"!KN9"G?*
M1,SFD9@Y$;R;>?"2:^[)/MGYU(EF3O9XDGJ"Q_"4$[/75M<<,(#6%V% >XM>
MXU;(_)-)&+%DRN%?Q#F; 9#3F'' A<?^E<)KNI;!\/IX>A3O\38 JGC.73S5
MP+\UX',F C?B3LSQ'/#7MMG/)X>Y\;Z;GTSV%5Z1#Q-!MC("L;0F^"0)"1[^
M R@0TR03%J81 [V2 + SN3]J,H'E!U<QPREIHY3'9_@-K@>'YSC$#WWN8$$$
MY_:=Z(I':Q&&<(W#9$K/B^#@6ER']#C_(7_/0(C-.KJABKW:JRRR,]]7E$8C
M%K.?RJ'RG/WZ$LQN>,39ZX%I+>J%OMG+/KA/R*V23H'7XU'#/YD2MRNB[E9"
MOBC\I,C<<(;[':GGWX!7N)Q@B]/Y'(9DFR$1NM0GL:>GE%"C',/T@%4I]N7)
MLF=S!7'I.)>Y1!<"O5W:VAO1]HE>OAEC?:QO *ZB,(Z9[-R))3?UAL !-*1O
MFYV?%OE'JG\_A)'J*47 S'S!JBM%4@';L^7Q/_,P%DC/HXC[=+*.:@J2G4SE
M!U5+4:=XQ!G'H9\FU8^4Q-\%>>?1CK24-5I$1_GG-._&F#M7_& ,<O;]P)D
ML$>.?^/<QJ_>+*QI!I9L"8?+RZ^V1XU4Y,2V90TCY9X8@GN%DH!O'._:"5S2
M6<CCF=<1<3>\"H@I3';L>?2;XZ.F([4@-V(38ZO9//!-(G(A-A$55#Q.!!^#
MP^$Z<S*L_]2:PWI*%^/9KQ1;8WJ;X<DL'-O^?LVQ[<_/_Z/]]F.J#LHOQ/:A
M_HQMCA;]&;L(<^[Q9YSY/ I_@".2P+?@" V[!F"!PI>^V5T.7Q8 /"  V1RP
M$7KDT<P<$12QS((/0K&(,UYR9W+-I4(?$5SS."&D@ I#7P4^C9PY3Q/A,B]*
M(=@1L1M>\^BV\&!VZL#LU(-A#\C4-#[N:$RP5YSI_'GE3.?]07<#U.,2MO,3
MM!^O&:V5#)!YN'&D9PU1%QJH# =F?UD7WJ/P%.@O/%]2/A;T>/VQH%J2M@UX
M]5FLVW U>LNNAET(U$I&M-?+10ASKR!#FP ' 40I.X)B%0D,1&#*Q2P)!.%I
MA&&. >/#"8]CBF;8A&,2^/2KH7RM.80]HG!$G%D8)>*?!4&-37:??)=7!^[)
MZ=?5P M&H8<#TQ-VT5&!X I&3R('UIFZ20IKNXK"&TRVRM",0J;@UGR(,:^M
M&=I:J6B,1CMQXBG[Z(<W>Y_RW1UWH!Q.0A^03.4-\/A3DFPE;W$6+LR<OT"Q
MH/R$ 4 <9P43%VDT01H=[2&1=B *ZR$O1$'F,L_SH_N.T:D2B=!UD2<,_LYX
M(CD]1=N(\7*.?R?'OZJ$COH4UI>S<T'V.%C.:X&&?WQ;.G5(VF_KD)Y[9*E4
M>L[WPUI*$KII%&$:H)1=6"F6PD+ H*)>P'RGZX8IZH"Y<TM[<LG0NVZ4P@M]
MX8R%+Y);-G9\]!?JU3';PIF-U0RGE-?1FF%7FD'D^%_6#(,^>>C2EQ]U!ML1
M]U5YKX2@5 55;UU, CIYC8+RAUEQ,TUXQ/C?J: 4JKF'S-188?XH E"A6IB?
M"?"S=79ZDM-@6:!K2.]BK2X3UJK97]MU=(.EE(#'LW1 <-<J1%PN!>0/484S
M=+^#NR"=$OZ#1ZZ ;Q1@MP^0_ 9ET^Z.-"-!IX& F)%K@WCZ  #-* 1"1?@E
M! G6TO?4H>@\XB G,ELD<S8Q9FT0-A08^(T.2B+N52P-5(L3^&!&82FU @58
MJT(7]$8DT\Q=19J"!80GYIC]OI+),1 C^)[/$VD[4=R^!0+_NDR(^!%:/C"Y
M$ $'SA6]A1)45%N;\60:>MAP)/*$^G?.^ +K.'&<SI10)5,G8<YD O9;]0I@
M HM3GBQ5836,Y^J$]LR9SF;'1S!&]\,8DUN4I*.5(515S\DW(<ZR--A:S&7S
MKP,I:VF0?8HJ 5<*(>0SA&$*(DQV"0PF)B!36'3-T:'>?R+3<)CB\U./&_@J
M>#;$"B0,P)9+HX@R(NYR<4V!!J@J7R43C75]%NQG@,1W7$DF>!L(K>2<))V%
M4?R+P:X=/U7I2<QZ4.,&*EJ/3WA$&MKYH5!9'@QS786A=R-\7V8ZI;)<*;S>
M.%'D2&)D1#?1>*> ;-F.%,-#J>\!';&]5-IYX**XQ#8RB%-8^O=_&]K6X"TV
MH2HE569HI98HCPMO1/_NGX*5EZ<X#@($Y(+(A7;B(_:Z6IV#_S* *7QXD"0&
M'[W\<((#R-#8MC1C=2S _A58+CBV:Y5-Q)<H#.!WR6X/, V/2RGO4%5_)(%)
M'&(90>I6BD#$KYR(NJ CPA8PCP!)X-ZB%BZC+5<\J%A<TL/ M"ZQ)V48-]?^
M!HO!43H+0=,!Q[XJZZ RU93,O,JD!$$C.<%O\6G*>I[D[STIO_=C_M[+LM4A
M149R=PH?,DNJ.A&OD;4_J\7H);8AVAW=AK@' 6W%CI_)Y."=S .RRRF'^"H/
M:1NQG/WTI/^;LZESS5D0XAZ6 Y6(93$1P./C!(O$L8 W.Q$+Q[ $F8A6S?7R
M9VF2!%R:V'%5LGKA$>DP9 $E^.[D<THW-\*'D\QAY9ZQJ,%% %H69HOXQ%>*
M7VK\W /-'":L-96RY5%)^6?Z;AET+Z1W7Z4.NF,<7==;5,B1=X! WA(:'NS/
M-*^:*[S_?"7L4;\W@N^=OM7K\5Y_V'$FO=[(X9.AU1F.^_]WV'NU\PY=LH]=
MD_V9 F% D5 _ OH \(&?_?T^#W+ :1V'::+ZPMB%B+\_>ZOQGJD'<'$H?@7/
M"(,J;*2803#$HU(<)STBD.55&;G;=]V0$0<-8<2>B>Y=$H6^RO-$H<L]Y+M&
M-K3O&)@/"P%Q(:0;XU#;^&T!?II@)K=(2N4Q/I:'P$P*584%Z>8Q[HL7\51E
MJ,#PPC^&3]B=MZ5\DENFXCRG(@VTWC(G9G'J3AFXWS-\N<?!#DNS?9&"(K&Z
MSH'5_YG_PE) C\Q=7W(WC60BZL,/=^H$5QS3(<@^UJ@+TG>>1J55&$4"@GP)
M5\QS=D/7X&0J^ 1F@EG)3H!_*5QX%6W7S;\O8K3L>_)D(GXM^ W&HIC&DJS,
M5>Q)*3F8,>!QWMMR/V80)2JGQ6G#L(1<%M*I=UYFWRD2_!M\$4"=?ZO4K,E.
M \!AC%$JYO\+H/#/S0 PP2[F:4F5"/LG=\""VZKG#'3K(&;'TMXTO&$WW/<5
M+ H_TN$BIPV86Y42((PE\)TX#&3E/U9=@92X= '[UUE.$&>+9-2.$(#3^)=$
M<6PH/LP!#[@+:)>E29&G7+TBSRK "?PK]:ZR2F4)3S+]Z$O?<"KF;,R3&\YE
M9#\&>DX$<=L2.*N45%F(;".IF,U]@@Y?$H#,5E)@%TFQIFBA=]QU4MF!*B@/
M,N742^)#<)%(FF#K*+!90%>/*E:XYF4?OO Z9LXMN>USRNU2F.+Q!)/E,Q$7
M>1Z3'?MQ2(VHQ%.JAP;YG2]8J$6Q!G::I-05*B4TRYH28V:-;A$XF%)\<H(C
M5&-.]X4!S!YP)^;2Q\72I5[+B@^RB!Y3)RY-)*7A"HMXJJW6%R0SA:[+T[B+
M3(EO1@0 M"B,=7VQQK-/27E-G9C2[G%\ETK>G)6D9EZHPIKLG4.]S8'2C_0Z
M:7;")3,D,WJ9(GZ@V3&DW0%857J07KNA:9$;0S,DK%M/5MI9JX]]W/5&NA(;
MMZ6F=)*E9&VA9\>\B-.SO*A$IC(F-YPJ!)0Y2,<@W9L;>0.!=V94N3:D@G?Q
M^@;/D.N-*3=0JEX@)O(D  J) B@!WLME%YM@Q$04X):@P ER2$["&6H/6''A
M(Z79!A@Z:8-^ [@<UTUGJ4QEJ.Z761I F*2*Y5MG$$(,;@N<1P)>8I#%P[(4
M+97.7W%%3/JMG%E79"N8R&3L8QIA^<PHV]4UC+=1!76MN[*0PD8-'>,K)HZ(
M<$>/H'H:NA1 'EGKPFP^:,%U=:C5_(U1D>PA,N0]QB5_"U>@/(FL3R+C# 4;
M,=MJ.?B;>6FNJ_ZN+1.WM]MI1XT4A24\S52UB@W9.:KJ0@0N,E6MTSF/[IL
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MG!_%43. (\@OYB__.'I_F]+^</(J]4]?S;_SR@\&2/'T"9,?9_#KRW'_]&P
M%^]]&4%>2OT%RX4H5<CYM_*T5VO3] 4)&<7S  3?A6$!>$4:[WKZ^C1?/HLD
MR/Y\,*E(\>UG5Z6W.?7]F@*^]>@*U$X?1$[A-,"H)JDWGGN-S@LB%RF,7_SI
M&;(V;G"I'30G/_X:F]-74QK_^'CPQYOWG]^^>7WX\<W;C\?3%\>'']Z_.< W
MCS_CS]_??OQ\?/CN]3\./O[][?'[C\>?#U__YS\./[QY>W3\]O_\\?[S_WV8
MMS@.(U)69&IF:\"_U1GX&O.(LOZP7Q:N#_CK?/3"XY;$ -\G,$R07K[HIU]?
M]C,WR5/F-/5"4NF<D<E2KD%)G9*WO3HD%'E<2&30Q!L4#<K"WEPB<> ##*;O
M]L['Y,3[L][Q!/?8LMVB".$]OASW9(X\@0;B7-)$.MPUG6:2>,^T+:\D-[=Q
M/+Z8%]F/PQ3)\R%>%1"\@L%D?/'.%!932"RG8J;GQ_/U?AC1?!C#&YC]__WP
M>-+$/[\T@X2FR-M_G?<G/XZ:P>!=,_KF1ZF'.K%6H5D0C4U$\D2)E=[@2J9-
M0(N @765F5Z1Q)L2N<+^P>A"-O-5Z)'+5+&MJF)CTFQ.)3-8('\O7S0C?-RO
M+^FZ"'K=G)XV,Q*/O_@1C _/)\7**H9KSW.:E5*<^$0SD=8""082_I!:4)>E
M5K(R7.ZC9_/8Z%2934>:N(T2MBY*;G/=L]8'K4-"_X$Z(@.Z$UYP3:+GT2EF
M!4A???U<I&*_$;&FU&_C@*^+@X/T_\['D[)8CC\W!RE-A>T'GWP_O1^^]F?]
MB1],P5N\HX2(/D/;<^IT'0$R,.Y/X!A&7_L1/L&HWZ0CB,W)3&7_Y0?GT$M>
M6.UX)MY"P)77,>*,%L10<)Y9KK*IO4%US=-^8W2G$'$;\:+*RO=^/#Z'].9\
MA$OQC,SY"CWY J->D"XXF1SQ1N+:+#,CP2M/(ACI/!@?+>]B);R7JOU&766M
MW,:-[ @W4TS/",R"<F#"$"$,$FBB)B%PA50FZJSVC/J\&=A<$?53HN:1.KD-
M&K4N:#["!.71G,*'9CSN&<:8M-X3*RBN?)JC]<<D$$6]<T%0Y2*K#) ;!.PW
M&!XOZ]N*UYUZ8=P$J2@N7=HFAK:_<L2QC*S:Q&D*T0A'M^:%5?$E*(U>)6I(
M1F>&2(:[O7-&D*2##ART\[$VAP_Y$FO$F#[[,(">=30&:G$ID< 1FQEY"M(2
MQ2)7%")X6=N2O4E!Q>E[+2W1>?QD#3'>Y?B^F 69?XF#!NW/7U].1N=P]68S
MG,#WR=O!=,!?7X[AI+RHAH09L(K1VPR+A7SPO3_N10,^4^N)B Z7&FHM<38$
M$I@3*"GN<"YT!8R["*J(DWM21??@YA&*7H:9M07>0>QD@:8WTZVP%5&]A>15
M)33<25#-S7Y9\NT>#*RON*8KJ6\,$D!UUM%S0G-"XC)ZNB'Y1*+06@8PUO/P
M=*%P(Z^Y?22L(NP.$'#-P/I]:A3W6-::*S3PM%>"R$@U\4%ZDI)4:/.!TN:.
MO&HM*^_W:SG735K\%92S/(S^",EVD&%9$A2;$Z>%E"XD3D"@]R(E& 2UT21[
M<-)(H9*.U0.>]Q"T#Q"H)_$.9OX13) _2&_]:(C>U'A.5: 0T,Z)2(9&DQD4
M+FX6C><HJ&3@.1,F5<;!W93L P JR'AI\N3?7RT(!MV>/]<J53D^/SWUHQ]-
M/NZ?#/NY'_UP<A!C<SZ<E!A5,^C'/HR/X"L,S^%:?/Q-X7(P?DR1RKI#UBI/
MJ<KZ0F&*E\PXIX-PQL@4K+,R6)N<\& DC;2W[N#KK@/SYQ:TSV*1N1F=EOK&
MPS#HGTQS)&^_GT&<0/K</\6O'.9C?'><?9R+>^YNBY@!BM?D+8);ZIB(C4X2
M:<!1&1P+H;;I4(_Z]=?3-2F9!8%93P2-\("24(5,I*<)Y8FB3-FBJ0E9>5/;
M_*Y%^^;7["VA]_9"OP7E=V CKLW'+(9",VZ6!F7GN2W5W<A%4-Z1',$(;SFC
MNG9-6QW*-Q6KW!?8KJ[N;<=&QZ-)[].H2>=Q<CB:9_RGKKUWB3NOT"<3S.+,
M<T"\P3E(LV>1J6"2;Y4]QP&NX15_N\+JLK&W%?G<AOJ;BFJHZ!5=HV=\,$QS
MBL9S'Z -4:L$2=MAY#8AFPV.UM'1;857$O#&M!^UABBU)Y8!KJM1H+LF-"?:
M!V5C$,FT*Y#8+:TOB8-N4.FKR+6BLHL7VGL'WU[CQC+"=>S"*]?*J.!,)J;D
M":53DEA=TH:XKP;G?5;@'O)GESQ[<W9Q18DW]<15T5(M#![YX<D,E"FF'%Q$
M#FQ$<YDQ-)=%$$0K-(JLUERD5@G[!Z;FY8 _Z4[].(%7K/N])&(.OC9D5-R0
MKPV]^2WXD<)?5-\:DJN\TUXG1V:IJ5%(#L1 I$J&."XD42(K*KS,SK<*=FQ;
M@??LIG7UMXK *NOM=_^]?WI^.B=$".549HH@&PH)X9$$:25AT<5D67(ZM$H4
M/*"Y&X-N=A]]M-B;&C*KO&?^CJ*Z(H3BTL^4H02)QXT@TTA\@D1$8B$RR=&>
M:U44]I#RK@_Z!)7W:)EUDJ];TP0XGOC1Y(V?S-8B+KPR0E " JT R80@%DU\
MXFDP @"D9W;70G0W./@)3;$=@,+2DRT[EX[L+=1);R0AV6.[DI)<9'\A*>D\
M$UG$X)UT4FH6M,O9L&AU]-G+N&Y2$H=_3DL^IR6?TY)/.[_SG);<-H2?TY+/
M:<GGM.1S6O(Y+?F<EGQ.2SZG)9_3DL]IR>>TY'-:\CDM^9R6?$Y+/J<EG].2
MSVG)]=.2];,W<].@<']IHI6KY5^?CR?-*8S&:YP::_WL6KF8QS&SD'))SG&5
M*,BLI#0Z.\6DQHD7DM>>>==K/<IZP=0W_;$_.1G!S#H[S/-AKT)W@7-5B"2!
M RX'6A9SW$N2%,W*!*ZAG?6Z0ICT(9HJ!9#?71/M/Z])]NWW.#@O=PH=C,>
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M(4 'EZ?7(O[GA//&U=Y%S>%C&?ETCJ8TOOEI5%J[9_SKTV9X/&GBG\A8+$>
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M6&-9.=;+J9"2:=JJ:O=I=%%<2>Q+NRBN(K.EYM F:J0NKX.?)IQFX<F#B(8
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MDCA)GO]K]2?)LR2)$0,PA1(@2# @B<0@3A0C:9YRF<17MW\J!($\Y@G "8<
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M40\UN*7T?O:Q6M[+:O7T48^ZNEZ(-__KH;PWL_W+TQ<]XO6WLIZE<2(D)AQ
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M+W9[X9MB<8.7,->WMU53._/=8E65B[KD?Z7S![G95V5YHJF":IHP)0)0EIF
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MJZQ-\8"%V+A>2_.KG4[2SPH,;!PXLVHWFZ,/=-[VPI(Q%9 KO5265+M+.(8
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M_TV^"(30WW\[^ZU?V9.V'GE-:\G_>+M\_%G?T[ZA^B_;%_-PI%%>QI,&K%_
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M9:5DN3(^^+O%1UF52_&L4W='P_)C57(Y2S,,*6<%B+FD #'3&\PT6E5*%KA
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M7NMS1JU?Y[/7C1ROU46XWCRLZA5=B')Q^RRR=5._8:=\PQ=9W26S1,2"\XR
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MMH'/WA H':QVRC?XFRQOOZZDN-8O,+V5ZS.CCU7)Y2PG.4^X3 %/S19S7 B
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M^V8G<U2OS F&Y\Z6V\UNI&2ZW;]I8GS?EG-9O=++]]ME]33C&8LSE3*0Q9@
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MZ*V"AKL&(Q?5& S189V-X4,-C7N[%D(_M?4K_=>;ZLOR]\4,(TXD3U. $"L
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M*6-V%13&ASZUJ>8>9%EA$SQ5,*=2BK7[-0A\XA2T<Z=_YM16G'5W[G3R[MR
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MB(%:K:M,]V5IC.K7CA4G@W6WY3@S@4X<<9@96$EI_PI4YH+;HU>@M-AS<:6
M?>*SUE((F..77@I(]L5*3"';&S;JW"_UG%D^TA^?5XLY?SU8K*!<(480E"32
MBQ66)I!DG$"1Q$E28)F1S,J'N:^AJ:E^A=-LS;F&/+52::?(/@@*K*A[;FY
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MLDJ$GA>(',>Y@ADU1[^(%9!EJ83Z>932B.92(K>CW_Y&IW?V>[C5+7S4S[C
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MOY6@I& "=9.']=E;EU%V1/WGJ*H\K"N\%5D>V/S  8]_D^)E(>N:SEUX-VV
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M,+ECT.$9,T8JY6,6@#)3]*+0T@:R!DI KZR2.IOF3ZC?1]#(UT?-X=-.^AU
MZ>9(PS,N(L-(IW8BL@W%IZAC'4%O2#Y,<0R"2]N^_^LV2L:M;&X/G@;R[@ U
M%\<X!<JXJ2V<J))$1H/@?9VL2L<U>,,5A,"-JU\IT?I2YT<J.IE4U- AWD_
M'4#DU3PMZRL7S_'TOZ_F/P:<[Q>SV<O%\L^PS!.MC'.UB3_9^F2+(./I5+!
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ML^<-S*X(>\1:[N8(&U0+G29IZN-U56!_GZX_/SM9K1?'N#QG\?M$2XJ7I"C
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M@+,>.&T(CH59%5M?'8UJY#=YRS<G]1VRFJD\JZ3X<!)7TSP-RYH=RC:(DK"
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M9A:ME<R!$;).A(X"8I:1X!DE]]Q+;%ZNTX%QFR06#"IMP=7N/.6);8>N@*;
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M<%Y6E_1M^1!F%XW%5LA@'<^0.$-0W 1PR!1XXY1+%'$)T7I\X@]$C%L;-1R
M#I-V!W!I$P*]OJ@QDX6YD((%%B0=^;DV]I14("M)81#]4/+6 WD:L]!+;TLO
MP>F8".E@@YQQAOG>'/$D(^:4&0.K; (EO(;(H@2TBDFCHJ=@KG7CPE:4C1N!
MC J>FST,[37YQ&I4WX3E:9C6]%;GAT\=\M;F?A;ZN)5)W',44H&1MEY<NCH
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M#)?H,#A74O.!=C>)^%E:2G<"P\U!=P=IIC=HG35-B<1$8,&"CS7>YD*#5[P
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M,S$R,#(R,3 M<65X,S$R+FAT;>U::V_;.!;]OK^"XV [">!WG$>=-$":!\9
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M#PY'[UNL?4?DW8N0!?;97#\N\MA9V*,GK>6U./>U)]"7?P%02P$"% ,4
M" ""ABQ5#5L(HU0- 0 RCPL $0              @ $     8W-B<BTR,#(R
M,#<S,2YH=&U02P$"% ,4    " ""ABQ56!U3070,  "X>0  $0
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M,3$N:'1M4$L! A0#%     @ @H8L5<-['K_?!P  ;RH  !H
M ( !YSP" &-S8G)Q,3<S,3(P,C(Q,"UQ97@S,3(N:'1M4$L! A0#%     @
M@H8L59- 8!0H!0  W!X  !H              ( !_D0" &-S8G)Q,3<S,3(P
E,C(Q,"UQ97@S,C$N:'1M4$L%!@     )  D 8@(  %Y* @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
